GO:0048407 platelet-derived growth factor binding
|
5
|
7.54e-04
|
-8.70e-01
|
3.48e-02
|
GO:0019773 proteasome core complex, alpha-subunit complex
|
7
|
1.36e-04
|
8.33e-01
|
1.12e-02
|
GO:0043534 blood vessel endothelial cell migration
|
6
|
5.60e-04
|
-8.13e-01
|
3.07e-02
|
GO:0071162 CMG complex
|
10
|
1.40e-05
|
-7.93e-01
|
1.91e-03
|
GO:0097490 sympathetic neuron projection extension
|
5
|
2.26e-03
|
-7.89e-01
|
7.28e-02
|
GO:0004185 serine-type carboxypeptidase activity
|
5
|
2.35e-03
|
7.86e-01
|
7.43e-02
|
GO:0000796 condensin complex
|
8
|
1.56e-04
|
-7.72e-01
|
1.22e-02
|
GO:1905821 positive regulation of chromosome condensation
|
8
|
1.56e-04
|
-7.72e-01
|
1.22e-02
|
GO:0045920 negative regulation of exocytosis
|
5
|
3.11e-03
|
7.64e-01
|
9.02e-02
|
GO:0005839 proteasome core complex
|
18
|
3.77e-08
|
7.49e-01
|
2.21e-05
|
GO:0098890 extrinsic component of postsynaptic membrane
|
5
|
3.79e-03
|
-7.48e-01
|
1.04e-01
|
GO:1903895 negative regulation of IRE1-mediated unfolded protein response
|
5
|
3.80e-03
|
7.47e-01
|
1.04e-01
|
GO:0030174 regulation of DNA-templated DNA replication initiation
|
11
|
2.08e-05
|
-7.41e-01
|
2.66e-03
|
GO:1902425 positive regulation of attachment of mitotic spindle microtubules to kinetochore
|
8
|
3.02e-04
|
-7.38e-01
|
2.01e-02
|
GO:0002476 antigen processing and presentation of endogenous peptide antigen via MHC class Ib
|
7
|
7.51e-04
|
7.36e-01
|
3.48e-02
|
GO:0002486 antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent
|
7
|
7.51e-04
|
7.36e-01
|
3.48e-02
|
GO:0035036 sperm-egg recognition
|
5
|
4.41e-03
|
7.35e-01
|
1.13e-01
|
GO:1902254 negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator
|
6
|
1.91e-03
|
7.32e-01
|
6.55e-02
|
GO:0050790 regulation of catalytic activity
|
5
|
4.72e-03
|
-7.30e-01
|
1.15e-01
|
GO:0004300 enoyl-CoA hydratase activity
|
7
|
1.07e-03
|
7.14e-01
|
4.66e-02
|
GO:0051984 positive regulation of chromosome segregation
|
13
|
1.04e-05
|
-7.06e-01
|
1.56e-03
|
GO:0007342 fusion of sperm to egg plasma membrane involved in single fertilization
|
7
|
1.25e-03
|
7.04e-01
|
5.22e-02
|
GO:0010032 meiotic chromosome condensation
|
6
|
2.90e-03
|
-7.02e-01
|
8.77e-02
|
GO:0042555 MCM complex
|
11
|
5.82e-05
|
-7.00e-01
|
6.03e-03
|
GO:0000727 double-strand break repair via break-induced replication
|
11
|
5.86e-05
|
-7.00e-01
|
6.03e-03
|
GO:0090235 regulation of metaphase plate congression
|
5
|
6.78e-03
|
-6.99e-01
|
1.45e-01
|
GO:0016126 sterol biosynthetic process
|
8
|
6.25e-04
|
-6.98e-01
|
3.27e-02
|
GO:0019774 proteasome core complex, beta-subunit complex
|
10
|
1.42e-04
|
6.95e-01
|
1.16e-02
|
GO:0000940 outer kinetochore
|
17
|
7.18e-07
|
-6.94e-01
|
2.12e-04
|
GO:0051450 myoblast proliferation
|
8
|
7.25e-04
|
-6.90e-01
|
3.48e-02
|
GO:1902975 mitotic DNA replication initiation
|
5
|
7.70e-03
|
-6.88e-01
|
1.55e-01
|
GO:0046935 1-phosphatidylinositol-3-kinase regulator activity
|
5
|
8.17e-03
|
-6.83e-01
|
1.58e-01
|
GO:0002260 lymphocyte homeostasis
|
5
|
8.21e-03
|
-6.83e-01
|
1.58e-01
|
GO:0032133 chromosome passenger complex
|
6
|
3.81e-03
|
-6.82e-01
|
1.04e-01
|
GO:0003279 cardiac septum development
|
7
|
2.19e-03
|
-6.69e-01
|
7.22e-02
|
GO:0098534 centriole assembly
|
5
|
9.70e-03
|
-6.68e-01
|
1.75e-01
|
GO:0006516 glycoprotein catabolic process
|
7
|
2.26e-03
|
6.67e-01
|
7.28e-02
|
GO:0005883 neurofilament
|
5
|
9.85e-03
|
-6.67e-01
|
1.75e-01
|
GO:0051983 regulation of chromosome segregation
|
10
|
2.82e-04
|
-6.63e-01
|
1.92e-02
|
GO:0051764 actin crosslink formation
|
12
|
7.74e-05
|
-6.59e-01
|
7.57e-03
|
GO:0032201 telomere maintenance via semi-conservative replication
|
5
|
1.10e-02
|
-6.56e-01
|
1.87e-01
|
GO:0032020 ISG15-protein conjugation
|
6
|
5.42e-03
|
6.56e-01
|
1.25e-01
|
GO:0042612 MHC class I protein complex
|
9
|
6.80e-04
|
6.54e-01
|
3.44e-02
|
GO:0031536 positive regulation of exit from mitosis
|
5
|
1.15e-02
|
-6.52e-01
|
1.90e-01
|
GO:0045059 positive thymic T cell selection
|
7
|
2.97e-03
|
-6.48e-01
|
8.89e-02
|
GO:0045569 TRAIL binding
|
5
|
1.21e-02
|
6.48e-01
|
1.95e-01
|
GO:0017116 single-stranded DNA helicase activity
|
19
|
1.24e-06
|
-6.43e-01
|
3.03e-04
|
GO:0051383 kinetochore organization
|
5
|
1.29e-02
|
-6.42e-01
|
2.02e-01
|
GO:0000127 transcription factor TFIIIC complex
|
6
|
6.46e-03
|
-6.42e-01
|
1.41e-01
|
GO:0042791 5S class rRNA transcription by RNA polymerase III
|
6
|
6.46e-03
|
-6.42e-01
|
1.41e-01
|
GO:0010369 chromocenter
|
10
|
4.61e-04
|
-6.40e-01
|
2.81e-02
|
GO:0035524 proline transmembrane transport
|
5
|
1.33e-02
|
-6.39e-01
|
2.03e-01
|
GO:0007076 mitotic chromosome condensation
|
17
|
5.01e-06
|
-6.39e-01
|
9.18e-04
|
GO:0003847 1-alkyl-2-acetylglycerophosphocholine esterase activity
|
5
|
1.37e-02
|
-6.37e-01
|
2.04e-01
|
GO:0043196 varicosity
|
6
|
6.99e-03
|
-6.36e-01
|
1.46e-01
|
GO:0007168 receptor guanylyl cyclase signaling pathway
|
5
|
1.38e-02
|
6.36e-01
|
2.04e-01
|
GO:0033010 paranodal junction
|
5
|
1.38e-02
|
-6.36e-01
|
2.04e-01
|
GO:0060044 negative regulation of cardiac muscle cell proliferation
|
5
|
1.41e-02
|
6.34e-01
|
2.07e-01
|
GO:1903724 positive regulation of centriole elongation
|
5
|
1.42e-02
|
6.33e-01
|
2.07e-01
|
GO:0010273 detoxification of copper ion
|
10
|
5.24e-04
|
6.33e-01
|
3.01e-02
|
GO:0042270 protection from natural killer cell mediated cytotoxicity
|
5
|
1.45e-02
|
6.32e-01
|
2.07e-01
|
GO:0098871 postsynaptic actin cytoskeleton
|
6
|
7.43e-03
|
-6.31e-01
|
1.54e-01
|
GO:1990023 mitotic spindle midzone
|
10
|
5.55e-04
|
-6.31e-01
|
3.07e-02
|
GO:0008186 ATP-dependent activity, acting on RNA
|
7
|
3.87e-03
|
-6.30e-01
|
1.05e-01
|
GO:0051256 mitotic spindle midzone assembly
|
10
|
5.58e-04
|
-6.30e-01
|
3.07e-02
|
GO:1903490 positive regulation of mitotic cytokinesis
|
6
|
7.66e-03
|
-6.29e-01
|
1.55e-01
|
GO:0140439 protein-cysteine S-stearoyltransferase activity
|
6
|
7.79e-03
|
6.27e-01
|
1.55e-01
|
GO:0008061 chitin binding
|
6
|
7.91e-03
|
6.26e-01
|
1.56e-01
|
GO:0070345 negative regulation of fat cell proliferation
|
5
|
1.54e-02
|
-6.26e-01
|
2.16e-01
|
GO:2000270 negative regulation of fibroblast apoptotic process
|
5
|
1.60e-02
|
-6.22e-01
|
2.18e-01
|
GO:0030263 apoptotic chromosome condensation
|
5
|
1.62e-02
|
-6.21e-01
|
2.18e-01
|
GO:1905832 positive regulation of spindle assembly
|
7
|
4.51e-03
|
-6.20e-01
|
1.13e-01
|
GO:1903059 regulation of protein lipidation
|
5
|
1.68e-02
|
6.18e-01
|
2.20e-01
|
GO:0031048 regulatory ncRNA-mediated heterochromatin formation
|
7
|
4.66e-03
|
-6.18e-01
|
1.15e-01
|
GO:1905820 positive regulation of chromosome separation
|
10
|
7.43e-04
|
-6.16e-01
|
3.48e-02
|
GO:0019705 protein-cysteine S-myristoyltransferase activity
|
5
|
1.77e-02
|
6.12e-01
|
2.23e-01
|
GO:0089720 caspase binding
|
7
|
5.08e-03
|
6.12e-01
|
1.21e-01
|
GO:0031390 Ctf18 RFC-like complex
|
7
|
5.14e-03
|
-6.11e-01
|
1.22e-01
|
GO:0031726 CCR1 chemokine receptor binding
|
6
|
9.86e-03
|
-6.08e-01
|
1.75e-01
|
GO:1905908 positive regulation of amyloid fibril formation
|
5
|
1.92e-02
|
6.05e-01
|
2.28e-01
|
GO:0071374 cellular response to parathyroid hormone stimulus
|
6
|
1.05e-02
|
-6.03e-01
|
1.84e-01
|
GO:0030992 intraciliary transport particle B
|
14
|
9.64e-05
|
6.02e-01
|
8.57e-03
|
GO:0010587 miRNA catabolic process
|
6
|
1.09e-02
|
-6.00e-01
|
1.86e-01
|
GO:0006268 DNA unwinding involved in DNA replication
|
19
|
5.96e-06
|
-6.00e-01
|
1.03e-03
|
GO:0030594 neurotransmitter receptor activity
|
5
|
2.06e-02
|
-5.98e-01
|
2.36e-01
|
GO:0034374 low-density lipoprotein particle remodeling
|
5
|
2.07e-02
|
5.97e-01
|
2.37e-01
|
GO:0021537 telencephalon development
|
6
|
1.15e-02
|
5.95e-01
|
1.90e-01
|
GO:0003953 NAD+ nucleosidase activity
|
6
|
1.17e-02
|
5.94e-01
|
1.92e-01
|
GO:0010040 response to iron(II) ion
|
5
|
2.20e-02
|
5.92e-01
|
2.41e-01
|
GO:0055105 ubiquitin-protein transferase inhibitor activity
|
5
|
2.22e-02
|
-5.91e-01
|
2.41e-01
|
GO:0008622 epsilon DNA polymerase complex
|
5
|
2.25e-02
|
-5.89e-01
|
2.43e-01
|
GO:1901652 response to peptide
|
5
|
2.26e-02
|
-5.89e-01
|
2.43e-01
|
GO:0004568 chitinase activity
|
5
|
2.27e-02
|
5.89e-01
|
2.43e-01
|
GO:0006032 chitin catabolic process
|
5
|
2.27e-02
|
5.89e-01
|
2.43e-01
|
GO:0097443 sorting endosome
|
5
|
2.29e-02
|
-5.87e-01
|
2.45e-01
|
GO:0043372 positive regulation of CD4-positive, alpha-beta T cell differentiation
|
6
|
1.31e-02
|
-5.85e-01
|
2.03e-01
|
GO:0048280 vesicle fusion with Golgi apparatus
|
8
|
4.51e-03
|
5.80e-01
|
1.13e-01
|
GO:0033391 chromatoid body
|
6
|
1.41e-02
|
-5.79e-01
|
2.07e-01
|
GO:0006271 DNA strand elongation involved in DNA replication
|
8
|
4.63e-03
|
-5.78e-01
|
1.15e-01
|
GO:0098971 anterograde dendritic transport of neurotransmitter receptor complex
|
5
|
2.53e-02
|
5.78e-01
|
2.58e-01
|
GO:0045322 unmethylated CpG binding
|
9
|
2.71e-03
|
-5.77e-01
|
8.32e-02
|
GO:0071139 resolution of DNA recombination intermediates
|
5
|
2.56e-02
|
-5.76e-01
|
2.60e-01
|
GO:0007379 segment specification
|
5
|
2.59e-02
|
-5.75e-01
|
2.60e-01
|
GO:0070106 interleukin-27-mediated signaling pathway
|
8
|
5.18e-03
|
5.71e-01
|
1.22e-01
|
GO:0006000 fructose metabolic process
|
6
|
1.57e-02
|
-5.69e-01
|
2.17e-01
|
GO:0001561 fatty acid alpha-oxidation
|
5
|
2.77e-02
|
5.69e-01
|
2.66e-01
|
GO:0030547 signaling receptor inhibitor activity
|
5
|
2.81e-02
|
5.67e-01
|
2.68e-01
|
GO:0048513 animal organ development
|
7
|
9.39e-03
|
-5.67e-01
|
1.72e-01
|
GO:0071787 endoplasmic reticulum tubular network formation
|
6
|
1.62e-02
|
5.67e-01
|
2.18e-01
|
GO:0043138 3’-5’ DNA helicase activity
|
12
|
6.91e-04
|
-5.66e-01
|
3.44e-02
|
GO:2000343 positive regulation of chemokine (C-X-C motif) ligand 2 production
|
10
|
1.95e-03
|
-5.66e-01
|
6.61e-02
|
GO:1904395 positive regulation of skeletal muscle acetylcholine-gated channel clustering
|
5
|
2.86e-02
|
-5.65e-01
|
2.70e-01
|
GO:0141199 GDP-mannose biosynthetic process from glucose
|
5
|
2.86e-02
|
-5.65e-01
|
2.70e-01
|
GO:0051223 regulation of protein transport
|
6
|
1.68e-02
|
5.64e-01
|
2.20e-01
|
GO:0031956 medium-chain fatty acid-CoA ligase activity
|
5
|
2.90e-02
|
5.64e-01
|
2.71e-01
|
GO:0140367 antibacterial innate immune response
|
6
|
1.72e-02
|
-5.61e-01
|
2.20e-01
|
GO:2000144 positive regulation of DNA-templated transcription initiation
|
6
|
1.75e-02
|
-5.60e-01
|
2.23e-01
|
GO:0003688 DNA replication origin binding
|
14
|
2.92e-04
|
-5.59e-01
|
1.97e-02
|
GO:0032494 response to peptidoglycan
|
5
|
3.04e-02
|
-5.59e-01
|
2.78e-01
|
GO:0002842 positive regulation of T cell mediated immune response to tumor cell
|
6
|
1.78e-02
|
-5.58e-01
|
2.24e-01
|
GO:0035735 intraciliary transport involved in cilium assembly
|
6
|
1.80e-02
|
5.58e-01
|
2.25e-01
|
GO:0006384 transcription initiation at RNA polymerase III promoter
|
7
|
1.09e-02
|
-5.56e-01
|
1.86e-01
|
GO:1903575 cornified envelope assembly
|
5
|
3.14e-02
|
-5.56e-01
|
2.82e-01
|
GO:0044613 nuclear pore central transport channel
|
6
|
1.86e-02
|
-5.55e-01
|
2.27e-01
|
GO:0009117 nucleotide metabolic process
|
6
|
1.88e-02
|
5.54e-01
|
2.27e-01
|
GO:0000070 mitotic sister chromatid segregation
|
30
|
1.53e-07
|
-5.54e-01
|
6.41e-05
|
GO:0035330 regulation of hippo signaling
|
6
|
1.90e-02
|
-5.53e-01
|
2.28e-01
|
GO:0018812 3-hydroxyacyl-CoA dehydratase activity
|
7
|
1.13e-02
|
5.53e-01
|
1.89e-01
|
GO:1990726 Lsm1-7-Pat1 complex
|
5
|
3.40e-02
|
-5.48e-01
|
2.91e-01
|
GO:0017038 protein import
|
5
|
3.44e-02
|
5.46e-01
|
2.91e-01
|
GO:0008541 proteasome regulatory particle, lid subcomplex
|
8
|
7.50e-03
|
5.46e-01
|
1.54e-01
|
GO:0072015 podocyte development
|
8
|
7.53e-03
|
-5.46e-01
|
1.54e-01
|
GO:0044027 negative regulation of gene expression via chromosomal CpG island methylation
|
14
|
4.12e-04
|
-5.45e-01
|
2.57e-02
|
GO:0000472 endonucleolytic cleavage to generate mature 5’-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
|
5
|
3.49e-02
|
-5.45e-01
|
2.94e-01
|
GO:0002161 aminoacyl-tRNA editing activity
|
5
|
3.55e-02
|
-5.43e-01
|
2.97e-01
|
GO:0007091 metaphase/anaphase transition of mitotic cell cycle
|
7
|
1.29e-02
|
-5.43e-01
|
2.02e-01
|
GO:0050911 detection of chemical stimulus involved in sensory perception of smell
|
5
|
3.59e-02
|
5.42e-01
|
2.97e-01
|
GO:0070552 BRISC complex
|
6
|
2.17e-02
|
5.41e-01
|
2.41e-01
|
GO:1990316 Atg1/ULK1 kinase complex
|
8
|
8.09e-03
|
5.41e-01
|
1.58e-01
|
GO:0008200 ion channel inhibitor activity
|
7
|
1.37e-02
|
5.38e-01
|
2.04e-01
|
GO:0070508 cholesterol import
|
5
|
3.74e-02
|
-5.37e-01
|
3.03e-01
|
GO:0036402 proteasome-activating activity
|
6
|
2.30e-02
|
5.36e-01
|
2.45e-01
|
GO:0048273 mitogen-activated protein kinase p38 binding
|
7
|
1.43e-02
|
-5.35e-01
|
2.07e-01
|
GO:0010812 negative regulation of cell-substrate adhesion
|
8
|
8.85e-03
|
-5.34e-01
|
1.66e-01
|
GO:2000573 positive regulation of DNA biosynthetic process
|
12
|
1.36e-03
|
-5.34e-01
|
5.41e-02
|
GO:0021785 branchiomotor neuron axon guidance
|
5
|
3.89e-02
|
-5.33e-01
|
3.08e-01
|
GO:0006335 DNA replication-dependent chromatin assembly
|
6
|
2.41e-02
|
-5.32e-01
|
2.53e-01
|
GO:1904385 cellular response to angiotensin
|
11
|
2.31e-03
|
-5.31e-01
|
7.37e-02
|
GO:0004298 threonine-type endopeptidase activity
|
7
|
1.51e-02
|
5.30e-01
|
2.12e-01
|
GO:0030853 negative regulation of granulocyte differentiation
|
5
|
4.02e-02
|
-5.30e-01
|
3.14e-01
|
GO:0010997 anaphase-promoting complex binding
|
8
|
9.62e-03
|
-5.29e-01
|
1.75e-01
|
GO:0001553 luteinization
|
6
|
2.50e-02
|
-5.29e-01
|
2.58e-01
|
GO:0120316 sperm flagellum assembly
|
10
|
3.83e-03
|
5.28e-01
|
1.04e-01
|
GO:0021952 central nervous system projection neuron axonogenesis
|
5
|
4.17e-02
|
5.26e-01
|
3.21e-01
|
GO:0006595 polyamine metabolic process
|
5
|
4.20e-02
|
-5.25e-01
|
3.22e-01
|
GO:0042438 melanin biosynthetic process
|
6
|
2.59e-02
|
-5.25e-01
|
2.60e-01
|
GO:0006555 methionine metabolic process
|
5
|
4.22e-02
|
-5.25e-01
|
3.22e-01
|
GO:0014912 negative regulation of smooth muscle cell migration
|
6
|
2.62e-02
|
-5.24e-01
|
2.60e-01
|
GO:0006270 DNA replication initiation
|
23
|
1.38e-05
|
-5.24e-01
|
1.91e-03
|
GO:0004691 cAMP-dependent protein kinase activity
|
6
|
2.66e-02
|
-5.23e-01
|
2.62e-01
|
GO:0042582 azurophil granule
|
9
|
6.71e-03
|
5.22e-01
|
1.45e-01
|
GO:0035720 intraciliary anterograde transport
|
14
|
7.24e-04
|
5.22e-01
|
3.48e-02
|
GO:0018393 internal peptidyl-lysine acetylation
|
5
|
4.36e-02
|
-5.21e-01
|
3.28e-01
|
GO:0030048 actin filament-based movement
|
14
|
7.52e-04
|
-5.20e-01
|
3.48e-02
|
GO:0051754 meiotic sister chromatid cohesion, centromeric
|
5
|
4.41e-02
|
-5.20e-01
|
3.30e-01
|
GO:1900264 positive regulation of DNA-directed DNA polymerase activity
|
8
|
1.09e-02
|
-5.20e-01
|
1.86e-01
|
GO:0002177 manchette
|
10
|
4.43e-03
|
5.20e-01
|
1.13e-01
|
GO:0001775 cell activation
|
7
|
1.81e-02
|
-5.16e-01
|
2.25e-01
|
GO:0030015 CCR4-NOT core complex
|
6
|
2.86e-02
|
-5.16e-01
|
2.70e-01
|
GO:0006689 ganglioside catabolic process
|
6
|
2.86e-02
|
5.16e-01
|
2.70e-01
|
GO:0051315 attachment of mitotic spindle microtubules to kinetochore
|
13
|
1.29e-03
|
-5.16e-01
|
5.25e-02
|
GO:0030195 negative regulation of blood coagulation
|
6
|
2.90e-02
|
5.15e-01
|
2.71e-01
|
GO:0007423 sensory organ development
|
5
|
4.63e-02
|
-5.15e-01
|
3.37e-01
|
GO:0047631 ADP-ribose diphosphatase activity
|
6
|
2.91e-02
|
5.14e-01
|
2.71e-01
|
GO:0150012 positive regulation of neuron projection arborization
|
6
|
2.92e-02
|
-5.14e-01
|
2.72e-01
|
GO:0015884 folic acid transport
|
7
|
1.85e-02
|
5.14e-01
|
2.27e-01
|
GO:0006693 prostaglandin metabolic process
|
15
|
5.69e-04
|
5.14e-01
|
3.09e-02
|
GO:0004523 RNA-DNA hybrid ribonuclease activity
|
5
|
4.67e-02
|
-5.14e-01
|
3.38e-01
|
GO:0098662 inorganic cation transmembrane transport
|
5
|
4.74e-02
|
5.12e-01
|
3.39e-01
|
GO:0042744 hydrogen peroxide catabolic process
|
11
|
3.30e-03
|
5.12e-01
|
9.45e-02
|
GO:0021675 nerve development
|
8
|
1.23e-02
|
-5.11e-01
|
1.96e-01
|
GO:0090435 protein localization to nuclear envelope
|
8
|
1.23e-02
|
-5.11e-01
|
1.96e-01
|
GO:0043009 chordate embryonic development
|
5
|
4.78e-02
|
-5.11e-01
|
3.39e-01
|
GO:0051444 negative regulation of ubiquitin-protein transferase activity
|
6
|
3.04e-02
|
-5.10e-01
|
2.78e-01
|
GO:0008097 5S rRNA binding
|
9
|
8.22e-03
|
5.09e-01
|
1.58e-01
|
GO:0016757 glycosyltransferase activity
|
9
|
8.24e-03
|
5.09e-01
|
1.58e-01
|
GO:0007190 activation of adenylate cyclase activity
|
8
|
1.28e-02
|
-5.08e-01
|
2.02e-01
|
GO:0032308 positive regulation of prostaglandin secretion
|
8
|
1.31e-02
|
5.06e-01
|
2.03e-01
|
GO:0042325 regulation of phosphorylation
|
8
|
1.32e-02
|
-5.06e-01
|
2.03e-01
|
GO:0014910 regulation of smooth muscle cell migration
|
5
|
5.00e-02
|
-5.06e-01
|
3.41e-01
|
GO:0030299 intestinal cholesterol absorption
|
5
|
5.04e-02
|
-5.05e-01
|
3.42e-01
|
GO:0044804 nucleophagy
|
5
|
5.04e-02
|
5.05e-01
|
3.42e-01
|
GO:0051156 glucose 6-phosphate metabolic process
|
6
|
3.22e-02
|
-5.05e-01
|
2.85e-01
|
GO:0061431 cellular response to methionine
|
5
|
5.11e-02
|
-5.04e-01
|
3.43e-01
|
GO:1905870 positive regulation of 3’-UTR-mediated mRNA stabilization
|
5
|
5.16e-02
|
-5.03e-01
|
3.45e-01
|
GO:0050806 positive regulation of synaptic transmission
|
10
|
5.94e-03
|
-5.02e-01
|
1.34e-01
|
GO:1904628 cellular response to phorbol 13-acetate 12-myristate
|
6
|
3.34e-02
|
-5.01e-01
|
2.91e-01
|
GO:0010466 negative regulation of peptidase activity
|
5
|
5.27e-02
|
5.00e-01
|
3.49e-01
|
GO:0061575 cyclin-dependent protein serine/threonine kinase activator activity
|
11
|
4.07e-03
|
-5.00e-01
|
1.08e-01
|
GO:2000320 negative regulation of T-helper 17 cell differentiation
|
6
|
3.41e-02
|
-4.99e-01
|
2.91e-01
|
GO:0044597 daunorubicin metabolic process
|
6
|
3.44e-02
|
4.99e-01
|
2.91e-01
|
GO:0044598 doxorubicin metabolic process
|
6
|
3.44e-02
|
4.99e-01
|
2.91e-01
|
GO:0034080 CENP-A containing chromatin assembly
|
9
|
9.64e-03
|
-4.98e-01
|
1.75e-01
|
GO:0006636 unsaturated fatty acid biosynthetic process
|
10
|
6.38e-03
|
-4.98e-01
|
1.41e-01
|
GO:1901018 positive regulation of potassium ion transmembrane transporter activity
|
5
|
5.43e-02
|
4.97e-01
|
3.52e-01
|
GO:0044806 G-quadruplex DNA unwinding
|
8
|
1.51e-02
|
-4.96e-01
|
2.12e-01
|
GO:0016208 AMP binding
|
11
|
4.45e-03
|
-4.95e-01
|
1.13e-01
|
GO:0033327 Leydig cell differentiation
|
5
|
5.54e-02
|
-4.95e-01
|
3.53e-01
|
GO:0071732 cellular response to nitric oxide
|
12
|
3.04e-03
|
-4.94e-01
|
8.94e-02
|
GO:2000646 positive regulation of receptor catabolic process
|
5
|
5.59e-02
|
-4.94e-01
|
3.53e-01
|
GO:0060379 cardiac muscle cell myoblast differentiation
|
6
|
3.63e-02
|
-4.94e-01
|
2.97e-01
|
GO:0030210 heparin biosynthetic process
|
8
|
1.57e-02
|
4.93e-01
|
2.17e-01
|
GO:0048103 somatic stem cell division
|
5
|
5.61e-02
|
-4.93e-01
|
3.53e-01
|
GO:0005001 transmembrane receptor protein tyrosine phosphatase activity
|
8
|
1.58e-02
|
-4.93e-01
|
2.17e-01
|
GO:0033033 negative regulation of myeloid cell apoptotic process
|
5
|
5.67e-02
|
-4.92e-01
|
3.54e-01
|
GO:0006995 cellular response to nitrogen starvation
|
9
|
1.06e-02
|
4.92e-01
|
1.84e-01
|
GO:1902115 regulation of organelle assembly
|
5
|
5.77e-02
|
-4.90e-01
|
3.55e-01
|
GO:0048039 ubiquinone binding
|
6
|
3.81e-02
|
4.89e-01
|
3.05e-01
|
GO:0009743 response to carbohydrate
|
5
|
5.85e-02
|
4.88e-01
|
3.58e-01
|
GO:0018242 protein O-linked glycosylation via serine
|
5
|
5.86e-02
|
-4.88e-01
|
3.58e-01
|
GO:0060287 epithelial cilium movement involved in determination of left/right asymmetry
|
6
|
3.84e-02
|
4.88e-01
|
3.07e-01
|
GO:1902305 regulation of sodium ion transmembrane transport
|
8
|
1.68e-02
|
4.88e-01
|
2.20e-01
|
GO:0051864 histone H3K36 demethylase activity
|
10
|
7.58e-03
|
-4.88e-01
|
1.55e-01
|
GO:0003985 acetyl-CoA C-acetyltransferase activity
|
6
|
3.86e-02
|
4.88e-01
|
3.07e-01
|
GO:0043515 kinetochore binding
|
6
|
3.86e-02
|
-4.88e-01
|
3.07e-01
|
GO:0034464 BBSome
|
8
|
1.71e-02
|
4.87e-01
|
2.20e-01
|
GO:0044665 MLL1/2 complex
|
8
|
1.71e-02
|
-4.87e-01
|
2.20e-01
|
GO:1990592 protein K69-linked ufmylation
|
5
|
5.95e-02
|
4.87e-01
|
3.61e-01
|
GO:0015020 glucuronosyltransferase activity
|
7
|
2.60e-02
|
4.86e-01
|
2.60e-01
|
GO:0031489 myosin V binding
|
10
|
7.83e-03
|
4.86e-01
|
1.55e-01
|
GO:0007094 mitotic spindle assembly checkpoint signaling
|
27
|
1.32e-05
|
-4.84e-01
|
1.89e-03
|
GO:0086100 endothelin receptor signaling pathway
|
5
|
6.08e-02
|
-4.84e-01
|
3.65e-01
|
GO:0050815 phosphoserine residue binding
|
5
|
6.09e-02
|
-4.84e-01
|
3.65e-01
|
GO:0010954 positive regulation of protein processing
|
7
|
2.67e-02
|
4.84e-01
|
2.62e-01
|
GO:0071667 DNA/RNA hybrid binding
|
5
|
6.11e-02
|
-4.84e-01
|
3.66e-01
|
GO:0005943 phosphatidylinositol 3-kinase complex, class IA
|
9
|
1.23e-02
|
-4.82e-01
|
1.96e-01
|
GO:2000394 positive regulation of lamellipodium morphogenesis
|
5
|
6.21e-02
|
-4.82e-01
|
3.68e-01
|
GO:0002768 immune response-regulating cell surface receptor signaling pathway
|
7
|
2.74e-02
|
-4.81e-01
|
2.66e-01
|
GO:0036500 ATF6-mediated unfolded protein response
|
7
|
2.76e-02
|
4.81e-01
|
2.66e-01
|
GO:0035456 response to interferon-beta
|
9
|
1.25e-02
|
4.81e-01
|
1.98e-01
|
GO:0043120 tumor necrosis factor binding
|
7
|
2.77e-02
|
-4.80e-01
|
2.66e-01
|
GO:0002735 positive regulation of myeloid dendritic cell cytokine production
|
5
|
6.34e-02
|
-4.79e-01
|
3.73e-01
|
GO:1900025 negative regulation of substrate adhesion-dependent cell spreading
|
8
|
1.91e-02
|
-4.79e-01
|
2.28e-01
|
GO:0070987 error-free translesion synthesis
|
5
|
6.39e-02
|
-4.78e-01
|
3.75e-01
|
GO:0016874 ligase activity
|
8
|
1.92e-02
|
4.78e-01
|
2.28e-01
|
GO:0016556 mRNA modification
|
7
|
2.87e-02
|
-4.78e-01
|
2.70e-01
|
GO:1903936 cellular response to sodium arsenite
|
5
|
6.53e-02
|
-4.76e-01
|
3.78e-01
|
GO:0015808 L-alanine transport
|
5
|
6.54e-02
|
-4.76e-01
|
3.78e-01
|
GO:0051220 cytoplasmic sequestering of protein
|
8
|
2.00e-02
|
-4.75e-01
|
2.33e-01
|
GO:0060037 pharyngeal system development
|
6
|
4.42e-02
|
4.74e-01
|
3.30e-01
|
GO:0006081 aldehyde metabolic process
|
8
|
2.05e-02
|
4.73e-01
|
2.36e-01
|
GO:2000391 positive regulation of neutrophil extravasation
|
6
|
4.49e-02
|
4.73e-01
|
3.32e-01
|
GO:0031529 ruffle organization
|
12
|
4.62e-03
|
-4.72e-01
|
1.15e-01
|
GO:0046833 positive regulation of RNA export from nucleus
|
5
|
6.80e-02
|
-4.71e-01
|
3.85e-01
|
GO:0005642 annulate lamellae
|
5
|
6.80e-02
|
-4.71e-01
|
3.85e-01
|
GO:0034165 positive regulation of toll-like receptor 9 signaling pathway
|
5
|
6.82e-02
|
4.71e-01
|
3.86e-01
|
GO:0097542 ciliary tip
|
35
|
1.43e-06
|
4.71e-01
|
3.22e-04
|
GO:0031616 spindle pole centrosome
|
12
|
4.74e-03
|
-4.71e-01
|
1.15e-01
|
GO:0031905 early endosome lumen
|
5
|
6.85e-02
|
4.70e-01
|
3.86e-01
|
GO:1902462 positive regulation of mesenchymal stem cell proliferation
|
5
|
6.88e-02
|
-4.70e-01
|
3.87e-01
|
GO:0072558 NLRP1 inflammasome complex
|
5
|
6.88e-02
|
4.70e-01
|
3.87e-01
|
GO:0070995 NADPH oxidation
|
6
|
4.65e-02
|
4.69e-01
|
3.38e-01
|
GO:0002084 protein depalmitoylation
|
7
|
3.17e-02
|
-4.69e-01
|
2.84e-01
|
GO:0061014 positive regulation of mRNA catabolic process
|
12
|
4.98e-03
|
-4.68e-01
|
1.20e-01
|
GO:0046579 positive regulation of Ras protein signal transduction
|
13
|
3.50e-03
|
-4.68e-01
|
9.74e-02
|
GO:0042587 glycogen granule
|
6
|
4.75e-02
|
-4.67e-01
|
3.39e-01
|
GO:0045010 actin nucleation
|
6
|
4.76e-02
|
-4.67e-01
|
3.39e-01
|
GO:0048312 intracellular distribution of mitochondria
|
6
|
4.77e-02
|
-4.67e-01
|
3.39e-01
|
GO:0021612 facial nerve structural organization
|
6
|
4.78e-02
|
-4.67e-01
|
3.39e-01
|
GO:0098974 postsynaptic actin cytoskeleton organization
|
9
|
1.54e-02
|
-4.66e-01
|
2.16e-01
|
GO:0008299 isoprenoid biosynthetic process
|
9
|
1.55e-02
|
-4.66e-01
|
2.16e-01
|
GO:0090521 podocyte cell migration
|
6
|
4.82e-02
|
-4.66e-01
|
3.39e-01
|
GO:1902817 negative regulation of protein localization to microtubule
|
5
|
7.14e-02
|
-4.66e-01
|
3.91e-01
|
GO:0001939 female pronucleus
|
9
|
1.56e-02
|
-4.65e-01
|
2.17e-01
|
GO:0015379 potassium:chloride symporter activity
|
6
|
4.85e-02
|
-4.65e-01
|
3.39e-01
|
GO:0008330 protein tyrosine/threonine phosphatase activity
|
5
|
7.19e-02
|
-4.65e-01
|
3.92e-01
|
GO:0004016 adenylate cyclase activity
|
7
|
3.32e-02
|
-4.65e-01
|
2.91e-01
|
GO:0022614 membrane to membrane docking
|
5
|
7.22e-02
|
-4.64e-01
|
3.93e-01
|
GO:0032184 SUMO polymer binding
|
6
|
4.94e-02
|
-4.63e-01
|
3.41e-01
|
GO:0031461 cullin-RING ubiquitin ligase complex
|
6
|
4.94e-02
|
-4.63e-01
|
3.41e-01
|
GO:0015288 porin activity
|
6
|
5.00e-02
|
-4.62e-01
|
3.41e-01
|
GO:0033572 transferrin transport
|
7
|
3.44e-02
|
-4.62e-01
|
2.91e-01
|
GO:0048846 axon extension involved in axon guidance
|
7
|
3.45e-02
|
-4.61e-01
|
2.92e-01
|
GO:0061549 sympathetic ganglion development
|
6
|
5.03e-02
|
-4.61e-01
|
3.42e-01
|
GO:0006564 L-serine biosynthetic process
|
6
|
5.05e-02
|
4.61e-01
|
3.42e-01
|
GO:0007100 mitotic centrosome separation
|
6
|
5.09e-02
|
-4.60e-01
|
3.43e-01
|
GO:0000712 resolution of meiotic recombination intermediates
|
12
|
5.81e-03
|
-4.60e-01
|
1.32e-01
|
GO:0021828 gonadotrophin-releasing hormone neuronal migration to the hypothalamus
|
5
|
7.50e-02
|
-4.60e-01
|
4.00e-01
|
GO:0015698 inorganic anion transport
|
5
|
7.52e-02
|
4.59e-01
|
4.01e-01
|
GO:0090267 positive regulation of mitotic cell cycle spindle assembly checkpoint
|
12
|
5.91e-03
|
-4.59e-01
|
1.34e-01
|
GO:0006695 cholesterol biosynthetic process
|
30
|
1.45e-05
|
-4.57e-01
|
1.94e-03
|
GO:0000939 inner kinetochore
|
17
|
1.10e-03
|
-4.57e-01
|
4.73e-02
|
GO:0017108 5’-flap endonuclease activity
|
6
|
5.24e-02
|
-4.57e-01
|
3.48e-01
|
GO:0046914 transition metal ion binding
|
7
|
3.63e-02
|
4.57e-01
|
2.97e-01
|
GO:0036109 alpha-linolenic acid metabolic process
|
8
|
2.52e-02
|
-4.57e-01
|
2.58e-01
|
GO:0008379 thioredoxin peroxidase activity
|
6
|
5.28e-02
|
4.57e-01
|
3.49e-01
|
GO:0010633 negative regulation of epithelial cell migration
|
8
|
2.53e-02
|
-4.57e-01
|
2.58e-01
|
GO:0071459 protein localization to chromosome, centromeric region
|
7
|
3.67e-02
|
-4.56e-01
|
2.98e-01
|
GO:0021794 thalamus development
|
5
|
7.75e-02
|
-4.56e-01
|
4.07e-01
|
GO:0051127 positive regulation of actin nucleation
|
5
|
7.75e-02
|
-4.56e-01
|
4.07e-01
|
GO:0005726 perichromatin fibrils
|
6
|
5.35e-02
|
-4.55e-01
|
3.51e-01
|
GO:1904355 positive regulation of telomere capping
|
5
|
7.80e-02
|
-4.55e-01
|
4.08e-01
|
GO:0035455 response to interferon-alpha
|
9
|
1.81e-02
|
4.55e-01
|
2.25e-01
|
GO:0007172 signal complex assembly
|
6
|
5.37e-02
|
-4.55e-01
|
3.51e-01
|
GO:0043393 regulation of protein binding
|
8
|
2.60e-02
|
-4.55e-01
|
2.60e-01
|
GO:0048515 spermatid differentiation
|
6
|
5.39e-02
|
4.55e-01
|
3.51e-01
|
GO:0005658 alpha DNA polymerase:primase complex
|
5
|
7.84e-02
|
-4.55e-01
|
4.09e-01
|
GO:0008559 ABC-type xenobiotic transporter activity
|
8
|
2.61e-02
|
-4.54e-01
|
2.60e-01
|
GO:1902164 positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator
|
5
|
7.88e-02
|
4.54e-01
|
4.10e-01
|
GO:0051988 regulation of attachment of spindle microtubules to kinetochore
|
9
|
1.84e-02
|
-4.54e-01
|
2.26e-01
|
GO:0030865 cortical cytoskeleton organization
|
10
|
1.31e-02
|
-4.53e-01
|
2.03e-01
|
GO:0009058 biosynthetic process
|
9
|
1.86e-02
|
4.53e-01
|
2.27e-01
|
GO:0035662 Toll-like receptor 4 binding
|
5
|
7.95e-02
|
-4.53e-01
|
4.11e-01
|
GO:0043240 Fanconi anaemia nuclear complex
|
13
|
4.71e-03
|
-4.53e-01
|
1.15e-01
|
GO:0036066 protein O-linked fucosylation
|
5
|
7.96e-02
|
4.53e-01
|
4.11e-01
|
GO:0007088 regulation of mitotic nuclear division
|
19
|
6.37e-04
|
-4.53e-01
|
3.27e-02
|
GO:0017154 semaphorin receptor activity
|
10
|
1.32e-02
|
-4.52e-01
|
2.03e-01
|
GO:0030098 lymphocyte differentiation
|
5
|
7.99e-02
|
-4.52e-01
|
4.12e-01
|
GO:0045670 regulation of osteoclast differentiation
|
8
|
2.71e-02
|
-4.51e-01
|
2.65e-01
|
GO:0010484 histone H3 acetyltransferase activity
|
8
|
2.73e-02
|
-4.51e-01
|
2.66e-01
|
GO:0007077 mitotic nuclear membrane disassembly
|
8
|
2.75e-02
|
-4.50e-01
|
2.66e-01
|
GO:0045859 regulation of protein kinase activity
|
5
|
8.19e-02
|
-4.49e-01
|
4.16e-01
|
GO:0016338 calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules
|
5
|
8.25e-02
|
4.48e-01
|
4.17e-01
|
GO:0048386 positive regulation of retinoic acid receptor signaling pathway
|
5
|
8.25e-02
|
4.48e-01
|
4.17e-01
|
GO:0043225 ATPase-coupled inorganic anion transmembrane transporter activity
|
6
|
5.73e-02
|
-4.48e-01
|
3.55e-01
|
GO:0071280 cellular response to copper ion
|
17
|
1.40e-03
|
4.47e-01
|
5.49e-02
|
GO:0043116 negative regulation of vascular permeability
|
7
|
4.09e-02
|
-4.46e-01
|
3.17e-01
|
GO:0048671 negative regulation of collateral sprouting
|
5
|
8.44e-02
|
4.46e-01
|
4.23e-01
|
GO:0051382 kinetochore assembly
|
13
|
5.48e-03
|
-4.45e-01
|
1.25e-01
|
GO:0000405 bubble DNA binding
|
6
|
5.93e-02
|
-4.45e-01
|
3.60e-01
|
GO:0097228 sperm principal piece
|
16
|
2.08e-03
|
4.45e-01
|
6.92e-02
|
GO:0099003 vesicle-mediated transport in synapse
|
6
|
6.01e-02
|
4.43e-01
|
3.63e-01
|
GO:0043067 regulation of programmed cell death
|
6
|
6.02e-02
|
4.43e-01
|
3.63e-01
|
GO:0051664 nuclear pore localization
|
5
|
8.63e-02
|
-4.43e-01
|
4.26e-01
|
GO:0010884 positive regulation of lipid storage
|
8
|
3.01e-02
|
-4.43e-01
|
2.76e-01
|
GO:0032233 positive regulation of actin filament bundle assembly
|
7
|
4.25e-02
|
-4.43e-01
|
3.24e-01
|
GO:0008603 cAMP-dependent protein kinase regulator activity
|
6
|
6.04e-02
|
-4.43e-01
|
3.65e-01
|
GO:0099641 anterograde axonal protein transport
|
5
|
8.67e-02
|
4.42e-01
|
4.26e-01
|
GO:0046849 bone remodeling
|
8
|
3.05e-02
|
-4.42e-01
|
2.78e-01
|
GO:0033622 integrin activation
|
6
|
6.10e-02
|
-4.42e-01
|
3.65e-01
|
GO:0045657 positive regulation of monocyte differentiation
|
9
|
2.18e-02
|
-4.42e-01
|
2.41e-01
|
GO:0010886 positive regulation of cholesterol storage
|
6
|
6.12e-02
|
-4.41e-01
|
3.66e-01
|
GO:0070878 primary miRNA binding
|
9
|
2.19e-02
|
-4.41e-01
|
2.41e-01
|
GO:0001940 male pronucleus
|
7
|
4.33e-02
|
-4.41e-01
|
3.27e-01
|
GO:0022624 proteasome accessory complex
|
17
|
1.66e-03
|
4.41e-01
|
5.91e-02
|
GO:0070778 L-aspartate transmembrane transport
|
5
|
8.80e-02
|
-4.41e-01
|
4.30e-01
|
GO:0060840 artery development
|
10
|
1.62e-02
|
4.39e-01
|
2.18e-01
|
GO:0019725 cellular homeostasis
|
10
|
1.62e-02
|
-4.39e-01
|
2.18e-01
|
GO:0072687 meiotic spindle
|
8
|
3.19e-02
|
-4.38e-01
|
2.85e-01
|
GO:0030169 low-density lipoprotein particle binding
|
13
|
6.27e-03
|
-4.38e-01
|
1.39e-01
|
GO:0061158 3’-UTR-mediated mRNA destabilization
|
15
|
3.33e-03
|
-4.38e-01
|
9.48e-02
|
GO:0033598 mammary gland epithelial cell proliferation
|
8
|
3.21e-02
|
-4.38e-01
|
2.85e-01
|
GO:0006999 nuclear pore organization
|
8
|
3.22e-02
|
-4.37e-01
|
2.85e-01
|
GO:0005159 insulin-like growth factor receptor binding
|
10
|
1.67e-02
|
-4.37e-01
|
2.20e-01
|
GO:0046875 ephrin receptor binding
|
19
|
9.73e-04
|
-4.37e-01
|
4.29e-02
|
GO:0071276 cellular response to cadmium ion
|
16
|
2.47e-03
|
4.37e-01
|
7.79e-02
|
GO:0033148 positive regulation of intracellular estrogen receptor signaling pathway
|
7
|
4.55e-02
|
-4.37e-01
|
3.35e-01
|
GO:0009313 oligosaccharide catabolic process
|
9
|
2.35e-02
|
4.36e-01
|
2.49e-01
|
GO:0045656 negative regulation of monocyte differentiation
|
5
|
9.13e-02
|
-4.36e-01
|
4.36e-01
|
GO:0000132 establishment of mitotic spindle orientation
|
29
|
4.85e-05
|
-4.36e-01
|
5.27e-03
|
GO:0016788 hydrolase activity, acting on ester bonds
|
7
|
4.61e-02
|
4.35e-01
|
3.36e-01
|
GO:0061809 NAD+ nucleotidase, cyclic ADP-ribose generating
|
10
|
1.71e-02
|
4.35e-01
|
2.20e-01
|
GO:0035729 cellular response to hepatocyte growth factor stimulus
|
12
|
9.07e-03
|
-4.35e-01
|
1.69e-01
|
GO:0008179 adenylate cyclase binding
|
5
|
9.23e-02
|
-4.35e-01
|
4.37e-01
|
GO:0048858 cell projection morphogenesis
|
5
|
9.24e-02
|
-4.35e-01
|
4.37e-01
|
GO:0071803 positive regulation of podosome assembly
|
9
|
2.42e-02
|
-4.34e-01
|
2.53e-01
|
GO:0002430 complement receptor mediated signaling pathway
|
11
|
1.28e-02
|
-4.34e-01
|
2.01e-01
|
GO:1903659 regulation of complement-dependent cytotoxicity
|
5
|
9.32e-02
|
4.34e-01
|
4.39e-01
|
GO:0070613 regulation of protein processing
|
7
|
4.70e-02
|
-4.33e-01
|
3.39e-01
|
GO:0030091 protein repair
|
5
|
9.38e-02
|
4.33e-01
|
4.40e-01
|
GO:0003300 cardiac muscle hypertrophy
|
6
|
6.67e-02
|
-4.32e-01
|
3.82e-01
|
GO:0030881 beta-2-microglobulin binding
|
8
|
3.43e-02
|
4.32e-01
|
2.91e-01
|
GO:0098684 photoreceptor ribbon synapse
|
5
|
9.44e-02
|
-4.32e-01
|
4.40e-01
|
GO:0000775 chromosome, centromeric region
|
54
|
4.14e-08
|
-4.32e-01
|
2.21e-05
|
GO:0031428 box C/D methylation guide snoRNP complex
|
5
|
9.49e-02
|
-4.31e-01
|
4.42e-01
|
GO:1990845 adaptive thermogenesis
|
10
|
1.82e-02
|
-4.31e-01
|
2.26e-01
|
GO:0007129 homologous chromosome pairing at meiosis
|
12
|
9.72e-03
|
-4.31e-01
|
1.75e-01
|
GO:0009374 biotin binding
|
5
|
9.53e-02
|
4.31e-01
|
4.42e-01
|
GO:0097011 cellular response to granulocyte macrophage colony-stimulating factor stimulus
|
9
|
2.53e-02
|
-4.31e-01
|
2.58e-01
|
GO:0042373 vitamin K metabolic process
|
7
|
4.86e-02
|
4.31e-01
|
3.39e-01
|
GO:0072546 EMC complex
|
10
|
1.88e-02
|
4.29e-01
|
2.27e-01
|
GO:0000138 Golgi trans cisterna
|
8
|
3.57e-02
|
4.29e-01
|
2.97e-01
|
GO:0019941 modification-dependent protein catabolic process
|
8
|
3.57e-02
|
4.29e-01
|
2.97e-01
|
GO:0000779 condensed chromosome, centromeric region
|
16
|
2.99e-03
|
-4.29e-01
|
8.91e-02
|
GO:0097400 interleukin-17-mediated signaling pathway
|
7
|
4.98e-02
|
-4.28e-01
|
3.41e-01
|
GO:0033700 phospholipid efflux
|
7
|
4.99e-02
|
4.28e-01
|
3.41e-01
|
GO:0010820 positive regulation of T cell chemotaxis
|
8
|
3.62e-02
|
-4.28e-01
|
2.97e-01
|
GO:0047045 testosterone 17-beta-dehydrogenase (NADP+) activity
|
5
|
9.78e-02
|
4.28e-01
|
4.48e-01
|
GO:0050730 regulation of peptidyl-tyrosine phosphorylation
|
8
|
3.65e-02
|
4.27e-01
|
2.97e-01
|
GO:0030121 AP-1 adaptor complex
|
10
|
1.94e-02
|
-4.27e-01
|
2.30e-01
|
GO:0032966 negative regulation of collagen biosynthetic process
|
6
|
7.03e-02
|
-4.27e-01
|
3.89e-01
|
GO:0033625 positive regulation of integrin activation
|
7
|
5.07e-02
|
-4.26e-01
|
3.42e-01
|
GO:0003993 acid phosphatase activity
|
6
|
7.10e-02
|
4.26e-01
|
3.90e-01
|
GO:0035519 protein K29-linked ubiquitination
|
10
|
1.98e-02
|
-4.26e-01
|
2.33e-01
|
GO:0050427 3’-phosphoadenosine 5’-phosphosulfate metabolic process
|
5
|
9.93e-02
|
4.26e-01
|
4.52e-01
|
GO:0021860 pyramidal neuron development
|
6
|
7.12e-02
|
-4.25e-01
|
3.91e-01
|
GO:0060766 negative regulation of androgen receptor signaling pathway
|
9
|
2.72e-02
|
-4.25e-01
|
2.66e-01
|
GO:0021532 neural tube patterning
|
5
|
9.97e-02
|
4.25e-01
|
4.52e-01
|
GO:0071313 cellular response to caffeine
|
7
|
5.20e-02
|
4.24e-01
|
3.46e-01
|
GO:0005838 proteasome regulatory particle
|
8
|
3.78e-02
|
4.24e-01
|
3.04e-01
|
GO:0043691 reverse cholesterol transport
|
10
|
2.03e-02
|
4.24e-01
|
2.35e-01
|
GO:0042564 NLS-dependent protein nuclear import complex
|
9
|
2.78e-02
|
-4.24e-01
|
2.66e-01
|
GO:0001736 establishment of planar polarity
|
10
|
2.07e-02
|
4.22e-01
|
2.37e-01
|
GO:0071476 cellular hypotonic response
|
8
|
3.86e-02
|
-4.22e-01
|
3.07e-01
|
GO:0045926 negative regulation of growth
|
16
|
3.47e-03
|
4.22e-01
|
9.71e-02
|
GO:0036128 CatSper complex
|
5
|
1.02e-01
|
4.22e-01
|
4.55e-01
|
GO:0071817 MMXD complex
|
5
|
1.02e-01
|
4.22e-01
|
4.55e-01
|
GO:0032927 positive regulation of activin receptor signaling pathway
|
5
|
1.03e-01
|
4.22e-01
|
4.55e-01
|
GO:0002011 morphogenesis of an epithelial sheet
|
8
|
3.93e-02
|
-4.21e-01
|
3.10e-01
|
GO:0097255 R2TP complex
|
5
|
1.03e-01
|
4.21e-01
|
4.56e-01
|
GO:0033211 adiponectin-activated signaling pathway
|
7
|
5.45e-02
|
4.20e-01
|
3.52e-01
|
GO:0006686 sphingomyelin biosynthetic process
|
10
|
2.16e-02
|
4.19e-01
|
2.41e-01
|
GO:0099054 presynapse assembly
|
5
|
1.05e-01
|
-4.19e-01
|
4.59e-01
|
GO:0031017 exocrine pancreas development
|
5
|
1.05e-01
|
4.19e-01
|
4.59e-01
|
GO:0005168 neurotrophin TRKA receptor binding
|
5
|
1.05e-01
|
-4.19e-01
|
4.59e-01
|
GO:0071548 response to dexamethasone
|
8
|
4.03e-02
|
-4.19e-01
|
3.14e-01
|
GO:1902231 positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage
|
6
|
7.60e-02
|
-4.18e-01
|
4.04e-01
|
GO:0045651 positive regulation of macrophage differentiation
|
11
|
1.64e-02
|
-4.18e-01
|
2.19e-01
|
GO:0071569 protein ufmylation
|
6
|
7.66e-02
|
4.17e-01
|
4.05e-01
|
GO:0045050 protein insertion into ER membrane by stop-transfer membrane-anchor sequence
|
11
|
1.66e-02
|
4.17e-01
|
2.20e-01
|
GO:0006959 humoral immune response
|
27
|
1.79e-04
|
-4.17e-01
|
1.36e-02
|
GO:0004126 cytidine deaminase activity
|
9
|
3.05e-02
|
4.17e-01
|
2.78e-01
|
GO:0000146 microfilament motor activity
|
20
|
1.26e-03
|
-4.17e-01
|
5.25e-02
|
GO:0051646 mitochondrion localization
|
8
|
4.14e-02
|
-4.16e-01
|
3.19e-01
|
GO:0030867 rough endoplasmic reticulum membrane
|
8
|
4.18e-02
|
-4.16e-01
|
3.22e-01
|
GO:0001057 RNA polymerase IV activity
|
7
|
5.76e-02
|
-4.15e-01
|
3.55e-01
|
GO:0001058 RNA polymerase V activity
|
7
|
5.76e-02
|
-4.15e-01
|
3.55e-01
|
GO:0001059 transcription by RNA polymerase IV
|
7
|
5.76e-02
|
-4.15e-01
|
3.55e-01
|
GO:0001060 transcription by RNA polymerase V
|
7
|
5.76e-02
|
-4.15e-01
|
3.55e-01
|
GO:0001065 mitochondrial single subunit type RNA polymerase activity
|
7
|
5.76e-02
|
-4.15e-01
|
3.55e-01
|
GO:0001066 plastid single subunit type RNA polymerase activity
|
7
|
5.76e-02
|
-4.15e-01
|
3.55e-01
|
GO:0042793 plastid transcription
|
7
|
5.76e-02
|
-4.15e-01
|
3.55e-01
|
GO:0002455 humoral immune response mediated by circulating immunoglobulin
|
5
|
1.10e-01
|
-4.13e-01
|
4.70e-01
|
GO:0060122 inner ear receptor cell stereocilium organization
|
12
|
1.32e-02
|
4.13e-01
|
2.03e-01
|
GO:0047184 1-acylglycerophosphocholine O-acyltransferase activity
|
7
|
5.88e-02
|
-4.13e-01
|
3.58e-01
|
GO:0009913 epidermal cell differentiation
|
5
|
1.11e-01
|
-4.12e-01
|
4.72e-01
|
GO:0033147 negative regulation of intracellular estrogen receptor signaling pathway
|
13
|
1.01e-02
|
-4.12e-01
|
1.79e-01
|
GO:0090557 establishment of endothelial intestinal barrier
|
12
|
1.36e-02
|
-4.12e-01
|
2.04e-01
|
GO:0006260 DNA replication
|
79
|
2.77e-10
|
-4.11e-01
|
2.70e-07
|
GO:0008429 phosphatidylethanolamine binding
|
14
|
7.81e-03
|
4.11e-01
|
1.55e-01
|
GO:0014909 smooth muscle cell migration
|
5
|
1.12e-01
|
4.11e-01
|
4.74e-01
|
GO:0010659 cardiac muscle cell apoptotic process
|
8
|
4.45e-02
|
4.10e-01
|
3.31e-01
|
GO:0034383 low-density lipoprotein particle clearance
|
10
|
2.49e-02
|
-4.10e-01
|
2.58e-01
|
GO:0031053 primary miRNA processing
|
13
|
1.06e-02
|
-4.09e-01
|
1.85e-01
|
GO:0046685 response to arsenic-containing substance
|
10
|
2.52e-02
|
-4.09e-01
|
2.58e-01
|
GO:0015760 glucose-6-phosphate transport
|
5
|
1.13e-01
|
-4.09e-01
|
4.77e-01
|
GO:0035855 megakaryocyte development
|
14
|
8.09e-03
|
-4.09e-01
|
1.58e-01
|
GO:0010936 negative regulation of macrophage cytokine production
|
8
|
4.55e-02
|
4.08e-01
|
3.35e-01
|
GO:0007167 enzyme-linked receptor protein signaling pathway
|
8
|
4.57e-02
|
-4.08e-01
|
3.35e-01
|
GO:0140492 metal-dependent deubiquitinase activity
|
11
|
1.92e-02
|
4.08e-01
|
2.28e-01
|
GO:0030833 regulation of actin filament polymerization
|
21
|
1.22e-03
|
-4.08e-01
|
5.18e-02
|
GO:0042554 superoxide anion generation
|
12
|
1.45e-02
|
4.08e-01
|
2.07e-01
|
GO:0043032 positive regulation of macrophage activation
|
11
|
1.93e-02
|
-4.07e-01
|
2.30e-01
|
GO:0001739 sex chromatin
|
5
|
1.15e-01
|
4.07e-01
|
4.79e-01
|
GO:0034340 response to type I interferon
|
8
|
4.61e-02
|
4.07e-01
|
3.36e-01
|
GO:0034138 toll-like receptor 3 signaling pathway
|
14
|
8.38e-03
|
-4.07e-01
|
1.61e-01
|
GO:0061384 heart trabecula morphogenesis
|
5
|
1.15e-01
|
4.07e-01
|
4.79e-01
|
GO:0005242 inward rectifier potassium channel activity
|
6
|
8.52e-02
|
-4.06e-01
|
4.24e-01
|
GO:0061723 glycophagy
|
12
|
1.49e-02
|
4.06e-01
|
2.11e-01
|
GO:0005869 dynactin complex
|
8
|
4.72e-02
|
4.05e-01
|
3.39e-01
|
GO:1904753 negative regulation of vascular associated smooth muscle cell migration
|
8
|
4.73e-02
|
-4.05e-01
|
3.39e-01
|
GO:0019079 viral genome replication
|
10
|
2.66e-02
|
-4.05e-01
|
2.62e-01
|
GO:0030686 90S preribosome
|
9
|
3.54e-02
|
-4.05e-01
|
2.97e-01
|
GO:0031434 mitogen-activated protein kinase kinase binding
|
8
|
4.75e-02
|
-4.05e-01
|
3.39e-01
|
GO:0000400 four-way junction DNA binding
|
18
|
3.01e-03
|
-4.04e-01
|
8.93e-02
|
GO:0070292 N-acylphosphatidylethanolamine metabolic process
|
5
|
1.18e-01
|
4.04e-01
|
4.84e-01
|
GO:1903566 positive regulation of protein localization to cilium
|
5
|
1.18e-01
|
-4.03e-01
|
4.84e-01
|
GO:0032473 cytoplasmic side of mitochondrial outer membrane
|
5
|
1.19e-01
|
-4.03e-01
|
4.84e-01
|
GO:0061564 axon development
|
13
|
1.19e-02
|
-4.03e-01
|
1.93e-01
|
GO:0035061 interchromatin granule
|
5
|
1.19e-01
|
-4.03e-01
|
4.84e-01
|
GO:0032933 SREBP signaling pathway
|
9
|
3.64e-02
|
-4.03e-01
|
2.97e-01
|
GO:0008970 phospholipase A1 activity
|
11
|
2.08e-02
|
4.03e-01
|
2.37e-01
|
GO:0035336 long-chain fatty-acyl-CoA metabolic process
|
6
|
8.77e-02
|
4.03e-01
|
4.29e-01
|
GO:0035242 protein-arginine omega-N asymmetric methyltransferase activity
|
6
|
8.80e-02
|
-4.02e-01
|
4.30e-01
|
GO:0120146 sulfatide binding
|
6
|
8.80e-02
|
-4.02e-01
|
4.30e-01
|
GO:0052650 all-trans-retinol dehydrogenase (NADP+) activity
|
10
|
2.79e-02
|
4.02e-01
|
2.66e-01
|
GO:0034274 Atg12-Atg5-Atg16 complex
|
6
|
8.85e-02
|
4.02e-01
|
4.31e-01
|
GO:0002637 regulation of immunoglobulin production
|
5
|
1.20e-01
|
-4.01e-01
|
4.88e-01
|
GO:0048630 skeletal muscle tissue growth
|
5
|
1.20e-01
|
-4.01e-01
|
4.89e-01
|
GO:0004683 calcium/calmodulin-dependent protein kinase activity
|
14
|
9.39e-03
|
-4.01e-01
|
1.72e-01
|
GO:0032471 negative regulation of endoplasmic reticulum calcium ion concentration
|
6
|
8.94e-02
|
-4.00e-01
|
4.33e-01
|
GO:0033280 response to vitamin D
|
11
|
2.15e-02
|
4.00e-01
|
2.41e-01
|
GO:0031113 regulation of microtubule polymerization
|
9
|
3.77e-02
|
-4.00e-01
|
3.04e-01
|
GO:0061003 positive regulation of dendritic spine morphogenesis
|
13
|
1.26e-02
|
-4.00e-01
|
1.99e-01
|
GO:0032466 negative regulation of cytokinesis
|
5
|
1.22e-01
|
-3.99e-01
|
4.93e-01
|
GO:0001741 XY body
|
12
|
1.66e-02
|
-3.99e-01
|
2.20e-01
|
GO:0005664 nuclear origin of replication recognition complex
|
7
|
6.75e-02
|
-3.99e-01
|
3.84e-01
|
GO:0043584 nose development
|
6
|
9.07e-02
|
3.99e-01
|
4.35e-01
|
GO:0071168 protein localization to chromatin
|
21
|
1.57e-03
|
-3.99e-01
|
5.70e-02
|
GO:1903706 regulation of hemopoiesis
|
8
|
5.13e-02
|
-3.98e-01
|
3.44e-01
|
GO:0032059 bleb
|
9
|
3.90e-02
|
-3.97e-01
|
3.09e-01
|
GO:0009063 amino acid catabolic process
|
5
|
1.24e-01
|
3.97e-01
|
4.97e-01
|
GO:0030892 mitotic cohesin complex
|
7
|
6.94e-02
|
-3.96e-01
|
3.88e-01
|
GO:0045064 T-helper 2 cell differentiation
|
7
|
6.97e-02
|
-3.96e-01
|
3.89e-01
|
GO:0071006 U2-type catalytic step 1 spliceosome
|
12
|
1.76e-02
|
-3.96e-01
|
2.23e-01
|
GO:0050849 negative regulation of calcium-mediated signaling
|
5
|
1.26e-01
|
3.95e-01
|
5.01e-01
|
GO:1902531 regulation of intracellular signal transduction
|
7
|
7.02e-02
|
-3.95e-01
|
3.89e-01
|
GO:0071773 cellular response to BMP stimulus
|
10
|
3.06e-02
|
3.95e-01
|
2.78e-01
|
GO:0042797 tRNA transcription by RNA polymerase III
|
11
|
2.34e-02
|
-3.95e-01
|
2.48e-01
|
GO:0001765 membrane raft assembly
|
5
|
1.27e-01
|
-3.95e-01
|
5.02e-01
|
GO:0045577 regulation of B cell differentiation
|
8
|
5.34e-02
|
-3.94e-01
|
3.50e-01
|
GO:0031424 keratinization
|
8
|
5.38e-02
|
3.94e-01
|
3.51e-01
|
GO:0042531 positive regulation of tyrosine phosphorylation of STAT protein
|
11
|
2.38e-02
|
3.94e-01
|
2.51e-01
|
GO:0000502 proteasome complex
|
56
|
3.66e-07
|
3.93e-01
|
1.26e-04
|
GO:0003857 3-hydroxyacyl-CoA dehydrogenase activity
|
6
|
9.59e-02
|
3.93e-01
|
4.43e-01
|
GO:0034616 response to laminar fluid shear stress
|
6
|
9.65e-02
|
-3.92e-01
|
4.46e-01
|
GO:0034121 regulation of toll-like receptor signaling pathway
|
9
|
4.21e-02
|
-3.91e-01
|
3.22e-01
|
GO:0030020 extracellular matrix structural constituent conferring tensile strength
|
16
|
6.76e-03
|
-3.91e-01
|
1.45e-01
|
GO:0086004 regulation of cardiac muscle cell contraction
|
6
|
9.72e-02
|
3.91e-01
|
4.47e-01
|
GO:1905198 manchette assembly
|
5
|
1.30e-01
|
3.91e-01
|
5.07e-01
|
GO:0006607 NLS-bearing protein import into nucleus
|
14
|
1.14e-02
|
-3.91e-01
|
1.89e-01
|
GO:0015431 ABC-type glutathione S-conjugate transporter activity
|
6
|
9.80e-02
|
-3.90e-01
|
4.49e-01
|
GO:0000076 DNA replication checkpoint signaling
|
11
|
2.52e-02
|
-3.90e-01
|
2.58e-01
|
GO:0060976 coronary vasculature development
|
17
|
5.44e-03
|
-3.89e-01
|
1.25e-01
|
GO:0071393 cellular response to progesterone stimulus
|
5
|
1.32e-01
|
-3.89e-01
|
5.10e-01
|
GO:0035097 histone methyltransferase complex
|
24
|
9.69e-04
|
-3.89e-01
|
4.29e-02
|
GO:0015193 L-proline transmembrane transporter activity
|
5
|
1.32e-01
|
-3.89e-01
|
5.11e-01
|
GO:0060789 hair follicle placode formation
|
5
|
1.33e-01
|
-3.88e-01
|
5.11e-01
|
GO:0006171 cAMP biosynthetic process
|
6
|
9.95e-02
|
-3.88e-01
|
4.52e-01
|
GO:0035435 phosphate ion transmembrane transport
|
11
|
2.58e-02
|
-3.88e-01
|
2.60e-01
|
GO:0000288 nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay
|
13
|
1.55e-02
|
-3.88e-01
|
2.16e-01
|
GO:0048589 developmental growth
|
15
|
9.34e-03
|
-3.88e-01
|
1.72e-01
|
GO:0141069 receptor ligand inhibitor activity
|
5
|
1.34e-01
|
3.87e-01
|
5.12e-01
|
GO:0000447 endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
|
9
|
4.45e-02
|
-3.87e-01
|
3.31e-01
|
GO:0098505 G-rich strand telomeric DNA binding
|
10
|
3.42e-02
|
-3.87e-01
|
2.91e-01
|
GO:0060538 skeletal muscle organ development
|
5
|
1.34e-01
|
3.87e-01
|
5.13e-01
|
GO:0042301 phosphate ion binding
|
6
|
1.01e-01
|
-3.86e-01
|
4.55e-01
|
GO:0070231 T cell apoptotic process
|
9
|
4.49e-02
|
3.86e-01
|
3.32e-01
|
GO:1904778 positive regulation of protein localization to cell cortex
|
5
|
1.35e-01
|
-3.86e-01
|
5.14e-01
|
GO:0005522 profilin binding
|
10
|
3.46e-02
|
-3.86e-01
|
2.92e-01
|
GO:0030118 clathrin coat
|
5
|
1.36e-01
|
-3.85e-01
|
5.16e-01
|
GO:0071541 eukaryotic translation initiation factor 3 complex, eIF3m
|
7
|
7.83e-02
|
3.84e-01
|
4.09e-01
|
GO:0071716 leukotriene transport
|
5
|
1.37e-01
|
-3.84e-01
|
5.17e-01
|
GO:0035082 axoneme assembly
|
13
|
1.67e-02
|
3.83e-01
|
2.20e-01
|
GO:0042719 mitochondrial intermembrane space protein transporter complex
|
6
|
1.04e-01
|
-3.83e-01
|
4.58e-01
|
GO:0014808 release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
|
6
|
1.05e-01
|
3.82e-01
|
4.60e-01
|
GO:0060296 regulation of cilium beat frequency involved in ciliary motility
|
6
|
1.06e-01
|
3.82e-01
|
4.60e-01
|
GO:0042754 negative regulation of circadian rhythm
|
6
|
1.06e-01
|
-3.81e-01
|
4.61e-01
|
GO:0032405 MutLalpha complex binding
|
6
|
1.06e-01
|
-3.81e-01
|
4.61e-01
|
GO:0010761 fibroblast migration
|
13
|
1.75e-02
|
-3.81e-01
|
2.23e-01
|
GO:0033189 response to vitamin A
|
7
|
8.14e-02
|
-3.80e-01
|
4.14e-01
|
GO:0035771 interleukin-4-mediated signaling pathway
|
5
|
1.41e-01
|
-3.80e-01
|
5.25e-01
|
GO:0000731 DNA synthesis involved in DNA repair
|
13
|
1.77e-02
|
-3.80e-01
|
2.23e-01
|
GO:0008306 associative learning
|
17
|
6.71e-03
|
-3.80e-01
|
1.45e-01
|
GO:0051248 negative regulation of protein metabolic process
|
6
|
1.07e-01
|
-3.80e-01
|
4.65e-01
|
GO:0034475 U4 snRNA 3’-end processing
|
8
|
6.30e-02
|
3.80e-01
|
3.72e-01
|
GO:0072091 regulation of stem cell proliferation
|
7
|
8.21e-02
|
-3.79e-01
|
4.17e-01
|
GO:0016538 cyclin-dependent protein serine/threonine kinase regulator activity
|
22
|
2.11e-03
|
-3.79e-01
|
7.00e-02
|
GO:0000995 RNA polymerase III general transcription initiation factor activity
|
12
|
2.32e-02
|
-3.79e-01
|
2.46e-01
|
GO:0051882 mitochondrial depolarization
|
6
|
1.08e-01
|
-3.79e-01
|
4.68e-01
|
GO:2001033 negative regulation of double-strand break repair via nonhomologous end joining
|
7
|
8.29e-02
|
-3.79e-01
|
4.18e-01
|
GO:0044206 UMP salvage
|
5
|
1.43e-01
|
3.78e-01
|
5.31e-01
|
GO:0043922 negative regulation by host of viral transcription
|
11
|
2.99e-02
|
-3.78e-01
|
2.75e-01
|
GO:0016918 retinal binding
|
5
|
1.43e-01
|
3.78e-01
|
5.31e-01
|
GO:0071028 nuclear mRNA surveillance
|
9
|
4.96e-02
|
3.78e-01
|
3.41e-01
|
GO:2001241 positive regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
9
|
4.97e-02
|
3.78e-01
|
3.41e-01
|
GO:0042753 positive regulation of circadian rhythm
|
7
|
8.36e-02
|
-3.78e-01
|
4.21e-01
|
GO:0005952 cAMP-dependent protein kinase complex
|
8
|
6.45e-02
|
-3.77e-01
|
3.77e-01
|
GO:0008381 mechanosensitive monoatomic ion channel activity
|
7
|
8.41e-02
|
-3.77e-01
|
4.22e-01
|
GO:0002026 regulation of the force of heart contraction
|
8
|
6.52e-02
|
-3.77e-01
|
3.78e-01
|
GO:0032964 collagen biosynthetic process
|
8
|
6.52e-02
|
-3.77e-01
|
3.78e-01
|
GO:0035825 homologous recombination
|
10
|
3.94e-02
|
-3.76e-01
|
3.10e-01
|
GO:0004601 peroxidase activity
|
14
|
1.49e-02
|
3.76e-01
|
2.11e-01
|
GO:0099617 matrix side of mitochondrial inner membrane
|
7
|
8.52e-02
|
-3.76e-01
|
4.24e-01
|
GO:0043651 linoleic acid metabolic process
|
9
|
5.11e-02
|
-3.76e-01
|
3.43e-01
|
GO:0005903 brush border
|
34
|
1.53e-04
|
-3.75e-01
|
1.22e-02
|
GO:0070836 caveola assembly
|
6
|
1.12e-01
|
-3.75e-01
|
4.74e-01
|
GO:0006640 monoacylglycerol biosynthetic process
|
5
|
1.47e-01
|
-3.75e-01
|
5.38e-01
|
GO:0002227 innate immune response in mucosa
|
5
|
1.47e-01
|
3.75e-01
|
5.38e-01
|
GO:0043378 positive regulation of CD8-positive, alpha-beta T cell differentiation
|
5
|
1.48e-01
|
-3.74e-01
|
5.38e-01
|
GO:0034405 response to fluid shear stress
|
5
|
1.48e-01
|
3.74e-01
|
5.38e-01
|
GO:0004536 DNA nuclease activity
|
5
|
1.48e-01
|
-3.73e-01
|
5.39e-01
|
GO:0043186 P granule
|
12
|
2.52e-02
|
-3.73e-01
|
2.58e-01
|
GO:0051639 actin filament network formation
|
8
|
6.77e-02
|
-3.73e-01
|
3.85e-01
|
GO:0042998 positive regulation of Golgi to plasma membrane protein transport
|
5
|
1.49e-01
|
3.73e-01
|
5.39e-01
|
GO:0051058 negative regulation of small GTPase mediated signal transduction
|
8
|
6.78e-02
|
-3.73e-01
|
3.85e-01
|
GO:0061061 muscle structure development
|
5
|
1.49e-01
|
-3.73e-01
|
5.39e-01
|
GO:0002262 myeloid cell homeostasis
|
9
|
5.30e-02
|
-3.73e-01
|
3.50e-01
|
GO:0007406 negative regulation of neuroblast proliferation
|
6
|
1.14e-01
|
3.72e-01
|
4.78e-01
|
GO:0048148 behavioral response to cocaine
|
9
|
5.34e-02
|
-3.72e-01
|
3.50e-01
|
GO:0070098 chemokine-mediated signaling pathway
|
17
|
7.96e-03
|
-3.72e-01
|
1.57e-01
|
GO:0008298 intracellular mRNA localization
|
7
|
8.96e-02
|
-3.70e-01
|
4.33e-01
|
GO:0050777 negative regulation of immune response
|
9
|
5.43e-02
|
3.70e-01
|
3.52e-01
|
GO:0051057 positive regulation of small GTPase mediated signal transduction
|
5
|
1.52e-01
|
-3.70e-01
|
5.45e-01
|
GO:0071380 cellular response to prostaglandin E stimulus
|
11
|
3.36e-02
|
-3.70e-01
|
2.91e-01
|
GO:0032793 positive regulation of CREB transcription factor activity
|
6
|
1.17e-01
|
-3.69e-01
|
4.84e-01
|
GO:0043149 stress fiber assembly
|
19
|
5.37e-03
|
-3.69e-01
|
1.25e-01
|
GO:0048663 neuron fate commitment
|
6
|
1.18e-01
|
-3.69e-01
|
4.84e-01
|
GO:0035148 tube formation
|
7
|
9.10e-02
|
-3.69e-01
|
4.35e-01
|
GO:0097178 ruffle assembly
|
10
|
4.36e-02
|
-3.69e-01
|
3.28e-01
|
GO:0030070 insulin processing
|
6
|
1.18e-01
|
3.68e-01
|
4.84e-01
|
GO:0051775 response to redox state
|
9
|
5.58e-02
|
3.68e-01
|
3.53e-01
|
GO:1903546 protein localization to photoreceptor outer segment
|
5
|
1.54e-01
|
3.68e-01
|
5.48e-01
|
GO:0003341 cilium movement
|
8
|
7.16e-02
|
3.68e-01
|
3.92e-01
|
GO:1903038 negative regulation of leukocyte cell-cell adhesion
|
5
|
1.55e-01
|
3.67e-01
|
5.50e-01
|
GO:0055064 chloride ion homeostasis
|
7
|
9.25e-02
|
-3.67e-01
|
4.38e-01
|
GO:0042800 histone H3K4 methyltransferase activity
|
12
|
2.78e-02
|
-3.67e-01
|
2.66e-01
|
GO:0048268 clathrin coat assembly
|
13
|
2.21e-02
|
-3.67e-01
|
2.41e-01
|
GO:0048007 antigen processing and presentation, exogenous lipid antigen via MHC class Ib
|
5
|
1.56e-01
|
-3.67e-01
|
5.51e-01
|
GO:0030863 cortical cytoskeleton
|
15
|
1.40e-02
|
-3.67e-01
|
2.06e-01
|
GO:0021954 central nervous system neuron development
|
7
|
9.38e-02
|
-3.66e-01
|
4.40e-01
|
GO:0042641 actomyosin
|
8
|
7.34e-02
|
-3.66e-01
|
3.95e-01
|
GO:0086005 ventricular cardiac muscle cell action potential
|
7
|
9.40e-02
|
3.66e-01
|
4.40e-01
|
GO:0072383 plus-end-directed vesicle transport along microtubule
|
6
|
1.21e-01
|
3.65e-01
|
4.91e-01
|
GO:0071294 cellular response to zinc ion
|
16
|
1.14e-02
|
3.65e-01
|
1.89e-01
|
GO:0048668 collateral sprouting
|
8
|
7.39e-02
|
-3.65e-01
|
3.96e-01
|
GO:0014911 positive regulation of smooth muscle cell migration
|
14
|
1.82e-02
|
-3.64e-01
|
2.26e-01
|
GO:0043504 mitochondrial DNA repair
|
8
|
7.45e-02
|
-3.64e-01
|
3.98e-01
|
GO:0060236 regulation of mitotic spindle organization
|
17
|
9.40e-03
|
-3.64e-01
|
1.72e-01
|
GO:0010888 negative regulation of lipid storage
|
7
|
9.57e-02
|
-3.64e-01
|
4.43e-01
|
GO:0061733 peptide-lysine-N-acetyltransferase activity
|
12
|
2.92e-02
|
-3.64e-01
|
2.71e-01
|
GO:0061469 regulation of type B pancreatic cell proliferation
|
6
|
1.23e-01
|
3.64e-01
|
4.96e-01
|
GO:0035457 cellular response to interferon-alpha
|
7
|
9.63e-02
|
3.63e-01
|
4.45e-01
|
GO:0001895 retina homeostasis
|
5
|
1.60e-01
|
3.63e-01
|
5.60e-01
|
GO:0009972 cytidine deamination
|
6
|
1.24e-01
|
3.62e-01
|
4.98e-01
|
GO:0032395 MHC class II receptor activity
|
8
|
7.60e-02
|
-3.62e-01
|
4.04e-01
|
GO:0034056 estrogen response element binding
|
7
|
9.71e-02
|
-3.62e-01
|
4.47e-01
|
GO:0046755 viral budding
|
8
|
7.62e-02
|
3.62e-01
|
4.04e-01
|
GO:1902475 L-alpha-amino acid transmembrane transport
|
5
|
1.61e-01
|
3.62e-01
|
5.61e-01
|
GO:0002315 marginal zone B cell differentiation
|
8
|
7.64e-02
|
-3.62e-01
|
4.04e-01
|
GO:0008235 metalloexopeptidase activity
|
10
|
4.78e-02
|
-3.62e-01
|
3.39e-01
|
GO:0005313 L-glutamate transmembrane transporter activity
|
8
|
7.68e-02
|
-3.61e-01
|
4.05e-01
|
GO:0031080 nuclear pore outer ring
|
10
|
4.79e-02
|
-3.61e-01
|
3.39e-01
|
GO:0001652 granular component
|
6
|
1.26e-01
|
-3.61e-01
|
5.01e-01
|
GO:0003678 DNA helicase activity
|
33
|
3.35e-04
|
-3.61e-01
|
2.16e-02
|
GO:0110025 DNA strand resection involved in replication fork processing
|
8
|
7.73e-02
|
-3.61e-01
|
4.07e-01
|
GO:0055003 cardiac myofibril assembly
|
5
|
1.63e-01
|
-3.60e-01
|
5.65e-01
|
GO:1900222 negative regulation of amyloid-beta clearance
|
6
|
1.27e-01
|
-3.60e-01
|
5.03e-01
|
GO:0009142 nucleoside triphosphate biosynthetic process
|
5
|
1.63e-01
|
3.60e-01
|
5.65e-01
|
GO:0052739 phosphatidylserine 1-acylhydrolase activity
|
7
|
9.91e-02
|
3.60e-01
|
4.51e-01
|
GO:0031123 RNA 3’-end processing
|
9
|
6.17e-02
|
-3.60e-01
|
3.68e-01
|
GO:0045955 negative regulation of calcium ion-dependent exocytosis
|
5
|
1.64e-01
|
-3.60e-01
|
5.66e-01
|
GO:0031681 G-protein beta-subunit binding
|
8
|
7.84e-02
|
3.59e-01
|
4.09e-01
|
GO:0070383 DNA cytosine deamination
|
8
|
7.84e-02
|
3.59e-01
|
4.09e-01
|
GO:0045637 regulation of myeloid cell differentiation
|
5
|
1.64e-01
|
-3.59e-01
|
5.66e-01
|
GO:0006346 DNA methylation-dependent constitutive heterochromatin formation
|
21
|
4.36e-03
|
-3.59e-01
|
1.13e-01
|
GO:0007097 nuclear migration
|
17
|
1.03e-02
|
-3.59e-01
|
1.82e-01
|
GO:0004065 arylsulfatase activity
|
8
|
7.85e-02
|
3.59e-01
|
4.09e-01
|
GO:0031143 pseudopodium
|
13
|
2.51e-02
|
-3.59e-01
|
2.58e-01
|
GO:0035904 aorta development
|
18
|
8.44e-03
|
-3.59e-01
|
1.61e-01
|
GO:0008327 methyl-CpG binding
|
21
|
4.45e-03
|
-3.59e-01
|
1.13e-01
|
GO:1900121 negative regulation of receptor binding
|
6
|
1.29e-01
|
-3.58e-01
|
5.06e-01
|
GO:1904724 tertiary granule lumen
|
40
|
9.00e-05
|
3.58e-01
|
8.12e-03
|
GO:0140092 bBAF complex
|
9
|
6.30e-02
|
-3.58e-01
|
3.72e-01
|
GO:0045945 positive regulation of transcription by RNA polymerase III
|
17
|
1.07e-02
|
-3.58e-01
|
1.85e-01
|
GO:0050665 hydrogen peroxide biosynthetic process
|
6
|
1.29e-01
|
3.58e-01
|
5.06e-01
|
GO:0090666 scaRNA localization to Cajal body
|
5
|
1.66e-01
|
-3.58e-01
|
5.70e-01
|
GO:0000030 mannosyltransferase activity
|
15
|
1.65e-02
|
-3.57e-01
|
2.20e-01
|
GO:0000492 box C/D snoRNP assembly
|
8
|
8.00e-02
|
3.57e-01
|
4.12e-01
|
GO:1901098 positive regulation of autophagosome maturation
|
6
|
1.30e-01
|
3.57e-01
|
5.07e-01
|
GO:0032651 regulation of interleukin-1 beta production
|
5
|
1.67e-01
|
3.57e-01
|
5.71e-01
|
GO:0045504 dynein heavy chain binding
|
7
|
1.02e-01
|
3.57e-01
|
4.55e-01
|
GO:0060670 branching involved in labyrinthine layer morphogenesis
|
7
|
1.02e-01
|
-3.57e-01
|
4.55e-01
|
GO:1902042 negative regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
21
|
4.67e-03
|
-3.57e-01
|
1.15e-01
|
GO:0004032 aldose reductase (NADPH) activity
|
6
|
1.31e-01
|
3.56e-01
|
5.07e-01
|
GO:0003351 epithelial cilium movement involved in extracellular fluid movement
|
14
|
2.10e-02
|
3.56e-01
|
2.38e-01
|
GO:0033234 negative regulation of protein sumoylation
|
8
|
8.12e-02
|
-3.56e-01
|
4.14e-01
|
GO:0014047 glutamate secretion
|
5
|
1.68e-01
|
3.56e-01
|
5.73e-01
|
GO:0033157 regulation of intracellular protein transport
|
5
|
1.68e-01
|
-3.56e-01
|
5.73e-01
|
GO:0051213 dioxygenase activity
|
8
|
8.14e-02
|
3.56e-01
|
4.14e-01
|
GO:0045182 translation regulator activity
|
11
|
4.12e-02
|
3.55e-01
|
3.19e-01
|
GO:0101019 nucleolar exosome (RNase complex)
|
10
|
5.17e-02
|
3.55e-01
|
3.45e-01
|
GO:0008206 bile acid metabolic process
|
9
|
6.50e-02
|
-3.55e-01
|
3.78e-01
|
GO:0045603 positive regulation of endothelial cell differentiation
|
7
|
1.04e-01
|
-3.55e-01
|
4.56e-01
|
GO:0060856 establishment of blood-brain barrier
|
6
|
1.33e-01
|
3.55e-01
|
5.11e-01
|
GO:1900087 positive regulation of G1/S transition of mitotic cell cycle
|
32
|
5.22e-04
|
-3.54e-01
|
3.01e-02
|
GO:0008035 high-density lipoprotein particle binding
|
8
|
8.27e-02
|
-3.54e-01
|
4.18e-01
|
GO:0034501 protein localization to kinetochore
|
11
|
4.19e-02
|
-3.54e-01
|
3.22e-01
|
GO:0006625 protein targeting to peroxisome
|
10
|
5.24e-02
|
3.54e-01
|
3.48e-01
|
GO:0031100 animal organ regeneration
|
20
|
6.11e-03
|
-3.54e-01
|
1.36e-01
|
GO:0043200 response to amino acid
|
12
|
3.38e-02
|
-3.54e-01
|
2.91e-01
|
GO:0048102 autophagic cell death
|
5
|
1.71e-01
|
3.54e-01
|
5.76e-01
|
GO:0018394 peptidyl-lysine acetylation
|
6
|
1.34e-01
|
-3.54e-01
|
5.12e-01
|
GO:0004527 exonuclease activity
|
12
|
3.43e-02
|
-3.53e-01
|
2.91e-01
|
GO:0005797 Golgi medial cisterna
|
9
|
6.67e-02
|
3.53e-01
|
3.82e-01
|
GO:0031514 motile cilium
|
62
|
1.57e-06
|
3.53e-01
|
3.41e-04
|
GO:0090559 regulation of membrane permeability
|
5
|
1.72e-01
|
-3.53e-01
|
5.77e-01
|
GO:0033018 sarcoplasmic reticulum lumen
|
5
|
1.72e-01
|
-3.53e-01
|
5.77e-01
|
GO:0042262 DNA protection
|
5
|
1.72e-01
|
-3.53e-01
|
5.77e-01
|
GO:0002437 inflammatory response to antigenic stimulus
|
13
|
2.78e-02
|
-3.52e-01
|
2.66e-01
|
GO:0008202 steroid metabolic process
|
11
|
4.32e-02
|
-3.52e-01
|
3.27e-01
|
GO:0098992 neuronal dense core vesicle
|
6
|
1.36e-01
|
-3.52e-01
|
5.15e-01
|
GO:0035909 aorta morphogenesis
|
8
|
8.48e-02
|
-3.52e-01
|
4.23e-01
|
GO:0071800 podosome assembly
|
7
|
1.07e-01
|
-3.52e-01
|
4.65e-01
|
GO:0048020 CCR chemokine receptor binding
|
11
|
4.35e-02
|
-3.52e-01
|
3.28e-01
|
GO:0006777 Mo-molybdopterin cofactor biosynthetic process
|
5
|
1.74e-01
|
-3.51e-01
|
5.78e-01
|
GO:1990414 replication-born double-strand break repair via sister chromatid exchange
|
6
|
1.37e-01
|
-3.51e-01
|
5.16e-01
|
GO:0048266 behavioral response to pain
|
10
|
5.51e-02
|
3.50e-01
|
3.53e-01
|
GO:0014037 Schwann cell differentiation
|
6
|
1.37e-01
|
-3.50e-01
|
5.18e-01
|
GO:0006801 superoxide metabolic process
|
15
|
1.89e-02
|
3.50e-01
|
2.27e-01
|
GO:0048146 positive regulation of fibroblast proliferation
|
35
|
3.39e-04
|
-3.50e-01
|
2.16e-02
|
GO:0005688 U6 snRNP
|
8
|
8.66e-02
|
-3.50e-01
|
4.26e-01
|
GO:0070061 fructose binding
|
5
|
1.76e-01
|
-3.49e-01
|
5.78e-01
|
GO:0140627 ubiquitin-dependent protein catabolic process via the C-end degron rule pathway
|
12
|
3.62e-02
|
-3.49e-01
|
2.97e-01
|
GO:0009052 pentose-phosphate shunt, non-oxidative branch
|
5
|
1.76e-01
|
3.49e-01
|
5.78e-01
|
GO:0035748 myelin sheath abaxonal region
|
5
|
1.77e-01
|
3.49e-01
|
5.78e-01
|
GO:0003161 cardiac conduction system development
|
9
|
7.01e-02
|
3.49e-01
|
3.89e-01
|
GO:0034351 negative regulation of glial cell apoptotic process
|
9
|
7.01e-02
|
-3.49e-01
|
3.89e-01
|
GO:0043276 anoikis
|
11
|
4.56e-02
|
-3.48e-01
|
3.35e-01
|
GO:0015721 bile acid and bile salt transport
|
10
|
5.67e-02
|
-3.48e-01
|
3.54e-01
|
GO:0071377 cellular response to glucagon stimulus
|
5
|
1.79e-01
|
-3.47e-01
|
5.81e-01
|
GO:0003720 telomerase activity
|
5
|
1.79e-01
|
-3.47e-01
|
5.81e-01
|
GO:0006207 ‘de novo’ pyrimidine nucleobase biosynthetic process
|
5
|
1.79e-01
|
-3.47e-01
|
5.81e-01
|
GO:0070723 response to cholesterol
|
8
|
8.92e-02
|
-3.47e-01
|
4.33e-01
|
GO:0034392 negative regulation of smooth muscle cell apoptotic process
|
6
|
1.41e-01
|
-3.47e-01
|
5.25e-01
|
GO:0006337 nucleosome disassembly
|
17
|
1.33e-02
|
-3.47e-01
|
2.03e-01
|
GO:0036002 pre-mRNA binding
|
15
|
2.01e-02
|
-3.47e-01
|
2.33e-01
|
GO:0061133 endopeptidase activator activity
|
14
|
2.47e-02
|
3.47e-01
|
2.58e-01
|
GO:0002755 MyD88-dependent toll-like receptor signaling pathway
|
14
|
2.48e-02
|
-3.47e-01
|
2.58e-01
|
GO:0016836 hydro-lyase activity
|
5
|
1.80e-01
|
3.46e-01
|
5.83e-01
|
GO:0045428 regulation of nitric oxide biosynthetic process
|
8
|
9.00e-02
|
3.46e-01
|
4.33e-01
|
GO:0090594 inflammatory response to wounding
|
5
|
1.80e-01
|
-3.46e-01
|
5.83e-01
|
GO:0042809 nuclear vitamin D receptor binding
|
15
|
2.04e-02
|
-3.46e-01
|
2.35e-01
|
GO:0034354 ‘de novo’ NAD biosynthetic process from tryptophan
|
5
|
1.81e-01
|
3.46e-01
|
5.83e-01
|
GO:0019371 cyclooxygenase pathway
|
8
|
9.06e-02
|
3.46e-01
|
4.35e-01
|
GO:2000643 positive regulation of early endosome to late endosome transport
|
9
|
7.27e-02
|
-3.45e-01
|
3.93e-01
|
GO:0051310 metaphase chromosome alignment
|
12
|
3.85e-02
|
-3.45e-01
|
3.07e-01
|
GO:0042088 T-helper 1 type immune response
|
7
|
1.14e-01
|
-3.45e-01
|
4.78e-01
|
GO:0070848 response to growth factor
|
8
|
9.14e-02
|
-3.45e-01
|
4.36e-01
|
GO:0006829 zinc ion transport
|
7
|
1.14e-01
|
-3.45e-01
|
4.78e-01
|
GO:0000338 protein deneddylation
|
11
|
4.80e-02
|
3.44e-01
|
3.39e-01
|
GO:0071514 genomic imprinting
|
11
|
4.80e-02
|
-3.44e-01
|
3.39e-01
|
GO:0061626 pharyngeal arch artery morphogenesis
|
6
|
1.44e-01
|
3.44e-01
|
5.33e-01
|
GO:0002116 semaphorin receptor complex
|
11
|
4.86e-02
|
-3.44e-01
|
3.39e-01
|
GO:0008525 phosphatidylcholine transporter activity
|
6
|
1.45e-01
|
-3.43e-01
|
5.35e-01
|
GO:1990961 xenobiotic detoxification by transmembrane export across the plasma membrane
|
6
|
1.45e-01
|
3.43e-01
|
5.35e-01
|
GO:0000220 vacuolar proton-transporting V-type ATPase, V0 domain
|
9
|
7.45e-02
|
-3.43e-01
|
3.98e-01
|
GO:0034115 negative regulation of heterotypic cell-cell adhesion
|
8
|
9.29e-02
|
-3.43e-01
|
4.39e-01
|
GO:0071806 protein transmembrane transport
|
15
|
2.14e-02
|
3.43e-01
|
2.41e-01
|
GO:0018022 peptidyl-lysine methylation
|
6
|
1.46e-01
|
3.43e-01
|
5.36e-01
|
GO:0015183 L-aspartate transmembrane transporter activity
|
6
|
1.46e-01
|
-3.43e-01
|
5.37e-01
|
GO:0044528 regulation of mitochondrial mRNA stability
|
7
|
1.17e-01
|
-3.43e-01
|
4.81e-01
|
GO:0032453 histone H3K4 demethylase activity
|
6
|
1.46e-01
|
-3.43e-01
|
5.37e-01
|
GO:0001780 neutrophil homeostasis
|
7
|
1.17e-01
|
-3.43e-01
|
4.81e-01
|
GO:0045842 positive regulation of mitotic metaphase/anaphase transition
|
11
|
4.94e-02
|
-3.42e-01
|
3.41e-01
|
GO:0042407 cristae formation
|
15
|
2.18e-02
|
-3.42e-01
|
2.41e-01
|
GO:0001935 endothelial cell proliferation
|
17
|
1.47e-02
|
3.42e-01
|
2.09e-01
|
GO:0019640 D-glucuronate catabolic process to D-xylulose 5-phosphate
|
5
|
1.86e-01
|
-3.42e-01
|
5.88e-01
|
GO:0090140 regulation of mitochondrial fission
|
5
|
1.86e-01
|
-3.42e-01
|
5.88e-01
|
GO:0006096 glycolytic process
|
29
|
1.46e-03
|
-3.41e-01
|
5.59e-02
|
GO:0007398 ectoderm development
|
8
|
9.45e-02
|
-3.41e-01
|
4.40e-01
|
GO:0005721 pericentric heterochromatin
|
29
|
1.47e-03
|
-3.41e-01
|
5.59e-02
|
GO:0017056 structural constituent of nuclear pore
|
21
|
6.84e-03
|
-3.41e-01
|
1.45e-01
|
GO:0007019 microtubule depolymerization
|
10
|
6.19e-02
|
-3.41e-01
|
3.68e-01
|
GO:0000828 inositol hexakisphosphate kinase activity
|
6
|
1.48e-01
|
-3.41e-01
|
5.39e-01
|
GO:0006287 base-excision repair, gap-filling
|
13
|
3.34e-02
|
-3.41e-01
|
2.91e-01
|
GO:0031629 synaptic vesicle fusion to presynaptic active zone membrane
|
7
|
1.19e-01
|
3.41e-01
|
4.84e-01
|
GO:0007520 myoblast fusion
|
12
|
4.12e-02
|
-3.40e-01
|
3.18e-01
|
GO:0001221 transcription coregulator binding
|
27
|
2.20e-03
|
-3.40e-01
|
7.22e-02
|
GO:0008406 gonad development
|
5
|
1.88e-01
|
3.40e-01
|
5.91e-01
|
GO:0120103 centriolar subdistal appendage
|
9
|
7.76e-02
|
-3.40e-01
|
4.07e-01
|
GO:0044770 cell cycle phase transition
|
6
|
1.50e-01
|
-3.39e-01
|
5.43e-01
|
GO:0045910 negative regulation of DNA recombination
|
6
|
1.51e-01
|
-3.39e-01
|
5.44e-01
|
GO:1900272 negative regulation of long-term synaptic potentiation
|
8
|
9.74e-02
|
3.38e-01
|
4.47e-01
|
GO:0007044 cell-substrate junction assembly
|
6
|
1.51e-01
|
-3.38e-01
|
5.44e-01
|
GO:0050793 regulation of developmental process
|
7
|
1.22e-01
|
-3.38e-01
|
4.92e-01
|
GO:0070776 MOZ/MORF histone acetyltransferase complex
|
7
|
1.22e-01
|
-3.38e-01
|
4.92e-01
|
GO:0120183 positive regulation of focal adhesion disassembly
|
6
|
1.52e-01
|
-3.37e-01
|
5.46e-01
|
GO:0015180 L-alanine transmembrane transporter activity
|
7
|
1.22e-01
|
-3.37e-01
|
4.94e-01
|
GO:0017070 U6 snRNA binding
|
12
|
4.32e-02
|
-3.37e-01
|
3.27e-01
|
GO:0052629 phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity
|
11
|
5.30e-02
|
-3.37e-01
|
3.50e-01
|
GO:0110016 B-WICH complex
|
8
|
9.89e-02
|
-3.37e-01
|
4.51e-01
|
GO:0140945 histone H3K4 monomethyltransferase activity
|
8
|
9.92e-02
|
-3.37e-01
|
4.51e-01
|
GO:0060076 excitatory synapse
|
16
|
1.98e-02
|
-3.37e-01
|
2.33e-01
|
GO:0061909 autophagosome-lysosome fusion
|
10
|
6.54e-02
|
-3.37e-01
|
3.78e-01
|
GO:2000330 positive regulation of T-helper 17 cell lineage commitment
|
6
|
1.54e-01
|
-3.36e-01
|
5.48e-01
|
GO:0031404 chloride ion binding
|
5
|
1.93e-01
|
-3.36e-01
|
5.98e-01
|
GO:0071813 lipoprotein particle binding
|
5
|
1.94e-01
|
-3.35e-01
|
5.98e-01
|
GO:0019871 sodium channel inhibitor activity
|
5
|
1.94e-01
|
3.35e-01
|
5.98e-01
|
GO:0030014 CCR4-NOT complex
|
16
|
2.03e-02
|
-3.35e-01
|
2.35e-01
|
GO:1903351 cellular response to dopamine
|
6
|
1.55e-01
|
-3.35e-01
|
5.51e-01
|
GO:0031402 sodium ion binding
|
5
|
1.95e-01
|
-3.35e-01
|
5.99e-01
|
GO:0022400 regulation of opsin-mediated signaling pathway
|
7
|
1.26e-01
|
3.34e-01
|
5.01e-01
|
GO:0042711 maternal behavior
|
5
|
1.96e-01
|
3.34e-01
|
6.01e-01
|
GO:0070937 CRD-mediated mRNA stability complex
|
5
|
1.97e-01
|
-3.34e-01
|
6.01e-01
|
GO:0106015 negative regulation of inflammatory response to wounding
|
6
|
1.57e-01
|
-3.33e-01
|
5.55e-01
|
GO:0005315 phosphate transmembrane transporter activity
|
6
|
1.58e-01
|
-3.33e-01
|
5.56e-01
|
GO:0001523 retinoid metabolic process
|
15
|
2.56e-02
|
3.33e-01
|
2.60e-01
|
GO:0030539 male genitalia development
|
8
|
1.03e-01
|
-3.32e-01
|
4.56e-01
|
GO:1900744 regulation of p38MAPK cascade
|
7
|
1.28e-01
|
-3.32e-01
|
5.06e-01
|
GO:0034162 toll-like receptor 9 signaling pathway
|
7
|
1.28e-01
|
-3.32e-01
|
5.06e-01
|
GO:0003091 renal water homeostasis
|
6
|
1.59e-01
|
-3.32e-01
|
5.59e-01
|
GO:0097197 tetraspanin-enriched microdomain
|
9
|
8.51e-02
|
-3.31e-01
|
4.24e-01
|
GO:0042903 tubulin deacetylase activity
|
7
|
1.29e-01
|
-3.31e-01
|
5.06e-01
|
GO:0032330 regulation of chondrocyte differentiation
|
7
|
1.29e-01
|
-3.31e-01
|
5.06e-01
|
GO:0033554 cellular response to stress
|
12
|
4.71e-02
|
-3.31e-01
|
3.39e-01
|
GO:0160111 axonemal A tubule inner sheath
|
7
|
1.29e-01
|
3.31e-01
|
5.06e-01
|
GO:1900029 positive regulation of ruffle assembly
|
11
|
5.74e-02
|
-3.31e-01
|
3.55e-01
|
GO:0021819 layer formation in cerebral cortex
|
10
|
7.00e-02
|
-3.31e-01
|
3.89e-01
|
GO:0016282 eukaryotic 43S preinitiation complex
|
17
|
1.83e-02
|
3.31e-01
|
2.26e-01
|
GO:0015014 heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process
|
6
|
1.61e-01
|
3.30e-01
|
5.61e-01
|
GO:0045071 negative regulation of viral genome replication
|
36
|
6.04e-04
|
3.30e-01
|
3.22e-02
|
GO:0120199 cone photoreceptor outer segment
|
5
|
2.01e-01
|
3.30e-01
|
6.05e-01
|
GO:0001091 RNA polymerase II general transcription initiation factor binding
|
6
|
1.62e-01
|
-3.30e-01
|
5.62e-01
|
GO:1904037 positive regulation of epithelial cell apoptotic process
|
5
|
2.02e-01
|
-3.30e-01
|
6.05e-01
|
GO:0001832 blastocyst growth
|
5
|
2.02e-01
|
3.30e-01
|
6.05e-01
|
GO:0035032 phosphatidylinositol 3-kinase complex, class III
|
6
|
1.62e-01
|
3.30e-01
|
5.63e-01
|
GO:0035976 transcription factor AP-1 complex
|
6
|
1.62e-01
|
-3.29e-01
|
5.63e-01
|
GO:0005859 muscle myosin complex
|
5
|
2.02e-01
|
3.29e-01
|
6.05e-01
|
GO:0035739 CD4-positive, alpha-beta T cell proliferation
|
6
|
1.63e-01
|
3.29e-01
|
5.65e-01
|
GO:0050650 chondroitin sulfate proteoglycan biosynthetic process
|
9
|
8.75e-02
|
3.29e-01
|
4.29e-01
|
GO:0097435 supramolecular fiber organization
|
10
|
7.22e-02
|
3.28e-01
|
3.93e-01
|
GO:0051011 microtubule minus-end binding
|
13
|
4.05e-02
|
-3.28e-01
|
3.15e-01
|
GO:0061649 ubiquitin-modified histone reader activity
|
8
|
1.09e-01
|
-3.28e-01
|
4.69e-01
|
GO:0031588 nucleotide-activated protein kinase complex
|
10
|
7.32e-02
|
-3.27e-01
|
3.95e-01
|
GO:0006360 transcription by RNA polymerase I
|
18
|
1.63e-02
|
-3.27e-01
|
2.18e-01
|
GO:0050873 brown fat cell differentiation
|
21
|
9.48e-03
|
3.27e-01
|
1.73e-01
|
GO:0001967 suckling behavior
|
6
|
1.65e-01
|
3.27e-01
|
5.68e-01
|
GO:0120044 stereocilium base
|
5
|
2.06e-01
|
-3.27e-01
|
6.11e-01
|
GO:0005123 death receptor binding
|
15
|
2.86e-02
|
-3.27e-01
|
2.70e-01
|
GO:0019222 regulation of metabolic process
|
8
|
1.10e-01
|
-3.26e-01
|
4.71e-01
|
GO:0006796 phosphate-containing compound metabolic process
|
12
|
5.03e-02
|
3.26e-01
|
3.42e-01
|
GO:0071447 cellular response to hydroperoxide
|
5
|
2.07e-01
|
-3.26e-01
|
6.11e-01
|
GO:0022625 cytosolic large ribosomal subunit
|
52
|
4.85e-05
|
3.26e-01
|
5.27e-03
|
GO:0016602 CCAAT-binding factor complex
|
5
|
2.07e-01
|
-3.26e-01
|
6.11e-01
|
GO:0050930 induction of positive chemotaxis
|
8
|
1.11e-01
|
3.25e-01
|
4.73e-01
|
GO:0008409 5’-3’ exonuclease activity
|
9
|
9.16e-02
|
-3.25e-01
|
4.36e-01
|
GO:0048708 astrocyte differentiation
|
9
|
9.17e-02
|
-3.25e-01
|
4.36e-01
|
GO:0004169 dolichyl-phosphate-mannose-protein mannosyltransferase activity
|
8
|
1.12e-01
|
-3.25e-01
|
4.74e-01
|
GO:0048025 negative regulation of mRNA splicing, via spliceosome
|
18
|
1.72e-02
|
-3.24e-01
|
2.20e-01
|
GO:0045672 positive regulation of osteoclast differentiation
|
18
|
1.72e-02
|
-3.24e-01
|
2.20e-01
|
GO:0006825 copper ion transport
|
9
|
9.22e-02
|
-3.24e-01
|
4.37e-01
|
GO:0060075 regulation of resting membrane potential
|
5
|
2.10e-01
|
-3.24e-01
|
6.13e-01
|
GO:0090129 positive regulation of synapse maturation
|
6
|
1.69e-01
|
-3.24e-01
|
5.75e-01
|
GO:0010744 positive regulation of macrophage derived foam cell differentiation
|
9
|
9.30e-02
|
-3.23e-01
|
4.39e-01
|
GO:0042590 antigen processing and presentation of exogenous peptide antigen via MHC class I
|
7
|
1.39e-01
|
3.23e-01
|
5.21e-01
|
GO:0008139 nuclear localization sequence binding
|
20
|
1.23e-02
|
-3.23e-01
|
1.96e-01
|
GO:0036312 phosphatidylinositol 3-kinase regulatory subunit binding
|
8
|
1.13e-01
|
-3.23e-01
|
4.77e-01
|
GO:0000794 condensed nuclear chromosome
|
33
|
1.32e-03
|
-3.23e-01
|
5.33e-02
|
GO:0051697 protein delipidation
|
5
|
2.11e-01
|
3.23e-01
|
6.15e-01
|
GO:0002102 podosome
|
37
|
6.91e-04
|
-3.22e-01
|
3.44e-02
|
GO:1902083 negative regulation of peptidyl-cysteine S-nitrosylation
|
6
|
1.72e-01
|
3.22e-01
|
5.77e-01
|
GO:0010459 negative regulation of heart rate
|
6
|
1.72e-01
|
3.22e-01
|
5.77e-01
|
GO:0120115 Lsm2-8 complex
|
7
|
1.40e-01
|
-3.22e-01
|
5.24e-01
|
GO:0045661 regulation of myoblast differentiation
|
5
|
2.13e-01
|
-3.22e-01
|
6.15e-01
|
GO:0019887 protein kinase regulator activity
|
15
|
3.11e-02
|
-3.21e-01
|
2.80e-01
|
GO:0001569 branching involved in blood vessel morphogenesis
|
14
|
3.75e-02
|
-3.21e-01
|
3.03e-01
|
GO:0032000 positive regulation of fatty acid beta-oxidation
|
6
|
1.74e-01
|
-3.20e-01
|
5.78e-01
|
GO:0038083 peptidyl-tyrosine autophosphorylation
|
6
|
1.75e-01
|
-3.20e-01
|
5.78e-01
|
GO:0051015 actin filament binding
|
147
|
2.29e-11
|
-3.20e-01
|
6.30e-08
|
GO:0033993 response to lipid
|
5
|
2.16e-01
|
3.20e-01
|
6.18e-01
|
GO:0030520 estrogen receptor signaling pathway
|
16
|
2.69e-02
|
-3.20e-01
|
2.64e-01
|
GO:1990446 U1 snRNP binding
|
7
|
1.43e-01
|
-3.19e-01
|
5.31e-01
|
GO:0030032 lamellipodium assembly
|
24
|
6.77e-03
|
-3.19e-01
|
1.45e-01
|
GO:0034553 mitochondrial respiratory chain complex II assembly
|
5
|
2.16e-01
|
3.19e-01
|
6.18e-01
|
GO:0044351 macropinocytosis
|
8
|
1.18e-01
|
-3.19e-01
|
4.84e-01
|
GO:0017124 SH3 domain binding
|
86
|
3.15e-07
|
-3.19e-01
|
1.15e-04
|
GO:0150094 amyloid-beta clearance by cellular catabolic process
|
7
|
1.44e-01
|
-3.19e-01
|
5.32e-01
|
GO:1900180 regulation of protein localization to nucleus
|
7
|
1.44e-01
|
-3.19e-01
|
5.32e-01
|
GO:0035902 response to immobilization stress
|
13
|
4.64e-02
|
-3.19e-01
|
3.37e-01
|
GO:0061099 negative regulation of protein tyrosine kinase activity
|
5
|
2.17e-01
|
-3.19e-01
|
6.18e-01
|
GO:0045740 positive regulation of DNA replication
|
27
|
4.13e-03
|
-3.19e-01
|
1.08e-01
|
GO:0046628 positive regulation of insulin receptor signaling pathway
|
11
|
6.71e-02
|
-3.19e-01
|
3.83e-01
|
GO:0048843 negative regulation of axon extension involved in axon guidance
|
5
|
2.17e-01
|
-3.19e-01
|
6.18e-01
|
GO:0140999 histone H3K4 trimethyltransferase activity
|
8
|
1.19e-01
|
-3.19e-01
|
4.84e-01
|
GO:2000042 negative regulation of double-strand break repair via homologous recombination
|
26
|
4.94e-03
|
-3.19e-01
|
1.19e-01
|
GO:0006369 termination of RNA polymerase II transcription
|
7
|
1.45e-01
|
-3.18e-01
|
5.35e-01
|
GO:1905064 negative regulation of vascular associated smooth muscle cell differentiation
|
5
|
2.18e-01
|
-3.18e-01
|
6.18e-01
|
GO:0055131 C3HC4-type RING finger domain binding
|
5
|
2.18e-01
|
3.18e-01
|
6.18e-01
|
GO:0030866 cortical actin cytoskeleton organization
|
25
|
5.93e-03
|
-3.18e-01
|
1.34e-01
|
GO:0034109 homotypic cell-cell adhesion
|
5
|
2.20e-01
|
3.17e-01
|
6.20e-01
|
GO:0005884 actin filament
|
65
|
1.01e-05
|
-3.17e-01
|
1.56e-03
|
GO:0036462 TRAIL-activated apoptotic signaling pathway
|
9
|
1.00e-01
|
3.17e-01
|
4.53e-01
|
GO:0035269 protein O-linked mannosylation
|
18
|
2.01e-02
|
-3.17e-01
|
2.33e-01
|
GO:0048188 Set1C/COMPASS complex
|
13
|
4.82e-02
|
-3.16e-01
|
3.39e-01
|
GO:0031641 regulation of myelination
|
15
|
3.40e-02
|
-3.16e-01
|
2.91e-01
|
GO:0045588 positive regulation of gamma-delta T cell differentiation
|
6
|
1.80e-01
|
-3.16e-01
|
5.83e-01
|
GO:0007015 actin filament organization
|
90
|
2.27e-07
|
-3.16e-01
|
8.88e-05
|
GO:0006405 RNA export from nucleus
|
16
|
2.88e-02
|
-3.16e-01
|
2.70e-01
|
GO:0010762 regulation of fibroblast migration
|
13
|
4.87e-02
|
-3.16e-01
|
3.40e-01
|
GO:0097696 cell surface receptor signaling pathway via STAT
|
9
|
1.01e-01
|
-3.16e-01
|
4.55e-01
|
GO:0036449 microtubule minus-end
|
6
|
1.81e-01
|
-3.15e-01
|
5.83e-01
|
GO:0055119 relaxation of cardiac muscle
|
12
|
5.86e-02
|
-3.15e-01
|
3.58e-01
|
GO:0019430 removal of superoxide radicals
|
11
|
7.02e-02
|
3.15e-01
|
3.89e-01
|
GO:0004656 procollagen-proline 4-dioxygenase activity
|
5
|
2.22e-01
|
3.15e-01
|
6.21e-01
|
GO:0006390 mitochondrial transcription
|
16
|
2.92e-02
|
-3.15e-01
|
2.71e-01
|
GO:0046653 tetrahydrofolate metabolic process
|
7
|
1.49e-01
|
3.15e-01
|
5.40e-01
|
GO:0043473 pigmentation
|
13
|
4.95e-02
|
-3.15e-01
|
3.41e-01
|
GO:0051233 spindle midzone
|
26
|
5.54e-03
|
-3.14e-01
|
1.26e-01
|
GO:0007263 nitric oxide mediated signal transduction
|
6
|
1.83e-01
|
-3.14e-01
|
5.85e-01
|
GO:0070181 small ribosomal subunit rRNA binding
|
8
|
1.24e-01
|
3.14e-01
|
4.97e-01
|
GO:1904179 positive regulation of adipose tissue development
|
8
|
1.24e-01
|
-3.14e-01
|
4.98e-01
|
GO:0003954 NADH dehydrogenase activity
|
10
|
8.56e-02
|
3.14e-01
|
4.24e-01
|
GO:1902533 positive regulation of intracellular signal transduction
|
6
|
1.83e-01
|
-3.14e-01
|
5.85e-01
|
GO:0032715 negative regulation of interleukin-6 production
|
31
|
2.51e-03
|
-3.14e-01
|
7.88e-02
|
GO:0016322 neuron remodeling
|
6
|
1.84e-01
|
-3.14e-01
|
5.85e-01
|
GO:0045445 myoblast differentiation
|
16
|
2.99e-02
|
-3.14e-01
|
2.75e-01
|
GO:0046464 acylglycerol catabolic process
|
5
|
2.25e-01
|
-3.13e-01
|
6.25e-01
|
GO:0042254 ribosome biogenesis
|
29
|
3.53e-03
|
-3.13e-01
|
9.77e-02
|
GO:0031386 protein tag activity
|
14
|
4.27e-02
|
3.13e-01
|
3.24e-01
|
GO:0008528 G protein-coupled peptide receptor activity
|
8
|
1.25e-01
|
-3.13e-01
|
5.01e-01
|
GO:0035770 ribonucleoprotein granule
|
15
|
3.60e-02
|
-3.13e-01
|
2.97e-01
|
GO:0070972 protein localization to endoplasmic reticulum
|
7
|
1.52e-01
|
3.13e-01
|
5.45e-01
|
GO:0034236 protein kinase A catalytic subunit binding
|
10
|
8.70e-02
|
-3.13e-01
|
4.28e-01
|
GO:0045646 regulation of erythrocyte differentiation
|
6
|
1.85e-01
|
3.12e-01
|
5.88e-01
|
GO:0050882 voluntary musculoskeletal movement
|
7
|
1.53e-01
|
3.12e-01
|
5.48e-01
|
GO:0022627 cytosolic small ribosomal subunit
|
39
|
7.59e-04
|
3.12e-01
|
3.48e-02
|
GO:0097421 liver regeneration
|
20
|
1.59e-02
|
-3.12e-01
|
2.18e-01
|
GO:0045860 positive regulation of protein kinase activity
|
33
|
1.96e-03
|
-3.11e-01
|
6.61e-02
|
GO:0006044 N-acetylglucosamine metabolic process
|
8
|
1.27e-01
|
3.11e-01
|
5.05e-01
|
GO:1902275 regulation of chromatin organization
|
9
|
1.06e-01
|
-3.11e-01
|
4.61e-01
|
GO:0006110 regulation of glycolytic process
|
11
|
7.42e-02
|
-3.11e-01
|
3.98e-01
|
GO:0016274 protein-arginine N-methyltransferase activity
|
9
|
1.06e-01
|
-3.11e-01
|
4.61e-01
|
GO:0051496 positive regulation of stress fiber assembly
|
40
|
6.73e-04
|
-3.11e-01
|
3.43e-02
|
GO:0098885 modification of postsynaptic actin cytoskeleton
|
6
|
1.88e-01
|
-3.10e-01
|
5.91e-01
|
GO:0042731 PH domain binding
|
7
|
1.55e-01
|
-3.10e-01
|
5.51e-01
|
GO:0090063 positive regulation of microtubule nucleation
|
8
|
1.29e-01
|
-3.10e-01
|
5.06e-01
|
GO:0160049 negative regulation of cGAS/STING signaling pathway
|
13
|
5.29e-02
|
-3.10e-01
|
3.50e-01
|
GO:0000389 mRNA 3’-splice site recognition
|
6
|
1.89e-01
|
-3.10e-01
|
5.92e-01
|
GO:0030621 U4 snRNA binding
|
6
|
1.89e-01
|
-3.10e-01
|
5.93e-01
|
GO:0004745 all-trans-retinol dehydrogenase (NAD+) activity
|
8
|
1.30e-01
|
3.10e-01
|
5.06e-01
|
GO:0007292 female gamete generation
|
7
|
1.56e-01
|
-3.09e-01
|
5.53e-01
|
GO:0030971 receptor tyrosine kinase binding
|
45
|
3.39e-04
|
-3.09e-01
|
2.16e-02
|
GO:0008045 motor neuron axon guidance
|
11
|
7.62e-02
|
-3.09e-01
|
4.04e-01
|
GO:0071354 cellular response to interleukin-6
|
7
|
1.57e-01
|
-3.09e-01
|
5.55e-01
|
GO:0046605 regulation of centrosome cycle
|
9
|
1.09e-01
|
-3.09e-01
|
4.69e-01
|
GO:0072572 poly-ADP-D-ribose binding
|
6
|
1.91e-01
|
3.08e-01
|
5.95e-01
|
GO:0051661 maintenance of centrosome location
|
6
|
1.91e-01
|
-3.08e-01
|
5.96e-01
|
GO:0032786 positive regulation of DNA-templated transcription, elongation
|
12
|
6.47e-02
|
-3.08e-01
|
3.78e-01
|
GO:1990817 poly(A) RNA polymerase activity
|
8
|
1.32e-01
|
-3.08e-01
|
5.10e-01
|
GO:0045906 negative regulation of vasoconstriction
|
6
|
1.92e-01
|
-3.08e-01
|
5.97e-01
|
GO:0035994 response to muscle stretch
|
13
|
5.48e-02
|
-3.08e-01
|
3.53e-01
|
GO:0141005 transposable element silencing by heterochromatin formation
|
7
|
1.59e-01
|
-3.08e-01
|
5.59e-01
|
GO:0005536 D-glucose binding
|
9
|
1.10e-01
|
-3.07e-01
|
4.72e-01
|
GO:0005044 scavenger receptor activity
|
12
|
6.52e-02
|
-3.07e-01
|
3.78e-01
|
GO:0031507 heterochromatin formation
|
34
|
1.94e-03
|
-3.07e-01
|
6.60e-02
|
GO:0070373 negative regulation of ERK1 and ERK2 cascade
|
47
|
2.73e-04
|
-3.07e-01
|
1.90e-02
|
GO:0006637 acyl-CoA metabolic process
|
15
|
3.96e-02
|
3.07e-01
|
3.11e-01
|
GO:0016459 myosin complex
|
16
|
3.36e-02
|
-3.07e-01
|
2.91e-01
|
GO:0031253 cell projection membrane
|
5
|
2.35e-01
|
-3.07e-01
|
6.38e-01
|
GO:0006359 regulation of transcription by RNA polymerase III
|
8
|
1.33e-01
|
3.07e-01
|
5.12e-01
|
GO:0042073 intraciliary transport
|
23
|
1.11e-02
|
3.06e-01
|
1.87e-01
|
GO:0050872 white fat cell differentiation
|
13
|
5.62e-02
|
-3.06e-01
|
3.53e-01
|
GO:0042327 positive regulation of phosphorylation
|
13
|
5.65e-02
|
-3.06e-01
|
3.54e-01
|
GO:1990745 EARP complex
|
5
|
2.37e-01
|
-3.05e-01
|
6.42e-01
|
GO:0035767 endothelial cell chemotaxis
|
6
|
1.95e-01
|
3.05e-01
|
5.99e-01
|
GO:0000792 heterochromatin
|
37
|
1.33e-03
|
-3.05e-01
|
5.36e-02
|
GO:0001836 release of cytochrome c from mitochondria
|
20
|
1.84e-02
|
3.05e-01
|
2.26e-01
|
GO:0060213 positive regulation of nuclear-transcribed mRNA poly(A) tail shortening
|
13
|
5.74e-02
|
-3.04e-01
|
3.55e-01
|
GO:0034136 negative regulation of toll-like receptor 2 signaling pathway
|
6
|
1.97e-01
|
-3.04e-01
|
6.01e-01
|
GO:0140673 transcription elongation-coupled chromatin remodeling
|
9
|
1.14e-01
|
-3.04e-01
|
4.78e-01
|
GO:0006552 L-leucine catabolic process
|
5
|
2.39e-01
|
3.04e-01
|
6.45e-01
|
GO:0006903 vesicle targeting
|
6
|
1.98e-01
|
3.03e-01
|
6.02e-01
|
GO:1904036 negative regulation of epithelial cell apoptotic process
|
7
|
1.65e-01
|
3.03e-01
|
5.67e-01
|
GO:0060397 growth hormone receptor signaling pathway via JAK-STAT
|
9
|
1.16e-01
|
-3.03e-01
|
4.79e-01
|
GO:1901800 positive regulation of proteasomal protein catabolic process
|
16
|
3.60e-02
|
3.03e-01
|
2.97e-01
|
GO:0009651 response to salt stress
|
6
|
1.99e-01
|
3.03e-01
|
6.02e-01
|
GO:0004033 aldo-keto reductase (NADPH) activity
|
8
|
1.38e-01
|
3.03e-01
|
5.20e-01
|
GO:0016929 deSUMOylase activity
|
7
|
1.66e-01
|
3.03e-01
|
5.68e-01
|
GO:1902806 regulation of cell cycle G1/S phase transition
|
9
|
1.16e-01
|
3.02e-01
|
4.81e-01
|
GO:0006308 DNA catabolic process
|
9
|
1.16e-01
|
-3.02e-01
|
4.81e-01
|
GO:0001732 formation of cytoplasmic translation initiation complex
|
14
|
5.03e-02
|
3.02e-01
|
3.42e-01
|
GO:0070842 aggresome assembly
|
5
|
2.42e-01
|
-3.02e-01
|
6.48e-01
|
GO:0140311 protein sequestering activity
|
26
|
7.74e-03
|
-3.02e-01
|
1.55e-01
|
GO:0051017 actin filament bundle assembly
|
27
|
6.70e-03
|
-3.02e-01
|
1.45e-01
|
GO:0072345 NAADP-sensitive calcium-release channel activity
|
5
|
2.43e-01
|
-3.02e-01
|
6.48e-01
|
GO:0006476 protein deacetylation
|
11
|
8.37e-02
|
-3.01e-01
|
4.21e-01
|
GO:0015939 pantothenate metabolic process
|
7
|
1.68e-01
|
3.01e-01
|
5.72e-01
|
GO:1902742 apoptotic process involved in development
|
6
|
2.02e-01
|
3.01e-01
|
6.05e-01
|
GO:0034713 type I transforming growth factor beta receptor binding
|
9
|
1.18e-01
|
-3.01e-01
|
4.84e-01
|
GO:0007000 nucleolus organization
|
5
|
2.44e-01
|
3.01e-01
|
6.49e-01
|
GO:0005542 folic acid binding
|
10
|
1.00e-01
|
3.00e-01
|
4.53e-01
|
GO:0030695 GTPase regulator activity
|
12
|
7.18e-02
|
-3.00e-01
|
3.92e-01
|
GO:0009101 glycoprotein biosynthetic process
|
7
|
1.69e-01
|
-3.00e-01
|
5.74e-01
|
GO:0005879 axonemal microtubule
|
15
|
4.44e-02
|
3.00e-01
|
3.31e-01
|
GO:0003376 sphingosine-1-phosphate receptor signaling pathway
|
9
|
1.19e-01
|
-3.00e-01
|
4.86e-01
|
GO:0008430 selenium binding
|
5
|
2.46e-01
|
-3.00e-01
|
6.50e-01
|
GO:0000480 endonucleolytic cleavage in 5’-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
|
7
|
1.70e-01
|
-3.00e-01
|
5.76e-01
|
GO:0097177 mitochondrial ribosome binding
|
6
|
2.04e-01
|
-2.99e-01
|
6.10e-01
|
GO:0000086 G2/M transition of mitotic cell cycle
|
42
|
7.99e-04
|
-2.99e-01
|
3.63e-02
|
GO:0043813 phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity
|
6
|
2.05e-01
|
-2.99e-01
|
6.10e-01
|
GO:0005868 cytoplasmic dynein complex
|
17
|
3.28e-02
|
2.99e-01
|
2.88e-01
|
GO:0060326 cell chemotaxis
|
35
|
2.23e-03
|
-2.99e-01
|
7.26e-02
|
GO:0009948 anterior/posterior axis specification
|
10
|
1.02e-01
|
2.99e-01
|
4.55e-01
|
GO:0035014 phosphatidylinositol 3-kinase regulator activity
|
5
|
2.48e-01
|
-2.99e-01
|
6.52e-01
|
GO:0070418 DNA-dependent protein kinase complex
|
5
|
2.48e-01
|
-2.99e-01
|
6.52e-01
|
GO:0043047 single-stranded telomeric DNA binding
|
5
|
2.48e-01
|
-2.98e-01
|
6.52e-01
|
GO:0003836 beta-galactoside (CMP) alpha-2,3-sialyltransferase activity
|
6
|
2.06e-01
|
-2.98e-01
|
6.11e-01
|
GO:0007288 sperm axoneme assembly
|
20
|
2.11e-02
|
2.98e-01
|
2.39e-01
|
GO:0005126 cytokine receptor binding
|
6
|
2.06e-01
|
-2.98e-01
|
6.11e-01
|
GO:0030295 protein kinase activator activity
|
33
|
3.07e-03
|
-2.98e-01
|
8.97e-02
|
GO:0002690 positive regulation of leukocyte chemotaxis
|
5
|
2.49e-01
|
-2.98e-01
|
6.52e-01
|
GO:0086064 cell communication by electrical coupling involved in cardiac conduction
|
5
|
2.49e-01
|
-2.98e-01
|
6.52e-01
|
GO:0030220 platelet formation
|
17
|
3.36e-02
|
-2.98e-01
|
2.91e-01
|
GO:0000182 rDNA binding
|
5
|
2.49e-01
|
-2.98e-01
|
6.52e-01
|
GO:0010310 regulation of hydrogen peroxide metabolic process
|
5
|
2.49e-01
|
2.98e-01
|
6.52e-01
|
GO:0071398 cellular response to fatty acid
|
12
|
7.43e-02
|
-2.98e-01
|
3.98e-01
|
GO:1990763 arrestin family protein binding
|
5
|
2.50e-01
|
-2.97e-01
|
6.52e-01
|
GO:0048024 regulation of mRNA splicing, via spliceosome
|
17
|
3.40e-02
|
-2.97e-01
|
2.91e-01
|
GO:0010332 response to gamma radiation
|
23
|
1.37e-02
|
-2.97e-01
|
2.04e-01
|
GO:0006884 cell volume homeostasis
|
18
|
2.95e-02
|
-2.96e-01
|
2.73e-01
|
GO:0016829 lyase activity
|
13
|
6.44e-02
|
2.96e-01
|
3.77e-01
|
GO:0043596 nuclear replication fork
|
16
|
4.04e-02
|
-2.96e-01
|
3.15e-01
|
GO:0006621 protein retention in ER lumen
|
6
|
2.10e-01
|
2.96e-01
|
6.13e-01
|
GO:0033344 cholesterol efflux
|
17
|
3.47e-02
|
2.96e-01
|
2.93e-01
|
GO:0002181 cytoplasmic translation
|
88
|
1.67e-06
|
2.96e-01
|
3.50e-04
|
GO:0032153 cell division site
|
11
|
8.97e-02
|
2.96e-01
|
4.33e-01
|
GO:0022626 cytosolic ribosome
|
93
|
8.61e-07
|
2.95e-01
|
2.29e-04
|
GO:0003785 actin monomer binding
|
19
|
2.60e-02
|
-2.95e-01
|
2.60e-01
|
GO:0098712 L-glutamate import across plasma membrane
|
5
|
2.53e-01
|
2.95e-01
|
6.56e-01
|
GO:0010989 negative regulation of low-density lipoprotein particle clearance
|
5
|
2.54e-01
|
-2.95e-01
|
6.56e-01
|
GO:0106035 protein maturation by [4Fe-4S] cluster transfer
|
8
|
1.49e-01
|
2.95e-01
|
5.39e-01
|
GO:0110095 cellular detoxification of aldehyde
|
5
|
2.54e-01
|
2.95e-01
|
6.56e-01
|
GO:0036289 peptidyl-serine autophosphorylation
|
9
|
1.26e-01
|
2.94e-01
|
5.02e-01
|
GO:0032049 cardiolipin biosynthetic process
|
7
|
1.77e-01
|
-2.94e-01
|
5.78e-01
|
GO:0045737 positive regulation of cyclin-dependent protein serine/threonine kinase activity
|
11
|
9.09e-02
|
-2.94e-01
|
4.35e-01
|
GO:0001731 formation of translation preinitiation complex
|
9
|
1.26e-01
|
2.94e-01
|
5.02e-01
|
GO:2000679 positive regulation of transcription regulatory region DNA binding
|
5
|
2.55e-01
|
-2.94e-01
|
6.56e-01
|
GO:0010626 negative regulation of Schwann cell proliferation
|
6
|
2.12e-01
|
-2.94e-01
|
6.15e-01
|
GO:0047429 nucleoside triphosphate diphosphatase activity
|
6
|
2.12e-01
|
-2.94e-01
|
6.15e-01
|
GO:0010543 regulation of platelet activation
|
5
|
2.55e-01
|
-2.94e-01
|
6.57e-01
|
GO:0046985 positive regulation of hemoglobin biosynthetic process
|
5
|
2.55e-01
|
-2.94e-01
|
6.57e-01
|
GO:0036297 interstrand cross-link repair
|
35
|
2.65e-03
|
-2.94e-01
|
8.23e-02
|
GO:0008121 ubiquinol-cytochrome-c reductase activity
|
6
|
2.13e-01
|
-2.93e-01
|
6.15e-01
|
GO:0072673 lamellipodium morphogenesis
|
7
|
1.79e-01
|
-2.93e-01
|
5.82e-01
|
GO:0005942 phosphatidylinositol 3-kinase complex
|
6
|
2.14e-01
|
-2.93e-01
|
6.15e-01
|
GO:0008378 galactosyltransferase activity
|
8
|
1.52e-01
|
2.93e-01
|
5.45e-01
|
GO:1903278 positive regulation of sodium ion export across plasma membrane
|
7
|
1.80e-01
|
2.93e-01
|
5.83e-01
|
GO:0021795 cerebral cortex cell migration
|
6
|
2.14e-01
|
2.93e-01
|
6.15e-01
|
GO:0002091 negative regulation of receptor internalization
|
9
|
1.29e-01
|
-2.93e-01
|
5.06e-01
|
GO:0001514 selenocysteine incorporation
|
5
|
2.57e-01
|
2.93e-01
|
6.58e-01
|
GO:0008356 asymmetric cell division
|
5
|
2.57e-01
|
-2.92e-01
|
6.58e-01
|
GO:0048514 blood vessel morphogenesis
|
9
|
1.29e-01
|
-2.92e-01
|
5.06e-01
|
GO:0045806 negative regulation of endocytosis
|
11
|
9.38e-02
|
2.92e-01
|
4.40e-01
|
GO:0036121 double-stranded DNA helicase activity
|
41
|
1.23e-03
|
-2.92e-01
|
5.18e-02
|
GO:0019985 translesion synthesis
|
12
|
8.02e-02
|
-2.92e-01
|
4.12e-01
|
GO:0050684 regulation of mRNA processing
|
18
|
3.21e-02
|
-2.92e-01
|
2.85e-01
|
GO:0071364 cellular response to epidermal growth factor stimulus
|
34
|
3.25e-03
|
-2.92e-01
|
9.35e-02
|
GO:0004623 phospholipase A2 activity
|
13
|
6.87e-02
|
2.92e-01
|
3.87e-01
|
GO:0042026 protein refolding
|
19
|
2.78e-02
|
2.92e-01
|
2.66e-01
|
GO:0003014 renal system process
|
9
|
1.30e-01
|
2.91e-01
|
5.07e-01
|
GO:0000963 mitochondrial RNA processing
|
6
|
2.17e-01
|
-2.91e-01
|
6.18e-01
|
GO:0038061 non-canonical NF-kappaB signal transduction
|
18
|
3.25e-02
|
-2.91e-01
|
2.87e-01
|
GO:0015179 L-amino acid transmembrane transporter activity
|
12
|
8.08e-02
|
2.91e-01
|
4.14e-01
|
GO:0071236 cellular response to antibiotic
|
5
|
2.60e-01
|
-2.91e-01
|
6.61e-01
|
GO:0043306 positive regulation of mast cell degranulation
|
7
|
1.82e-01
|
-2.91e-01
|
5.85e-01
|
GO:0140444 cytoskeleton-nuclear membrane anchor activity
|
5
|
2.60e-01
|
-2.91e-01
|
6.61e-01
|
GO:0007059 chromosome segregation
|
84
|
4.18e-06
|
-2.91e-01
|
8.45e-04
|
GO:0009378 four-way junction helicase activity
|
41
|
1.29e-03
|
-2.91e-01
|
5.25e-02
|
GO:0000347 THO complex
|
5
|
2.61e-01
|
2.90e-01
|
6.62e-01
|
GO:0030870 Mre11 complex
|
5
|
2.61e-01
|
2.90e-01
|
6.62e-01
|
GO:0070935 3’-UTR-mediated mRNA stabilization
|
15
|
5.18e-02
|
-2.90e-01
|
3.46e-01
|
GO:1904377 positive regulation of protein localization to cell periphery
|
5
|
2.62e-01
|
2.90e-01
|
6.63e-01
|
GO:0097494 regulation of vesicle size
|
6
|
2.19e-01
|
-2.90e-01
|
6.20e-01
|
GO:0007064 mitotic sister chromatid cohesion
|
14
|
6.08e-02
|
-2.89e-01
|
3.65e-01
|
GO:0097062 dendritic spine maintenance
|
10
|
1.13e-01
|
2.89e-01
|
4.77e-01
|
GO:0030497 fatty acid elongation
|
6
|
2.20e-01
|
2.89e-01
|
6.20e-01
|
GO:0071878 negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway
|
5
|
2.63e-01
|
-2.89e-01
|
6.63e-01
|
GO:0031465 Cul4B-RING E3 ubiquitin ligase complex
|
6
|
2.20e-01
|
-2.89e-01
|
6.20e-01
|
GO:0140036 ubiquitin-modified protein reader activity
|
9
|
1.34e-01
|
-2.89e-01
|
5.12e-01
|
GO:0016185 synaptic vesicle budding from presynaptic endocytic zone membrane
|
6
|
2.21e-01
|
-2.89e-01
|
6.21e-01
|
GO:0000421 autophagosome membrane
|
48
|
5.51e-04
|
2.88e-01
|
3.07e-02
|
GO:0006650 glycerophospholipid metabolic process
|
6
|
2.21e-01
|
-2.88e-01
|
6.21e-01
|
GO:0010760 negative regulation of macrophage chemotaxis
|
6
|
2.21e-01
|
-2.88e-01
|
6.21e-01
|
GO:0033555 multicellular organismal response to stress
|
6
|
2.22e-01
|
2.88e-01
|
6.21e-01
|
GO:0001756 somitogenesis
|
22
|
1.94e-02
|
-2.88e-01
|
2.30e-01
|
GO:0071203 WASH complex
|
13
|
7.24e-02
|
-2.88e-01
|
3.93e-01
|
GO:0038166 angiotensin-activated signaling pathway
|
6
|
2.22e-01
|
-2.88e-01
|
6.21e-01
|
GO:0018344 protein geranylgeranylation
|
6
|
2.22e-01
|
2.88e-01
|
6.22e-01
|
GO:0033108 mitochondrial respiratory chain complex assembly
|
7
|
1.88e-01
|
-2.88e-01
|
5.90e-01
|
GO:0120197 mucociliary clearance
|
5
|
2.66e-01
|
2.88e-01
|
6.67e-01
|
GO:0015012 heparan sulfate proteoglycan biosynthetic process
|
12
|
8.50e-02
|
2.87e-01
|
4.23e-01
|
GO:0035613 RNA stem-loop binding
|
15
|
5.42e-02
|
-2.87e-01
|
3.52e-01
|
GO:0015866 ADP transport
|
8
|
1.60e-01
|
-2.87e-01
|
5.60e-01
|
GO:0001750 photoreceptor outer segment
|
33
|
4.34e-03
|
2.87e-01
|
1.13e-01
|
GO:2000271 positive regulation of fibroblast apoptotic process
|
9
|
1.36e-01
|
2.87e-01
|
5.16e-01
|
GO:0060068 vagina development
|
5
|
2.67e-01
|
-2.87e-01
|
6.68e-01
|
GO:0005697 telomerase holoenzyme complex
|
20
|
2.64e-02
|
-2.87e-01
|
2.62e-01
|
GO:0000278 mitotic cell cycle
|
100
|
7.34e-07
|
-2.87e-01
|
2.12e-04
|
GO:0023035 CD40 signaling pathway
|
9
|
1.37e-01
|
-2.87e-01
|
5.16e-01
|
GO:0005523 tropomyosin binding
|
6
|
2.25e-01
|
2.86e-01
|
6.24e-01
|
GO:0030388 fructose 1,6-bisphosphate metabolic process
|
5
|
2.68e-01
|
-2.86e-01
|
6.68e-01
|
GO:1900153 positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay
|
12
|
8.61e-02
|
-2.86e-01
|
4.25e-01
|
GO:0006687 glycosphingolipid metabolic process
|
5
|
2.68e-01
|
-2.86e-01
|
6.68e-01
|
GO:0050901 leukocyte tethering or rolling
|
12
|
8.63e-02
|
-2.86e-01
|
4.26e-01
|
GO:0070182 DNA polymerase binding
|
20
|
2.69e-02
|
-2.86e-01
|
2.64e-01
|
GO:1990072 TRAPPIII protein complex
|
12
|
8.64e-02
|
2.86e-01
|
4.26e-01
|
GO:0008209 androgen metabolic process
|
11
|
1.01e-01
|
-2.86e-01
|
4.55e-01
|
GO:2000278 regulation of DNA biosynthetic process
|
11
|
1.01e-01
|
-2.85e-01
|
4.55e-01
|
GO:1990075 periciliary membrane compartment
|
5
|
2.69e-01
|
2.85e-01
|
6.70e-01
|
GO:0033631 cell-cell adhesion mediated by integrin
|
5
|
2.69e-01
|
-2.85e-01
|
6.70e-01
|
GO:0000266 mitochondrial fission
|
16
|
4.83e-02
|
-2.85e-01
|
3.39e-01
|
GO:0032728 positive regulation of interferon-beta production
|
37
|
2.70e-03
|
2.85e-01
|
8.32e-02
|
GO:2000242 negative regulation of reproductive process
|
5
|
2.70e-01
|
2.85e-01
|
6.70e-01
|
GO:0071316 cellular response to nicotine
|
5
|
2.70e-01
|
-2.85e-01
|
6.70e-01
|
GO:0035845 photoreceptor cell outer segment organization
|
9
|
1.39e-01
|
2.85e-01
|
5.23e-01
|
GO:0003009 skeletal muscle contraction
|
12
|
8.83e-02
|
-2.84e-01
|
4.30e-01
|
GO:0005680 anaphase-promoting complex
|
21
|
2.42e-02
|
-2.84e-01
|
2.53e-01
|
GO:0007051 spindle organization
|
17
|
4.26e-02
|
-2.84e-01
|
3.24e-01
|
GO:0090280 positive regulation of calcium ion import
|
7
|
1.93e-01
|
-2.84e-01
|
5.98e-01
|
GO:1990518 single-stranded 3’-5’ DNA helicase activity
|
41
|
1.66e-03
|
-2.84e-01
|
5.91e-02
|
GO:0036006 cellular response to macrophage colony-stimulating factor stimulus
|
5
|
2.72e-01
|
-2.84e-01
|
6.70e-01
|
GO:0008499 N-acetyl-beta-D-glucosaminide beta-(1,3)-galactosyltransferase activity
|
6
|
2.28e-01
|
2.84e-01
|
6.29e-01
|
GO:0099173 postsynapse organization
|
9
|
1.41e-01
|
-2.84e-01
|
5.25e-01
|
GO:0061337 cardiac conduction
|
5
|
2.73e-01
|
2.83e-01
|
6.70e-01
|
GO:0042989 sequestering of actin monomers
|
8
|
1.67e-01
|
-2.82e-01
|
5.71e-01
|
GO:0030071 regulation of mitotic metaphase/anaphase transition
|
30
|
7.46e-03
|
-2.82e-01
|
1.54e-01
|
GO:0006613 cotranslational protein targeting to membrane
|
10
|
1.22e-01
|
2.82e-01
|
4.95e-01
|
GO:2000556 positive regulation of T-helper 1 cell cytokine production
|
5
|
2.75e-01
|
2.82e-01
|
6.71e-01
|
GO:0090307 mitotic spindle assembly
|
41
|
1.78e-03
|
-2.82e-01
|
6.31e-02
|
GO:0001725 stress fiber
|
63
|
1.09e-04
|
-2.82e-01
|
9.40e-03
|
GO:0097539 ciliary transition fiber
|
7
|
1.96e-01
|
-2.82e-01
|
6.01e-01
|
GO:0030859 polarized epithelial cell differentiation
|
5
|
2.75e-01
|
2.82e-01
|
6.71e-01
|
GO:0048853 forebrain morphogenesis
|
5
|
2.75e-01
|
2.82e-01
|
6.71e-01
|
GO:0045815 transcription initiation-coupled chromatin remodeling
|
36
|
3.46e-03
|
-2.82e-01
|
9.71e-02
|
GO:0005852 eukaryotic translation initiation factor 3 complex
|
15
|
5.90e-02
|
2.82e-01
|
3.59e-01
|
GO:0035727 lysophosphatidic acid binding
|
5
|
2.76e-01
|
-2.81e-01
|
6.71e-01
|
GO:0060996 dendritic spine development
|
10
|
1.24e-01
|
2.81e-01
|
4.97e-01
|
GO:0034141 positive regulation of toll-like receptor 3 signaling pathway
|
6
|
2.33e-01
|
-2.81e-01
|
6.35e-01
|
GO:1900017 positive regulation of cytokine production involved in inflammatory response
|
20
|
2.96e-02
|
-2.81e-01
|
2.73e-01
|
GO:0015909 long-chain fatty acid transport
|
12
|
9.18e-02
|
2.81e-01
|
4.36e-01
|
GO:0090554 phosphatidylcholine floppase activity
|
6
|
2.34e-01
|
2.81e-01
|
6.35e-01
|
GO:0043490 malate-aspartate shuttle
|
8
|
1.69e-01
|
-2.81e-01
|
5.74e-01
|
GO:0097730 non-motile cilium
|
21
|
2.60e-02
|
2.81e-01
|
2.60e-01
|
GO:0007416 synapse assembly
|
30
|
7.80e-03
|
-2.81e-01
|
1.55e-01
|
GO:0030162 regulation of proteolysis
|
10
|
1.24e-01
|
-2.81e-01
|
4.98e-01
|
GO:0070740 tubulin-glutamic acid ligase activity
|
5
|
2.78e-01
|
-2.80e-01
|
6.75e-01
|
GO:0002070 epithelial cell maturation
|
7
|
2.00e-01
|
2.80e-01
|
6.03e-01
|
GO:0031032 actomyosin structure organization
|
23
|
2.02e-02
|
-2.80e-01
|
2.35e-01
|
GO:0045053 protein retention in Golgi apparatus
|
5
|
2.79e-01
|
-2.80e-01
|
6.76e-01
|
GO:0006101 citrate metabolic process
|
5
|
2.79e-01
|
-2.80e-01
|
6.76e-01
|
GO:0036126 sperm flagellum
|
50
|
6.31e-04
|
2.80e-01
|
3.27e-02
|
GO:0031904 endosome lumen
|
12
|
9.40e-02
|
2.79e-01
|
4.40e-01
|
GO:0000931 gamma-tubulin ring complex
|
11
|
1.09e-01
|
-2.79e-01
|
4.69e-01
|
GO:0050811 GABA receptor binding
|
10
|
1.26e-01
|
2.79e-01
|
5.02e-01
|
GO:0007009 plasma membrane organization
|
14
|
7.06e-02
|
2.79e-01
|
3.90e-01
|
GO:0047144 2-acylglycerol-3-phosphate O-acyltransferase activity
|
9
|
1.47e-01
|
-2.79e-01
|
5.38e-01
|
GO:0002446 neutrophil mediated immunity
|
9
|
1.47e-01
|
-2.79e-01
|
5.38e-01
|
GO:0090026 positive regulation of monocyte chemotaxis
|
12
|
9.45e-02
|
-2.79e-01
|
4.40e-01
|
GO:0042058 regulation of epidermal growth factor receptor signaling pathway
|
7
|
2.02e-01
|
2.79e-01
|
6.05e-01
|
GO:0070527 platelet aggregation
|
35
|
4.37e-03
|
-2.78e-01
|
1.13e-01
|
GO:0004029 aldehyde dehydrogenase (NAD+) activity
|
12
|
9.49e-02
|
2.78e-01
|
4.42e-01
|
GO:0006004 fucose metabolic process
|
7
|
2.02e-01
|
2.78e-01
|
6.05e-01
|
GO:0008494 translation activator activity
|
8
|
1.73e-01
|
2.78e-01
|
5.78e-01
|
GO:0001518 voltage-gated sodium channel complex
|
5
|
2.81e-01
|
2.78e-01
|
6.78e-01
|
GO:0035145 exon-exon junction complex
|
21
|
2.77e-02
|
-2.78e-01
|
2.66e-01
|
GO:0061621 canonical glycolysis
|
15
|
6.28e-02
|
-2.77e-01
|
3.71e-01
|
GO:0016018 cyclosporin A binding
|
10
|
1.29e-01
|
2.77e-01
|
5.06e-01
|
GO:0030042 actin filament depolymerization
|
11
|
1.11e-01
|
-2.77e-01
|
4.73e-01
|
GO:0006352 DNA-templated transcription initiation
|
16
|
5.52e-02
|
2.77e-01
|
3.53e-01
|
GO:0032025 response to cobalt ion
|
6
|
2.41e-01
|
-2.77e-01
|
6.46e-01
|
GO:0030515 snoRNA binding
|
20
|
3.23e-02
|
-2.77e-01
|
2.86e-01
|
GO:0045542 positive regulation of cholesterol biosynthetic process
|
12
|
9.73e-02
|
-2.76e-01
|
4.47e-01
|
GO:0098831 presynaptic active zone cytoplasmic component
|
10
|
1.30e-01
|
-2.76e-01
|
5.07e-01
|
GO:0046626 regulation of insulin receptor signaling pathway
|
6
|
2.41e-01
|
-2.76e-01
|
6.46e-01
|
GO:0034341 response to type II interferon
|
20
|
3.26e-02
|
2.76e-01
|
2.87e-01
|
GO:0008064 regulation of actin polymerization or depolymerization
|
5
|
2.85e-01
|
-2.76e-01
|
6.81e-01
|
GO:0030050 vesicle transport along actin filament
|
5
|
2.85e-01
|
-2.76e-01
|
6.81e-01
|
GO:0044782 cilium organization
|
17
|
4.90e-02
|
2.76e-01
|
3.41e-01
|
GO:0007020 microtubule nucleation
|
25
|
1.71e-02
|
-2.76e-01
|
2.20e-01
|
GO:0035356 intracellular triglyceride homeostasis
|
7
|
2.07e-01
|
2.75e-01
|
6.11e-01
|
GO:0006166 purine ribonucleoside salvage
|
7
|
2.07e-01
|
-2.75e-01
|
6.11e-01
|
GO:0036150 phosphatidylserine acyl-chain remodeling
|
7
|
2.07e-01
|
-2.75e-01
|
6.11e-01
|
GO:0032486 Rap protein signal transduction
|
9
|
1.53e-01
|
-2.75e-01
|
5.48e-01
|
GO:0010994 free ubiquitin chain polymerization
|
7
|
2.08e-01
|
-2.75e-01
|
6.12e-01
|
GO:0030132 clathrin coat of coated pit
|
7
|
2.08e-01
|
-2.75e-01
|
6.12e-01
|
GO:0061749 forked DNA-dependent helicase activity
|
40
|
2.65e-03
|
-2.75e-01
|
8.23e-02
|
GO:0030510 regulation of BMP signaling pathway
|
7
|
2.08e-01
|
-2.75e-01
|
6.12e-01
|
GO:0045742 positive regulation of epidermal growth factor receptor signaling pathway
|
20
|
3.37e-02
|
-2.74e-01
|
2.91e-01
|
GO:0033263 CORVET complex
|
7
|
2.09e-01
|
-2.74e-01
|
6.12e-01
|
GO:0001216 DNA-binding transcription activator activity
|
12
|
1.00e-01
|
-2.74e-01
|
4.53e-01
|
GO:0009887 animal organ morphogenesis
|
43
|
1.88e-03
|
-2.74e-01
|
6.49e-02
|
GO:0048512 circadian behavior
|
7
|
2.09e-01
|
2.74e-01
|
6.13e-01
|
GO:0042157 lipoprotein metabolic process
|
10
|
1.34e-01
|
2.74e-01
|
5.12e-01
|
GO:0007143 female meiotic nuclear division
|
5
|
2.89e-01
|
-2.74e-01
|
6.82e-01
|
GO:0120019 phosphatidylcholine transfer activity
|
5
|
2.89e-01
|
-2.74e-01
|
6.82e-01
|
GO:0070123 transforming growth factor beta receptor activity, type III
|
10
|
1.34e-01
|
2.74e-01
|
5.13e-01
|
GO:0035987 endodermal cell differentiation
|
22
|
2.64e-02
|
-2.74e-01
|
2.62e-01
|
GO:0030546 signaling receptor activator activity
|
5
|
2.90e-01
|
2.73e-01
|
6.82e-01
|
GO:0023052 signaling
|
8
|
1.81e-01
|
-2.73e-01
|
5.83e-01
|
GO:0008154 actin polymerization or depolymerization
|
18
|
4.47e-02
|
-2.73e-01
|
3.32e-01
|
GO:0045780 positive regulation of bone resorption
|
14
|
7.67e-02
|
-2.73e-01
|
4.05e-01
|
GO:0004438 phosphatidylinositol-3-phosphate phosphatase activity
|
17
|
5.11e-02
|
-2.73e-01
|
3.43e-01
|
GO:0016175 superoxide-generating NAD(P)H oxidase activity
|
5
|
2.90e-01
|
2.73e-01
|
6.82e-01
|
GO:0006998 nuclear envelope organization
|
16
|
5.87e-02
|
-2.73e-01
|
3.58e-01
|
GO:0070371 ERK1 and ERK2 cascade
|
35
|
5.24e-03
|
-2.73e-01
|
1.23e-01
|
GO:0005462 UDP-N-acetylglucosamine transmembrane transporter activity
|
5
|
2.91e-01
|
2.73e-01
|
6.83e-01
|
GO:1990569 UDP-N-acetylglucosamine transmembrane transport
|
5
|
2.91e-01
|
2.73e-01
|
6.83e-01
|
GO:0050965 detection of temperature stimulus involved in sensory perception of pain
|
13
|
8.89e-02
|
2.73e-01
|
4.32e-01
|
GO:0031642 negative regulation of myelination
|
7
|
2.12e-01
|
-2.72e-01
|
6.15e-01
|
GO:0150078 positive regulation of neuroinflammatory response
|
6
|
2.48e-01
|
2.72e-01
|
6.52e-01
|
GO:0019262 N-acetylneuraminate catabolic process
|
6
|
2.48e-01
|
2.72e-01
|
6.52e-01
|
GO:0033558 protein lysine deacetylase activity
|
12
|
1.03e-01
|
-2.72e-01
|
4.55e-01
|
GO:0035871 protein K11-linked deubiquitination
|
10
|
1.36e-01
|
-2.72e-01
|
5.16e-01
|
GO:0035060 brahma complex
|
12
|
1.03e-01
|
-2.72e-01
|
4.55e-01
|
GO:1990459 transferrin receptor binding
|
8
|
1.83e-01
|
-2.72e-01
|
5.85e-01
|
GO:0010485 histone H4 acetyltransferase activity
|
12
|
1.04e-01
|
-2.71e-01
|
4.56e-01
|
GO:0007221 positive regulation of transcription of Notch receptor target
|
6
|
2.50e-01
|
-2.71e-01
|
6.52e-01
|
GO:0034446 substrate adhesion-dependent cell spreading
|
31
|
8.97e-03
|
-2.71e-01
|
1.68e-01
|
GO:0051081 nuclear membrane disassembly
|
5
|
2.94e-01
|
-2.71e-01
|
6.88e-01
|
GO:0050765 negative regulation of phagocytosis
|
15
|
6.91e-02
|
2.71e-01
|
3.88e-01
|
GO:0022011 myelination in peripheral nervous system
|
12
|
1.04e-01
|
-2.71e-01
|
4.58e-01
|
GO:0046600 negative regulation of centriole replication
|
7
|
2.15e-01
|
-2.71e-01
|
6.16e-01
|
GO:0071044 histone mRNA catabolic process
|
14
|
7.95e-02
|
-2.71e-01
|
4.11e-01
|
GO:0070244 negative regulation of thymocyte apoptotic process
|
5
|
2.95e-01
|
2.71e-01
|
6.89e-01
|
GO:2000406 positive regulation of T cell migration
|
16
|
6.09e-02
|
-2.71e-01
|
3.65e-01
|
GO:0097190 apoptotic signaling pathway
|
55
|
5.22e-04
|
-2.71e-01
|
3.01e-02
|
GO:0097428 protein maturation by iron-sulfur cluster transfer
|
8
|
1.86e-01
|
2.70e-01
|
5.88e-01
|
GO:0044355 clearance of foreign intracellular DNA
|
5
|
2.96e-01
|
2.70e-01
|
6.90e-01
|
GO:0030291 protein serine/threonine kinase inhibitor activity
|
16
|
6.16e-02
|
-2.70e-01
|
3.68e-01
|
GO:0051291 protein heterooligomerization
|
10
|
1.39e-01
|
-2.70e-01
|
5.23e-01
|
GO:0003887 DNA-directed DNA polymerase activity
|
22
|
2.84e-02
|
-2.70e-01
|
2.70e-01
|
GO:0001954 positive regulation of cell-matrix adhesion
|
16
|
6.17e-02
|
-2.70e-01
|
3.68e-01
|
GO:0051056 regulation of small GTPase mediated signal transduction
|
93
|
7.30e-06
|
-2.69e-01
|
1.22e-03
|
GO:0000152 nuclear ubiquitin ligase complex
|
6
|
2.54e-01
|
-2.69e-01
|
6.56e-01
|
GO:0140597 protein carrier chaperone
|
7
|
2.17e-01
|
-2.69e-01
|
6.18e-01
|
GO:0034058 endosomal vesicle fusion
|
14
|
8.12e-02
|
-2.69e-01
|
4.14e-01
|
GO:0035458 cellular response to interferon-beta
|
19
|
4.23e-02
|
2.69e-01
|
3.22e-01
|
GO:0031401 positive regulation of protein modification process
|
6
|
2.54e-01
|
2.69e-01
|
6.56e-01
|
GO:0042476 odontogenesis
|
9
|
1.63e-01
|
-2.69e-01
|
5.64e-01
|
GO:0018108 peptidyl-tyrosine phosphorylation
|
25
|
2.00e-02
|
-2.69e-01
|
2.33e-01
|
GO:0086013 membrane repolarization during cardiac muscle cell action potential
|
7
|
2.18e-01
|
-2.69e-01
|
6.19e-01
|
GO:0031258 lamellipodium membrane
|
18
|
4.86e-02
|
-2.68e-01
|
3.40e-01
|
GO:0071897 DNA biosynthetic process
|
20
|
3.78e-02
|
-2.68e-01
|
3.04e-01
|
GO:0045214 sarcomere organization
|
21
|
3.33e-02
|
-2.68e-01
|
2.91e-01
|
GO:0120192 tight junction assembly
|
5
|
2.99e-01
|
2.68e-01
|
6.91e-01
|
GO:0051901 positive regulation of mitochondrial depolarization
|
6
|
2.56e-01
|
2.68e-01
|
6.58e-01
|
GO:0061025 membrane fusion
|
30
|
1.12e-02
|
2.68e-01
|
1.88e-01
|
GO:0046578 regulation of Ras protein signal transduction
|
8
|
1.90e-01
|
-2.68e-01
|
5.95e-01
|
GO:0005757 mitochondrial permeability transition pore complex
|
6
|
2.57e-01
|
-2.67e-01
|
6.58e-01
|
GO:0019732 antifungal humoral response
|
5
|
3.01e-01
|
2.67e-01
|
6.92e-01
|
GO:0007159 leukocyte cell-cell adhesion
|
19
|
4.37e-02
|
-2.67e-01
|
3.28e-01
|
GO:1904383 response to sodium phosphate
|
6
|
2.57e-01
|
-2.67e-01
|
6.58e-01
|
GO:2001224 positive regulation of neuron migration
|
15
|
7.33e-02
|
-2.67e-01
|
3.95e-01
|
GO:0030449 regulation of complement activation
|
6
|
2.57e-01
|
2.67e-01
|
6.58e-01
|
GO:0060586 multicellular organismal-level iron ion homeostasis
|
21
|
3.43e-02
|
-2.67e-01
|
2.91e-01
|
GO:0031110 regulation of microtubule polymerization or depolymerization
|
7
|
2.22e-01
|
-2.67e-01
|
6.21e-01
|
GO:0033962 P-body assembly
|
16
|
6.51e-02
|
-2.66e-01
|
3.78e-01
|
GO:0009952 anterior/posterior pattern specification
|
39
|
4.03e-03
|
2.66e-01
|
1.07e-01
|
GO:0046686 response to cadmium ion
|
18
|
5.07e-02
|
-2.66e-01
|
3.42e-01
|
GO:0032836 glomerular basement membrane development
|
5
|
3.04e-01
|
2.66e-01
|
6.93e-01
|
GO:0014898 cardiac muscle hypertrophy in response to stress
|
8
|
1.93e-01
|
-2.66e-01
|
5.98e-01
|
GO:0060425 lung morphogenesis
|
9
|
1.68e-01
|
-2.66e-01
|
5.72e-01
|
GO:0051224 negative regulation of protein transport
|
6
|
2.60e-01
|
-2.66e-01
|
6.61e-01
|
GO:0006297 nucleotide-excision repair, DNA gap filling
|
6
|
2.60e-01
|
-2.65e-01
|
6.61e-01
|
GO:0045736 negative regulation of cyclin-dependent protein serine/threonine kinase activity
|
15
|
7.51e-02
|
-2.65e-01
|
4.00e-01
|
GO:0002009 morphogenesis of an epithelium
|
7
|
2.24e-01
|
-2.65e-01
|
6.24e-01
|
GO:0045921 positive regulation of exocytosis
|
13
|
9.78e-02
|
2.65e-01
|
4.48e-01
|
GO:0061608 nuclear import signal receptor activity
|
19
|
4.55e-02
|
-2.65e-01
|
3.35e-01
|
GO:0010389 regulation of G2/M transition of mitotic cell cycle
|
10
|
1.47e-01
|
-2.65e-01
|
5.38e-01
|
GO:0032541 cortical endoplasmic reticulum
|
8
|
1.94e-01
|
-2.65e-01
|
5.98e-01
|
GO:0046340 diacylglycerol catabolic process
|
5
|
3.05e-01
|
-2.65e-01
|
6.95e-01
|
GO:0001946 lymphangiogenesis
|
7
|
2.26e-01
|
2.64e-01
|
6.26e-01
|
GO:0038196 type III interferon-mediated signaling pathway
|
6
|
2.62e-01
|
-2.64e-01
|
6.63e-01
|
GO:0032911 negative regulation of transforming growth factor beta1 production
|
5
|
3.07e-01
|
2.64e-01
|
6.97e-01
|
GO:0021895 cerebral cortex neuron differentiation
|
7
|
2.26e-01
|
-2.64e-01
|
6.26e-01
|
GO:0010458 exit from mitosis
|
13
|
9.94e-02
|
-2.64e-01
|
4.52e-01
|
GO:0000123 histone acetyltransferase complex
|
21
|
3.63e-02
|
-2.64e-01
|
2.97e-01
|
GO:0061617 MICOS complex
|
9
|
1.71e-01
|
-2.64e-01
|
5.76e-01
|
GO:1901838 positive regulation of transcription of nucleolar large rRNA by RNA polymerase I
|
9
|
1.71e-01
|
-2.64e-01
|
5.76e-01
|
GO:0035631 CD40 receptor complex
|
11
|
1.30e-01
|
-2.63e-01
|
5.07e-01
|
GO:0140463 chromatin-protein adaptor activity
|
11
|
1.30e-01
|
-2.63e-01
|
5.07e-01
|
GO:0019885 antigen processing and presentation of endogenous peptide antigen via MHC class I
|
8
|
1.97e-01
|
2.63e-01
|
6.01e-01
|
GO:1902414 protein localization to cell junction
|
6
|
2.64e-01
|
-2.63e-01
|
6.65e-01
|
GO:0045840 positive regulation of mitotic nuclear division
|
16
|
6.84e-02
|
-2.63e-01
|
3.86e-01
|
GO:0046598 positive regulation of viral entry into host cell
|
13
|
1.01e-01
|
-2.63e-01
|
4.54e-01
|
GO:0032693 negative regulation of interleukin-10 production
|
15
|
7.78e-02
|
2.63e-01
|
4.08e-01
|
GO:0051923 sulfation
|
5
|
3.09e-01
|
2.63e-01
|
6.99e-01
|
GO:0042771 intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator
|
31
|
1.14e-02
|
2.63e-01
|
1.89e-01
|
GO:0032958 inositol phosphate biosynthetic process
|
8
|
1.98e-01
|
-2.63e-01
|
6.02e-01
|
GO:0042921 nuclear receptor-mediated glucocorticoid signaling pathway
|
5
|
3.09e-01
|
-2.63e-01
|
7.00e-01
|
GO:0042169 SH2 domain binding
|
33
|
9.12e-03
|
-2.62e-01
|
1.70e-01
|
GO:0002725 negative regulation of T cell cytokine production
|
5
|
3.10e-01
|
2.62e-01
|
7.01e-01
|
GO:0071565 nBAF complex
|
13
|
1.02e-01
|
-2.62e-01
|
4.55e-01
|
GO:1904948 midbrain dopaminergic neuron differentiation
|
5
|
3.11e-01
|
-2.62e-01
|
7.01e-01
|
GO:0038096 Fc-gamma receptor signaling pathway involved in phagocytosis
|
20
|
4.29e-02
|
-2.62e-01
|
3.26e-01
|
GO:0001875 lipopolysaccharide immune receptor activity
|
6
|
2.67e-01
|
2.61e-01
|
6.68e-01
|
GO:0006812 monoatomic cation transport
|
11
|
1.34e-01
|
-2.61e-01
|
5.12e-01
|
GO:0046934 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity
|
7
|
2.31e-01
|
-2.61e-01
|
6.33e-01
|
GO:0010571 positive regulation of nuclear cell cycle DNA replication
|
6
|
2.68e-01
|
-2.61e-01
|
6.68e-01
|
GO:0004518 nuclease activity
|
12
|
1.17e-01
|
-2.61e-01
|
4.84e-01
|
GO:0008375 acetylglucosaminyltransferase activity
|
17
|
6.25e-02
|
2.61e-01
|
3.70e-01
|
GO:0051445 regulation of meiotic cell cycle
|
19
|
4.90e-02
|
-2.61e-01
|
3.41e-01
|
GO:1901612 cardiolipin binding
|
10
|
1.54e-01
|
2.61e-01
|
5.48e-01
|
GO:0005212 structural constituent of eye lens
|
5
|
3.13e-01
|
-2.61e-01
|
7.04e-01
|
GO:0035335 peptidyl-tyrosine dephosphorylation
|
18
|
5.57e-02
|
-2.61e-01
|
3.53e-01
|
GO:0006104 succinyl-CoA metabolic process
|
5
|
3.13e-01
|
-2.60e-01
|
7.04e-01
|
GO:0032931 histone H3K56 acetyltransferase activity
|
18
|
5.60e-02
|
-2.60e-01
|
3.53e-01
|
GO:0043992 histone H3K9 acetyltransferase activity
|
18
|
5.60e-02
|
-2.60e-01
|
3.53e-01
|
GO:0043993 histone H3K18 acetyltransferase activity
|
18
|
5.60e-02
|
-2.60e-01
|
3.53e-01
|
GO:0043994 histone H3K23 acetyltransferase activity
|
18
|
5.60e-02
|
-2.60e-01
|
3.53e-01
|
GO:0043999 histone H2AK5 acetyltransferase activity
|
18
|
5.60e-02
|
-2.60e-01
|
3.53e-01
|
GO:0044012 histone H2AK9 acetyltransferase activity
|
18
|
5.60e-02
|
-2.60e-01
|
3.53e-01
|
GO:0044014 histone H2BK5 acetyltransferase activity
|
18
|
5.60e-02
|
-2.60e-01
|
3.53e-01
|
GO:0044015 histone H2BK12 acetyltransferase activity
|
18
|
5.60e-02
|
-2.60e-01
|
3.53e-01
|
GO:0044016 histone H3K4 acetyltransferase activity
|
18
|
5.60e-02
|
-2.60e-01
|
3.53e-01
|
GO:0044017 histone H3K27 acetyltransferase activity
|
18
|
5.60e-02
|
-2.60e-01
|
3.53e-01
|
GO:0044018 histone H3K36 acetyltransferase activity
|
18
|
5.60e-02
|
-2.60e-01
|
3.53e-01
|
GO:0140908 histone H3K122 acetyltransferase activity
|
18
|
5.60e-02
|
-2.60e-01
|
3.53e-01
|
GO:0070966 nuclear-transcribed mRNA catabolic process, no-go decay
|
5
|
3.14e-01
|
2.60e-01
|
7.05e-01
|
GO:0002548 monocyte chemotaxis
|
15
|
8.13e-02
|
-2.60e-01
|
4.14e-01
|
GO:1902041 regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
6
|
2.70e-01
|
-2.60e-01
|
6.70e-01
|
GO:0004407 histone deacetylase activity
|
18
|
5.65e-02
|
-2.60e-01
|
3.54e-01
|
GO:0043995 histone H4K5 acetyltransferase activity
|
26
|
2.19e-02
|
-2.60e-01
|
2.41e-01
|
GO:0043996 histone H4K8 acetyltransferase activity
|
26
|
2.19e-02
|
-2.60e-01
|
2.41e-01
|
GO:0043997 histone H4K12 acetyltransferase activity
|
26
|
2.19e-02
|
-2.60e-01
|
2.41e-01
|
GO:0048593 camera-type eye morphogenesis
|
15
|
8.18e-02
|
2.60e-01
|
4.16e-01
|
GO:0045664 regulation of neuron differentiation
|
16
|
7.24e-02
|
-2.59e-01
|
3.93e-01
|
GO:0016616 oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
15
|
8.20e-02
|
2.59e-01
|
4.16e-01
|
GO:0010224 response to UV-B
|
6
|
2.71e-01
|
-2.59e-01
|
6.70e-01
|
GO:0042162 telomeric DNA binding
|
27
|
1.99e-02
|
-2.59e-01
|
2.33e-01
|
GO:2001032 regulation of double-strand break repair via nonhomologous end joining
|
7
|
2.36e-01
|
-2.59e-01
|
6.39e-01
|
GO:0048511 rhythmic process
|
50
|
1.55e-03
|
-2.59e-01
|
5.70e-02
|
GO:0042100 B cell proliferation
|
22
|
3.58e-02
|
-2.59e-01
|
2.97e-01
|
GO:0120186 negative regulation of protein localization to chromatin
|
6
|
2.73e-01
|
-2.59e-01
|
6.70e-01
|
GO:1901990 regulation of mitotic cell cycle phase transition
|
8
|
2.06e-01
|
-2.58e-01
|
6.11e-01
|
GO:0010821 regulation of mitochondrion organization
|
18
|
5.79e-02
|
-2.58e-01
|
3.56e-01
|
GO:0070593 dendrite self-avoidance
|
8
|
2.06e-01
|
2.58e-01
|
6.11e-01
|
GO:0019563 glycerol catabolic process
|
5
|
3.18e-01
|
-2.58e-01
|
7.10e-01
|
GO:0006353 DNA-templated transcription termination
|
10
|
1.58e-01
|
-2.58e-01
|
5.56e-01
|
GO:0019915 lipid storage
|
18
|
5.84e-02
|
2.58e-01
|
3.58e-01
|
GO:0017145 stem cell division
|
7
|
2.38e-01
|
2.57e-01
|
6.43e-01
|
GO:0050870 positive regulation of T cell activation
|
28
|
1.84e-02
|
-2.57e-01
|
2.26e-01
|
GO:0008361 regulation of cell size
|
23
|
3.27e-02
|
-2.57e-01
|
2.87e-01
|
GO:0001709 cell fate determination
|
7
|
2.39e-01
|
-2.57e-01
|
6.43e-01
|
GO:0045060 negative thymic T cell selection
|
6
|
2.75e-01
|
-2.57e-01
|
6.71e-01
|
GO:1900747 negative regulation of vascular endothelial growth factor signaling pathway
|
6
|
2.75e-01
|
-2.57e-01
|
6.71e-01
|
GO:0042048 olfactory behavior
|
5
|
3.19e-01
|
-2.57e-01
|
7.10e-01
|
GO:1990948 ubiquitin ligase inhibitor activity
|
10
|
1.59e-01
|
2.57e-01
|
5.59e-01
|
GO:0030890 positive regulation of B cell proliferation
|
37
|
6.82e-03
|
-2.57e-01
|
1.45e-01
|
GO:0070700 BMP receptor binding
|
5
|
3.20e-01
|
-2.57e-01
|
7.10e-01
|
GO:0030836 positive regulation of actin filament depolymerization
|
6
|
2.76e-01
|
-2.57e-01
|
6.71e-01
|
GO:0090181 regulation of cholesterol metabolic process
|
8
|
2.08e-01
|
2.57e-01
|
6.12e-01
|
GO:0016010 dystrophin-associated glycoprotein complex
|
11
|
1.41e-01
|
2.57e-01
|
5.25e-01
|
GO:0008009 chemokine activity
|
17
|
6.71e-02
|
-2.57e-01
|
3.83e-01
|
GO:0043295 glutathione binding
|
9
|
1.83e-01
|
2.57e-01
|
5.85e-01
|
GO:0061827 sperm head
|
5
|
3.21e-01
|
-2.56e-01
|
7.12e-01
|
GO:0140359 ABC-type transporter activity
|
13
|
1.10e-01
|
-2.56e-01
|
4.70e-01
|
GO:0140288 GBAF complex
|
13
|
1.10e-01
|
-2.56e-01
|
4.71e-01
|
GO:0008360 regulation of cell shape
|
102
|
7.99e-06
|
-2.56e-01
|
1.30e-03
|
GO:0030502 negative regulation of bone mineralization
|
10
|
1.61e-01
|
-2.56e-01
|
5.61e-01
|
GO:0032982 myosin filament
|
7
|
2.41e-01
|
-2.56e-01
|
6.46e-01
|
GO:0008198 ferrous iron binding
|
19
|
5.40e-02
|
2.55e-01
|
3.52e-01
|
GO:0030125 clathrin vesicle coat
|
8
|
2.11e-01
|
2.55e-01
|
6.15e-01
|
GO:0070139 SUMO-specific endopeptidase activity
|
5
|
3.23e-01
|
2.55e-01
|
7.15e-01
|
GO:0030879 mammary gland development
|
8
|
2.12e-01
|
-2.55e-01
|
6.15e-01
|
GO:0032026 response to magnesium ion
|
8
|
2.12e-01
|
2.55e-01
|
6.15e-01
|
GO:0030957 Tat protein binding
|
10
|
1.63e-01
|
-2.55e-01
|
5.65e-01
|
GO:2000819 regulation of nucleotide-excision repair
|
24
|
3.10e-02
|
-2.54e-01
|
2.80e-01
|
GO:0032688 negative regulation of interferon-beta production
|
11
|
1.44e-01
|
-2.54e-01
|
5.33e-01
|
GO:0042382 paraspeckles
|
9
|
1.87e-01
|
-2.54e-01
|
5.89e-01
|
GO:0071035 nuclear polyadenylation-dependent rRNA catabolic process
|
7
|
2.44e-01
|
2.54e-01
|
6.49e-01
|
GO:0071038 TRAMP-dependent tRNA surveillance pathway
|
7
|
2.44e-01
|
2.54e-01
|
6.49e-01
|
GO:1900246 positive regulation of RIG-I signaling pathway
|
9
|
1.87e-01
|
2.54e-01
|
5.90e-01
|
GO:0099634 postsynaptic specialization membrane
|
5
|
3.26e-01
|
-2.54e-01
|
7.18e-01
|
GO:0015867 ATP transport
|
9
|
1.87e-01
|
-2.54e-01
|
5.90e-01
|
GO:0070573 metallodipeptidase activity
|
6
|
2.82e-01
|
-2.54e-01
|
6.78e-01
|
GO:0070201 regulation of establishment of protein localization
|
7
|
2.45e-01
|
2.54e-01
|
6.50e-01
|
GO:0034394 protein localization to cell surface
|
21
|
4.46e-02
|
-2.53e-01
|
3.32e-01
|
GO:0045722 positive regulation of gluconeogenesis
|
17
|
7.08e-02
|
-2.53e-01
|
3.90e-01
|
GO:0061824 cytosolic ciliogenesis
|
5
|
3.27e-01
|
2.53e-01
|
7.18e-01
|
GO:0052651 monoacylglycerol catabolic process
|
5
|
3.27e-01
|
-2.53e-01
|
7.18e-01
|
GO:0070886 positive regulation of calcineurin-NFAT signaling cascade
|
13
|
1.14e-01
|
-2.53e-01
|
4.78e-01
|
GO:0010839 negative regulation of keratinocyte proliferation
|
14
|
1.01e-01
|
2.53e-01
|
4.55e-01
|
GO:1902895 positive regulation of miRNA transcription
|
37
|
7.83e-03
|
-2.53e-01
|
1.55e-01
|
GO:0070533 BRCA1-C complex
|
6
|
2.84e-01
|
-2.53e-01
|
6.80e-01
|
GO:0051148 negative regulation of muscle cell differentiation
|
5
|
3.28e-01
|
-2.52e-01
|
7.19e-01
|
GO:2000001 regulation of DNA damage checkpoint
|
15
|
9.06e-02
|
-2.52e-01
|
4.35e-01
|
GO:0010801 negative regulation of peptidyl-threonine phosphorylation
|
12
|
1.30e-01
|
-2.52e-01
|
5.07e-01
|
GO:0035970 peptidyl-threonine dephosphorylation
|
14
|
1.02e-01
|
-2.52e-01
|
4.55e-01
|
GO:0001054 RNA polymerase I activity
|
14
|
1.02e-01
|
-2.52e-01
|
4.55e-01
|
GO:0001056 RNA polymerase III activity
|
14
|
1.02e-01
|
-2.52e-01
|
4.55e-01
|
GO:0045880 positive regulation of smoothened signaling pathway
|
21
|
4.57e-02
|
2.52e-01
|
3.35e-01
|
GO:0015015 heparan sulfate proteoglycan biosynthetic process, enzymatic modification
|
6
|
2.85e-01
|
-2.52e-01
|
6.81e-01
|
GO:1904491 protein localization to ciliary transition zone
|
6
|
2.86e-01
|
2.52e-01
|
6.81e-01
|
GO:0002024 diet induced thermogenesis
|
6
|
2.86e-01
|
-2.51e-01
|
6.81e-01
|
GO:0016709 oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen
|
6
|
2.86e-01
|
-2.51e-01
|
6.81e-01
|
GO:0006596 polyamine biosynthetic process
|
6
|
2.86e-01
|
2.51e-01
|
6.81e-01
|
GO:0140694 membraneless organelle assembly
|
11
|
1.49e-01
|
-2.51e-01
|
5.39e-01
|
GO:0019237 centromeric DNA binding
|
6
|
2.86e-01
|
-2.51e-01
|
6.81e-01
|
GO:0051000 positive regulation of nitric-oxide synthase activity
|
10
|
1.69e-01
|
-2.51e-01
|
5.74e-01
|
GO:0034657 GID complex
|
5
|
3.31e-01
|
-2.51e-01
|
7.21e-01
|
GO:0038065 collagen-activated signaling pathway
|
5
|
3.31e-01
|
2.51e-01
|
7.21e-01
|
GO:0090331 negative regulation of platelet aggregation
|
7
|
2.50e-01
|
-2.51e-01
|
6.52e-01
|
GO:0070475 rRNA base methylation
|
6
|
2.87e-01
|
-2.51e-01
|
6.81e-01
|
GO:0007585 respiratory gaseous exchange by respiratory system
|
14
|
1.04e-01
|
-2.51e-01
|
4.58e-01
|
GO:0032725 positive regulation of granulocyte macrophage colony-stimulating factor production
|
7
|
2.51e-01
|
2.51e-01
|
6.53e-01
|
GO:0072655 establishment of protein localization to mitochondrion
|
6
|
2.88e-01
|
2.51e-01
|
6.82e-01
|
GO:0003170 heart valve development
|
7
|
2.51e-01
|
-2.51e-01
|
6.53e-01
|
GO:0006656 phosphatidylcholine biosynthetic process
|
15
|
9.31e-02
|
2.50e-01
|
4.39e-01
|
GO:0008608 attachment of spindle microtubules to kinetochore
|
16
|
8.29e-02
|
-2.50e-01
|
4.18e-01
|
GO:0090443 FAR/SIN/STRIPAK complex
|
16
|
8.30e-02
|
2.50e-01
|
4.18e-01
|
GO:0051549 positive regulation of keratinocyte migration
|
8
|
2.20e-01
|
-2.50e-01
|
6.20e-01
|
GO:0031667 response to nutrient levels
|
25
|
3.03e-02
|
-2.50e-01
|
2.78e-01
|
GO:0010818 T cell chemotaxis
|
8
|
2.20e-01
|
-2.50e-01
|
6.20e-01
|
GO:0070574 cadmium ion transmembrane transport
|
5
|
3.33e-01
|
-2.50e-01
|
7.22e-01
|
GO:0050796 regulation of insulin secretion
|
23
|
3.79e-02
|
-2.50e-01
|
3.04e-01
|
GO:0006839 mitochondrial transport
|
12
|
1.34e-01
|
-2.50e-01
|
5.12e-01
|
GO:0042572 retinol metabolic process
|
24
|
3.41e-02
|
2.50e-01
|
2.91e-01
|
GO:0005801 cis-Golgi network
|
44
|
4.13e-03
|
2.50e-01
|
1.08e-01
|
GO:0016064 immunoglobulin mediated immune response
|
15
|
9.39e-02
|
-2.50e-01
|
4.40e-01
|
GO:0030500 regulation of bone mineralization
|
9
|
1.95e-01
|
2.50e-01
|
5.98e-01
|
GO:0001784 phosphotyrosine residue binding
|
37
|
8.59e-03
|
-2.50e-01
|
1.63e-01
|
GO:0006089 lactate metabolic process
|
5
|
3.34e-01
|
-2.50e-01
|
7.22e-01
|
GO:0017020 myosin phosphatase regulator activity
|
6
|
2.90e-01
|
2.49e-01
|
6.82e-01
|
GO:0098734 macromolecule depalmitoylation
|
6
|
2.90e-01
|
2.49e-01
|
6.82e-01
|
GO:0034260 negative regulation of GTPase activity
|
15
|
9.54e-02
|
-2.49e-01
|
4.42e-01
|
GO:0007422 peripheral nervous system development
|
8
|
2.23e-01
|
2.49e-01
|
6.22e-01
|
GO:0051142 positive regulation of NK T cell proliferation
|
5
|
3.36e-01
|
2.49e-01
|
7.23e-01
|
GO:0000725 recombinational repair
|
5
|
3.36e-01
|
-2.49e-01
|
7.23e-01
|
GO:0055091 phospholipid homeostasis
|
10
|
1.74e-01
|
2.48e-01
|
5.78e-01
|
GO:0017157 regulation of exocytosis
|
14
|
1.08e-01
|
2.48e-01
|
4.65e-01
|
GO:0032722 positive regulation of chemokine production
|
30
|
1.86e-02
|
-2.48e-01
|
2.27e-01
|
GO:0043274 phospholipase binding
|
16
|
8.56e-02
|
-2.48e-01
|
4.24e-01
|
GO:0031201 SNARE complex
|
38
|
8.12e-03
|
2.48e-01
|
1.58e-01
|
GO:0004721 phosphoprotein phosphatase activity
|
33
|
1.37e-02
|
-2.48e-01
|
2.04e-01
|
GO:0030111 regulation of Wnt signaling pathway
|
11
|
1.54e-01
|
2.48e-01
|
5.49e-01
|
GO:0048245 eosinophil chemotaxis
|
8
|
2.24e-01
|
-2.48e-01
|
6.24e-01
|
GO:0009967 positive regulation of signal transduction
|
6
|
2.93e-01
|
-2.48e-01
|
6.87e-01
|
GO:1901030 positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway
|
7
|
2.56e-01
|
-2.48e-01
|
6.58e-01
|
GO:0006048 UDP-N-acetylglucosamine biosynthetic process
|
9
|
1.98e-01
|
2.48e-01
|
6.02e-01
|
GO:0016176 superoxide-generating NADPH oxidase activator activity
|
7
|
2.57e-01
|
2.48e-01
|
6.58e-01
|
GO:0005537 D-mannose binding
|
15
|
9.71e-02
|
2.47e-01
|
4.47e-01
|
GO:0007602 phototransduction
|
6
|
2.94e-01
|
2.47e-01
|
6.88e-01
|
GO:0019953 sexual reproduction
|
5
|
3.38e-01
|
-2.47e-01
|
7.25e-01
|
GO:1901981 phosphatidylinositol phosphate binding
|
21
|
4.99e-02
|
-2.47e-01
|
3.41e-01
|
GO:0001787 natural killer cell proliferation
|
5
|
3.38e-01
|
-2.47e-01
|
7.25e-01
|
GO:0005025 transforming growth factor beta receptor activity, type I
|
9
|
1.99e-01
|
2.47e-01
|
6.02e-01
|
GO:0005026 transforming growth factor beta receptor activity, type II
|
9
|
1.99e-01
|
2.47e-01
|
6.02e-01
|
GO:0016361 activin receptor activity, type I
|
9
|
1.99e-01
|
2.47e-01
|
6.02e-01
|
GO:0016362 activin receptor activity, type II
|
9
|
1.99e-01
|
2.47e-01
|
6.02e-01
|
GO:0098821 BMP receptor activity
|
9
|
1.99e-01
|
2.47e-01
|
6.02e-01
|
GO:0014823 response to activity
|
37
|
9.29e-03
|
-2.47e-01
|
1.72e-01
|
GO:0071578 zinc ion import across plasma membrane
|
7
|
2.57e-01
|
2.47e-01
|
6.58e-01
|
GO:0034389 lipid droplet organization
|
13
|
1.23e-01
|
2.47e-01
|
4.96e-01
|
GO:0003283 atrial septum development
|
5
|
3.39e-01
|
2.47e-01
|
7.25e-01
|
GO:0031095 platelet dense tubular network membrane
|
6
|
2.95e-01
|
-2.47e-01
|
6.89e-01
|
GO:1990246 uniplex complex
|
6
|
2.95e-01
|
2.47e-01
|
6.89e-01
|
GO:0060337 type I interferon-mediated signaling pathway
|
29
|
2.14e-02
|
2.47e-01
|
2.41e-01
|
GO:0046972 histone H4K16 acetyltransferase activity
|
22
|
4.51e-02
|
-2.47e-01
|
3.33e-01
|
GO:1905394 retromer complex binding
|
10
|
1.77e-01
|
-2.47e-01
|
5.78e-01
|
GO:0060336 negative regulation of type II interferon-mediated signaling pathway
|
6
|
2.95e-01
|
2.47e-01
|
6.89e-01
|
GO:0060100 positive regulation of phagocytosis, engulfment
|
10
|
1.77e-01
|
-2.47e-01
|
5.78e-01
|
GO:0032432 actin filament bundle
|
9
|
2.00e-01
|
-2.46e-01
|
6.04e-01
|
GO:0045721 negative regulation of gluconeogenesis
|
10
|
1.77e-01
|
-2.46e-01
|
5.78e-01
|
GO:0010972 negative regulation of G2/M transition of mitotic cell cycle
|
11
|
1.57e-01
|
-2.46e-01
|
5.55e-01
|
GO:0006108 malate metabolic process
|
7
|
2.59e-01
|
2.46e-01
|
6.61e-01
|
GO:0045292 mRNA cis splicing, via spliceosome
|
16
|
8.84e-02
|
-2.46e-01
|
4.31e-01
|
GO:1901097 negative regulation of autophagosome maturation
|
5
|
3.41e-01
|
2.46e-01
|
7.27e-01
|
GO:0007266 Rho protein signal transduction
|
46
|
3.96e-03
|
-2.46e-01
|
1.07e-01
|
GO:0010544 negative regulation of platelet activation
|
5
|
3.42e-01
|
-2.46e-01
|
7.27e-01
|
GO:0034983 peptidyl-lysine deacetylation
|
6
|
2.98e-01
|
-2.46e-01
|
6.90e-01
|
GO:0001162 RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding
|
6
|
2.98e-01
|
2.45e-01
|
6.90e-01
|
GO:0033290 eukaryotic 48S preinitiation complex
|
16
|
8.93e-02
|
2.45e-01
|
4.33e-01
|
GO:0003823 antigen binding
|
8
|
2.30e-01
|
2.45e-01
|
6.31e-01
|
GO:0085020 protein K6-linked ubiquitination
|
16
|
8.95e-02
|
-2.45e-01
|
4.33e-01
|
GO:0061000 negative regulation of dendritic spine development
|
6
|
2.98e-01
|
2.45e-01
|
6.91e-01
|
GO:0034241 positive regulation of macrophage fusion
|
5
|
3.42e-01
|
-2.45e-01
|
7.28e-01
|
GO:0030208 dermatan sulfate biosynthetic process
|
5
|
3.42e-01
|
2.45e-01
|
7.28e-01
|
GO:0030203 glycosaminoglycan metabolic process
|
7
|
2.61e-01
|
2.45e-01
|
6.62e-01
|
GO:0044020 histone H4R3 methyltransferase activity
|
8
|
2.31e-01
|
-2.45e-01
|
6.32e-01
|
GO:0032649 regulation of type II interferon production
|
7
|
2.62e-01
|
2.45e-01
|
6.63e-01
|
GO:2000273 positive regulation of signaling receptor activity
|
8
|
2.31e-01
|
-2.44e-01
|
6.33e-01
|
GO:0047238 glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity
|
6
|
3.01e-01
|
2.44e-01
|
6.92e-01
|
GO:0030296 protein tyrosine kinase activator activity
|
7
|
2.64e-01
|
-2.44e-01
|
6.65e-01
|
GO:0005663 DNA replication factor C complex
|
5
|
3.45e-01
|
-2.44e-01
|
7.30e-01
|
GO:0070059 intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress
|
30
|
2.09e-02
|
2.44e-01
|
2.38e-01
|
GO:2000463 positive regulation of excitatory postsynaptic potential
|
15
|
1.03e-01
|
-2.43e-01
|
4.55e-01
|
GO:0071559 response to transforming growth factor beta
|
6
|
3.02e-01
|
-2.43e-01
|
6.93e-01
|
GO:0006473 protein acetylation
|
13
|
1.29e-01
|
-2.43e-01
|
5.06e-01
|
GO:0005786 signal recognition particle, endoplasmic reticulum targeting
|
6
|
3.03e-01
|
2.43e-01
|
6.93e-01
|
GO:0022904 respiratory electron transport chain
|
19
|
6.70e-02
|
2.43e-01
|
3.83e-01
|
GO:0098837 postsynaptic recycling endosome
|
8
|
2.35e-01
|
2.43e-01
|
6.38e-01
|
GO:0032391 photoreceptor connecting cilium
|
30
|
2.15e-02
|
2.43e-01
|
2.41e-01
|
GO:0010887 negative regulation of cholesterol storage
|
10
|
1.84e-01
|
2.42e-01
|
5.87e-01
|
GO:1902902 negative regulation of autophagosome assembly
|
13
|
1.30e-01
|
2.42e-01
|
5.07e-01
|
GO:0032511 late endosome to vacuole transport via multivesicular body sorting pathway
|
11
|
1.64e-01
|
2.42e-01
|
5.66e-01
|
GO:0050877 nervous system process
|
10
|
1.85e-01
|
2.42e-01
|
5.88e-01
|
GO:0007084 mitotic nuclear membrane reassembly
|
10
|
1.85e-01
|
-2.42e-01
|
5.88e-01
|
GO:0005793 endoplasmic reticulum-Golgi intermediate compartment
|
67
|
6.23e-04
|
2.42e-01
|
3.27e-02
|
GO:2000562 negative regulation of CD4-positive, alpha-beta T cell proliferation
|
8
|
2.38e-01
|
2.41e-01
|
6.42e-01
|
GO:0045294 alpha-catenin binding
|
5
|
3.50e-01
|
-2.41e-01
|
7.35e-01
|
GO:0051893 regulation of focal adhesion assembly
|
21
|
5.58e-02
|
-2.41e-01
|
3.53e-01
|
GO:2000008 regulation of protein localization to cell surface
|
8
|
2.38e-01
|
-2.41e-01
|
6.43e-01
|
GO:0003697 single-stranded DNA binding
|
95
|
5.04e-05
|
-2.41e-01
|
5.37e-03
|
GO:0007080 mitotic metaphase chromosome alignment
|
43
|
6.32e-03
|
-2.41e-01
|
1.40e-01
|
GO:0060253 negative regulation of glial cell proliferation
|
6
|
3.07e-01
|
2.41e-01
|
6.98e-01
|
GO:0007229 integrin-mediated signaling pathway
|
70
|
5.02e-04
|
-2.41e-01
|
2.97e-02
|
GO:0051575 5’-deoxyribose-5-phosphate lyase activity
|
7
|
2.70e-01
|
-2.41e-01
|
6.70e-01
|
GO:0021955 central nervous system neuron axonogenesis
|
6
|
3.08e-01
|
2.41e-01
|
6.98e-01
|
GO:0060307 regulation of ventricular cardiac muscle cell membrane repolarization
|
11
|
1.67e-01
|
2.40e-01
|
5.72e-01
|
GO:2000179 positive regulation of neural precursor cell proliferation
|
7
|
2.71e-01
|
-2.40e-01
|
6.70e-01
|
GO:0046325 negative regulation of D-glucose import
|
9
|
2.12e-01
|
-2.40e-01
|
6.15e-01
|
GO:0032400 melanosome localization
|
5
|
3.53e-01
|
2.40e-01
|
7.37e-01
|
GO:0022038 corpus callosum development
|
15
|
1.08e-01
|
-2.40e-01
|
4.65e-01
|
GO:0002052 positive regulation of neuroblast proliferation
|
13
|
1.34e-01
|
-2.40e-01
|
5.13e-01
|
GO:0045145 single-stranded DNA 5’-3’ DNA exonuclease activity
|
5
|
3.53e-01
|
-2.40e-01
|
7.38e-01
|
GO:0035810 positive regulation of urine volume
|
5
|
3.53e-01
|
-2.40e-01
|
7.38e-01
|
GO:0034472 snRNA 3’-end processing
|
11
|
1.69e-01
|
-2.40e-01
|
5.74e-01
|
GO:0031145 anaphase-promoting complex-dependent catabolic process
|
20
|
6.37e-02
|
-2.40e-01
|
3.74e-01
|
GO:0019966 interleukin-1 binding
|
5
|
3.54e-01
|
2.39e-01
|
7.38e-01
|
GO:0071347 cellular response to interleukin-1
|
35
|
1.43e-02
|
-2.39e-01
|
2.07e-01
|
GO:0006085 acetyl-CoA biosynthetic process
|
7
|
2.73e-01
|
-2.39e-01
|
6.70e-01
|
GO:0072006 nephron development
|
7
|
2.73e-01
|
-2.39e-01
|
6.70e-01
|
GO:0042975 peroxisome proliferator activated receptor binding
|
7
|
2.74e-01
|
-2.39e-01
|
6.71e-01
|
GO:0005742 mitochondrial outer membrane translocase complex
|
7
|
2.74e-01
|
-2.39e-01
|
6.71e-01
|
GO:0043560 insulin receptor substrate binding
|
11
|
1.70e-01
|
-2.39e-01
|
5.76e-01
|
GO:0035023 regulation of Rho protein signal transduction
|
30
|
2.37e-02
|
-2.39e-01
|
2.50e-01
|
GO:0033106 cis-Golgi network membrane
|
7
|
2.74e-01
|
2.39e-01
|
6.71e-01
|
GO:0016050 vesicle organization
|
13
|
1.37e-01
|
2.39e-01
|
5.16e-01
|
GO:0006107 oxaloacetate metabolic process
|
9
|
2.16e-01
|
2.38e-01
|
6.18e-01
|
GO:0001164 RNA polymerase I core promoter sequence-specific DNA binding
|
8
|
2.43e-01
|
-2.38e-01
|
6.48e-01
|
GO:0043277 apoptotic cell clearance
|
13
|
1.37e-01
|
-2.38e-01
|
5.17e-01
|
GO:0010181 FMN binding
|
9
|
2.16e-01
|
-2.38e-01
|
6.18e-01
|
GO:0008276 protein methyltransferase activity
|
10
|
1.92e-01
|
-2.38e-01
|
5.97e-01
|
GO:0032809 neuronal cell body membrane
|
12
|
1.53e-01
|
-2.38e-01
|
5.48e-01
|
GO:0006383 transcription by RNA polymerase III
|
29
|
2.65e-02
|
-2.38e-01
|
2.62e-01
|
GO:0032508 DNA duplex unwinding
|
60
|
1.43e-03
|
-2.38e-01
|
5.53e-02
|
GO:0032396 inhibitory MHC class I receptor activity
|
10
|
1.92e-01
|
-2.38e-01
|
5.97e-01
|
GO:0035516 broad specificity oxidative DNA demethylase activity
|
5
|
3.57e-01
|
2.38e-01
|
7.40e-01
|
GO:0042775 mitochondrial ATP synthesis coupled electron transport
|
9
|
2.16e-01
|
2.38e-01
|
6.18e-01
|
GO:0042276 error-prone translesion synthesis
|
11
|
1.72e-01
|
-2.38e-01
|
5.77e-01
|
GO:0048820 hair follicle maturation
|
6
|
3.13e-01
|
-2.38e-01
|
7.04e-01
|
GO:0010831 positive regulation of myotube differentiation
|
7
|
2.76e-01
|
-2.38e-01
|
6.71e-01
|
GO:0001055 RNA polymerase II activity
|
15
|
1.11e-01
|
-2.38e-01
|
4.73e-01
|
GO:0005736 RNA polymerase I complex
|
10
|
1.94e-01
|
-2.37e-01
|
5.98e-01
|
GO:0046034 ATP metabolic process
|
23
|
4.89e-02
|
-2.37e-01
|
3.40e-01
|
GO:0048205 COPI coating of Golgi vesicle
|
6
|
3.14e-01
|
-2.37e-01
|
7.06e-01
|
GO:0043139 5’-3’ DNA helicase activity
|
8
|
2.46e-01
|
-2.37e-01
|
6.50e-01
|
GO:0005798 Golgi-associated vesicle
|
13
|
1.39e-01
|
2.37e-01
|
5.22e-01
|
GO:0007340 acrosome reaction
|
5
|
3.59e-01
|
-2.37e-01
|
7.41e-01
|
GO:0050853 B cell receptor signaling pathway
|
34
|
1.69e-02
|
-2.37e-01
|
2.20e-01
|
GO:0095500 acetylcholine receptor signaling pathway
|
8
|
2.46e-01
|
-2.37e-01
|
6.50e-01
|
GO:0007188 adenylate cyclase-modulating G protein-coupled receptor signaling pathway
|
16
|
1.01e-01
|
-2.37e-01
|
4.55e-01
|
GO:0003229 ventricular cardiac muscle tissue development
|
5
|
3.59e-01
|
-2.37e-01
|
7.41e-01
|
GO:0005547 phosphatidylinositol-3,4,5-trisphosphate binding
|
34
|
1.69e-02
|
-2.37e-01
|
2.20e-01
|
GO:0071481 cellular response to X-ray
|
7
|
2.78e-01
|
-2.37e-01
|
6.75e-01
|
GO:1905166 negative regulation of lysosomal protein catabolic process
|
5
|
3.60e-01
|
2.37e-01
|
7.41e-01
|
GO:0051787 misfolded protein binding
|
16
|
1.02e-01
|
2.37e-01
|
4.55e-01
|
GO:0031466 Cul5-RING ubiquitin ligase complex
|
11
|
1.75e-01
|
2.36e-01
|
5.78e-01
|
GO:0030889 negative regulation of B cell proliferation
|
14
|
1.26e-01
|
-2.36e-01
|
5.01e-01
|
GO:2000810 regulation of bicellular tight junction assembly
|
7
|
2.79e-01
|
-2.36e-01
|
6.76e-01
|
GO:0005068 transmembrane receptor protein tyrosine kinase adaptor activity
|
14
|
1.26e-01
|
-2.36e-01
|
5.01e-01
|
GO:0048008 platelet-derived growth factor receptor signaling pathway
|
25
|
4.09e-02
|
-2.36e-01
|
3.17e-01
|
GO:0006901 vesicle coating
|
11
|
1.75e-01
|
2.36e-01
|
5.78e-01
|
GO:1990071 TRAPPII protein complex
|
11
|
1.75e-01
|
2.36e-01
|
5.78e-01
|
GO:0072669 tRNA-splicing ligase complex
|
8
|
2.47e-01
|
2.36e-01
|
6.52e-01
|
GO:2000811 negative regulation of anoikis
|
14
|
1.26e-01
|
-2.36e-01
|
5.02e-01
|
GO:0042043 neurexin family protein binding
|
9
|
2.20e-01
|
2.36e-01
|
6.20e-01
|
GO:0007204 positive regulation of cytosolic calcium ion concentration
|
60
|
1.57e-03
|
-2.36e-01
|
5.70e-02
|
GO:0005655 nucleolar ribonuclease P complex
|
7
|
2.80e-01
|
-2.36e-01
|
6.76e-01
|
GO:0005694 chromosome
|
180
|
5.06e-08
|
-2.36e-01
|
2.47e-05
|
GO:0005581 collagen trimer
|
22
|
5.56e-02
|
-2.36e-01
|
3.53e-01
|
GO:0001188 RNA polymerase I preinitiation complex assembly
|
9
|
2.21e-01
|
-2.36e-01
|
6.21e-01
|
GO:0000244 spliceosomal tri-snRNP complex assembly
|
13
|
1.41e-01
|
-2.36e-01
|
5.26e-01
|
GO:0009566 fertilization
|
20
|
6.84e-02
|
2.35e-01
|
3.86e-01
|
GO:0061041 regulation of wound healing
|
5
|
3.62e-01
|
-2.35e-01
|
7.44e-01
|
GO:0007224 smoothened signaling pathway
|
50
|
4.01e-03
|
2.35e-01
|
1.07e-01
|
GO:0051013 microtubule severing
|
7
|
2.81e-01
|
-2.35e-01
|
6.78e-01
|
GO:0035542 regulation of SNARE complex assembly
|
10
|
1.98e-01
|
-2.35e-01
|
6.02e-01
|
GO:0051715 cytolysis in another organism
|
6
|
3.19e-01
|
2.35e-01
|
7.10e-01
|
GO:0006509 membrane protein ectodomain proteolysis
|
22
|
5.65e-02
|
-2.35e-01
|
3.54e-01
|
GO:0006885 regulation of pH
|
7
|
2.82e-01
|
2.35e-01
|
6.78e-01
|
GO:0032006 regulation of TOR signaling
|
14
|
1.28e-01
|
-2.35e-01
|
5.06e-01
|
GO:0036408 histone H3K14 acetyltransferase activity
|
24
|
4.66e-02
|
-2.35e-01
|
3.38e-01
|
GO:0047498 calcium-dependent phospholipase A2 activity
|
15
|
1.16e-01
|
2.35e-01
|
4.79e-01
|
GO:0050321 tau-protein kinase activity
|
18
|
8.49e-02
|
-2.35e-01
|
4.23e-01
|
GO:0060907 positive regulation of macrophage cytokine production
|
22
|
5.72e-02
|
-2.34e-01
|
3.55e-01
|
GO:1901016 regulation of potassium ion transmembrane transporter activity
|
5
|
3.64e-01
|
-2.34e-01
|
7.47e-01
|
GO:0006891 intra-Golgi vesicle-mediated transport
|
28
|
3.20e-02
|
2.34e-01
|
2.85e-01
|
GO:0001726 ruffle
|
89
|
1.35e-04
|
-2.34e-01
|
1.12e-02
|
GO:1990259 histone H2AQ104 methyltransferase activity
|
8
|
2.51e-01
|
-2.34e-01
|
6.53e-01
|
GO:0005940 septin ring
|
10
|
2.00e-01
|
2.34e-01
|
6.03e-01
|
GO:0031105 septin complex
|
10
|
2.00e-01
|
2.34e-01
|
6.03e-01
|
GO:0010613 positive regulation of cardiac muscle hypertrophy
|
16
|
1.05e-01
|
-2.34e-01
|
4.60e-01
|
GO:0009880 embryonic pattern specification
|
12
|
1.61e-01
|
2.34e-01
|
5.61e-01
|
GO:0050482 arachidonate secretion
|
7
|
2.84e-01
|
2.34e-01
|
6.81e-01
|
GO:0048179 activin receptor complex
|
6
|
3.22e-01
|
2.34e-01
|
7.13e-01
|
GO:0071468 cellular response to acidic pH
|
8
|
2.53e-01
|
2.33e-01
|
6.55e-01
|
GO:0034511 U3 snoRNA binding
|
11
|
1.80e-01
|
-2.33e-01
|
5.83e-01
|
GO:0048499 synaptic vesicle membrane organization
|
5
|
3.66e-01
|
-2.33e-01
|
7.49e-01
|
GO:0030036 actin cytoskeleton organization
|
158
|
4.34e-07
|
-2.33e-01
|
1.41e-04
|
GO:0048661 positive regulation of smooth muscle cell proliferation
|
35
|
1.70e-02
|
-2.33e-01
|
2.20e-01
|
GO:0033627 cell adhesion mediated by integrin
|
27
|
3.60e-02
|
-2.33e-01
|
2.97e-01
|
GO:0032211 negative regulation of telomere maintenance via telomerase
|
22
|
5.84e-02
|
-2.33e-01
|
3.58e-01
|
GO:0140596 TOM complex
|
7
|
2.86e-01
|
-2.33e-01
|
6.81e-01
|
GO:0048489 synaptic vesicle transport
|
17
|
9.68e-02
|
2.33e-01
|
4.46e-01
|
GO:0000467 exonucleolytic trimming to generate mature 3’-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
|
7
|
2.86e-01
|
2.33e-01
|
6.81e-01
|
GO:0050678 regulation of epithelial cell proliferation
|
10
|
2.03e-01
|
-2.33e-01
|
6.06e-01
|
GO:0051603 proteolysis involved in protein catabolic process
|
25
|
4.42e-02
|
2.33e-01
|
3.30e-01
|
GO:0071681 cellular response to indole-3-methanol
|
5
|
3.68e-01
|
-2.32e-01
|
7.50e-01
|
GO:0002720 positive regulation of cytokine production involved in immune response
|
12
|
1.64e-01
|
-2.32e-01
|
5.65e-01
|
GO:1905370 serine-type endopeptidase complex
|
5
|
3.69e-01
|
2.32e-01
|
7.50e-01
|
GO:0070374 positive regulation of ERK1 and ERK2 cascade
|
106
|
3.71e-05
|
-2.32e-01
|
4.35e-03
|
GO:0071314 cellular response to cocaine
|
7
|
2.88e-01
|
-2.32e-01
|
6.82e-01
|
GO:0031256 leading edge membrane
|
5
|
3.69e-01
|
-2.32e-01
|
7.50e-01
|
GO:0000055 ribosomal large subunit export from nucleus
|
7
|
2.88e-01
|
2.32e-01
|
6.82e-01
|
GO:0010917 negative regulation of mitochondrial membrane potential
|
9
|
2.28e-01
|
2.32e-01
|
6.29e-01
|
GO:0036020 endolysosome membrane
|
15
|
1.20e-01
|
-2.32e-01
|
4.88e-01
|
GO:0070064 proline-rich region binding
|
16
|
1.09e-01
|
-2.32e-01
|
4.69e-01
|
GO:0034775 glutathione transmembrane transport
|
5
|
3.70e-01
|
2.32e-01
|
7.50e-01
|
GO:0048019 receptor antagonist activity
|
7
|
2.89e-01
|
2.32e-01
|
6.82e-01
|
GO:0097305 response to alcohol
|
6
|
3.26e-01
|
-2.31e-01
|
7.18e-01
|
GO:0016554 cytidine to uridine editing
|
8
|
2.57e-01
|
2.31e-01
|
6.58e-01
|
GO:0097025 MPP7-DLG1-LIN7 complex
|
5
|
3.70e-01
|
2.31e-01
|
7.51e-01
|
GO:0061700 GATOR2 complex
|
10
|
2.05e-01
|
-2.31e-01
|
6.11e-01
|
GO:1900028 negative regulation of ruffle assembly
|
6
|
3.27e-01
|
-2.31e-01
|
7.18e-01
|
GO:0046847 filopodium assembly
|
19
|
8.11e-02
|
-2.31e-01
|
4.14e-01
|
GO:0008526 phosphatidylinositol transfer activity
|
10
|
2.06e-01
|
-2.31e-01
|
6.11e-01
|
GO:0004000 adenosine deaminase activity
|
6
|
3.27e-01
|
-2.31e-01
|
7.18e-01
|
GO:0008037 cell recognition
|
5
|
3.71e-01
|
-2.31e-01
|
7.51e-01
|
GO:0010631 epithelial cell migration
|
8
|
2.58e-01
|
2.31e-01
|
6.58e-01
|
GO:0035371 microtubule plus-end
|
20
|
7.38e-02
|
-2.31e-01
|
3.96e-01
|
GO:1901799 negative regulation of proteasomal protein catabolic process
|
7
|
2.90e-01
|
2.31e-01
|
6.82e-01
|
GO:0120013 lipid transfer activity
|
5
|
3.71e-01
|
-2.31e-01
|
7.51e-01
|
GO:0140031 phosphorylation-dependent protein binding
|
9
|
2.31e-01
|
-2.31e-01
|
6.32e-01
|
GO:0006122 mitochondrial electron transport, ubiquinol to cytochrome c
|
13
|
1.50e-01
|
-2.31e-01
|
5.43e-01
|
GO:0043531 ADP binding
|
33
|
2.19e-02
|
-2.31e-01
|
2.41e-01
|
GO:0034596 phosphatidylinositol phosphate 4-phosphatase activity
|
5
|
3.72e-01
|
-2.31e-01
|
7.51e-01
|
GO:0033691 sialic acid binding
|
10
|
2.07e-01
|
-2.30e-01
|
6.11e-01
|
GO:0006749 glutathione metabolic process
|
26
|
4.21e-02
|
2.30e-01
|
3.22e-01
|
GO:0019104 DNA N-glycosylase activity
|
9
|
2.32e-01
|
2.30e-01
|
6.33e-01
|
GO:0009611 response to wounding
|
40
|
1.18e-02
|
-2.30e-01
|
1.92e-01
|
GO:0045743 positive regulation of fibroblast growth factor receptor signaling pathway
|
6
|
3.29e-01
|
-2.30e-01
|
7.20e-01
|
GO:1903238 positive regulation of leukocyte tethering or rolling
|
6
|
3.29e-01
|
-2.30e-01
|
7.20e-01
|
GO:0051457 maintenance of protein location in nucleus
|
13
|
1.51e-01
|
2.30e-01
|
5.44e-01
|
GO:0044224 juxtaparanode region of axon
|
9
|
2.32e-01
|
-2.30e-01
|
6.34e-01
|
GO:0016075 rRNA catabolic process
|
12
|
1.68e-01
|
2.30e-01
|
5.73e-01
|
GO:1905146 lysosomal protein catabolic process
|
11
|
1.87e-01
|
2.30e-01
|
5.90e-01
|
GO:0008630 intrinsic apoptotic signaling pathway in response to DNA damage
|
39
|
1.31e-02
|
-2.30e-01
|
2.03e-01
|
GO:0038191 neuropilin binding
|
13
|
1.52e-01
|
-2.30e-01
|
5.45e-01
|
GO:0004709 MAP kinase kinase kinase activity
|
15
|
1.24e-01
|
-2.30e-01
|
4.97e-01
|
GO:0033689 negative regulation of osteoblast proliferation
|
7
|
2.93e-01
|
2.29e-01
|
6.87e-01
|
GO:0004386 helicase activity
|
41
|
1.11e-02
|
-2.29e-01
|
1.87e-01
|
GO:0036158 outer dynein arm assembly
|
6
|
3.31e-01
|
2.29e-01
|
7.21e-01
|
GO:0032147 activation of protein kinase activity
|
16
|
1.13e-01
|
-2.29e-01
|
4.75e-01
|
GO:0044321 response to leptin
|
5
|
3.75e-01
|
-2.29e-01
|
7.55e-01
|
GO:0035418 protein localization to synapse
|
11
|
1.89e-01
|
-2.29e-01
|
5.92e-01
|
GO:0018027 peptidyl-lysine dimethylation
|
5
|
3.76e-01
|
2.29e-01
|
7.55e-01
|
GO:0017080 sodium channel regulator activity
|
20
|
7.68e-02
|
2.29e-01
|
4.05e-01
|
GO:0033687 osteoblast proliferation
|
8
|
2.64e-01
|
2.28e-01
|
6.64e-01
|
GO:0035914 skeletal muscle cell differentiation
|
27
|
4.02e-02
|
-2.28e-01
|
3.14e-01
|
GO:0002080 acrosomal membrane
|
10
|
2.12e-01
|
2.28e-01
|
6.15e-01
|
GO:0141196 transposable element silencing by piRNA-mediated DNA methylation
|
6
|
3.34e-01
|
-2.28e-01
|
7.22e-01
|
GO:0098884 postsynaptic neurotransmitter receptor internalization
|
7
|
2.96e-01
|
-2.28e-01
|
6.90e-01
|
GO:0007043 cell-cell junction assembly
|
11
|
1.91e-01
|
-2.28e-01
|
5.95e-01
|
GO:0006269 DNA replication, synthesis of primer
|
7
|
2.97e-01
|
-2.28e-01
|
6.90e-01
|
GO:0003382 epithelial cell morphogenesis
|
5
|
3.78e-01
|
2.28e-01
|
7.57e-01
|
GO:0039702 viral budding via host ESCRT complex
|
21
|
7.09e-02
|
2.28e-01
|
3.90e-01
|
GO:0050908 detection of light stimulus involved in visual perception
|
12
|
1.72e-01
|
2.28e-01
|
5.77e-01
|
GO:0004659 prenyltransferase activity
|
5
|
3.78e-01
|
-2.28e-01
|
7.57e-01
|
GO:0090522 vesicle tethering involved in exocytosis
|
9
|
2.37e-01
|
2.28e-01
|
6.42e-01
|
GO:0044788 modulation by host of viral process
|
7
|
2.97e-01
|
-2.28e-01
|
6.90e-01
|
GO:0007270 neuron-neuron synaptic transmission
|
5
|
3.78e-01
|
2.27e-01
|
7.57e-01
|
GO:0005850 eukaryotic translation initiation factor 2 complex
|
5
|
3.79e-01
|
2.27e-01
|
7.57e-01
|
GO:0000781 chromosome, telomeric region
|
136
|
4.79e-06
|
-2.27e-01
|
9.06e-04
|
GO:0022900 electron transport chain
|
10
|
2.13e-01
|
2.27e-01
|
6.15e-01
|
GO:0043507 positive regulation of JUN kinase activity
|
24
|
5.39e-02
|
-2.27e-01
|
3.51e-01
|
GO:0014004 microglia differentiation
|
8
|
2.66e-01
|
-2.27e-01
|
6.67e-01
|
GO:0034361 very-low-density lipoprotein particle
|
14
|
1.41e-01
|
2.27e-01
|
5.25e-01
|
GO:0035617 stress granule disassembly
|
7
|
2.98e-01
|
2.27e-01
|
6.91e-01
|
GO:0005080 protein kinase C binding
|
38
|
1.55e-02
|
-2.27e-01
|
2.16e-01
|
GO:0010745 negative regulation of macrophage derived foam cell differentiation
|
10
|
2.14e-01
|
2.27e-01
|
6.15e-01
|
GO:0070034 telomerase RNA binding
|
21
|
7.21e-02
|
-2.27e-01
|
3.93e-01
|
GO:0040037 negative regulation of fibroblast growth factor receptor signaling pathway
|
7
|
2.99e-01
|
-2.27e-01
|
6.91e-01
|
GO:0031589 cell-substrate adhesion
|
15
|
1.29e-01
|
-2.27e-01
|
5.06e-01
|
GO:0003756 protein disulfide isomerase activity
|
19
|
8.74e-02
|
2.27e-01
|
4.29e-01
|
GO:0045987 positive regulation of smooth muscle contraction
|
8
|
2.67e-01
|
2.27e-01
|
6.68e-01
|
GO:0000176 nuclear exosome (RNase complex)
|
17
|
1.06e-01
|
2.26e-01
|
4.61e-01
|
GO:0032210 regulation of telomere maintenance via telomerase
|
6
|
3.37e-01
|
-2.26e-01
|
7.24e-01
|
GO:0046322 negative regulation of fatty acid oxidation
|
5
|
3.81e-01
|
2.26e-01
|
7.58e-01
|
GO:0051321 meiotic cell cycle
|
41
|
1.22e-02
|
-2.26e-01
|
1.96e-01
|
GO:0046790 virion binding
|
7
|
3.00e-01
|
2.26e-01
|
6.92e-01
|
GO:0021772 olfactory bulb development
|
12
|
1.75e-01
|
-2.26e-01
|
5.78e-01
|
GO:0030688 preribosome, small subunit precursor
|
11
|
1.94e-01
|
-2.26e-01
|
5.98e-01
|
GO:0046596 regulation of viral entry into host cell
|
6
|
3.38e-01
|
2.26e-01
|
7.25e-01
|
GO:0032703 negative regulation of interleukin-2 production
|
19
|
8.82e-02
|
-2.26e-01
|
4.30e-01
|
GO:0042581 specific granule
|
9
|
2.41e-01
|
2.26e-01
|
6.46e-01
|
GO:0045667 regulation of osteoblast differentiation
|
7
|
3.01e-01
|
-2.26e-01
|
6.92e-01
|
GO:0015078 proton transmembrane transporter activity
|
12
|
1.76e-01
|
-2.26e-01
|
5.78e-01
|
GO:0005484 SNAP receptor activity
|
33
|
2.48e-02
|
2.26e-01
|
2.58e-01
|
GO:1905168 positive regulation of double-strand break repair via homologous recombination
|
42
|
1.14e-02
|
-2.26e-01
|
1.89e-01
|
GO:0042500 aspartic endopeptidase activity, intramembrane cleaving
|
7
|
3.01e-01
|
-2.26e-01
|
6.92e-01
|
GO:0060445 branching involved in salivary gland morphogenesis
|
5
|
3.83e-01
|
-2.26e-01
|
7.60e-01
|
GO:0006855 xenobiotic transmembrane transport
|
13
|
1.59e-01
|
2.25e-01
|
5.59e-01
|
GO:0043622 cortical microtubule organization
|
9
|
2.42e-01
|
-2.25e-01
|
6.47e-01
|
GO:0060087 relaxation of vascular associated smooth muscle
|
5
|
3.83e-01
|
2.25e-01
|
7.60e-01
|
GO:0010586 miRNA metabolic process
|
10
|
2.17e-01
|
-2.25e-01
|
6.18e-01
|
GO:0015190 L-leucine transmembrane transporter activity
|
6
|
3.40e-01
|
2.25e-01
|
7.26e-01
|
GO:0016235 aggresome
|
28
|
3.93e-02
|
-2.25e-01
|
3.10e-01
|
GO:0035615 clathrin adaptor activity
|
15
|
1.32e-01
|
-2.25e-01
|
5.10e-01
|
GO:0061470 T follicular helper cell differentiation
|
8
|
2.71e-01
|
-2.25e-01
|
6.70e-01
|
GO:0000012 single strand break repair
|
9
|
2.43e-01
|
2.25e-01
|
6.48e-01
|
GO:0030595 leukocyte chemotaxis
|
7
|
3.03e-01
|
-2.25e-01
|
6.93e-01
|
GO:1903432 regulation of TORC1 signaling
|
10
|
2.19e-01
|
2.25e-01
|
6.19e-01
|
GO:0050771 negative regulation of axonogenesis
|
7
|
3.03e-01
|
2.25e-01
|
6.93e-01
|
GO:0005326 neurotransmitter transmembrane transporter activity
|
6
|
3.41e-01
|
2.25e-01
|
7.27e-01
|
GO:0006977 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest
|
16
|
1.20e-01
|
2.25e-01
|
4.88e-01
|
GO:0031915 positive regulation of synaptic plasticity
|
8
|
2.71e-01
|
-2.25e-01
|
6.70e-01
|
GO:1903298 negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway
|
6
|
3.41e-01
|
2.25e-01
|
7.27e-01
|
GO:0043129 surfactant homeostasis
|
10
|
2.19e-01
|
2.25e-01
|
6.20e-01
|
GO:0007599 hemostasis
|
5
|
3.85e-01
|
-2.25e-01
|
7.62e-01
|
GO:0010832 negative regulation of myotube differentiation
|
8
|
2.72e-01
|
-2.25e-01
|
6.70e-01
|
GO:0046930 pore complex
|
13
|
1.61e-01
|
-2.24e-01
|
5.61e-01
|
GO:0033628 regulation of cell adhesion mediated by integrin
|
10
|
2.19e-01
|
-2.24e-01
|
6.20e-01
|
GO:0061098 positive regulation of protein tyrosine kinase activity
|
8
|
2.72e-01
|
-2.24e-01
|
6.70e-01
|
GO:0062029 positive regulation of stress granule assembly
|
7
|
3.04e-01
|
-2.24e-01
|
6.94e-01
|
GO:0004707 MAP kinase activity
|
9
|
2.44e-01
|
-2.24e-01
|
6.49e-01
|
GO:0098989 NMDA selective glutamate receptor signaling pathway
|
5
|
3.86e-01
|
-2.24e-01
|
7.63e-01
|
GO:0005890 sodium:potassium-exchanging ATPase complex
|
5
|
3.86e-01
|
2.24e-01
|
7.63e-01
|
GO:0004364 glutathione transferase activity
|
19
|
9.14e-02
|
2.24e-01
|
4.36e-01
|
GO:0006898 receptor-mediated endocytosis
|
59
|
2.97e-03
|
-2.24e-01
|
8.89e-02
|
GO:0004045 aminoacyl-tRNA hydrolase activity
|
5
|
3.86e-01
|
2.24e-01
|
7.63e-01
|
GO:0072711 cellular response to hydroxyurea
|
9
|
2.45e-01
|
-2.24e-01
|
6.50e-01
|
GO:0030023 extracellular matrix constituent conferring elasticity
|
5
|
3.86e-01
|
-2.24e-01
|
7.63e-01
|
GO:0030175 filopodium
|
54
|
4.50e-03
|
-2.24e-01
|
1.13e-01
|
GO:0000776 kinetochore
|
141
|
4.71e-06
|
-2.24e-01
|
9.06e-04
|
GO:0051384 response to glucocorticoid
|
28
|
4.07e-02
|
-2.24e-01
|
3.16e-01
|
GO:0060333 type II interferon-mediated signaling pathway
|
11
|
1.99e-01
|
2.23e-01
|
6.02e-01
|
GO:0010759 positive regulation of macrophage chemotaxis
|
15
|
1.34e-01
|
-2.23e-01
|
5.13e-01
|
GO:0051642 centrosome localization
|
17
|
1.11e-01
|
-2.23e-01
|
4.73e-01
|
GO:0044666 MLL3/4 complex
|
12
|
1.80e-01
|
-2.23e-01
|
5.83e-01
|
GO:1902966 positive regulation of protein localization to early endosome
|
9
|
2.46e-01
|
-2.23e-01
|
6.50e-01
|
GO:0043484 regulation of RNA splicing
|
65
|
1.86e-03
|
-2.23e-01
|
6.48e-02
|
GO:0035331 negative regulation of hippo signaling
|
20
|
8.40e-02
|
-2.23e-01
|
4.22e-01
|
GO:0070493 thrombin-activated receptor signaling pathway
|
6
|
3.44e-01
|
2.23e-01
|
7.30e-01
|
GO:0000082 G1/S transition of mitotic cell cycle
|
68
|
1.49e-03
|
-2.23e-01
|
5.65e-02
|
GO:0070507 regulation of microtubule cytoskeleton organization
|
22
|
7.06e-02
|
-2.23e-01
|
3.90e-01
|
GO:0043422 protein kinase B binding
|
9
|
2.47e-01
|
-2.23e-01
|
6.52e-01
|
GO:0045947 negative regulation of translational initiation
|
17
|
1.12e-01
|
2.22e-01
|
4.75e-01
|
GO:0046627 negative regulation of insulin receptor signaling pathway
|
31
|
3.22e-02
|
-2.22e-01
|
2.85e-01
|
GO:1902043 positive regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
7
|
3.09e-01
|
-2.22e-01
|
6.99e-01
|
GO:0006635 fatty acid beta-oxidation
|
39
|
1.64e-02
|
2.22e-01
|
2.19e-01
|
GO:0140950 histone H2A deubiquitinase activity
|
6
|
3.46e-01
|
-2.22e-01
|
7.31e-01
|
GO:0045295 gamma-catenin binding
|
5
|
3.90e-01
|
2.22e-01
|
7.67e-01
|
GO:0050769 positive regulation of neurogenesis
|
18
|
1.03e-01
|
-2.22e-01
|
4.56e-01
|
GO:0016853 isomerase activity
|
24
|
6.00e-02
|
-2.22e-01
|
3.63e-01
|
GO:0043536 positive regulation of blood vessel endothelial cell migration
|
30
|
3.56e-02
|
-2.22e-01
|
2.97e-01
|
GO:0008305 integrin complex
|
20
|
8.61e-02
|
-2.22e-01
|
4.25e-01
|
GO:0031931 TORC1 complex
|
6
|
3.47e-01
|
-2.22e-01
|
7.32e-01
|
GO:0043405 regulation of MAP kinase activity
|
7
|
3.10e-01
|
2.21e-01
|
7.01e-01
|
GO:2001222 regulation of neuron migration
|
11
|
2.04e-01
|
-2.21e-01
|
6.09e-01
|
GO:0019933 cAMP-mediated signaling
|
17
|
1.14e-01
|
-2.21e-01
|
4.78e-01
|
GO:0021540 corpus callosum morphogenesis
|
5
|
3.92e-01
|
2.21e-01
|
7.68e-01
|
GO:0042473 outer ear morphogenesis
|
6
|
3.48e-01
|
2.21e-01
|
7.33e-01
|
GO:0000165 MAPK cascade
|
93
|
2.32e-04
|
-2.21e-01
|
1.68e-02
|
GO:0034704 calcium channel complex
|
21
|
7.97e-02
|
2.21e-01
|
4.11e-01
|
GO:0008024 cyclin/CDK positive transcription elongation factor complex
|
8
|
2.80e-01
|
2.21e-01
|
6.76e-01
|
GO:0045943 positive regulation of transcription by RNA polymerase I
|
23
|
6.70e-02
|
-2.21e-01
|
3.83e-01
|
GO:0008540 proteasome regulatory particle, base subcomplex
|
12
|
1.86e-01
|
2.21e-01
|
5.88e-01
|
GO:0002407 dendritic cell chemotaxis
|
10
|
2.27e-01
|
-2.21e-01
|
6.28e-01
|
GO:0030011 maintenance of cell polarity
|
6
|
3.50e-01
|
-2.21e-01
|
7.35e-01
|
GO:0030279 negative regulation of ossification
|
15
|
1.40e-01
|
-2.20e-01
|
5.23e-01
|
GO:0016339 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules
|
5
|
3.94e-01
|
2.20e-01
|
7.70e-01
|
GO:0043409 negative regulation of MAPK cascade
|
31
|
3.41e-02
|
-2.20e-01
|
2.91e-01
|
GO:2000434 regulation of protein neddylation
|
15
|
1.41e-01
|
2.20e-01
|
5.25e-01
|
GO:0010827 regulation of D-glucose transmembrane transport
|
5
|
3.95e-01
|
2.20e-01
|
7.71e-01
|
GO:0000791 euchromatin
|
42
|
1.38e-02
|
-2.20e-01
|
2.04e-01
|
GO:1990138 neuron projection extension
|
15
|
1.41e-01
|
-2.20e-01
|
5.25e-01
|
GO:0000307 cyclin-dependent protein kinase holoenzyme complex
|
36
|
2.26e-02
|
-2.20e-01
|
2.43e-01
|
GO:0000793 condensed chromosome
|
25
|
5.75e-02
|
-2.20e-01
|
3.55e-01
|
GO:1901844 regulation of cell communication by electrical coupling involved in cardiac conduction
|
6
|
3.52e-01
|
2.19e-01
|
7.37e-01
|
GO:0032924 activin receptor signaling pathway
|
13
|
1.71e-01
|
2.19e-01
|
5.76e-01
|
GO:0030514 negative regulation of BMP signaling pathway
|
33
|
2.93e-02
|
-2.19e-01
|
2.72e-01
|
GO:0003779 actin binding
|
195
|
1.37e-07
|
-2.19e-01
|
6.17e-05
|
GO:0004896 cytokine receptor activity
|
22
|
7.53e-02
|
-2.19e-01
|
4.01e-01
|
GO:0031167 rRNA methylation
|
13
|
1.72e-01
|
2.19e-01
|
5.77e-01
|
GO:2000145 regulation of cell motility
|
17
|
1.18e-01
|
-2.19e-01
|
4.84e-01
|
GO:0030669 clathrin-coated endocytic vesicle membrane
|
44
|
1.21e-02
|
-2.19e-01
|
1.95e-01
|
GO:0050966 detection of mechanical stimulus involved in sensory perception of pain
|
10
|
2.31e-01
|
-2.19e-01
|
6.33e-01
|
GO:0099536 synaptic signaling
|
6
|
3.54e-01
|
2.19e-01
|
7.38e-01
|
GO:0070577 lysine-acetylated histone binding
|
20
|
9.10e-02
|
-2.18e-01
|
4.35e-01
|
GO:0042805 actinin binding
|
9
|
2.57e-01
|
-2.18e-01
|
6.58e-01
|
GO:0030705 cytoskeleton-dependent intracellular transport
|
11
|
2.10e-01
|
-2.18e-01
|
6.14e-01
|
GO:0035092 sperm DNA condensation
|
7
|
3.18e-01
|
-2.18e-01
|
7.10e-01
|
GO:0051301 cell division
|
315
|
3.23e-11
|
-2.18e-01
|
6.30e-08
|
GO:0003899 DNA-directed 5’-3’ RNA polymerase activity
|
20
|
9.16e-02
|
-2.18e-01
|
4.36e-01
|
GO:0071763 nuclear membrane organization
|
7
|
3.18e-01
|
-2.18e-01
|
7.10e-01
|
GO:0005049 nuclear export signal receptor activity
|
12
|
1.92e-01
|
-2.18e-01
|
5.96e-01
|
GO:0140078 class I DNA-(apurinic or apyrimidinic site) endonuclease activity
|
7
|
3.19e-01
|
2.18e-01
|
7.10e-01
|
GO:0031638 zymogen activation
|
11
|
2.11e-01
|
2.18e-01
|
6.15e-01
|
GO:0048680 positive regulation of axon regeneration
|
7
|
3.19e-01
|
2.18e-01
|
7.10e-01
|
GO:0000987 cis-regulatory region sequence-specific DNA binding
|
37
|
2.21e-02
|
-2.17e-01
|
2.41e-01
|
GO:1904851 positive regulation of establishment of protein localization to telomere
|
7
|
3.19e-01
|
-2.17e-01
|
7.10e-01
|
GO:0033365 protein localization to organelle
|
13
|
1.75e-01
|
2.17e-01
|
5.78e-01
|
GO:0008278 cohesin complex
|
5
|
4.00e-01
|
-2.17e-01
|
7.75e-01
|
GO:1903672 positive regulation of sprouting angiogenesis
|
14
|
1.59e-01
|
-2.17e-01
|
5.59e-01
|
GO:0010706 ganglioside biosynthetic process via lactosylceramide
|
5
|
4.00e-01
|
-2.17e-01
|
7.76e-01
|
GO:0002526 acute inflammatory response
|
8
|
2.87e-01
|
2.17e-01
|
6.81e-01
|
GO:0016298 lipase activity
|
5
|
4.00e-01
|
2.17e-01
|
7.76e-01
|
GO:0030330 DNA damage response, signal transduction by p53 class mediator
|
18
|
1.11e-01
|
2.17e-01
|
4.73e-01
|
GO:0060412 ventricular septum morphogenesis
|
24
|
6.58e-02
|
2.17e-01
|
3.79e-01
|
GO:0032587 ruffle membrane
|
85
|
5.54e-04
|
-2.17e-01
|
3.07e-02
|
GO:0045717 negative regulation of fatty acid biosynthetic process
|
11
|
2.13e-01
|
-2.17e-01
|
6.15e-01
|
GO:0045104 intermediate filament cytoskeleton organization
|
11
|
2.13e-01
|
2.17e-01
|
6.15e-01
|
GO:0015936 coenzyme A metabolic process
|
5
|
4.02e-01
|
-2.17e-01
|
7.77e-01
|
GO:0051492 regulation of stress fiber assembly
|
15
|
1.47e-01
|
-2.16e-01
|
5.38e-01
|
GO:0001678 intracellular glucose homeostasis
|
15
|
1.47e-01
|
-2.16e-01
|
5.38e-01
|
GO:1902358 sulfate transmembrane transport
|
10
|
2.36e-01
|
-2.16e-01
|
6.41e-01
|
GO:0007031 peroxisome organization
|
19
|
1.03e-01
|
2.16e-01
|
4.55e-01
|
GO:0060998 regulation of dendritic spine development
|
8
|
2.90e-01
|
-2.16e-01
|
6.82e-01
|
GO:0016082 synaptic vesicle priming
|
9
|
2.61e-01
|
2.16e-01
|
6.62e-01
|
GO:0097342 ripoptosome
|
6
|
3.61e-01
|
-2.16e-01
|
7.42e-01
|
GO:0007160 cell-matrix adhesion
|
64
|
2.88e-03
|
-2.16e-01
|
8.76e-02
|
GO:0032482 Rab protein signal transduction
|
12
|
1.96e-01
|
2.16e-01
|
6.01e-01
|
GO:1902857 positive regulation of non-motile cilium assembly
|
6
|
3.61e-01
|
-2.15e-01
|
7.42e-01
|
GO:0042626 ATPase-coupled transmembrane transporter activity
|
20
|
9.56e-02
|
-2.15e-01
|
4.43e-01
|
GO:0021510 spinal cord development
|
19
|
1.04e-01
|
2.15e-01
|
4.58e-01
|
GO:0035195 miRNA-mediated post-transcriptional gene silencing
|
10
|
2.39e-01
|
-2.15e-01
|
6.44e-01
|
GO:0002027 regulation of heart rate
|
18
|
1.14e-01
|
2.15e-01
|
4.78e-01
|
GO:0071526 semaphorin-plexin signaling pathway
|
30
|
4.16e-02
|
-2.15e-01
|
3.21e-01
|
GO:0070938 contractile ring
|
7
|
3.25e-01
|
-2.15e-01
|
7.17e-01
|
GO:1902514 regulation of calcium ion transmembrane transport via high voltage-gated calcium channel
|
5
|
4.05e-01
|
2.15e-01
|
7.80e-01
|
GO:0042609 CD4 receptor binding
|
6
|
3.62e-01
|
-2.15e-01
|
7.44e-01
|
GO:0005929 cilium
|
145
|
8.23e-06
|
2.15e-01
|
1.30e-03
|
GO:0046426 negative regulation of receptor signaling pathway via JAK-STAT
|
14
|
1.64e-01
|
-2.15e-01
|
5.66e-01
|
GO:0016926 protein desumoylation
|
9
|
2.65e-01
|
2.15e-01
|
6.67e-01
|
GO:0046928 regulation of neurotransmitter secretion
|
11
|
2.18e-01
|
2.15e-01
|
6.18e-01
|
GO:0006189 ‘de novo’ IMP biosynthetic process
|
6
|
3.63e-01
|
2.14e-01
|
7.45e-01
|
GO:0044208 ‘de novo’ AMP biosynthetic process
|
6
|
3.63e-01
|
2.14e-01
|
7.45e-01
|
GO:0004602 glutathione peroxidase activity
|
16
|
1.38e-01
|
2.14e-01
|
5.18e-01
|
GO:0043616 keratinocyte proliferation
|
15
|
1.51e-01
|
2.14e-01
|
5.44e-01
|
GO:0031941 filamentous actin
|
20
|
9.73e-02
|
-2.14e-01
|
4.47e-01
|
GO:0032956 regulation of actin cytoskeleton organization
|
75
|
1.35e-03
|
-2.14e-01
|
5.39e-02
|
GO:0061459 L-arginine transmembrane transporter activity
|
7
|
3.27e-01
|
2.14e-01
|
7.18e-01
|
GO:0038024 cargo receptor activity
|
20
|
9.78e-02
|
-2.14e-01
|
4.48e-01
|
GO:0005885 Arp2/3 protein complex
|
9
|
2.67e-01
|
-2.14e-01
|
6.68e-01
|
GO:0075525 viral translational termination-reinitiation
|
5
|
4.08e-01
|
2.14e-01
|
7.82e-01
|
GO:0071651 positive regulation of chemokine (C-C motif) ligand 5 production
|
5
|
4.08e-01
|
-2.14e-01
|
7.82e-01
|
GO:0008301 DNA binding, bending
|
9
|
2.67e-01
|
-2.14e-01
|
6.68e-01
|
GO:0051152 positive regulation of smooth muscle cell differentiation
|
6
|
3.65e-01
|
-2.13e-01
|
7.48e-01
|
GO:0015132 prostaglandin transmembrane transporter activity
|
5
|
4.09e-01
|
-2.13e-01
|
7.82e-01
|
GO:0015732 prostaglandin transport
|
5
|
4.09e-01
|
-2.13e-01
|
7.82e-01
|
GO:0033198 response to ATP
|
7
|
3.29e-01
|
2.13e-01
|
7.20e-01
|
GO:0018105 peptidyl-serine phosphorylation
|
64
|
3.24e-03
|
-2.13e-01
|
9.35e-02
|
GO:0150076 neuroinflammatory response
|
6
|
3.67e-01
|
2.13e-01
|
7.49e-01
|
GO:0042492 gamma-delta T cell differentiation
|
5
|
4.10e-01
|
-2.13e-01
|
7.83e-01
|
GO:0042985 negative regulation of amyloid precursor protein biosynthetic process
|
6
|
3.67e-01
|
2.13e-01
|
7.50e-01
|
GO:0033629 negative regulation of cell adhesion mediated by integrin
|
5
|
4.11e-01
|
-2.12e-01
|
7.83e-01
|
GO:0015035 protein-disulfide reductase activity
|
21
|
9.23e-02
|
2.12e-01
|
4.37e-01
|
GO:0046949 fatty-acyl-CoA biosynthetic process
|
6
|
3.68e-01
|
-2.12e-01
|
7.50e-01
|
GO:0031092 platelet alpha granule membrane
|
13
|
1.85e-01
|
2.12e-01
|
5.88e-01
|
GO:0030055 cell-substrate junction
|
5
|
4.11e-01
|
-2.12e-01
|
7.84e-01
|
GO:0045446 endothelial cell differentiation
|
7
|
3.31e-01
|
-2.12e-01
|
7.21e-01
|
GO:0055093 response to hyperoxia
|
11
|
2.23e-01
|
2.12e-01
|
6.22e-01
|
GO:0006785 heme B biosynthetic process
|
9
|
2.71e-01
|
-2.12e-01
|
6.70e-01
|
GO:0032755 positive regulation of interleukin-6 production
|
76
|
1.40e-03
|
-2.12e-01
|
5.49e-02
|
GO:0031492 nucleosomal DNA binding
|
24
|
7.23e-02
|
-2.12e-01
|
3.93e-01
|
GO:0043248 proteasome assembly
|
9
|
2.71e-01
|
2.12e-01
|
6.70e-01
|
GO:0008593 regulation of Notch signaling pathway
|
15
|
1.55e-01
|
-2.12e-01
|
5.51e-01
|
GO:0071144 heteromeric SMAD protein complex
|
7
|
3.32e-01
|
-2.12e-01
|
7.21e-01
|
GO:0003945 N-acetyllactosamine synthase activity
|
5
|
4.12e-01
|
2.12e-01
|
7.85e-01
|
GO:0006833 water transport
|
6
|
3.69e-01
|
-2.12e-01
|
7.50e-01
|
GO:0061024 membrane organization
|
28
|
5.25e-02
|
-2.12e-01
|
3.48e-01
|
GO:0032502 developmental process
|
5
|
4.13e-01
|
2.11e-01
|
7.85e-01
|
GO:1905671 regulation of lysosome organization
|
5
|
4.13e-01
|
-2.11e-01
|
7.85e-01
|
GO:0032584 growth cone membrane
|
5
|
4.13e-01
|
2.11e-01
|
7.85e-01
|
GO:0035865 cellular response to potassium ion
|
8
|
3.01e-01
|
-2.11e-01
|
6.92e-01
|
GO:0047372 monoacylglycerol lipase activity
|
11
|
2.25e-01
|
-2.11e-01
|
6.25e-01
|
GO:0017017 MAP kinase tyrosine/serine/threonine phosphatase activity
|
7
|
3.35e-01
|
-2.11e-01
|
7.23e-01
|
GO:0005657 replication fork
|
29
|
4.98e-02
|
-2.11e-01
|
3.41e-01
|
GO:0035774 positive regulation of insulin secretion involved in cellular response to glucose stimulus
|
16
|
1.45e-01
|
-2.11e-01
|
5.35e-01
|
GO:0006910 phagocytosis, recognition
|
5
|
4.15e-01
|
-2.10e-01
|
7.87e-01
|
GO:0045824 negative regulation of innate immune response
|
24
|
7.45e-02
|
-2.10e-01
|
3.98e-01
|
GO:1900034 regulation of cellular response to heat
|
14
|
1.73e-01
|
-2.10e-01
|
5.78e-01
|
GO:1904668 positive regulation of ubiquitin protein ligase activity
|
9
|
2.75e-01
|
-2.10e-01
|
6.71e-01
|
GO:0000422 autophagy of mitochondrion
|
23
|
8.13e-02
|
2.10e-01
|
4.14e-01
|
GO:0035162 embryonic hemopoiesis
|
10
|
2.50e-01
|
-2.10e-01
|
6.53e-01
|
GO:0051044 positive regulation of membrane protein ectodomain proteolysis
|
13
|
1.90e-01
|
2.10e-01
|
5.95e-01
|
GO:0030217 T cell differentiation
|
29
|
5.05e-02
|
-2.10e-01
|
3.42e-01
|
GO:0010225 response to UV-C
|
10
|
2.51e-01
|
-2.10e-01
|
6.53e-01
|
GO:0009615 response to virus
|
82
|
1.03e-03
|
2.10e-01
|
4.51e-02
|
GO:0016233 telomere capping
|
12
|
2.09e-01
|
-2.10e-01
|
6.12e-01
|
GO:0060349 bone morphogenesis
|
14
|
1.75e-01
|
2.10e-01
|
5.78e-01
|
GO:0060765 regulation of androgen receptor signaling pathway
|
14
|
1.75e-01
|
-2.10e-01
|
5.78e-01
|
GO:0008514 organic anion transmembrane transporter activity
|
8
|
3.05e-01
|
-2.09e-01
|
6.95e-01
|
GO:0043408 regulation of MAPK cascade
|
25
|
6.99e-02
|
-2.09e-01
|
3.89e-01
|
GO:0071711 basement membrane organization
|
17
|
1.35e-01
|
-2.09e-01
|
5.14e-01
|
GO:0010955 negative regulation of protein processing
|
8
|
3.05e-01
|
2.09e-01
|
6.95e-01
|
GO:0036035 osteoclast development
|
7
|
3.38e-01
|
-2.09e-01
|
7.25e-01
|
GO:0007052 mitotic spindle organization
|
51
|
9.83e-03
|
-2.09e-01
|
1.75e-01
|
GO:0140566 histone reader activity
|
20
|
1.06e-01
|
-2.09e-01
|
4.61e-01
|
GO:0060411 cardiac septum morphogenesis
|
10
|
2.53e-01
|
2.09e-01
|
6.55e-01
|
GO:0042277 peptide binding
|
28
|
5.58e-02
|
-2.09e-01
|
3.53e-01
|
GO:1901222 regulation of non-canonical NF-kappaB signal transduction
|
13
|
1.92e-01
|
-2.09e-01
|
5.97e-01
|
GO:0009931 calcium-dependent protein serine/threonine kinase activity
|
5
|
4.19e-01
|
-2.09e-01
|
7.87e-01
|
GO:0045666 positive regulation of neuron differentiation
|
38
|
2.61e-02
|
-2.09e-01
|
2.60e-01
|
GO:0005251 delayed rectifier potassium channel activity
|
7
|
3.39e-01
|
-2.09e-01
|
7.26e-01
|
GO:0048015 phosphatidylinositol-mediated signaling
|
19
|
1.16e-01
|
-2.09e-01
|
4.79e-01
|
GO:0035050 embryonic heart tube development
|
5
|
4.19e-01
|
-2.09e-01
|
7.87e-01
|
GO:0010737 protein kinase A signaling
|
8
|
3.07e-01
|
-2.08e-01
|
6.98e-01
|
GO:0043249 erythrocyte maturation
|
13
|
1.94e-01
|
-2.08e-01
|
5.98e-01
|
GO:1902260 negative regulation of delayed rectifier potassium channel activity
|
5
|
4.20e-01
|
2.08e-01
|
7.87e-01
|
GO:0002634 regulation of germinal center formation
|
5
|
4.20e-01
|
-2.08e-01
|
7.87e-01
|
GO:0034551 mitochondrial respiratory chain complex III assembly
|
10
|
2.55e-01
|
-2.08e-01
|
6.56e-01
|
GO:0003680 minor groove of adenine-thymine-rich DNA binding
|
5
|
4.21e-01
|
-2.08e-01
|
7.87e-01
|
GO:0032873 negative regulation of stress-activated MAPK cascade
|
8
|
3.08e-01
|
-2.08e-01
|
6.99e-01
|
GO:2000648 positive regulation of stem cell proliferation
|
9
|
2.80e-01
|
-2.08e-01
|
6.76e-01
|
GO:0060767 epithelial cell proliferation involved in prostate gland development
|
6
|
3.78e-01
|
-2.08e-01
|
7.57e-01
|
GO:0000045 autophagosome assembly
|
64
|
4.09e-03
|
2.08e-01
|
1.08e-01
|
GO:0030331 nuclear estrogen receptor binding
|
34
|
3.62e-02
|
-2.08e-01
|
2.97e-01
|
GO:0046718 symbiont entry into host cell
|
79
|
1.43e-03
|
-2.08e-01
|
5.53e-02
|
GO:0005047 signal recognition particle binding
|
8
|
3.10e-01
|
2.07e-01
|
7.00e-01
|
GO:0072537 fibroblast activation
|
5
|
4.22e-01
|
-2.07e-01
|
7.87e-01
|
GO:2000563 positive regulation of CD4-positive, alpha-beta T cell proliferation
|
7
|
3.42e-01
|
2.07e-01
|
7.28e-01
|
GO:0031573 mitotic intra-S DNA damage checkpoint signaling
|
15
|
1.65e-01
|
-2.07e-01
|
5.68e-01
|
GO:0000079 regulation of cyclin-dependent protein serine/threonine kinase activity
|
25
|
7.32e-02
|
-2.07e-01
|
3.95e-01
|
GO:0032741 positive regulation of interleukin-18 production
|
7
|
3.43e-01
|
2.07e-01
|
7.28e-01
|
GO:1903214 regulation of protein targeting to mitochondrion
|
8
|
3.11e-01
|
2.07e-01
|
7.01e-01
|
GO:0005849 mRNA cleavage factor complex
|
6
|
3.80e-01
|
-2.07e-01
|
7.58e-01
|
GO:0000183 rDNA heterochromatin formation
|
7
|
3.43e-01
|
-2.07e-01
|
7.29e-01
|
GO:0070100 negative regulation of chemokine-mediated signaling pathway
|
5
|
4.23e-01
|
-2.07e-01
|
7.88e-01
|
GO:0061136 regulation of proteasomal protein catabolic process
|
18
|
1.29e-01
|
2.07e-01
|
5.06e-01
|
GO:0032230 positive regulation of synaptic transmission, GABAergic
|
6
|
3.81e-01
|
2.07e-01
|
7.58e-01
|
GO:0045779 negative regulation of bone resorption
|
9
|
2.83e-01
|
-2.07e-01
|
6.79e-01
|
GO:0006091 generation of precursor metabolites and energy
|
31
|
4.69e-02
|
-2.06e-01
|
3.39e-01
|
GO:0070266 necroptotic process
|
13
|
1.98e-01
|
-2.06e-01
|
6.02e-01
|
GO:0016125 sterol metabolic process
|
9
|
2.84e-01
|
-2.06e-01
|
6.80e-01
|
GO:0072357 PTW/PP1 phosphatase complex
|
7
|
3.45e-01
|
-2.06e-01
|
7.30e-01
|
GO:0047499 calcium-independent phospholipase A2 activity
|
16
|
1.54e-01
|
2.06e-01
|
5.48e-01
|
GO:0098696 regulation of neurotransmitter receptor localization to postsynaptic specialization membrane
|
13
|
1.99e-01
|
-2.06e-01
|
6.02e-01
|
GO:0005216 monoatomic ion channel activity
|
5
|
4.26e-01
|
-2.06e-01
|
7.90e-01
|
GO:0034458 3’-5’ RNA helicase activity
|
6
|
3.83e-01
|
-2.06e-01
|
7.60e-01
|
GO:0015278 intracellularly gated calcium channel activity
|
5
|
4.26e-01
|
2.06e-01
|
7.90e-01
|
GO:0045671 negative regulation of osteoclast differentiation
|
22
|
9.50e-02
|
-2.06e-01
|
4.42e-01
|
GO:0003711 transcription elongation factor activity
|
7
|
3.46e-01
|
2.06e-01
|
7.31e-01
|
GO:2001046 positive regulation of integrin-mediated signaling pathway
|
11
|
2.38e-01
|
-2.05e-01
|
6.43e-01
|
GO:0014902 myotube differentiation
|
5
|
4.27e-01
|
2.05e-01
|
7.90e-01
|
GO:0070286 axonemal dynein complex assembly
|
5
|
4.27e-01
|
2.05e-01
|
7.90e-01
|
GO:0030658 transport vesicle membrane
|
26
|
7.03e-02
|
-2.05e-01
|
3.89e-01
|
GO:0043203 axon hillock
|
5
|
4.27e-01
|
-2.05e-01
|
7.90e-01
|
GO:0030516 regulation of axon extension
|
10
|
2.62e-01
|
-2.05e-01
|
6.62e-01
|
GO:0006968 cellular defense response
|
27
|
6.55e-02
|
-2.05e-01
|
3.78e-01
|
GO:0006334 nucleosome assembly
|
44
|
1.88e-02
|
-2.05e-01
|
2.27e-01
|
GO:0003689 DNA clamp loader activity
|
137
|
3.56e-05
|
-2.05e-01
|
4.26e-03
|
GO:0044209 AMP salvage
|
5
|
4.28e-01
|
-2.05e-01
|
7.90e-01
|
GO:0006449 regulation of translational termination
|
5
|
4.28e-01
|
-2.05e-01
|
7.90e-01
|
GO:0001956 positive regulation of neurotransmitter secretion
|
6
|
3.86e-01
|
2.05e-01
|
7.63e-01
|
GO:0043232 intracellular membraneless organelle
|
13
|
2.02e-01
|
-2.05e-01
|
6.05e-01
|
GO:0060088 auditory receptor cell stereocilium organization
|
12
|
2.20e-01
|
-2.04e-01
|
6.20e-01
|
GO:0060323 head morphogenesis
|
5
|
4.29e-01
|
2.04e-01
|
7.91e-01
|
GO:0015629 actin cytoskeleton
|
189
|
1.32e-06
|
-2.04e-01
|
3.10e-04
|
GO:0061202 clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane
|
5
|
4.29e-01
|
-2.04e-01
|
7.91e-01
|
GO:0032977 membrane insertase activity
|
17
|
1.45e-01
|
2.04e-01
|
5.35e-01
|
GO:0045627 positive regulation of T-helper 1 cell differentiation
|
5
|
4.30e-01
|
2.04e-01
|
7.92e-01
|
GO:0008090 retrograde axonal transport
|
7
|
3.50e-01
|
2.04e-01
|
7.35e-01
|
GO:0009306 protein secretion
|
36
|
3.44e-02
|
2.04e-01
|
2.91e-01
|
GO:0051146 striated muscle cell differentiation
|
12
|
2.22e-01
|
-2.04e-01
|
6.21e-01
|
GO:0006707 cholesterol catabolic process
|
5
|
4.30e-01
|
2.04e-01
|
7.92e-01
|
GO:0070427 nucleotide-binding oligomerization domain containing 1 signaling pathway
|
5
|
4.30e-01
|
-2.04e-01
|
7.92e-01
|
GO:2001171 positive regulation of ATP biosynthetic process
|
8
|
3.19e-01
|
-2.03e-01
|
7.10e-01
|
GO:1904262 negative regulation of TORC1 signaling
|
45
|
1.83e-02
|
-2.03e-01
|
2.26e-01
|
GO:0043086 negative regulation of catalytic activity
|
10
|
2.66e-01
|
-2.03e-01
|
6.68e-01
|
GO:0000774 adenyl-nucleotide exchange factor activity
|
15
|
1.73e-01
|
-2.03e-01
|
5.78e-01
|
GO:0097503 sialylation
|
5
|
4.31e-01
|
-2.03e-01
|
7.94e-01
|
GO:0045454 cell redox homeostasis
|
36
|
3.50e-02
|
2.03e-01
|
2.94e-01
|
GO:0043367 CD4-positive, alpha-beta T cell differentiation
|
5
|
4.32e-01
|
-2.03e-01
|
7.94e-01
|
GO:0036010 protein localization to endosome
|
11
|
2.44e-01
|
-2.03e-01
|
6.48e-01
|
GO:0008171 O-methyltransferase activity
|
7
|
3.53e-01
|
2.03e-01
|
7.37e-01
|
GO:0051497 negative regulation of stress fiber assembly
|
18
|
1.37e-01
|
-2.03e-01
|
5.16e-01
|
GO:0005024 transforming growth factor beta receptor activity
|
7
|
3.53e-01
|
2.03e-01
|
7.38e-01
|
GO:0009953 dorsal/ventral pattern formation
|
14
|
1.90e-01
|
2.02e-01
|
5.94e-01
|
GO:0046425 regulation of receptor signaling pathway via JAK-STAT
|
9
|
2.93e-01
|
2.02e-01
|
6.87e-01
|
GO:0015562 efflux transmembrane transporter activity
|
8
|
3.22e-01
|
-2.02e-01
|
7.13e-01
|
GO:0035861 site of double-strand break
|
94
|
7.17e-04
|
-2.02e-01
|
3.48e-02
|
GO:0046033 AMP metabolic process
|
6
|
3.91e-01
|
-2.02e-01
|
7.68e-01
|
GO:0042755 eating behavior
|
13
|
2.07e-01
|
2.02e-01
|
6.11e-01
|
GO:0060294 cilium movement involved in cell motility
|
7
|
3.55e-01
|
2.02e-01
|
7.39e-01
|
GO:0090166 Golgi disassembly
|
6
|
3.92e-01
|
-2.02e-01
|
7.68e-01
|
GO:0006824 cobalt ion transport
|
6
|
3.92e-01
|
-2.02e-01
|
7.68e-01
|
GO:0004629 phospholipase C activity
|
7
|
3.55e-01
|
-2.02e-01
|
7.39e-01
|
GO:0034087 establishment of mitotic sister chromatid cohesion
|
7
|
3.56e-01
|
-2.02e-01
|
7.39e-01
|
GO:0010564 regulation of cell cycle process
|
10
|
2.70e-01
|
-2.02e-01
|
6.70e-01
|
GO:0045261 proton-transporting ATP synthase complex, catalytic core F(1)
|
5
|
4.35e-01
|
-2.02e-01
|
7.94e-01
|
GO:0071287 cellular response to manganese ion
|
5
|
4.35e-01
|
-2.02e-01
|
7.94e-01
|
GO:0044233 mitochondria-associated endoplasmic reticulum membrane contact site
|
23
|
9.45e-02
|
2.01e-01
|
4.40e-01
|
GO:0098761 cellular response to interleukin-7
|
12
|
2.27e-01
|
-2.01e-01
|
6.28e-01
|
GO:0030838 positive regulation of actin filament polymerization
|
35
|
3.94e-02
|
-2.01e-01
|
3.10e-01
|
GO:0052689 carboxylic ester hydrolase activity
|
17
|
1.51e-01
|
2.01e-01
|
5.44e-01
|
GO:0010614 negative regulation of cardiac muscle hypertrophy
|
9
|
2.96e-01
|
-2.01e-01
|
6.90e-01
|
GO:0048304 positive regulation of isotype switching to IgG isotypes
|
7
|
3.57e-01
|
-2.01e-01
|
7.40e-01
|
GO:1901797 negative regulation of signal transduction by p53 class mediator
|
5
|
4.36e-01
|
2.01e-01
|
7.95e-01
|
GO:0002089 lens morphogenesis in camera-type eye
|
6
|
3.93e-01
|
-2.01e-01
|
7.70e-01
|
GO:1904667 negative regulation of ubiquitin protein ligase activity
|
10
|
2.71e-01
|
2.01e-01
|
6.70e-01
|
GO:0010248 establishment or maintenance of transmembrane electrochemical gradient
|
6
|
3.94e-01
|
-2.01e-01
|
7.70e-01
|
GO:2001244 positive regulation of intrinsic apoptotic signaling pathway
|
27
|
7.06e-02
|
2.01e-01
|
3.90e-01
|
GO:0099092 postsynaptic density, intracellular component
|
12
|
2.28e-01
|
-2.01e-01
|
6.28e-01
|
GO:0034364 high-density lipoprotein particle
|
11
|
2.48e-01
|
2.01e-01
|
6.52e-01
|
GO:0070536 protein K63-linked deubiquitination
|
24
|
8.87e-02
|
2.01e-01
|
4.31e-01
|
GO:0010765 positive regulation of sodium ion transport
|
7
|
3.58e-01
|
-2.01e-01
|
7.41e-01
|
GO:0071598 neuronal ribonucleoprotein granule
|
5
|
4.37e-01
|
-2.01e-01
|
7.95e-01
|
GO:0010255 glucose mediated signaling pathway
|
5
|
4.37e-01
|
-2.01e-01
|
7.95e-01
|
GO:0097361 cytosolic [4Fe-4S] assembly targeting complex
|
5
|
4.37e-01
|
2.01e-01
|
7.95e-01
|
GO:0000243 commitment complex
|
5
|
4.37e-01
|
-2.01e-01
|
7.95e-01
|
GO:0098839 postsynaptic density membrane
|
43
|
2.30e-02
|
-2.01e-01
|
2.45e-01
|
GO:1902894 negative regulation of miRNA transcription
|
21
|
1.12e-01
|
-2.00e-01
|
4.75e-01
|
GO:0140984 histone H4K12 methyltransferase activity
|
8
|
3.27e-01
|
-2.00e-01
|
7.18e-01
|
GO:0001893 maternal placenta development
|
7
|
3.59e-01
|
2.00e-01
|
7.41e-01
|
GO:0010944 negative regulation of transcription by competitive promoter binding
|
9
|
2.99e-01
|
-2.00e-01
|
6.91e-01
|
GO:0140584 chromatin extrusion motor activity
|
129
|
8.84e-05
|
-2.00e-01
|
8.10e-03
|
GO:0140665 ATP-dependent H3-H4 histone complex chaperone activity
|
129
|
8.84e-05
|
-2.00e-01
|
8.10e-03
|
GO:0140849 ATP-dependent H2AZ histone chaperone activity
|
129
|
8.84e-05
|
-2.00e-01
|
8.10e-03
|
GO:2001135 regulation of endocytic recycling
|
5
|
4.38e-01
|
2.00e-01
|
7.95e-01
|
GO:0031297 replication fork processing
|
34
|
4.35e-02
|
-2.00e-01
|
3.28e-01
|
GO:0000808 origin recognition complex
|
5
|
4.39e-01
|
-2.00e-01
|
7.95e-01
|
GO:0047676 arachidonate-CoA ligase activity
|
7
|
3.60e-01
|
2.00e-01
|
7.41e-01
|
GO:0005652 nuclear lamina
|
12
|
2.30e-01
|
-2.00e-01
|
6.32e-01
|
GO:0005784 Sec61 translocon complex
|
5
|
4.39e-01
|
2.00e-01
|
7.96e-01
|
GO:0031098 stress-activated protein kinase signaling cascade
|
5
|
4.39e-01
|
-2.00e-01
|
7.96e-01
|
GO:0003085 negative regulation of systemic arterial blood pressure
|
8
|
3.29e-01
|
2.00e-01
|
7.20e-01
|
GO:0007010 cytoskeleton organization
|
103
|
4.74e-04
|
-1.99e-01
|
2.87e-02
|
GO:0071786 endoplasmic reticulum tubular network organization
|
11
|
2.52e-01
|
1.99e-01
|
6.55e-01
|
GO:1901381 positive regulation of potassium ion transmembrane transport
|
10
|
2.75e-01
|
-1.99e-01
|
6.71e-01
|
GO:0051028 mRNA transport
|
55
|
1.06e-02
|
-1.99e-01
|
1.84e-01
|
GO:1990204 oxidoreductase complex
|
6
|
3.98e-01
|
1.99e-01
|
7.73e-01
|
GO:0071816 tail-anchored membrane protein insertion into ER membrane
|
16
|
1.68e-01
|
1.99e-01
|
5.72e-01
|
GO:0005819 spindle
|
117
|
2.00e-04
|
-1.99e-01
|
1.49e-02
|
GO:0050795 regulation of behavior
|
6
|
3.98e-01
|
1.99e-01
|
7.73e-01
|
GO:0032036 myosin heavy chain binding
|
6
|
3.98e-01
|
-1.99e-01
|
7.73e-01
|
GO:0070530 K63-linked polyubiquitin modification-dependent protein binding
|
26
|
7.89e-02
|
-1.99e-01
|
4.10e-01
|
GO:0045088 regulation of innate immune response
|
23
|
9.84e-02
|
-1.99e-01
|
4.50e-01
|
GO:0030225 macrophage differentiation
|
26
|
7.93e-02
|
-1.99e-01
|
4.11e-01
|
GO:0045869 negative regulation of single stranded viral RNA replication via double stranded DNA intermediate
|
9
|
3.02e-01
|
1.99e-01
|
6.93e-01
|
GO:0004663 Rab geranylgeranyltransferase activity
|
5
|
4.41e-01
|
1.99e-01
|
7.96e-01
|
GO:0005518 collagen binding
|
43
|
2.41e-02
|
-1.99e-01
|
2.53e-01
|
GO:0045595 regulation of cell differentiation
|
23
|
9.89e-02
|
-1.99e-01
|
4.51e-01
|
GO:0090190 positive regulation of branching involved in ureteric bud morphogenesis
|
8
|
3.30e-01
|
1.99e-01
|
7.21e-01
|
GO:0070306 lens fiber cell differentiation
|
11
|
2.54e-01
|
-1.99e-01
|
6.56e-01
|
GO:0042116 macrophage activation
|
11
|
2.54e-01
|
-1.99e-01
|
6.56e-01
|
GO:0032872 regulation of stress-activated MAPK cascade
|
9
|
3.02e-01
|
1.99e-01
|
6.93e-01
|
GO:1902993 positive regulation of amyloid precursor protein catabolic process
|
5
|
4.42e-01
|
-1.98e-01
|
7.96e-01
|
GO:0060749 mammary gland alveolus development
|
10
|
2.77e-01
|
-1.98e-01
|
6.74e-01
|
GO:0106300 protein-DNA covalent cross-linking repair
|
8
|
3.31e-01
|
-1.98e-01
|
7.21e-01
|
GO:0043426 MRF binding
|
5
|
4.43e-01
|
-1.98e-01
|
7.96e-01
|
GO:0003222 ventricular trabecula myocardium morphogenesis
|
9
|
3.03e-01
|
-1.98e-01
|
6.93e-01
|
GO:0002232 leukocyte chemotaxis involved in inflammatory response
|
5
|
4.43e-01
|
1.98e-01
|
7.97e-01
|
GO:0034332 adherens junction organization
|
10
|
2.78e-01
|
-1.98e-01
|
6.75e-01
|
GO:0010881 regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion
|
15
|
1.84e-01
|
1.98e-01
|
5.87e-01
|
GO:0007346 regulation of mitotic cell cycle
|
55
|
1.12e-02
|
-1.98e-01
|
1.88e-01
|
GO:0008138 protein tyrosine/serine/threonine phosphatase activity
|
15
|
1.85e-01
|
-1.98e-01
|
5.88e-01
|
GO:0031669 cellular response to nutrient levels
|
29
|
6.53e-02
|
-1.98e-01
|
3.78e-01
|
GO:0004402 histone acetyltransferase activity
|
24
|
9.37e-02
|
-1.98e-01
|
4.40e-01
|
GO:0001845 phagolysosome assembly
|
5
|
4.44e-01
|
-1.98e-01
|
7.97e-01
|
GO:0015810 aspartate transmembrane transport
|
8
|
3.33e-01
|
-1.98e-01
|
7.22e-01
|
GO:0097352 autophagosome maturation
|
48
|
1.80e-02
|
1.97e-01
|
2.25e-01
|
GO:2000369 regulation of clathrin-dependent endocytosis
|
7
|
3.66e-01
|
1.97e-01
|
7.49e-01
|
GO:0043923 positive regulation by host of viral transcription
|
16
|
1.72e-01
|
-1.97e-01
|
5.77e-01
|
GO:1990869 cellular response to chemokine
|
12
|
2.37e-01
|
-1.97e-01
|
6.42e-01
|
GO:0061775 cohesin loader activity
|
131
|
1.00e-04
|
-1.97e-01
|
8.76e-03
|
GO:0040015 negative regulation of multicellular organism growth
|
9
|
3.06e-01
|
1.97e-01
|
6.96e-01
|
GO:0006401 RNA catabolic process
|
30
|
6.21e-02
|
1.97e-01
|
3.68e-01
|
GO:0030317 flagellated sperm motility
|
50
|
1.61e-02
|
1.97e-01
|
2.18e-01
|
GO:0048565 digestive tract development
|
13
|
2.20e-01
|
-1.97e-01
|
6.20e-01
|
GO:0007275 multicellular organism development
|
16
|
1.73e-01
|
-1.97e-01
|
5.78e-01
|
GO:0045616 regulation of keratinocyte differentiation
|
8
|
3.36e-01
|
-1.97e-01
|
7.23e-01
|
GO:1901857 positive regulation of cellular respiration
|
8
|
3.36e-01
|
-1.96e-01
|
7.24e-01
|
GO:0006298 mismatch repair
|
22
|
1.11e-01
|
-1.96e-01
|
4.73e-01
|
GO:0043542 endothelial cell migration
|
22
|
1.11e-01
|
-1.96e-01
|
4.73e-01
|
GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway
|
53
|
1.35e-02
|
-1.96e-01
|
2.04e-01
|
GO:0004771 sterol ester esterase activity
|
5
|
4.47e-01
|
1.96e-01
|
8.00e-01
|
GO:0022857 transmembrane transporter activity
|
47
|
2.01e-02
|
-1.96e-01
|
2.33e-01
|
GO:0030544 Hsp70 protein binding
|
41
|
2.99e-02
|
1.96e-01
|
2.75e-01
|
GO:0090161 Golgi ribbon formation
|
10
|
2.83e-01
|
1.96e-01
|
6.79e-01
|
GO:0004382 GDP phosphatase activity
|
7
|
3.69e-01
|
-1.96e-01
|
7.50e-01
|
GO:0032024 positive regulation of insulin secretion
|
37
|
3.92e-02
|
1.96e-01
|
3.10e-01
|
GO:0061484 hematopoietic stem cell homeostasis
|
14
|
2.04e-01
|
1.96e-01
|
6.10e-01
|
GO:0090671 telomerase RNA localization to Cajal body
|
7
|
3.70e-01
|
-1.96e-01
|
7.50e-01
|
GO:0035325 Toll-like receptor binding
|
6
|
4.06e-01
|
-1.96e-01
|
7.81e-01
|
GO:0008310 single-stranded DNA 3’-5’ DNA exonuclease activity
|
5
|
4.49e-01
|
1.96e-01
|
8.00e-01
|
GO:0004303 estradiol 17-beta-dehydrogenase [NAD(P)+] activity
|
11
|
2.61e-01
|
1.96e-01
|
6.62e-01
|
GO:1904951 positive regulation of establishment of protein localization
|
6
|
4.07e-01
|
1.95e-01
|
7.82e-01
|
GO:0006996 organelle organization
|
5
|
4.49e-01
|
1.95e-01
|
8.01e-01
|
GO:0071013 catalytic step 2 spliceosome
|
85
|
1.87e-03
|
-1.95e-01
|
6.48e-02
|
GO:0140545 ATP-dependent protein disaggregase activity
|
6
|
4.07e-01
|
-1.95e-01
|
7.82e-01
|
GO:0070403 NAD+ binding
|
18
|
1.52e-01
|
1.95e-01
|
5.45e-01
|
GO:0035064 methylated histone binding
|
64
|
6.93e-03
|
-1.95e-01
|
1.46e-01
|
GO:0048023 positive regulation of melanin biosynthetic process
|
7
|
3.71e-01
|
-1.95e-01
|
7.51e-01
|
GO:0060315 negative regulation of ryanodine-sensitive calcium-release channel activity
|
7
|
3.72e-01
|
1.95e-01
|
7.51e-01
|
GO:0006086 acetyl-CoA biosynthetic process from pyruvate
|
6
|
4.08e-01
|
-1.95e-01
|
7.82e-01
|
GO:0006979 response to oxidative stress
|
99
|
8.18e-04
|
1.95e-01
|
3.66e-02
|
GO:0004115 3’,5’-cyclic-AMP phosphodiesterase activity
|
12
|
2.43e-01
|
-1.95e-01
|
6.48e-01
|
GO:0047555 3’,5’-cyclic-GMP phosphodiesterase activity
|
12
|
2.43e-01
|
-1.95e-01
|
6.48e-01
|
GO:0000922 spindle pole
|
117
|
2.78e-04
|
-1.95e-01
|
1.92e-02
|
GO:0030134 COPII-coated ER to Golgi transport vesicle
|
34
|
4.95e-02
|
1.95e-01
|
3.41e-01
|
GO:0035005 1-phosphatidylinositol-4-phosphate 3-kinase activity
|
6
|
4.09e-01
|
-1.95e-01
|
7.82e-01
|
GO:1903265 positive regulation of tumor necrosis factor-mediated signaling pathway
|
13
|
2.25e-01
|
1.94e-01
|
6.24e-01
|
GO:0000164 protein phosphatase type 1 complex
|
12
|
2.43e-01
|
-1.94e-01
|
6.48e-01
|
GO:0007389 pattern specification process
|
12
|
2.44e-01
|
1.94e-01
|
6.48e-01
|
GO:0000786 nucleosome
|
33
|
5.34e-02
|
-1.94e-01
|
3.51e-01
|
GO:0050775 positive regulation of dendrite morphogenesis
|
15
|
1.93e-01
|
-1.94e-01
|
5.98e-01
|
GO:0070316 regulation of G0 to G1 transition
|
22
|
1.15e-01
|
-1.94e-01
|
4.79e-01
|
GO:0010572 positive regulation of platelet activation
|
6
|
4.10e-01
|
-1.94e-01
|
7.83e-01
|
GO:0070160 tight junction
|
13
|
2.26e-01
|
-1.94e-01
|
6.26e-01
|
GO:0140507 granzyme-mediated programmed cell death signaling pathway
|
5
|
4.53e-01
|
1.94e-01
|
8.02e-01
|
GO:2001238 positive regulation of extrinsic apoptotic signaling pathway
|
29
|
7.10e-02
|
-1.94e-01
|
3.90e-01
|
GO:0031234 extrinsic component of cytoplasmic side of plasma membrane
|
9
|
3.15e-01
|
-1.93e-01
|
7.07e-01
|
GO:0042178 xenobiotic catabolic process
|
10
|
2.90e-01
|
1.93e-01
|
6.82e-01
|
GO:0035869 ciliary transition zone
|
30
|
6.68e-02
|
1.93e-01
|
3.82e-01
|
GO:0071564 npBAF complex
|
14
|
2.10e-01
|
-1.93e-01
|
6.14e-01
|
GO:0046621 negative regulation of organ growth
|
6
|
4.12e-01
|
-1.93e-01
|
7.85e-01
|
GO:1903896 positive regulation of IRE1-mediated unfolded protein response
|
7
|
3.76e-01
|
-1.93e-01
|
7.55e-01
|
GO:0030687 preribosome, large subunit precursor
|
16
|
1.81e-01
|
-1.93e-01
|
5.83e-01
|
GO:0097677 STAT family protein binding
|
8
|
3.44e-01
|
-1.93e-01
|
7.30e-01
|
GO:0050688 regulation of defense response to virus
|
7
|
3.76e-01
|
1.93e-01
|
7.56e-01
|
GO:0001891 phagocytic cup
|
24
|
1.02e-01
|
-1.93e-01
|
4.55e-01
|
GO:0032204 regulation of telomere maintenance
|
20
|
1.35e-01
|
-1.93e-01
|
5.15e-01
|
GO:0016504 peptidase activator activity
|
8
|
3.45e-01
|
-1.93e-01
|
7.30e-01
|
GO:0034728 nucleosome organization
|
6
|
4.14e-01
|
1.93e-01
|
7.86e-01
|
GO:0090382 phagosome maturation
|
11
|
2.69e-01
|
-1.93e-01
|
6.70e-01
|
GO:0045617 negative regulation of keratinocyte differentiation
|
5
|
4.56e-01
|
-1.93e-01
|
8.03e-01
|
GO:0048706 embryonic skeletal system development
|
12
|
2.48e-01
|
1.92e-01
|
6.52e-01
|
GO:0032495 response to muramyl dipeptide
|
12
|
2.49e-01
|
-1.92e-01
|
6.52e-01
|
GO:0071004 U2-type prespliceosome
|
17
|
1.70e-01
|
-1.92e-01
|
5.76e-01
|
GO:0030334 regulation of cell migration
|
55
|
1.37e-02
|
-1.92e-01
|
2.04e-01
|
GO:0140588 chromatin looping
|
142
|
7.95e-05
|
-1.92e-01
|
7.65e-03
|
GO:0098691 dopaminergic synapse
|
7
|
3.79e-01
|
1.92e-01
|
7.58e-01
|
GO:0030008 TRAPP complex
|
14
|
2.14e-01
|
1.92e-01
|
6.15e-01
|
GO:0140937 histone H4K12 deacetylase activity, hydrolytic mechanism
|
11
|
2.70e-01
|
-1.92e-01
|
6.70e-01
|
GO:0006972 hyperosmotic response
|
5
|
4.58e-01
|
-1.92e-01
|
8.04e-01
|
GO:0120015 sterol transfer activity
|
8
|
3.48e-01
|
1.92e-01
|
7.32e-01
|
GO:0060816 random inactivation of X chromosome
|
13
|
2.31e-01
|
-1.92e-01
|
6.33e-01
|
GO:0034116 positive regulation of heterotypic cell-cell adhesion
|
9
|
3.19e-01
|
1.92e-01
|
7.10e-01
|
GO:0000432 positive regulation of transcription from RNA polymerase II promoter by glucose
|
5
|
4.58e-01
|
-1.91e-01
|
8.05e-01
|
GO:0140833 RNA polymerase II CTD heptapeptide repeat Y1 kinase activity
|
6
|
4.17e-01
|
1.91e-01
|
7.87e-01
|
GO:0140834 RNA polymerase II CTD heptapeptide repeat S2 kinase activity
|
6
|
4.17e-01
|
1.91e-01
|
7.87e-01
|
GO:0140835 RNA polymerase II CTD heptapeptide repeat T4 kinase activity
|
6
|
4.17e-01
|
1.91e-01
|
7.87e-01
|
GO:0140836 RNA polymerase II CTD heptapeptide repeat S5 kinase activity
|
6
|
4.17e-01
|
1.91e-01
|
7.87e-01
|
GO:0140837 RNA polymerase II CTD heptapeptide repeat S7 kinase activity
|
6
|
4.17e-01
|
1.91e-01
|
7.87e-01
|
GO:0046007 negative regulation of activated T cell proliferation
|
11
|
2.72e-01
|
1.91e-01
|
6.70e-01
|
GO:0098915 membrane repolarization during ventricular cardiac muscle cell action potential
|
5
|
4.59e-01
|
1.91e-01
|
8.05e-01
|
GO:0098850 extrinsic component of synaptic vesicle membrane
|
9
|
3.20e-01
|
-1.91e-01
|
7.11e-01
|
GO:0075522 IRES-dependent viral translational initiation
|
11
|
2.72e-01
|
1.91e-01
|
6.70e-01
|
GO:0044194 cytolytic granule
|
6
|
4.17e-01
|
-1.91e-01
|
7.87e-01
|
GO:0060009 Sertoli cell development
|
5
|
4.59e-01
|
1.91e-01
|
8.05e-01
|
GO:0045931 positive regulation of mitotic cell cycle
|
28
|
8.02e-02
|
-1.91e-01
|
4.12e-01
|
GO:0045184 establishment of protein localization
|
27
|
8.60e-02
|
-1.91e-01
|
4.25e-01
|
GO:0061665 SUMO ligase activity
|
13
|
2.33e-01
|
-1.91e-01
|
6.35e-01
|
GO:0016740 transferase activity
|
28
|
8.06e-02
|
1.91e-01
|
4.13e-01
|
GO:0034314 Arp2/3 complex-mediated actin nucleation
|
15
|
2.01e-01
|
-1.91e-01
|
6.05e-01
|
GO:0001972 retinoic acid binding
|
5
|
4.60e-01
|
-1.91e-01
|
8.06e-01
|
GO:0001829 trophectodermal cell differentiation
|
11
|
2.74e-01
|
-1.91e-01
|
6.71e-01
|
GO:0042974 nuclear retinoic acid receptor binding
|
11
|
2.74e-01
|
-1.90e-01
|
6.71e-01
|
GO:0016407 acetyltransferase activity
|
14
|
2.17e-01
|
-1.90e-01
|
6.18e-01
|
GO:0004532 RNA exonuclease activity
|
14
|
2.17e-01
|
1.90e-01
|
6.18e-01
|
GO:0021591 ventricular system development
|
15
|
2.02e-01
|
1.90e-01
|
6.05e-01
|
GO:0090556 phosphatidylserine floppase activity
|
8
|
3.51e-01
|
1.90e-01
|
7.36e-01
|
GO:0048041 focal adhesion assembly
|
20
|
1.41e-01
|
-1.90e-01
|
5.25e-01
|
GO:0060045 positive regulation of cardiac muscle cell proliferation
|
10
|
2.98e-01
|
-1.90e-01
|
6.90e-01
|
GO:0014059 regulation of dopamine secretion
|
6
|
4.20e-01
|
1.90e-01
|
7.87e-01
|
GO:0015853 adenine transport
|
6
|
4.20e-01
|
-1.90e-01
|
7.87e-01
|
GO:0035372 protein localization to microtubule
|
10
|
2.98e-01
|
-1.90e-01
|
6.90e-01
|
GO:0070063 RNA polymerase binding
|
17
|
1.75e-01
|
-1.90e-01
|
5.78e-01
|
GO:0005096 GTPase activator activity
|
221
|
1.19e-06
|
-1.90e-01
|
3.03e-04
|
GO:0097381 photoreceptor disc membrane
|
8
|
3.52e-01
|
1.90e-01
|
7.37e-01
|
GO:0045792 negative regulation of cell size
|
8
|
3.52e-01
|
-1.90e-01
|
7.37e-01
|
GO:0032433 filopodium tip
|
14
|
2.19e-01
|
-1.90e-01
|
6.20e-01
|
GO:0002244 hematopoietic progenitor cell differentiation
|
46
|
2.62e-02
|
-1.90e-01
|
2.60e-01
|
GO:0090304 nucleic acid metabolic process
|
7
|
3.86e-01
|
-1.89e-01
|
7.63e-01
|
GO:0046961 proton-transporting ATPase activity, rotational mechanism
|
20
|
1.43e-01
|
-1.89e-01
|
5.31e-01
|
GO:0001223 transcription coactivator binding
|
34
|
5.64e-02
|
-1.89e-01
|
3.54e-01
|
GO:0030374 nuclear receptor coactivator activity
|
54
|
1.63e-02
|
-1.89e-01
|
2.18e-01
|
GO:0060317 cardiac epithelial to mesenchymal transition
|
7
|
3.86e-01
|
1.89e-01
|
7.63e-01
|
GO:0043328 protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway
|
15
|
2.05e-01
|
1.89e-01
|
6.10e-01
|
GO:0046580 negative regulation of Ras protein signal transduction
|
21
|
1.34e-01
|
-1.89e-01
|
5.13e-01
|
GO:0042118 endothelial cell activation
|
6
|
4.23e-01
|
1.89e-01
|
7.87e-01
|
GO:0048286 lung alveolus development
|
27
|
8.95e-02
|
-1.89e-01
|
4.33e-01
|
GO:1900027 regulation of ruffle assembly
|
8
|
3.55e-01
|
-1.89e-01
|
7.39e-01
|
GO:0050995 negative regulation of lipid catabolic process
|
9
|
3.27e-01
|
-1.89e-01
|
7.18e-01
|
GO:0006626 protein targeting to mitochondrion
|
28
|
8.41e-02
|
-1.89e-01
|
4.22e-01
|
GO:0090630 activation of GTPase activity
|
25
|
1.03e-01
|
-1.89e-01
|
4.55e-01
|
GO:0035279 miRNA-mediated gene silencing by mRNA destabilization
|
8
|
3.56e-01
|
-1.89e-01
|
7.39e-01
|
GO:0004712 protein serine/threonine/tyrosine kinase activity
|
27
|
9.04e-02
|
-1.88e-01
|
4.35e-01
|
GO:0046854 phosphatidylinositol phosphate biosynthetic process
|
29
|
7.93e-02
|
-1.88e-01
|
4.11e-01
|
GO:0140693 molecular condensate scaffold activity
|
38
|
4.47e-02
|
-1.88e-01
|
3.32e-01
|
GO:0001771 immunological synapse formation
|
10
|
3.03e-01
|
-1.88e-01
|
6.93e-01
|
GO:0043184 vascular endothelial growth factor receptor 2 binding
|
8
|
3.57e-01
|
-1.88e-01
|
7.40e-01
|
GO:0090051 negative regulation of cell migration involved in sprouting angiogenesis
|
11
|
2.80e-01
|
-1.88e-01
|
6.76e-01
|
GO:0031119 tRNA pseudouridine synthesis
|
5
|
4.67e-01
|
1.88e-01
|
8.11e-01
|
GO:0007213 G protein-coupled acetylcholine receptor signaling pathway
|
10
|
3.04e-01
|
-1.88e-01
|
6.94e-01
|
GO:0036120 cellular response to platelet-derived growth factor stimulus
|
16
|
1.94e-01
|
-1.88e-01
|
5.98e-01
|
GO:0010950 positive regulation of endopeptidase activity
|
6
|
4.26e-01
|
1.88e-01
|
7.90e-01
|
GO:0033539 fatty acid beta-oxidation using acyl-CoA dehydrogenase
|
10
|
3.04e-01
|
1.88e-01
|
6.94e-01
|
GO:0071230 cellular response to amino acid stimulus
|
40
|
4.02e-02
|
-1.88e-01
|
3.14e-01
|
GO:0008253 5’-nucleotidase activity
|
8
|
3.59e-01
|
-1.87e-01
|
7.41e-01
|
GO:0061028 establishment of endothelial barrier
|
16
|
1.95e-01
|
-1.87e-01
|
5.98e-01
|
GO:0070213 protein auto-ADP-ribosylation
|
11
|
2.82e-01
|
-1.87e-01
|
6.78e-01
|
GO:0003824 catalytic activity
|
12
|
2.61e-01
|
-1.87e-01
|
6.62e-01
|
GO:0042101 T cell receptor complex
|
7
|
3.91e-01
|
-1.87e-01
|
7.68e-01
|
GO:0010470 regulation of gastrulation
|
6
|
4.27e-01
|
-1.87e-01
|
7.90e-01
|
GO:0050767 regulation of neurogenesis
|
20
|
1.48e-01
|
1.87e-01
|
5.38e-01
|
GO:0005244 voltage-gated monoatomic ion channel activity
|
7
|
3.92e-01
|
-1.87e-01
|
7.68e-01
|
GO:0032717 negative regulation of interleukin-8 production
|
15
|
2.10e-01
|
-1.87e-01
|
6.14e-01
|
GO:0045116 protein neddylation
|
20
|
1.49e-01
|
1.87e-01
|
5.39e-01
|
GO:0097526 spliceosomal tri-snRNP complex
|
6
|
4.29e-01
|
-1.86e-01
|
7.91e-01
|
GO:0030027 lamellipodium
|
155
|
6.53e-05
|
-1.86e-01
|
6.49e-03
|
GO:0009968 negative regulation of signal transduction
|
26
|
1.01e-01
|
-1.86e-01
|
4.55e-01
|
GO:0008656 cysteine-type endopeptidase activator activity involved in apoptotic process
|
14
|
2.29e-01
|
1.86e-01
|
6.29e-01
|
GO:0045597 positive regulation of cell differentiation
|
34
|
6.08e-02
|
-1.86e-01
|
3.65e-01
|
GO:0046651 lymphocyte proliferation
|
5
|
4.72e-01
|
-1.86e-01
|
8.14e-01
|
GO:0021554 optic nerve development
|
9
|
3.35e-01
|
-1.86e-01
|
7.23e-01
|
GO:1903426 regulation of reactive oxygen species biosynthetic process
|
7
|
3.95e-01
|
1.86e-01
|
7.71e-01
|
GO:0004129 cytochrome-c oxidase activity
|
12
|
2.66e-01
|
1.86e-01
|
6.68e-01
|
GO:0000957 mitochondrial RNA catabolic process
|
6
|
4.31e-01
|
-1.85e-01
|
7.94e-01
|
GO:0036376 sodium ion export across plasma membrane
|
6
|
4.31e-01
|
1.85e-01
|
7.94e-01
|
GO:0016423 tRNA (guanine) methyltransferase activity
|
5
|
4.73e-01
|
1.85e-01
|
8.14e-01
|
GO:0046632 alpha-beta T cell differentiation
|
5
|
4.73e-01
|
1.85e-01
|
8.14e-01
|
GO:0005662 DNA replication factor A complex
|
12
|
2.66e-01
|
1.85e-01
|
6.68e-01
|
GO:0001837 epithelial to mesenchymal transition
|
35
|
5.78e-02
|
-1.85e-01
|
3.56e-01
|
GO:0048870 cell motility
|
28
|
8.97e-02
|
-1.85e-01
|
4.33e-01
|
GO:0035198 miRNA binding
|
29
|
8.43e-02
|
-1.85e-01
|
4.22e-01
|
GO:0010918 positive regulation of mitochondrial membrane potential
|
8
|
3.65e-01
|
-1.85e-01
|
7.47e-01
|
GO:0031314 extrinsic component of mitochondrial inner membrane
|
6
|
4.32e-01
|
1.85e-01
|
7.94e-01
|
GO:0071466 cellular response to xenobiotic stimulus
|
45
|
3.18e-02
|
-1.85e-01
|
2.85e-01
|
GO:0043410 positive regulation of MAPK cascade
|
93
|
2.06e-03
|
-1.85e-01
|
6.92e-02
|
GO:0045095 keratin filament
|
10
|
3.11e-01
|
1.85e-01
|
7.01e-01
|
GO:0097386 glial cell projection
|
12
|
2.67e-01
|
-1.85e-01
|
6.68e-01
|
GO:0035721 intraciliary retrograde transport
|
10
|
3.11e-01
|
1.85e-01
|
7.01e-01
|
GO:0015175 neutral L-amino acid transmembrane transporter activity
|
10
|
3.12e-01
|
1.85e-01
|
7.03e-01
|
GO:0030159 signaling receptor complex adaptor activity
|
25
|
1.10e-01
|
-1.85e-01
|
4.72e-01
|
GO:0002223 stimulatory C-type lectin receptor signaling pathway
|
16
|
2.01e-01
|
-1.85e-01
|
6.05e-01
|
GO:0070840 dynein complex binding
|
18
|
1.75e-01
|
-1.85e-01
|
5.78e-01
|
GO:0035313 wound healing, spreading of epidermal cells
|
10
|
3.12e-01
|
-1.85e-01
|
7.03e-01
|
GO:0034587 piRNA processing
|
9
|
3.38e-01
|
-1.84e-01
|
7.25e-01
|
GO:0032088 negative regulation of NF-kappaB transcription factor activity
|
57
|
1.62e-02
|
-1.84e-01
|
2.18e-01
|
GO:0050772 positive regulation of axonogenesis
|
16
|
2.02e-01
|
-1.84e-01
|
6.05e-01
|
GO:0071361 cellular response to ethanol
|
11
|
2.90e-01
|
-1.84e-01
|
6.83e-01
|
GO:0044306 neuron projection terminus
|
14
|
2.33e-01
|
1.84e-01
|
6.35e-01
|
GO:0042307 positive regulation of protein import into nucleus
|
34
|
6.35e-02
|
-1.84e-01
|
3.74e-01
|
GO:0141111 positive regulation of cGAS/STING signaling pathway
|
5
|
4.77e-01
|
-1.84e-01
|
8.18e-01
|
GO:0071470 cellular response to osmotic stress
|
13
|
2.51e-01
|
1.84e-01
|
6.53e-01
|
GO:0110142 ubiquinone biosynthesis complex
|
6
|
4.36e-01
|
1.84e-01
|
7.95e-01
|
GO:0045275 respiratory chain complex III
|
12
|
2.71e-01
|
-1.84e-01
|
6.70e-01
|
GO:0060047 heart contraction
|
8
|
3.69e-01
|
1.84e-01
|
7.50e-01
|
GO:0032437 cuticular plate
|
6
|
4.36e-01
|
-1.84e-01
|
7.95e-01
|
GO:0060761 negative regulation of response to cytokine stimulus
|
5
|
4.77e-01
|
-1.83e-01
|
8.19e-01
|
GO:0140252 regulation protein catabolic process at postsynapse
|
5
|
4.78e-01
|
-1.83e-01
|
8.19e-01
|
GO:0035357 peroxisome proliferator activated receptor signaling pathway
|
9
|
3.41e-01
|
-1.83e-01
|
7.27e-01
|
GO:0061179 negative regulation of insulin secretion involved in cellular response to glucose stimulus
|
8
|
3.69e-01
|
1.83e-01
|
7.50e-01
|
GO:0032060 bleb assembly
|
9
|
3.41e-01
|
-1.83e-01
|
7.27e-01
|
GO:0006913 nucleocytoplasmic transport
|
42
|
4.00e-02
|
-1.83e-01
|
3.14e-01
|
GO:0000177 cytoplasmic exosome (RNase complex)
|
14
|
2.35e-01
|
1.83e-01
|
6.39e-01
|
GO:0006865 amino acid transport
|
26
|
1.06e-01
|
1.83e-01
|
4.61e-01
|
GO:0120099 procentriole replication complex
|
5
|
4.78e-01
|
-1.83e-01
|
8.19e-01
|
GO:0043425 bHLH transcription factor binding
|
17
|
1.91e-01
|
-1.83e-01
|
5.96e-01
|
GO:0022604 regulation of cell morphogenesis
|
19
|
1.67e-01
|
-1.83e-01
|
5.72e-01
|
GO:0035108 limb morphogenesis
|
8
|
3.70e-01
|
-1.83e-01
|
7.51e-01
|
GO:0007338 single fertilization
|
33
|
6.93e-02
|
1.83e-01
|
3.88e-01
|
GO:0060382 regulation of DNA strand elongation
|
16
|
2.06e-01
|
-1.83e-01
|
6.11e-01
|
GO:0005200 structural constituent of cytoskeleton
|
60
|
1.46e-02
|
-1.82e-01
|
2.08e-01
|
GO:0048813 dendrite morphogenesis
|
26
|
1.08e-01
|
-1.82e-01
|
4.65e-01
|
GO:0045724 positive regulation of cilium assembly
|
21
|
1.48e-01
|
1.82e-01
|
5.39e-01
|
GO:0044691 tooth eruption
|
5
|
4.80e-01
|
1.82e-01
|
8.19e-01
|
GO:1990573 potassium ion import across plasma membrane
|
15
|
2.22e-01
|
-1.82e-01
|
6.21e-01
|
GO:0061702 canonical inflammasome complex
|
6
|
4.40e-01
|
1.82e-01
|
7.96e-01
|
GO:0099022 vesicle tethering
|
16
|
2.07e-01
|
1.82e-01
|
6.11e-01
|
GO:0045177 apical part of cell
|
47
|
3.08e-02
|
-1.82e-01
|
2.79e-01
|
GO:0032331 negative regulation of chondrocyte differentiation
|
8
|
3.73e-01
|
-1.82e-01
|
7.52e-01
|
GO:0050850 positive regulation of calcium-mediated signaling
|
18
|
1.81e-01
|
-1.82e-01
|
5.84e-01
|
GO:0048557 embryonic digestive tract morphogenesis
|
7
|
4.04e-01
|
-1.82e-01
|
7.79e-01
|
GO:0043262 ADP phosphatase activity
|
5
|
4.81e-01
|
-1.82e-01
|
8.20e-01
|
GO:0046079 dUMP catabolic process
|
5
|
4.81e-01
|
-1.82e-01
|
8.20e-01
|
GO:1990748 cellular detoxification
|
9
|
3.45e-01
|
1.82e-01
|
7.30e-01
|
GO:0010606 positive regulation of cytoplasmic mRNA processing body assembly
|
6
|
4.41e-01
|
1.82e-01
|
7.96e-01
|
GO:0032675 regulation of interleukin-6 production
|
7
|
4.05e-01
|
1.82e-01
|
7.80e-01
|
GO:0016303 1-phosphatidylinositol-3-kinase activity
|
9
|
3.45e-01
|
-1.82e-01
|
7.30e-01
|
GO:0051059 NF-kappaB binding
|
31
|
8.01e-02
|
-1.82e-01
|
4.12e-01
|
GO:0005774 vacuolar membrane
|
14
|
2.39e-01
|
-1.82e-01
|
6.45e-01
|
GO:1990226 histone methyltransferase binding
|
14
|
2.40e-01
|
-1.82e-01
|
6.45e-01
|
GO:0015171 amino acid transmembrane transporter activity
|
19
|
1.71e-01
|
1.81e-01
|
5.76e-01
|
GO:0071281 cellular response to iron ion
|
5
|
4.82e-01
|
-1.81e-01
|
8.21e-01
|
GO:0000445 THO complex part of transcription export complex
|
6
|
4.42e-01
|
1.81e-01
|
7.96e-01
|
GO:0043491 phosphatidylinositol 3-kinase/protein kinase B signal transduction
|
51
|
2.53e-02
|
-1.81e-01
|
2.58e-01
|
GO:0006811 monoatomic ion transport
|
59
|
1.62e-02
|
-1.81e-01
|
2.18e-01
|
GO:0060271 cilium assembly
|
170
|
4.81e-05
|
1.81e-01
|
5.27e-03
|
GO:0007271 synaptic transmission, cholinergic
|
8
|
3.76e-01
|
1.81e-01
|
7.55e-01
|
GO:0055088 lipid homeostasis
|
36
|
6.08e-02
|
1.81e-01
|
3.65e-01
|
GO:0090110 COPII-coated vesicle cargo loading
|
17
|
1.98e-01
|
-1.81e-01
|
6.02e-01
|
GO:0047497 mitochondrion transport along microtubule
|
8
|
3.77e-01
|
1.80e-01
|
7.56e-01
|
GO:1904781 positive regulation of protein localization to centrosome
|
7
|
4.08e-01
|
-1.80e-01
|
7.82e-01
|
GO:0007096 regulation of exit from mitosis
|
12
|
2.80e-01
|
-1.80e-01
|
6.76e-01
|
GO:0051894 positive regulation of focal adhesion assembly
|
18
|
1.86e-01
|
-1.80e-01
|
5.88e-01
|
GO:0007625 grooming behavior
|
6
|
4.45e-01
|
-1.80e-01
|
7.98e-01
|
GO:0010212 response to ionizing radiation
|
35
|
6.53e-02
|
-1.80e-01
|
3.78e-01
|
GO:0090128 regulation of synapse maturation
|
11
|
3.02e-01
|
-1.80e-01
|
6.93e-01
|
GO:0003724 RNA helicase activity
|
63
|
1.37e-02
|
-1.80e-01
|
2.04e-01
|
GO:0048208 COPII vesicle coating
|
23
|
1.36e-01
|
1.80e-01
|
5.16e-01
|
GO:0004726 non-membrane spanning protein tyrosine phosphatase activity
|
62
|
1.45e-02
|
-1.80e-01
|
2.07e-01
|
GO:0030946 protein tyrosine phosphatase activity, metal-dependent
|
62
|
1.45e-02
|
-1.80e-01
|
2.07e-01
|
GO:0140793 histone H2AXY142 phosphatase activity
|
62
|
1.45e-02
|
-1.80e-01
|
2.07e-01
|
GO:0051293 establishment of spindle localization
|
5
|
4.87e-01
|
-1.80e-01
|
8.24e-01
|
GO:0007006 mitochondrial membrane organization
|
5
|
4.87e-01
|
-1.79e-01
|
8.24e-01
|
GO:0045063 T-helper 1 cell differentiation
|
8
|
3.80e-01
|
-1.79e-01
|
7.58e-01
|
GO:0043406 positive regulation of MAP kinase activity
|
24
|
1.28e-01
|
-1.79e-01
|
5.06e-01
|
GO:0004862 cAMP-dependent protein kinase inhibitor activity
|
7
|
4.11e-01
|
-1.79e-01
|
7.84e-01
|
GO:0047617 fatty acyl-CoA hydrolase activity
|
10
|
3.26e-01
|
1.79e-01
|
7.18e-01
|
GO:0031078 histone H3K14 deacetylase activity, hydrolytic mechanism
|
10
|
3.26e-01
|
-1.79e-01
|
7.18e-01
|
GO:0034739 histone H4K16 deacetylase activity, hydrolytic mechanism
|
10
|
3.26e-01
|
-1.79e-01
|
7.18e-01
|
GO:0180032 histone H4K5 deacetylase activity, hydrolytic mechanism
|
10
|
3.26e-01
|
-1.79e-01
|
7.18e-01
|
GO:0180033 histone H4K8 deacetylase activity, hydrolytic mechanism
|
10
|
3.26e-01
|
-1.79e-01
|
7.18e-01
|
GO:1990162 histone H3K4 deacetylase activity, hydrolytic mechanism
|
10
|
3.26e-01
|
-1.79e-01
|
7.18e-01
|
GO:0032434 regulation of proteasomal ubiquitin-dependent protein catabolic process
|
12
|
2.82e-01
|
1.79e-01
|
6.78e-01
|
GO:0034333 adherens junction assembly
|
11
|
3.04e-01
|
-1.79e-01
|
6.93e-01
|
GO:0009055 electron transfer activity
|
47
|
3.38e-02
|
1.79e-01
|
2.91e-01
|
GO:0050544 arachidonate binding
|
6
|
4.48e-01
|
-1.79e-01
|
8.00e-01
|
GO:0097731 9+0 non-motile cilium
|
7
|
4.12e-01
|
1.79e-01
|
7.85e-01
|
GO:0034137 positive regulation of toll-like receptor 2 signaling pathway
|
5
|
4.89e-01
|
-1.79e-01
|
8.24e-01
|
GO:0051045 negative regulation of membrane protein ectodomain proteolysis
|
7
|
4.13e-01
|
-1.79e-01
|
7.85e-01
|
GO:0004866 endopeptidase inhibitor activity
|
23
|
1.38e-01
|
1.79e-01
|
5.21e-01
|
GO:1902775 mitochondrial large ribosomal subunit assembly
|
5
|
4.89e-01
|
-1.78e-01
|
8.24e-01
|
GO:0036258 multivesicular body assembly
|
31
|
8.57e-02
|
1.78e-01
|
4.24e-01
|
GO:0044314 protein K27-linked ubiquitination
|
12
|
2.85e-01
|
-1.78e-01
|
6.81e-01
|
GO:0006406 mRNA export from nucleus
|
52
|
2.62e-02
|
-1.78e-01
|
2.60e-01
|
GO:0002183 cytoplasmic translational initiation
|
11
|
3.06e-01
|
1.78e-01
|
6.96e-01
|
GO:0048193 Golgi vesicle transport
|
8
|
3.83e-01
|
1.78e-01
|
7.60e-01
|
GO:0034375 high-density lipoprotein particle remodeling
|
9
|
3.55e-01
|
1.78e-01
|
7.39e-01
|
GO:0001530 lipopolysaccharide binding
|
22
|
1.48e-01
|
1.78e-01
|
5.39e-01
|
GO:0042659 regulation of cell fate specification
|
13
|
2.66e-01
|
-1.78e-01
|
6.68e-01
|
GO:0000722 telomere maintenance via recombination
|
10
|
3.30e-01
|
-1.78e-01
|
7.20e-01
|
GO:0002467 germinal center formation
|
9
|
3.55e-01
|
-1.78e-01
|
7.39e-01
|
GO:0098803 respiratory chain complex
|
10
|
3.31e-01
|
1.78e-01
|
7.21e-01
|
GO:0005930 axoneme
|
69
|
1.07e-02
|
1.78e-01
|
1.85e-01
|
GO:0001835 blastocyst hatching
|
18
|
1.92e-01
|
-1.78e-01
|
5.97e-01
|
GO:0031571 mitotic G1 DNA damage checkpoint signaling
|
12
|
2.87e-01
|
-1.77e-01
|
6.81e-01
|
GO:0010756 positive regulation of plasminogen activation
|
6
|
4.52e-01
|
1.77e-01
|
8.02e-01
|
GO:0045930 negative regulation of mitotic cell cycle
|
13
|
2.68e-01
|
-1.77e-01
|
6.69e-01
|
GO:0016586 RSC-type complex
|
14
|
2.51e-01
|
-1.77e-01
|
6.53e-01
|
GO:0061629 RNA polymerase II-specific DNA-binding transcription factor binding
|
126
|
6.01e-04
|
-1.77e-01
|
3.22e-02
|
GO:0051968 positive regulation of synaptic transmission, glutamatergic
|
10
|
3.32e-01
|
-1.77e-01
|
7.21e-01
|
GO:0008140 cAMP response element binding protein binding
|
9
|
3.57e-01
|
-1.77e-01
|
7.40e-01
|
GO:0048699 generation of neurons
|
6
|
4.52e-01
|
-1.77e-01
|
8.02e-01
|
GO:0042054 histone methyltransferase activity
|
25
|
1.26e-01
|
-1.77e-01
|
5.01e-01
|
GO:0034703 cation channel complex
|
5
|
4.93e-01
|
1.77e-01
|
8.25e-01
|
GO:0032839 dendrite cytoplasm
|
17
|
2.07e-01
|
1.77e-01
|
6.11e-01
|
GO:0007144 female meiosis I
|
5
|
4.93e-01
|
1.77e-01
|
8.25e-01
|
GO:0007200 phospholipase C-activating G protein-coupled receptor signaling pathway
|
46
|
3.79e-02
|
-1.77e-01
|
3.04e-01
|
GO:1901796 regulation of signal transduction by p53 class mediator
|
42
|
4.74e-02
|
-1.77e-01
|
3.39e-01
|
GO:0050728 negative regulation of inflammatory response
|
69
|
1.11e-02
|
-1.77e-01
|
1.88e-01
|
GO:0006986 response to unfolded protein
|
47
|
3.60e-02
|
1.77e-01
|
2.97e-01
|
GO:0007231 osmosensory signaling pathway
|
6
|
4.54e-01
|
-1.77e-01
|
8.03e-01
|
GO:0004675 transmembrane receptor protein serine/threonine kinase activity
|
7
|
4.18e-01
|
1.77e-01
|
7.87e-01
|
GO:0031593 polyubiquitin modification-dependent protein binding
|
33
|
7.92e-02
|
1.77e-01
|
4.11e-01
|
GO:0006651 diacylglycerol biosynthetic process
|
5
|
4.94e-01
|
1.77e-01
|
8.25e-01
|
GO:0048709 oligodendrocyte differentiation
|
18
|
1.95e-01
|
-1.77e-01
|
5.98e-01
|
GO:0051403 stress-activated MAPK cascade
|
22
|
1.52e-01
|
-1.77e-01
|
5.45e-01
|
GO:0042110 T cell activation
|
42
|
4.79e-02
|
-1.76e-01
|
3.39e-01
|
GO:0051674 localization of cell
|
5
|
4.95e-01
|
-1.76e-01
|
8.25e-01
|
GO:0000178 exosome (RNase complex)
|
17
|
2.09e-01
|
1.76e-01
|
6.12e-01
|
GO:0045995 regulation of embryonic development
|
43
|
4.59e-02
|
-1.76e-01
|
3.36e-01
|
GO:1901380 negative regulation of potassium ion transmembrane transport
|
6
|
4.56e-01
|
-1.76e-01
|
8.03e-01
|
GO:0005773 vacuole
|
9
|
3.61e-01
|
-1.76e-01
|
7.42e-01
|
GO:0016409 palmitoyltransferase activity
|
18
|
1.97e-01
|
1.76e-01
|
6.01e-01
|
GO:1901096 regulation of autophagosome maturation
|
6
|
4.56e-01
|
1.76e-01
|
8.03e-01
|
GO:0098552 side of membrane
|
34
|
7.64e-02
|
1.76e-01
|
4.04e-01
|
GO:0002819 regulation of adaptive immune response
|
9
|
3.62e-01
|
-1.75e-01
|
7.44e-01
|
GO:0023026 MHC class II protein complex binding
|
23
|
1.46e-01
|
-1.75e-01
|
5.36e-01
|
GO:0008194 UDP-glycosyltransferase activity
|
5
|
4.98e-01
|
1.75e-01
|
8.27e-01
|
GO:0030214 hyaluronan catabolic process
|
10
|
3.38e-01
|
1.75e-01
|
7.25e-01
|
GO:0043247 telomere maintenance in response to DNA damage
|
9
|
3.63e-01
|
-1.75e-01
|
7.45e-01
|
GO:0045089 positive regulation of innate immune response
|
27
|
1.16e-01
|
1.75e-01
|
4.79e-01
|
GO:0030665 clathrin-coated vesicle membrane
|
27
|
1.16e-01
|
-1.75e-01
|
4.79e-01
|
GO:0030955 potassium ion binding
|
7
|
4.23e-01
|
-1.75e-01
|
7.87e-01
|
GO:0050919 negative chemotaxis
|
19
|
1.87e-01
|
-1.75e-01
|
5.90e-01
|
GO:0090734 site of DNA damage
|
35
|
7.36e-02
|
-1.75e-01
|
3.95e-01
|
GO:0045028 G protein-coupled purinergic nucleotide receptor activity
|
6
|
4.58e-01
|
1.75e-01
|
8.05e-01
|
GO:2000736 regulation of stem cell differentiation
|
19
|
1.87e-01
|
-1.75e-01
|
5.90e-01
|
GO:0030133 transport vesicle
|
72
|
1.04e-02
|
1.75e-01
|
1.83e-01
|
GO:0031011 Ino80 complex
|
16
|
2.27e-01
|
-1.75e-01
|
6.27e-01
|
GO:0035563 positive regulation of chromatin binding
|
8
|
3.93e-01
|
-1.75e-01
|
7.69e-01
|
GO:1904754 positive regulation of vascular associated smooth muscle cell migration
|
10
|
3.40e-01
|
-1.74e-01
|
7.26e-01
|
GO:0000027 ribosomal large subunit assembly
|
11
|
3.17e-01
|
1.74e-01
|
7.09e-01
|
GO:0038026 reelin-mediated signaling pathway
|
11
|
3.17e-01
|
-1.74e-01
|
7.09e-01
|
GO:0071985 multivesicular body sorting pathway
|
20
|
1.77e-01
|
1.74e-01
|
5.78e-01
|
GO:0008016 regulation of heart contraction
|
16
|
2.28e-01
|
-1.74e-01
|
6.28e-01
|
GO:0008094 ATP-dependent activity, acting on DNA
|
27
|
1.18e-01
|
-1.74e-01
|
4.84e-01
|
GO:0021680 cerebellar Purkinje cell layer development
|
5
|
5.00e-01
|
-1.74e-01
|
8.28e-01
|
GO:0046456 icosanoid biosynthetic process
|
5
|
5.01e-01
|
-1.74e-01
|
8.28e-01
|
GO:0051371 muscle alpha-actinin binding
|
8
|
3.95e-01
|
-1.74e-01
|
7.71e-01
|
GO:0070973 protein localization to endoplasmic reticulum exit site
|
8
|
3.95e-01
|
1.74e-01
|
7.71e-01
|
GO:2000009 negative regulation of protein localization to cell surface
|
10
|
3.42e-01
|
1.74e-01
|
7.27e-01
|
GO:0010043 response to zinc ion
|
19
|
1.90e-01
|
-1.74e-01
|
5.95e-01
|
GO:0042799 histone H4K20 methyltransferase activity
|
7
|
4.27e-01
|
-1.74e-01
|
7.90e-01
|
GO:0019934 cGMP-mediated signaling
|
13
|
2.79e-01
|
-1.73e-01
|
6.76e-01
|
GO:0045948 positive regulation of translational initiation
|
15
|
2.45e-01
|
-1.73e-01
|
6.49e-01
|
GO:0030507 spectrin binding
|
19
|
1.91e-01
|
-1.73e-01
|
5.95e-01
|
GO:0019888 protein phosphatase regulator activity
|
33
|
8.50e-02
|
-1.73e-01
|
4.23e-01
|
GO:0016559 peroxisome fission
|
11
|
3.20e-01
|
1.73e-01
|
7.11e-01
|
GO:2000177 regulation of neural precursor cell proliferation
|
7
|
4.27e-01
|
-1.73e-01
|
7.90e-01
|
GO:0046655 folic acid metabolic process
|
13
|
2.80e-01
|
1.73e-01
|
6.76e-01
|
GO:0035094 response to nicotine
|
14
|
2.62e-01
|
-1.73e-01
|
6.63e-01
|
GO:0060021 roof of mouth development
|
39
|
6.18e-02
|
1.73e-01
|
3.68e-01
|
GO:0032467 positive regulation of cytokinesis
|
27
|
1.20e-01
|
-1.73e-01
|
4.88e-01
|
GO:0060135 maternal process involved in female pregnancy
|
9
|
3.69e-01
|
-1.73e-01
|
7.50e-01
|
GO:1904707 positive regulation of vascular associated smooth muscle cell proliferation
|
26
|
1.27e-01
|
-1.73e-01
|
5.05e-01
|
GO:0097038 perinuclear endoplasmic reticulum
|
16
|
2.32e-01
|
1.73e-01
|
6.33e-01
|
GO:0048027 mRNA 5’-UTR binding
|
23
|
1.52e-01
|
1.73e-01
|
5.45e-01
|
GO:0008142 oxysterol binding
|
12
|
3.01e-01
|
-1.73e-01
|
6.92e-01
|
GO:0042832 defense response to protozoan
|
18
|
2.06e-01
|
-1.72e-01
|
6.11e-01
|
GO:0007623 circadian rhythm
|
38
|
6.67e-02
|
-1.72e-01
|
3.82e-01
|
GO:1903979 negative regulation of microglial cell activation
|
6
|
4.66e-01
|
1.72e-01
|
8.10e-01
|
GO:0090266 regulation of mitotic cell cycle spindle assembly checkpoint
|
7
|
4.32e-01
|
-1.72e-01
|
7.94e-01
|
GO:0006627 protein processing involved in protein targeting to mitochondrion
|
5
|
5.07e-01
|
1.71e-01
|
8.33e-01
|
GO:0086009 membrane repolarization
|
7
|
4.32e-01
|
1.71e-01
|
7.94e-01
|
GO:0001937 negative regulation of endothelial cell proliferation
|
19
|
1.96e-01
|
1.71e-01
|
6.01e-01
|
GO:0050700 CARD domain binding
|
13
|
2.85e-01
|
1.71e-01
|
6.81e-01
|
GO:1902883 negative regulation of response to oxidative stress
|
5
|
5.07e-01
|
1.71e-01
|
8.33e-01
|
GO:0001618 virus receptor activity
|
60
|
2.19e-02
|
-1.71e-01
|
2.41e-01
|
GO:0006261 DNA-templated DNA replication
|
27
|
1.24e-01
|
-1.71e-01
|
4.97e-01
|
GO:0019900 kinase binding
|
79
|
8.62e-03
|
-1.71e-01
|
1.63e-01
|
GO:0016493 C-C chemokine receptor activity
|
5
|
5.08e-01
|
1.71e-01
|
8.33e-01
|
GO:0019221 cytokine-mediated signaling pathway
|
89
|
5.34e-03
|
-1.71e-01
|
1.24e-01
|
GO:0038094 Fc-gamma receptor signaling pathway
|
9
|
3.75e-01
|
1.71e-01
|
7.54e-01
|
GO:0046209 nitric oxide metabolic process
|
5
|
5.08e-01
|
-1.71e-01
|
8.34e-01
|
GO:0035098 ESC/E(Z) complex
|
15
|
2.52e-01
|
-1.71e-01
|
6.55e-01
|
GO:0003214 cardiac left ventricle morphogenesis
|
5
|
5.09e-01
|
-1.71e-01
|
8.34e-01
|
GO:0033081 regulation of T cell differentiation in thymus
|
5
|
5.09e-01
|
1.70e-01
|
8.34e-01
|
GO:0060347 heart trabecula formation
|
8
|
4.04e-01
|
1.70e-01
|
7.79e-01
|
GO:0007157 heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules
|
19
|
1.99e-01
|
-1.70e-01
|
6.02e-01
|
GO:0097264 self proteolysis
|
8
|
4.04e-01
|
-1.70e-01
|
7.79e-01
|
GO:0009624 response to nematode
|
6
|
4.70e-01
|
1.70e-01
|
8.13e-01
|
GO:0032816 positive regulation of natural killer cell activation
|
6
|
4.70e-01
|
1.70e-01
|
8.13e-01
|
GO:0030517 negative regulation of axon extension
|
15
|
2.54e-01
|
1.70e-01
|
6.56e-01
|
GO:0010764 negative regulation of fibroblast migration
|
7
|
4.36e-01
|
-1.70e-01
|
7.95e-01
|
GO:0050708 regulation of protein secretion
|
7
|
4.36e-01
|
-1.70e-01
|
7.95e-01
|
GO:0110076 negative regulation of ferroptosis
|
9
|
3.77e-01
|
1.70e-01
|
7.57e-01
|
GO:0000813 ESCRT I complex
|
11
|
3.30e-01
|
1.70e-01
|
7.20e-01
|
GO:0006418 tRNA aminoacylation for protein translation
|
7
|
4.37e-01
|
-1.70e-01
|
7.95e-01
|
GO:0031674 I band
|
12
|
3.09e-01
|
-1.70e-01
|
7.00e-01
|
GO:0032534 regulation of microvillus assembly
|
5
|
5.11e-01
|
-1.70e-01
|
8.34e-01
|
GO:0007062 sister chromatid cohesion
|
18
|
2.13e-01
|
-1.70e-01
|
6.15e-01
|
GO:0008574 plus-end-directed microtubule motor activity
|
14
|
2.72e-01
|
-1.69e-01
|
6.70e-01
|
GO:0005858 axonemal dynein complex
|
5
|
5.12e-01
|
-1.69e-01
|
8.34e-01
|
GO:0005682 U5 snRNP
|
19
|
2.01e-01
|
-1.69e-01
|
6.05e-01
|
GO:0042613 MHC class II protein complex
|
14
|
2.72e-01
|
-1.69e-01
|
6.70e-01
|
GO:0007498 mesoderm development
|
19
|
2.01e-01
|
1.69e-01
|
6.05e-01
|
GO:0048675 axon extension
|
22
|
1.69e-01
|
-1.69e-01
|
5.74e-01
|
GO:0007207 phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway
|
5
|
5.12e-01
|
1.69e-01
|
8.34e-01
|
GO:0071257 cellular response to electrical stimulus
|
5
|
5.12e-01
|
-1.69e-01
|
8.34e-01
|
GO:0010039 response to iron ion
|
11
|
3.32e-01
|
-1.69e-01
|
7.21e-01
|
GO:0030855 epithelial cell differentiation
|
37
|
7.57e-02
|
1.69e-01
|
4.02e-01
|
GO:0042392 sphingosine-1-phosphate phosphatase activity
|
6
|
4.74e-01
|
1.69e-01
|
8.15e-01
|
GO:0030970 retrograde protein transport, ER to cytosol
|
16
|
2.43e-01
|
1.69e-01
|
6.48e-01
|
GO:0030837 negative regulation of actin filament polymerization
|
16
|
2.43e-01
|
-1.69e-01
|
6.48e-01
|
GO:0006612 protein targeting to membrane
|
40
|
6.52e-02
|
1.69e-01
|
3.78e-01
|
GO:0032328 alanine transport
|
5
|
5.14e-01
|
1.69e-01
|
8.34e-01
|
GO:0042256 cytosolic ribosome assembly
|
5
|
5.14e-01
|
1.69e-01
|
8.34e-01
|
GO:0033176 proton-transporting V-type ATPase complex
|
12
|
3.12e-01
|
-1.68e-01
|
7.03e-01
|
GO:0034142 toll-like receptor 4 signaling pathway
|
28
|
1.23e-01
|
-1.68e-01
|
4.96e-01
|
GO:0097136 Bcl-2 family protein complex
|
7
|
4.41e-01
|
-1.68e-01
|
7.96e-01
|
GO:0044295 axonal growth cone
|
20
|
1.93e-01
|
-1.68e-01
|
5.97e-01
|
GO:1900024 regulation of substrate adhesion-dependent cell spreading
|
5
|
5.15e-01
|
-1.68e-01
|
8.34e-01
|
GO:1903944 negative regulation of hepatocyte apoptotic process
|
6
|
4.76e-01
|
-1.68e-01
|
8.18e-01
|
GO:1902036 regulation of hematopoietic stem cell differentiation
|
11
|
3.34e-01
|
-1.68e-01
|
7.23e-01
|
GO:0009750 response to fructose
|
5
|
5.15e-01
|
-1.68e-01
|
8.34e-01
|
GO:0043588 skin development
|
24
|
1.54e-01
|
-1.68e-01
|
5.48e-01
|
GO:0006412 translation
|
158
|
2.72e-04
|
1.68e-01
|
1.90e-02
|
GO:0035577 azurophil granule membrane
|
51
|
3.79e-02
|
1.68e-01
|
3.04e-01
|
GO:1902459 positive regulation of stem cell population maintenance
|
42
|
5.97e-02
|
-1.68e-01
|
3.62e-01
|
GO:0043382 positive regulation of memory T cell differentiation
|
6
|
4.76e-01
|
-1.68e-01
|
8.18e-01
|
GO:0031643 positive regulation of myelination
|
12
|
3.14e-01
|
-1.68e-01
|
7.05e-01
|
GO:0030948 negative regulation of vascular endothelial growth factor receptor signaling pathway
|
9
|
3.83e-01
|
-1.68e-01
|
7.60e-01
|
GO:0010815 bradykinin catabolic process
|
6
|
4.77e-01
|
1.68e-01
|
8.18e-01
|
GO:0002039 p53 binding
|
60
|
2.46e-02
|
-1.68e-01
|
2.58e-01
|
GO:0035590 purinergic nucleotide receptor signaling pathway
|
5
|
5.16e-01
|
1.68e-01
|
8.34e-01
|
GO:0036152 phosphatidylethanolamine acyl-chain remodeling
|
10
|
3.59e-01
|
1.68e-01
|
7.41e-01
|
GO:0042159 lipoprotein catabolic process
|
6
|
4.77e-01
|
1.68e-01
|
8.19e-01
|
GO:0044571 [2Fe-2S] cluster assembly
|
10
|
3.59e-01
|
-1.67e-01
|
7.41e-01
|
GO:0048255 mRNA stabilization
|
27
|
1.32e-01
|
-1.67e-01
|
5.11e-01
|
GO:0006225 UDP biosynthetic process
|
5
|
5.17e-01
|
-1.67e-01
|
8.34e-01
|
GO:0015937 coenzyme A biosynthetic process
|
10
|
3.60e-01
|
1.67e-01
|
7.41e-01
|
GO:0097100 supercoiled DNA binding
|
6
|
4.78e-01
|
1.67e-01
|
8.19e-01
|
GO:0043020 NADPH oxidase complex
|
10
|
3.60e-01
|
1.67e-01
|
7.41e-01
|
GO:0006941 striated muscle contraction
|
9
|
3.85e-01
|
-1.67e-01
|
7.62e-01
|
GO:2000035 regulation of stem cell division
|
8
|
4.13e-01
|
-1.67e-01
|
7.85e-01
|
GO:0005876 spindle microtubule
|
35
|
8.73e-02
|
-1.67e-01
|
4.29e-01
|
GO:0006094 gluconeogenesis
|
32
|
1.02e-01
|
-1.67e-01
|
4.55e-01
|
GO:0007274 neuromuscular synaptic transmission
|
13
|
2.97e-01
|
-1.67e-01
|
6.90e-01
|
GO:0050921 positive regulation of chemotaxis
|
12
|
3.18e-01
|
-1.67e-01
|
7.10e-01
|
GO:0031591 wybutosine biosynthetic process
|
6
|
4.80e-01
|
1.66e-01
|
8.19e-01
|
GO:0016428 tRNA (cytidine-5-)-methyltransferase activity
|
5
|
5.20e-01
|
-1.66e-01
|
8.35e-01
|
GO:0030003 intracellular monoatomic cation homeostasis
|
11
|
3.40e-01
|
1.66e-01
|
7.26e-01
|
GO:0017183 protein histidyl modification to diphthamide
|
7
|
4.46e-01
|
1.66e-01
|
7.99e-01
|
GO:0045334 clathrin-coated endocytic vesicle
|
17
|
2.36e-01
|
-1.66e-01
|
6.39e-01
|
GO:0044548 S100 protein binding
|
12
|
3.19e-01
|
-1.66e-01
|
7.10e-01
|
GO:0031432 titin binding
|
8
|
4.16e-01
|
-1.66e-01
|
7.87e-01
|
GO:0010447 response to acidic pH
|
8
|
4.17e-01
|
-1.66e-01
|
7.87e-01
|
GO:0045647 negative regulation of erythrocyte differentiation
|
8
|
4.17e-01
|
-1.66e-01
|
7.87e-01
|
GO:0034485 phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity
|
6
|
4.82e-01
|
-1.66e-01
|
8.21e-01
|
GO:0051493 regulation of cytoskeleton organization
|
17
|
2.37e-01
|
-1.66e-01
|
6.42e-01
|
GO:0032754 positive regulation of interleukin-5 production
|
5
|
5.22e-01
|
1.65e-01
|
8.37e-01
|
GO:0140938 histone H3 methyltransferase activity
|
19
|
2.12e-01
|
-1.65e-01
|
6.15e-01
|
GO:0046697 decidualization
|
18
|
2.25e-01
|
1.65e-01
|
6.25e-01
|
GO:0010717 regulation of epithelial to mesenchymal transition
|
12
|
3.22e-01
|
-1.65e-01
|
7.13e-01
|
GO:0004740 pyruvate dehydrogenase (acetyl-transferring) kinase activity
|
5
|
5.23e-01
|
1.65e-01
|
8.37e-01
|
GO:0036038 MKS complex
|
13
|
3.03e-01
|
1.65e-01
|
6.93e-01
|
GO:0050658 RNA transport
|
8
|
4.20e-01
|
1.65e-01
|
7.87e-01
|
GO:0008349 MAP kinase kinase kinase kinase activity
|
5
|
5.24e-01
|
1.65e-01
|
8.37e-01
|
GO:0006275 regulation of DNA replication
|
43
|
6.18e-02
|
-1.65e-01
|
3.68e-01
|
GO:1904417 positive regulation of xenophagy
|
8
|
4.20e-01
|
1.65e-01
|
7.87e-01
|
GO:0060576 intestinal epithelial cell development
|
7
|
4.51e-01
|
1.65e-01
|
8.02e-01
|
GO:0043488 regulation of mRNA stability
|
30
|
1.19e-01
|
-1.64e-01
|
4.85e-01
|
GO:0006606 protein import into nucleus
|
89
|
7.39e-03
|
-1.64e-01
|
1.54e-01
|
GO:0043254 regulation of protein-containing complex assembly
|
17
|
2.41e-01
|
-1.64e-01
|
6.46e-01
|
GO:0038128 ERBB2 signaling pathway
|
5
|
5.25e-01
|
-1.64e-01
|
8.37e-01
|
GO:0003735 structural constituent of ribosome
|
154
|
4.46e-04
|
1.64e-01
|
2.75e-02
|
GO:0090398 cellular senescence
|
48
|
4.92e-02
|
-1.64e-01
|
3.41e-01
|
GO:0006112 energy reserve metabolic process
|
5
|
5.25e-01
|
-1.64e-01
|
8.37e-01
|
GO:0070402 NADPH binding
|
16
|
2.56e-01
|
-1.64e-01
|
6.58e-01
|
GO:0070358 actin polymerization-dependent cell motility
|
7
|
4.52e-01
|
-1.64e-01
|
8.02e-01
|
GO:0015271 outward rectifier potassium channel activity
|
5
|
5.25e-01
|
-1.64e-01
|
8.37e-01
|
GO:0032819 positive regulation of natural killer cell proliferation
|
8
|
4.22e-01
|
1.64e-01
|
7.87e-01
|
GO:1903441 protein localization to ciliary membrane
|
5
|
5.25e-01
|
1.64e-01
|
8.37e-01
|
GO:0061820 telomeric D-loop disassembly
|
7
|
4.53e-01
|
-1.64e-01
|
8.02e-01
|
GO:0005385 zinc ion transmembrane transporter activity
|
20
|
2.05e-01
|
-1.64e-01
|
6.10e-01
|
GO:0070434 positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway
|
6
|
4.87e-01
|
1.64e-01
|
8.24e-01
|
GO:1990909 Wnt signalosome
|
9
|
3.95e-01
|
-1.64e-01
|
7.71e-01
|
GO:0000724 double-strand break repair via homologous recombination
|
94
|
6.11e-03
|
-1.64e-01
|
1.36e-01
|
GO:1901888 regulation of cell junction assembly
|
7
|
4.54e-01
|
-1.64e-01
|
8.03e-01
|
GO:0032735 positive regulation of interleukin-12 production
|
32
|
1.09e-01
|
-1.64e-01
|
4.70e-01
|
GO:0006957 complement activation, alternative pathway
|
9
|
3.95e-01
|
1.64e-01
|
7.71e-01
|
GO:0017134 fibroblast growth factor binding
|
14
|
2.90e-01
|
1.63e-01
|
6.82e-01
|
GO:0018107 peptidyl-threonine phosphorylation
|
35
|
9.45e-02
|
-1.63e-01
|
4.40e-01
|
GO:0006470 protein dephosphorylation
|
61
|
2.74e-02
|
-1.63e-01
|
2.66e-01
|
GO:0005324 long-chain fatty acid transmembrane transporter activity
|
11
|
3.48e-01
|
-1.63e-01
|
7.33e-01
|
GO:0097294 ‘de novo’ XMP biosynthetic process
|
7
|
4.55e-01
|
1.63e-01
|
8.03e-01
|
GO:0033209 tumor necrosis factor-mediated signaling pathway
|
41
|
7.10e-02
|
-1.63e-01
|
3.90e-01
|
GO:0010976 positive regulation of neuron projection development
|
80
|
1.18e-02
|
-1.63e-01
|
1.92e-01
|
GO:0030276 clathrin binding
|
25
|
1.58e-01
|
-1.63e-01
|
5.57e-01
|
GO:0031666 positive regulation of lipopolysaccharide-mediated signaling pathway
|
11
|
3.49e-01
|
-1.63e-01
|
7.35e-01
|
GO:0030198 extracellular matrix organization
|
66
|
2.21e-02
|
-1.63e-01
|
2.41e-01
|
GO:0044291 cell-cell contact zone
|
17
|
2.45e-01
|
-1.63e-01
|
6.50e-01
|
GO:0060982 coronary artery morphogenesis
|
7
|
4.56e-01
|
-1.63e-01
|
8.03e-01
|
GO:0006414 translational elongation
|
16
|
2.60e-01
|
1.63e-01
|
6.61e-01
|
GO:0097708 intracellular vesicle
|
12
|
3.29e-01
|
-1.63e-01
|
7.20e-01
|
GO:0005112 Notch binding
|
15
|
2.75e-01
|
-1.63e-01
|
6.71e-01
|
GO:0001916 positive regulation of T cell mediated cytotoxicity
|
20
|
2.08e-01
|
1.63e-01
|
6.12e-01
|
GO:0007026 negative regulation of microtubule depolymerization
|
25
|
1.60e-01
|
-1.63e-01
|
5.59e-01
|
GO:0001768 establishment of T cell polarity
|
5
|
5.29e-01
|
-1.62e-01
|
8.41e-01
|
GO:2000781 positive regulation of double-strand break repair
|
37
|
8.75e-02
|
-1.62e-01
|
4.29e-01
|
GO:0035249 synaptic transmission, glutamatergic
|
23
|
1.78e-01
|
1.62e-01
|
5.79e-01
|
GO:0008347 glial cell migration
|
8
|
4.27e-01
|
1.62e-01
|
7.90e-01
|
GO:0052659 inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity
|
5
|
5.30e-01
|
1.62e-01
|
8.41e-01
|
GO:0031265 CD95 death-inducing signaling complex
|
6
|
4.92e-01
|
-1.62e-01
|
8.25e-01
|
GO:0070679 inositol 1,4,5 trisphosphate binding
|
5
|
5.30e-01
|
1.62e-01
|
8.41e-01
|
GO:0048156 tau protein binding
|
37
|
8.86e-02
|
-1.62e-01
|
4.31e-01
|
GO:0001917 photoreceptor inner segment
|
34
|
1.03e-01
|
1.62e-01
|
4.55e-01
|
GO:0009642 response to light intensity
|
5
|
5.32e-01
|
-1.62e-01
|
8.43e-01
|
GO:0008307 structural constituent of muscle
|
23
|
1.80e-01
|
-1.61e-01
|
5.83e-01
|
GO:0035641 locomotory exploration behavior
|
9
|
4.02e-01
|
1.61e-01
|
7.77e-01
|
GO:0042987 amyloid precursor protein catabolic process
|
13
|
3.14e-01
|
-1.61e-01
|
7.05e-01
|
GO:1900119 positive regulation of execution phase of apoptosis
|
12
|
3.34e-01
|
-1.61e-01
|
7.22e-01
|
GO:0031665 negative regulation of lipopolysaccharide-mediated signaling pathway
|
10
|
3.78e-01
|
1.61e-01
|
7.57e-01
|
GO:0140955 histone H3K36 trimethyltransferase activity
|
5
|
5.33e-01
|
-1.61e-01
|
8.43e-01
|
GO:0015085 calcium ion transmembrane transporter activity
|
7
|
4.61e-01
|
-1.61e-01
|
8.06e-01
|
GO:0031683 G-protein beta/gamma-subunit complex binding
|
13
|
3.16e-01
|
-1.61e-01
|
7.07e-01
|
GO:0005881 cytoplasmic microtubule
|
45
|
6.23e-02
|
-1.61e-01
|
3.69e-01
|
GO:0019882 antigen processing and presentation
|
20
|
2.14e-01
|
1.61e-01
|
6.15e-01
|
GO:0042761 very long-chain fatty acid biosynthetic process
|
9
|
4.04e-01
|
1.61e-01
|
7.79e-01
|
GO:0090043 regulation of tubulin deacetylation
|
12
|
3.36e-01
|
-1.60e-01
|
7.24e-01
|
GO:0009725 response to hormone
|
23
|
1.83e-01
|
-1.60e-01
|
5.85e-01
|
GO:0017111 ribonucleoside triphosphate phosphatase activity
|
8
|
4.33e-01
|
-1.60e-01
|
7.94e-01
|
GO:0033173 calcineurin-NFAT signaling cascade
|
15
|
2.83e-01
|
-1.60e-01
|
6.79e-01
|
GO:0035694 mitochondrial protein catabolic process
|
10
|
3.81e-01
|
1.60e-01
|
7.58e-01
|
GO:0000375 RNA splicing, via transesterification reactions
|
25
|
1.66e-01
|
-1.60e-01
|
5.70e-01
|
GO:0045109 intermediate filament organization
|
13
|
3.18e-01
|
1.60e-01
|
7.10e-01
|
GO:0140297 DNA-binding transcription factor binding
|
132
|
1.54e-03
|
-1.60e-01
|
5.70e-02
|
GO:0008173 RNA methyltransferase activity
|
7
|
4.64e-01
|
1.60e-01
|
8.09e-01
|
GO:0016581 NuRD complex
|
15
|
2.84e-01
|
-1.60e-01
|
6.80e-01
|
GO:0046822 regulation of nucleocytoplasmic transport
|
8
|
4.34e-01
|
1.60e-01
|
7.94e-01
|
GO:0005138 interleukin-6 receptor binding
|
5
|
5.36e-01
|
-1.60e-01
|
8.44e-01
|
GO:0005544 calcium-dependent phospholipid binding
|
30
|
1.30e-01
|
1.60e-01
|
5.07e-01
|
GO:0048034 heme O biosynthetic process
|
9
|
4.07e-01
|
-1.60e-01
|
7.82e-01
|
GO:0140058 neuron projection arborization
|
6
|
4.99e-01
|
-1.60e-01
|
8.27e-01
|
GO:0051014 actin filament severing
|
12
|
3.39e-01
|
-1.60e-01
|
7.25e-01
|
GO:0044305 calyx of Held
|
11
|
3.60e-01
|
-1.60e-01
|
7.41e-01
|
GO:0030902 hindbrain development
|
8
|
4.35e-01
|
1.59e-01
|
7.94e-01
|
GO:0098887 neurotransmitter receptor transport, endosome to postsynaptic membrane
|
8
|
4.35e-01
|
1.59e-01
|
7.94e-01
|
GO:0003743 translation initiation factor activity
|
49
|
5.37e-02
|
1.59e-01
|
3.51e-01
|
GO:0000723 telomere maintenance
|
52
|
4.71e-02
|
-1.59e-01
|
3.39e-01
|
GO:0003755 peptidyl-prolyl cis-trans isomerase activity
|
29
|
1.38e-01
|
1.59e-01
|
5.19e-01
|
GO:2000774 positive regulation of cellular senescence
|
10
|
3.84e-01
|
1.59e-01
|
7.60e-01
|
GO:0043068 positive regulation of programmed cell death
|
11
|
3.61e-01
|
1.59e-01
|
7.42e-01
|
GO:0010592 positive regulation of lamellipodium assembly
|
21
|
2.07e-01
|
-1.59e-01
|
6.11e-01
|
GO:0061178 regulation of insulin secretion involved in cellular response to glucose stimulus
|
7
|
4.66e-01
|
1.59e-01
|
8.10e-01
|
GO:0008385 IkappaB kinase complex
|
7
|
4.66e-01
|
-1.59e-01
|
8.10e-01
|
GO:0017053 transcription repressor complex
|
49
|
5.42e-02
|
-1.59e-01
|
3.52e-01
|
GO:0000221 vacuolar proton-transporting V-type ATPase, V1 domain
|
9
|
4.09e-01
|
-1.59e-01
|
7.82e-01
|
GO:0001533 cornified envelope
|
15
|
2.87e-01
|
1.59e-01
|
6.81e-01
|
GO:0048240 sperm capacitation
|
9
|
4.10e-01
|
1.59e-01
|
7.83e-01
|
GO:0033601 positive regulation of mammary gland epithelial cell proliferation
|
6
|
5.01e-01
|
-1.59e-01
|
8.28e-01
|
GO:0043931 ossification involved in bone maturation
|
7
|
4.68e-01
|
1.59e-01
|
8.11e-01
|
GO:0030991 intraciliary transport particle A
|
8
|
4.38e-01
|
1.58e-01
|
7.95e-01
|
GO:0051660 establishment of centrosome localization
|
8
|
4.38e-01
|
-1.58e-01
|
7.95e-01
|
GO:0030628 pre-mRNA 3’-splice site binding
|
5
|
5.40e-01
|
1.58e-01
|
8.45e-01
|
GO:0050786 RAGE receptor binding
|
9
|
4.11e-01
|
-1.58e-01
|
7.84e-01
|
GO:0032435 negative regulation of proteasomal ubiquitin-dependent protein catabolic process
|
33
|
1.16e-01
|
1.58e-01
|
4.80e-01
|
GO:0006310 DNA recombination
|
45
|
6.65e-02
|
-1.58e-01
|
3.82e-01
|
GO:0007616 long-term memory
|
21
|
2.10e-01
|
-1.58e-01
|
6.13e-01
|
GO:0030900 forebrain development
|
29
|
1.41e-01
|
-1.58e-01
|
5.25e-01
|
GO:0071243 cellular response to arsenic-containing substance
|
8
|
4.39e-01
|
-1.58e-01
|
7.96e-01
|
GO:0019784 deNEDDylase activity
|
6
|
5.03e-01
|
1.58e-01
|
8.30e-01
|
GO:0140331 aminophospholipid translocation
|
6
|
5.03e-01
|
1.58e-01
|
8.30e-01
|
GO:1900026 positive regulation of substrate adhesion-dependent cell spreading
|
33
|
1.16e-01
|
-1.58e-01
|
4.81e-01
|
GO:0007023 post-chaperonin tubulin folding pathway
|
7
|
4.69e-01
|
1.58e-01
|
8.13e-01
|
GO:0062009 secondary palate development
|
6
|
5.03e-01
|
1.58e-01
|
8.30e-01
|
GO:0051260 protein homooligomerization
|
80
|
1.47e-02
|
-1.58e-01
|
2.09e-01
|
GO:0061001 regulation of dendritic spine morphogenesis
|
12
|
3.44e-01
|
-1.58e-01
|
7.30e-01
|
GO:1904507 positive regulation of telomere maintenance in response to DNA damage
|
15
|
2.91e-01
|
-1.58e-01
|
6.83e-01
|
GO:0004540 RNA nuclease activity
|
14
|
3.07e-01
|
-1.58e-01
|
6.98e-01
|
GO:0050863 regulation of T cell activation
|
8
|
4.41e-01
|
-1.57e-01
|
7.96e-01
|
GO:0071233 cellular response to L-leucine
|
10
|
3.89e-01
|
-1.57e-01
|
7.66e-01
|
GO:0045171 intercellular bridge
|
63
|
3.10e-02
|
-1.57e-01
|
2.80e-01
|
GO:0046037 GMP metabolic process
|
11
|
3.67e-01
|
1.57e-01
|
7.50e-01
|
GO:0018149 peptide cross-linking
|
8
|
4.42e-01
|
1.57e-01
|
7.96e-01
|
GO:0034663 endoplasmic reticulum chaperone complex
|
9
|
4.15e-01
|
-1.57e-01
|
7.87e-01
|
GO:0010524 positive regulation of calcium ion transport into cytosol
|
6
|
5.06e-01
|
-1.57e-01
|
8.33e-01
|
GO:2000121 regulation of removal of superoxide radicals
|
6
|
5.07e-01
|
-1.57e-01
|
8.33e-01
|
GO:0003181 atrioventricular valve morphogenesis
|
9
|
4.16e-01
|
1.57e-01
|
7.87e-01
|
GO:0007179 transforming growth factor beta receptor signaling pathway
|
71
|
2.27e-02
|
-1.56e-01
|
2.44e-01
|
GO:0008517 folic acid transmembrane transporter activity
|
5
|
5.45e-01
|
1.56e-01
|
8.47e-01
|
GO:0033130 acetylcholine receptor binding
|
11
|
3.69e-01
|
1.56e-01
|
7.50e-01
|
GO:0023019 signal transduction involved in regulation of gene expression
|
11
|
3.69e-01
|
-1.56e-01
|
7.50e-01
|
GO:0017025 TBP-class protein binding
|
23
|
1.94e-01
|
-1.56e-01
|
5.98e-01
|
GO:0007595 lactation
|
25
|
1.76e-01
|
-1.56e-01
|
5.78e-01
|
GO:0045505 dynein intermediate chain binding
|
21
|
2.15e-01
|
1.56e-01
|
6.17e-01
|
GO:0072686 mitotic spindle
|
109
|
4.91e-03
|
-1.56e-01
|
1.19e-01
|
GO:0051091 positive regulation of DNA-binding transcription factor activity
|
60
|
3.66e-02
|
-1.56e-01
|
2.98e-01
|
GO:0019674 NAD metabolic process
|
9
|
4.18e-01
|
1.56e-01
|
7.87e-01
|
GO:0006013 mannose metabolic process
|
8
|
4.45e-01
|
1.56e-01
|
7.98e-01
|
GO:0008092 cytoskeletal protein binding
|
31
|
1.33e-01
|
-1.56e-01
|
5.12e-01
|
GO:0046839 phospholipid dephosphorylation
|
7
|
4.75e-01
|
1.56e-01
|
8.17e-01
|
GO:1901798 positive regulation of signal transduction by p53 class mediator
|
9
|
4.18e-01
|
1.56e-01
|
7.87e-01
|
GO:0016251 RNA polymerase II general transcription initiation factor activity
|
37
|
1.01e-01
|
1.56e-01
|
4.55e-01
|
GO:0005782 peroxisomal matrix
|
42
|
8.06e-02
|
1.56e-01
|
4.13e-01
|
GO:0006644 phospholipid metabolic process
|
27
|
1.61e-01
|
1.56e-01
|
5.62e-01
|
GO:0071360 cellular response to exogenous dsRNA
|
13
|
3.31e-01
|
-1.56e-01
|
7.21e-01
|
GO:0061157 mRNA destabilization
|
19
|
2.40e-01
|
-1.56e-01
|
6.46e-01
|
GO:0008199 ferric iron binding
|
5
|
5.47e-01
|
1.56e-01
|
8.48e-01
|
GO:0030660 Golgi-associated vesicle membrane
|
11
|
3.71e-01
|
1.56e-01
|
7.51e-01
|
GO:0006892 post-Golgi vesicle-mediated transport
|
16
|
2.81e-01
|
-1.56e-01
|
6.78e-01
|
GO:1990166 protein localization to site of double-strand break
|
15
|
2.97e-01
|
-1.56e-01
|
6.90e-01
|
GO:1902035 positive regulation of hematopoietic stem cell proliferation
|
5
|
5.47e-01
|
-1.55e-01
|
8.48e-01
|
GO:0019827 stem cell population maintenance
|
28
|
1.55e-01
|
-1.55e-01
|
5.49e-01
|
GO:2000048 negative regulation of cell-cell adhesion mediated by cadherin
|
7
|
4.77e-01
|
-1.55e-01
|
8.18e-01
|
GO:0072594 establishment of protein localization to organelle
|
7
|
4.77e-01
|
1.55e-01
|
8.18e-01
|
GO:0003712 transcription coregulator activity
|
102
|
6.87e-03
|
-1.55e-01
|
1.45e-01
|
GO:0000255 allantoin metabolic process
|
5
|
5.48e-01
|
-1.55e-01
|
8.49e-01
|
GO:0001931 uropod
|
13
|
3.34e-01
|
-1.55e-01
|
7.22e-01
|
GO:0007021 tubulin complex assembly
|
8
|
4.48e-01
|
1.55e-01
|
8.00e-01
|
GO:0060487 lung epithelial cell differentiation
|
5
|
5.49e-01
|
-1.55e-01
|
8.49e-01
|
GO:0005225 volume-sensitive anion channel activity
|
7
|
4.78e-01
|
-1.55e-01
|
8.19e-01
|
GO:0030097 hemopoiesis
|
42
|
8.28e-02
|
-1.55e-01
|
4.18e-01
|
GO:0006890 retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum
|
45
|
7.28e-02
|
1.55e-01
|
3.93e-01
|
GO:0080008 Cul4-RING E3 ubiquitin ligase complex
|
26
|
1.73e-01
|
-1.55e-01
|
5.78e-01
|
GO:0072359 circulatory system development
|
6
|
5.12e-01
|
1.54e-01
|
8.34e-01
|
GO:0008308 voltage-gated monoatomic anion channel activity
|
5
|
5.50e-01
|
-1.54e-01
|
8.49e-01
|
GO:0010811 positive regulation of cell-substrate adhesion
|
20
|
2.32e-01
|
1.54e-01
|
6.34e-01
|
GO:0008420 RNA polymerase II CTD heptapeptide repeat phosphatase activity
|
7
|
4.80e-01
|
1.54e-01
|
8.19e-01
|
GO:0038187 pattern recognition receptor activity
|
25
|
1.82e-01
|
1.54e-01
|
5.85e-01
|
GO:0000137 Golgi cis cisterna
|
7
|
4.80e-01
|
1.54e-01
|
8.19e-01
|
GO:0002675 positive regulation of acute inflammatory response
|
5
|
5.51e-01
|
1.54e-01
|
8.49e-01
|
GO:0071636 positive regulation of transforming growth factor beta production
|
5
|
5.51e-01
|
1.54e-01
|
8.49e-01
|
GO:0071385 cellular response to glucocorticoid stimulus
|
13
|
3.36e-01
|
-1.54e-01
|
7.24e-01
|
GO:0061640 cytoskeleton-dependent cytokinesis
|
16
|
2.86e-01
|
1.54e-01
|
6.81e-01
|
GO:0070419 nonhomologous end joining complex
|
8
|
4.51e-01
|
-1.54e-01
|
8.02e-01
|
GO:0014002 astrocyte development
|
9
|
4.24e-01
|
-1.54e-01
|
7.88e-01
|
GO:0007017 microtubule-based process
|
14
|
3.19e-01
|
-1.54e-01
|
7.10e-01
|
GO:0060316 positive regulation of ryanodine-sensitive calcium-release channel activity
|
6
|
5.14e-01
|
1.54e-01
|
8.34e-01
|
GO:0031396 regulation of protein ubiquitination
|
18
|
2.59e-01
|
1.54e-01
|
6.61e-01
|
GO:0090201 negative regulation of release of cytochrome c from mitochondria
|
19
|
2.47e-01
|
-1.53e-01
|
6.52e-01
|
GO:0008195 phosphatidate phosphatase activity
|
8
|
4.52e-01
|
1.53e-01
|
8.02e-01
|
GO:0038172 interleukin-33-mediated signaling pathway
|
6
|
5.15e-01
|
-1.53e-01
|
8.34e-01
|
GO:0003682 chromatin binding
|
355
|
7.60e-07
|
-1.53e-01
|
2.12e-04
|
GO:0042059 negative regulation of epidermal growth factor receptor signaling pathway
|
13
|
3.38e-01
|
-1.53e-01
|
7.25e-01
|
GO:0072559 NLRP3 inflammasome complex
|
8
|
4.53e-01
|
1.53e-01
|
8.02e-01
|
GO:0045638 negative regulation of myeloid cell differentiation
|
11
|
3.79e-01
|
-1.53e-01
|
7.57e-01
|
GO:0038063 collagen-activated tyrosine kinase receptor signaling pathway
|
19
|
2.47e-01
|
-1.53e-01
|
6.52e-01
|
GO:0019788 NEDD8 transferase activity
|
5
|
5.53e-01
|
1.53e-01
|
8.50e-01
|
GO:0001825 blastocyst formation
|
18
|
2.60e-01
|
-1.53e-01
|
6.62e-01
|
GO:0005790 smooth endoplasmic reticulum
|
16
|
2.89e-01
|
1.53e-01
|
6.82e-01
|
GO:0031491 nucleosome binding
|
33
|
1.28e-01
|
-1.53e-01
|
5.06e-01
|
GO:0030868 smooth endoplasmic reticulum membrane
|
5
|
5.54e-01
|
1.53e-01
|
8.50e-01
|
GO:0006896 Golgi to vacuole transport
|
9
|
4.27e-01
|
1.53e-01
|
7.90e-01
|
GO:0032700 negative regulation of interleukin-17 production
|
10
|
4.02e-01
|
1.53e-01
|
7.77e-01
|
GO:0043679 axon terminus
|
25
|
1.86e-01
|
-1.53e-01
|
5.88e-01
|
GO:0097060 synaptic membrane
|
25
|
1.86e-01
|
-1.53e-01
|
5.88e-01
|
GO:0002237 response to molecule of bacterial origin
|
6
|
5.17e-01
|
1.53e-01
|
8.34e-01
|
GO:0000506 glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex
|
6
|
5.17e-01
|
-1.53e-01
|
8.34e-01
|
GO:0032790 ribosome disassembly
|
17
|
2.76e-01
|
1.53e-01
|
6.71e-01
|
GO:0045596 negative regulation of cell differentiation
|
25
|
1.87e-01
|
-1.53e-01
|
5.89e-01
|
GO:0006309 apoptotic DNA fragmentation
|
10
|
4.03e-01
|
-1.53e-01
|
7.79e-01
|
GO:0042752 regulation of circadian rhythm
|
53
|
5.50e-02
|
-1.52e-01
|
3.53e-01
|
GO:0051966 regulation of synaptic transmission, glutamatergic
|
16
|
2.91e-01
|
-1.52e-01
|
6.83e-01
|
GO:0000289 nuclear-transcribed mRNA poly(A) tail shortening
|
19
|
2.50e-01
|
-1.52e-01
|
6.53e-01
|
GO:0005539 glycosaminoglycan binding
|
14
|
3.24e-01
|
1.52e-01
|
7.15e-01
|
GO:0004725 protein tyrosine phosphatase activity
|
57
|
4.68e-02
|
-1.52e-01
|
3.39e-01
|
GO:0071532 ankyrin repeat binding
|
6
|
5.18e-01
|
-1.52e-01
|
8.35e-01
|
GO:0071277 cellular response to calcium ion
|
54
|
5.32e-02
|
-1.52e-01
|
3.50e-01
|
GO:0031730 CCR5 chemokine receptor binding
|
7
|
4.86e-01
|
-1.52e-01
|
8.23e-01
|
GO:1990234 transferase complex
|
7
|
4.86e-01
|
1.52e-01
|
8.23e-01
|
GO:2001200 positive regulation of dendritic cell differentiation
|
6
|
5.19e-01
|
-1.52e-01
|
8.35e-01
|
GO:0016183 synaptic vesicle coating
|
5
|
5.57e-01
|
1.52e-01
|
8.53e-01
|
GO:0005507 copper ion binding
|
34
|
1.26e-01
|
1.52e-01
|
5.01e-01
|
GO:0032483 regulation of Rab protein signal transduction
|
7
|
4.87e-01
|
-1.52e-01
|
8.24e-01
|
GO:0090136 epithelial cell-cell adhesion
|
8
|
4.58e-01
|
-1.52e-01
|
8.05e-01
|
GO:0030126 COPI vesicle coat
|
13
|
3.44e-01
|
1.52e-01
|
7.30e-01
|
GO:0004175 endopeptidase activity
|
56
|
5.01e-02
|
1.51e-01
|
3.42e-01
|
GO:0140410 monoatomic cation:bicarbonate symporter activity
|
5
|
5.58e-01
|
1.51e-01
|
8.54e-01
|
GO:0140468 HRI-mediated signaling
|
7
|
4.88e-01
|
-1.51e-01
|
8.24e-01
|
GO:0060038 cardiac muscle cell proliferation
|
14
|
3.27e-01
|
-1.51e-01
|
7.18e-01
|
GO:1900152 negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay
|
8
|
4.59e-01
|
-1.51e-01
|
8.05e-01
|
GO:0005921 gap junction
|
7
|
4.89e-01
|
-1.51e-01
|
8.24e-01
|
GO:0006111 regulation of gluconeogenesis
|
13
|
3.46e-01
|
-1.51e-01
|
7.31e-01
|
GO:0007187 G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger
|
12
|
3.65e-01
|
-1.51e-01
|
7.48e-01
|
GO:0019226 transmission of nerve impulse
|
8
|
4.60e-01
|
-1.51e-01
|
8.06e-01
|
GO:0140718 facultative heterochromatin formation
|
5
|
5.59e-01
|
1.51e-01
|
8.55e-01
|
GO:0034454 microtubule anchoring at centrosome
|
10
|
4.10e-01
|
1.51e-01
|
7.83e-01
|
GO:0090091 positive regulation of extracellular matrix disassembly
|
5
|
5.60e-01
|
-1.51e-01
|
8.55e-01
|
GO:0007628 adult walking behavior
|
19
|
2.56e-01
|
-1.51e-01
|
6.58e-01
|
GO:0007130 synaptonemal complex assembly
|
13
|
3.47e-01
|
-1.51e-01
|
7.32e-01
|
GO:0042220 response to cocaine
|
16
|
2.97e-01
|
-1.51e-01
|
6.90e-01
|
GO:0033615 mitochondrial proton-transporting ATP synthase complex assembly
|
8
|
4.61e-01
|
-1.51e-01
|
8.06e-01
|
GO:0006198 cAMP catabolic process
|
7
|
4.90e-01
|
-1.51e-01
|
8.24e-01
|
GO:0032680 regulation of tumor necrosis factor production
|
6
|
5.23e-01
|
-1.50e-01
|
8.37e-01
|
GO:0010833 telomere maintenance via telomere lengthening
|
7
|
4.91e-01
|
-1.50e-01
|
8.24e-01
|
GO:0005154 epidermal growth factor receptor binding
|
26
|
1.84e-01
|
-1.50e-01
|
5.87e-01
|
GO:1905515 non-motile cilium assembly
|
51
|
6.34e-02
|
1.50e-01
|
3.73e-01
|
GO:0034144 negative regulation of toll-like receptor 4 signaling pathway
|
12
|
3.67e-01
|
-1.50e-01
|
7.50e-01
|
GO:0097681 double-strand break repair via alternative nonhomologous end joining
|
9
|
4.35e-01
|
-1.50e-01
|
7.94e-01
|
GO:0071320 cellular response to cAMP
|
36
|
1.19e-01
|
-1.50e-01
|
4.86e-01
|
GO:0016281 eukaryotic translation initiation factor 4F complex
|
12
|
3.68e-01
|
-1.50e-01
|
7.50e-01
|
GO:1990314 cellular response to insulin-like growth factor stimulus
|
8
|
4.63e-01
|
-1.50e-01
|
8.08e-01
|
GO:0046540 U4/U6 x U5 tri-snRNP complex
|
37
|
1.15e-01
|
-1.50e-01
|
4.79e-01
|
GO:0050691 regulation of defense response to virus by host
|
7
|
4.93e-01
|
-1.50e-01
|
8.25e-01
|
GO:0035640 exploration behavior
|
9
|
4.37e-01
|
1.50e-01
|
7.95e-01
|
GO:0006102 isocitrate metabolic process
|
6
|
5.25e-01
|
-1.50e-01
|
8.37e-01
|
GO:0006900 vesicle budding from membrane
|
14
|
3.33e-01
|
1.50e-01
|
7.22e-01
|
GO:0003841 1-acylglycerol-3-phosphate O-acyltransferase activity
|
20
|
2.48e-01
|
-1.49e-01
|
6.52e-01
|
GO:0048539 bone marrow development
|
8
|
4.65e-01
|
1.49e-01
|
8.10e-01
|
GO:0030553 cGMP binding
|
7
|
4.95e-01
|
-1.49e-01
|
8.25e-01
|
GO:0032129 histone H3K9 deacetylase activity, hydrolytic mechanism
|
11
|
3.92e-01
|
-1.49e-01
|
7.68e-01
|
GO:0032012 regulation of ARF protein signal transduction
|
17
|
2.87e-01
|
-1.49e-01
|
6.81e-01
|
GO:0031464 Cul4A-RING E3 ubiquitin ligase complex
|
14
|
3.34e-01
|
-1.49e-01
|
7.23e-01
|
GO:0097720 calcineurin-mediated signaling
|
6
|
5.28e-01
|
1.49e-01
|
8.40e-01
|
GO:0030150 protein import into mitochondrial matrix
|
18
|
2.75e-01
|
-1.49e-01
|
6.71e-01
|
GO:0048278 vesicle docking
|
17
|
2.89e-01
|
1.49e-01
|
6.82e-01
|
GO:0055062 phosphate ion homeostasis
|
5
|
5.65e-01
|
1.49e-01
|
8.56e-01
|
GO:0006121 mitochondrial electron transport, succinate to ubiquinone
|
5
|
5.65e-01
|
1.48e-01
|
8.56e-01
|
GO:0034063 stress granule assembly
|
25
|
1.99e-01
|
-1.48e-01
|
6.02e-01
|
GO:0032993 protein-DNA complex
|
31
|
1.53e-01
|
-1.48e-01
|
5.48e-01
|
GO:0008013 beta-catenin binding
|
58
|
5.08e-02
|
-1.48e-01
|
3.43e-01
|
GO:0032732 positive regulation of interleukin-1 production
|
9
|
4.41e-01
|
1.48e-01
|
7.96e-01
|
GO:0030149 sphingolipid catabolic process
|
10
|
4.17e-01
|
1.48e-01
|
7.87e-01
|
GO:0014003 oligodendrocyte development
|
14
|
3.37e-01
|
-1.48e-01
|
7.25e-01
|
GO:0031204 post-translational protein targeting to membrane, translocation
|
7
|
4.97e-01
|
1.48e-01
|
8.27e-01
|
GO:0048806 genitalia development
|
5
|
5.66e-01
|
1.48e-01
|
8.56e-01
|
GO:0008484 sulfuric ester hydrolase activity
|
5
|
5.66e-01
|
1.48e-01
|
8.56e-01
|
GO:0016477 cell migration
|
163
|
1.13e-03
|
-1.48e-01
|
4.83e-02
|
GO:0045719 negative regulation of glycogen biosynthetic process
|
7
|
4.98e-01
|
-1.48e-01
|
8.27e-01
|
GO:0014850 response to muscle activity
|
19
|
2.65e-01
|
-1.48e-01
|
6.66e-01
|
GO:0008015 blood circulation
|
15
|
3.22e-01
|
-1.48e-01
|
7.13e-01
|
GO:0003333 amino acid transmembrane transport
|
15
|
3.22e-01
|
1.48e-01
|
7.13e-01
|
GO:1903671 negative regulation of sprouting angiogenesis
|
10
|
4.19e-01
|
1.48e-01
|
7.87e-01
|
GO:0048568 embryonic organ development
|
22
|
2.31e-01
|
1.47e-01
|
6.33e-01
|
GO:0009410 response to xenobiotic stimulus
|
161
|
1.28e-03
|
-1.47e-01
|
5.25e-02
|
GO:0071260 cellular response to mechanical stimulus
|
58
|
5.25e-02
|
-1.47e-01
|
3.48e-01
|
GO:0016746 acyltransferase activity
|
16
|
3.08e-01
|
-1.47e-01
|
6.99e-01
|
GO:0030183 B cell differentiation
|
53
|
6.42e-02
|
-1.47e-01
|
3.77e-01
|
GO:1902455 negative regulation of stem cell population maintenance
|
19
|
2.67e-01
|
-1.47e-01
|
6.68e-01
|
GO:0022008 neurogenesis
|
39
|
1.12e-01
|
-1.47e-01
|
4.75e-01
|
GO:1902037 negative regulation of hematopoietic stem cell differentiation
|
5
|
5.70e-01
|
-1.47e-01
|
8.59e-01
|
GO:0030864 cortical actin cytoskeleton
|
42
|
9.98e-02
|
-1.47e-01
|
4.53e-01
|
GO:0048821 erythrocyte development
|
16
|
3.09e-01
|
-1.47e-01
|
7.00e-01
|
GO:0005227 calcium-activated cation channel activity
|
10
|
4.22e-01
|
1.47e-01
|
7.87e-01
|
GO:0003906 DNA-(apurinic or apyrimidinic site) endonuclease activity
|
9
|
4.46e-01
|
1.47e-01
|
7.98e-01
|
GO:0061709 reticulophagy
|
20
|
2.56e-01
|
1.47e-01
|
6.58e-01
|
GO:1904047 S-adenosyl-L-methionine binding
|
17
|
2.96e-01
|
-1.46e-01
|
6.90e-01
|
GO:0044322 endoplasmic reticulum quality control compartment
|
21
|
2.46e-01
|
1.46e-01
|
6.50e-01
|
GO:0043395 heparan sulfate proteoglycan binding
|
9
|
4.47e-01
|
1.46e-01
|
8.00e-01
|
GO:0001968 fibronectin binding
|
20
|
2.58e-01
|
1.46e-01
|
6.58e-01
|
GO:0016514 SWI/SNF complex
|
26
|
1.97e-01
|
-1.46e-01
|
6.01e-01
|
GO:0045333 cellular respiration
|
35
|
1.35e-01
|
-1.46e-01
|
5.14e-01
|
GO:0008157 protein phosphatase 1 binding
|
21
|
2.47e-01
|
-1.46e-01
|
6.52e-01
|
GO:0031430 M band
|
19
|
2.71e-01
|
-1.46e-01
|
6.70e-01
|
GO:1990062 RPAP3/R2TP/prefoldin-like complex
|
10
|
4.25e-01
|
1.46e-01
|
7.89e-01
|
GO:0000159 protein phosphatase type 2A complex
|
16
|
3.13e-01
|
-1.46e-01
|
7.04e-01
|
GO:0000460 maturation of 5.8S rRNA
|
14
|
3.46e-01
|
-1.46e-01
|
7.30e-01
|
GO:0034638 phosphatidylcholine catabolic process
|
8
|
4.76e-01
|
-1.46e-01
|
8.18e-01
|
GO:0036336 dendritic cell migration
|
7
|
5.05e-01
|
1.46e-01
|
8.31e-01
|
GO:0051591 response to cAMP
|
23
|
2.27e-01
|
-1.45e-01
|
6.28e-01
|
GO:0015871 choline transport
|
6
|
5.37e-01
|
1.45e-01
|
8.45e-01
|
GO:0016311 dephosphorylation
|
21
|
2.49e-01
|
-1.45e-01
|
6.52e-01
|
GO:0035633 maintenance of blood-brain barrier
|
20
|
2.61e-01
|
-1.45e-01
|
6.62e-01
|
GO:0010501 RNA secondary structure unwinding
|
9
|
4.51e-01
|
-1.45e-01
|
8.02e-01
|
GO:0001580 detection of chemical stimulus involved in sensory perception of bitter taste
|
6
|
5.39e-01
|
1.45e-01
|
8.45e-01
|
GO:0045793 positive regulation of cell size
|
9
|
4.52e-01
|
1.45e-01
|
8.02e-01
|
GO:0062176 R-loop processing
|
9
|
4.52e-01
|
-1.45e-01
|
8.02e-01
|
GO:0032452 histone demethylase activity
|
22
|
2.40e-01
|
-1.45e-01
|
6.46e-01
|
GO:0006887 exocytosis
|
69
|
3.80e-02
|
1.45e-01
|
3.04e-01
|
GO:0007254 JNK cascade
|
60
|
5.31e-02
|
-1.44e-01
|
3.50e-01
|
GO:0030371 translation repressor activity
|
13
|
3.68e-01
|
1.44e-01
|
7.50e-01
|
GO:2000060 positive regulation of ubiquitin-dependent protein catabolic process
|
23
|
2.31e-01
|
1.44e-01
|
6.33e-01
|
GO:0007140 male meiotic nuclear division
|
13
|
3.68e-01
|
-1.44e-01
|
7.50e-01
|
GO:0001527 microfibril
|
6
|
5.41e-01
|
1.44e-01
|
8.45e-01
|
GO:0045252 oxoglutarate dehydrogenase complex
|
9
|
4.55e-01
|
-1.44e-01
|
8.03e-01
|
GO:0005840 ribosome
|
52
|
7.28e-02
|
1.44e-01
|
3.93e-01
|
GO:0045598 regulation of fat cell differentiation
|
9
|
4.55e-01
|
1.44e-01
|
8.03e-01
|
GO:0010165 response to X-ray
|
17
|
3.05e-01
|
1.44e-01
|
6.94e-01
|
GO:0006882 intracellular zinc ion homeostasis
|
24
|
2.23e-01
|
1.44e-01
|
6.22e-01
|
GO:0006895 Golgi to endosome transport
|
15
|
3.35e-01
|
-1.44e-01
|
7.23e-01
|
GO:0021861 forebrain radial glial cell differentiation
|
5
|
5.78e-01
|
1.44e-01
|
8.64e-01
|
GO:0060997 dendritic spine morphogenesis
|
12
|
3.89e-01
|
-1.44e-01
|
7.66e-01
|
GO:0034243 regulation of transcription elongation by RNA polymerase II
|
21
|
2.55e-01
|
-1.44e-01
|
6.56e-01
|
GO:0034755 iron ion transmembrane transport
|
9
|
4.56e-01
|
-1.44e-01
|
8.03e-01
|
GO:0070888 E-box binding
|
25
|
2.14e-01
|
-1.44e-01
|
6.15e-01
|
GO:1903753 negative regulation of p38MAPK cascade
|
7
|
5.11e-01
|
-1.43e-01
|
8.34e-01
|
GO:0005669 transcription factor TFIID complex
|
32
|
1.60e-01
|
1.43e-01
|
5.61e-01
|
GO:0046548 retinal rod cell development
|
5
|
5.79e-01
|
-1.43e-01
|
8.65e-01
|
GO:0008143 poly(A) binding
|
19
|
2.80e-01
|
-1.43e-01
|
6.76e-01
|
GO:0070431 nucleotide-binding oligomerization domain containing 2 signaling pathway
|
8
|
4.83e-01
|
-1.43e-01
|
8.22e-01
|
GO:0009617 response to bacterium
|
53
|
7.14e-02
|
1.43e-01
|
3.91e-01
|
GO:0002474 antigen processing and presentation of peptide antigen via MHC class I
|
7
|
5.12e-01
|
1.43e-01
|
8.34e-01
|
GO:0070212 protein poly-ADP-ribosylation
|
10
|
4.33e-01
|
1.43e-01
|
7.94e-01
|
GO:0005740 mitochondrial envelope
|
7
|
5.12e-01
|
-1.43e-01
|
8.34e-01
|
GO:2001256 regulation of store-operated calcium entry
|
10
|
4.33e-01
|
1.43e-01
|
7.94e-01
|
GO:0046629 gamma-delta T cell activation
|
5
|
5.80e-01
|
1.43e-01
|
8.65e-01
|
GO:1900182 positive regulation of protein localization to nucleus
|
32
|
1.62e-01
|
-1.43e-01
|
5.63e-01
|
GO:0043117 positive regulation of vascular permeability
|
8
|
4.84e-01
|
-1.43e-01
|
8.22e-01
|
GO:0048333 mesodermal cell differentiation
|
6
|
5.45e-01
|
1.43e-01
|
8.47e-01
|
GO:0000028 ribosomal small subunit assembly
|
12
|
3.92e-01
|
1.43e-01
|
7.68e-01
|
GO:0048596 embryonic camera-type eye morphogenesis
|
9
|
4.58e-01
|
1.43e-01
|
8.05e-01
|
GO:0140803 NAD+-protein-cysteine ADP-ribosyltransferase activity
|
6
|
5.45e-01
|
-1.43e-01
|
8.47e-01
|
GO:1905091 positive regulation of type 2 mitophagy
|
10
|
4.35e-01
|
1.43e-01
|
7.94e-01
|
GO:0051928 positive regulation of calcium ion transport
|
21
|
2.58e-01
|
-1.43e-01
|
6.58e-01
|
GO:0003323 type B pancreatic cell development
|
6
|
5.45e-01
|
-1.43e-01
|
8.47e-01
|
GO:0032041 histone H3K14 deacetylase activity, NAD-dependent
|
5
|
5.81e-01
|
-1.43e-01
|
8.65e-01
|
GO:0046969 histone H3K9 deacetylase activity, NAD-dependent
|
5
|
5.81e-01
|
-1.43e-01
|
8.65e-01
|
GO:0046970 histone H4K16 deacetylase activity, NAD-dependent
|
5
|
5.81e-01
|
-1.43e-01
|
8.65e-01
|
GO:0097372 histone H3K18 deacetylase activity, NAD-dependent
|
5
|
5.81e-01
|
-1.43e-01
|
8.65e-01
|
GO:0140765 histone H3K56 deacetylase activity, NAD-dependent
|
5
|
5.81e-01
|
-1.43e-01
|
8.65e-01
|
GO:0141222 histone H3K4 deacetylase activity, NAD-dependent
|
5
|
5.81e-01
|
-1.43e-01
|
8.65e-01
|
GO:0050673 epithelial cell proliferation
|
24
|
2.27e-01
|
-1.42e-01
|
6.28e-01
|
GO:0003143 embryonic heart tube morphogenesis
|
5
|
5.81e-01
|
1.42e-01
|
8.65e-01
|
GO:1903108 regulation of mitochondrial transcription
|
6
|
5.46e-01
|
1.42e-01
|
8.48e-01
|
GO:0043198 dendritic shaft
|
22
|
2.49e-01
|
-1.42e-01
|
6.52e-01
|
GO:1904515 positive regulation of TORC2 signaling
|
7
|
5.15e-01
|
-1.42e-01
|
8.34e-01
|
GO:0090200 positive regulation of release of cytochrome c from mitochondria
|
20
|
2.72e-01
|
1.42e-01
|
6.70e-01
|
GO:0006883 intracellular sodium ion homeostasis
|
9
|
4.61e-01
|
1.42e-01
|
8.06e-01
|
GO:0061760 antifungal innate immune response
|
8
|
4.87e-01
|
1.42e-01
|
8.24e-01
|
GO:0070087 chromo shadow domain binding
|
6
|
5.47e-01
|
-1.42e-01
|
8.48e-01
|
GO:0031647 regulation of protein stability
|
92
|
1.89e-02
|
-1.42e-01
|
2.27e-01
|
GO:0042472 inner ear morphogenesis
|
19
|
2.85e-01
|
-1.42e-01
|
6.81e-01
|
GO:0140750 nucleosome array spacer activity
|
5
|
5.83e-01
|
-1.42e-01
|
8.66e-01
|
GO:0036092 phosphatidylinositol-3-phosphate biosynthetic process
|
20
|
2.73e-01
|
-1.42e-01
|
6.70e-01
|
GO:0005978 glycogen biosynthetic process
|
16
|
3.27e-01
|
-1.42e-01
|
7.18e-01
|
GO:0030414 peptidase inhibitor activity
|
8
|
4.88e-01
|
1.42e-01
|
8.24e-01
|
GO:1903715 regulation of aerobic respiration
|
9
|
4.62e-01
|
1.42e-01
|
8.07e-01
|
GO:0048599 oocyte development
|
11
|
4.16e-01
|
-1.42e-01
|
7.87e-01
|
GO:1990542 mitochondrial transmembrane transport
|
8
|
4.89e-01
|
-1.41e-01
|
8.24e-01
|
GO:0000398 mRNA splicing, via spliceosome
|
168
|
1.60e-03
|
-1.41e-01
|
5.74e-02
|
GO:0030335 positive regulation of cell migration
|
164
|
1.82e-03
|
-1.41e-01
|
6.40e-02
|
GO:0030139 endocytic vesicle
|
55
|
7.01e-02
|
-1.41e-01
|
3.89e-01
|
GO:0006909 phagocytosis
|
50
|
8.45e-02
|
-1.41e-01
|
4.23e-01
|
GO:0010763 positive regulation of fibroblast migration
|
9
|
4.64e-01
|
1.41e-01
|
8.09e-01
|
GO:0098637 protein complex involved in cell-matrix adhesion
|
8
|
4.90e-01
|
1.41e-01
|
8.24e-01
|
GO:0032407 MutSalpha complex binding
|
6
|
5.50e-01
|
-1.41e-01
|
8.49e-01
|
GO:0010971 positive regulation of G2/M transition of mitotic cell cycle
|
22
|
2.53e-01
|
-1.41e-01
|
6.55e-01
|
GO:2000272 negative regulation of signaling receptor activity
|
7
|
5.18e-01
|
1.41e-01
|
8.35e-01
|
GO:0035646 endosome to melanosome transport
|
10
|
4.40e-01
|
-1.41e-01
|
7.96e-01
|
GO:0062122 histone H3K37 methyltransferase activity
|
7
|
5.19e-01
|
-1.41e-01
|
8.35e-01
|
GO:0070611 histone H3R2 methyltransferase activity
|
7
|
5.19e-01
|
-1.41e-01
|
8.35e-01
|
GO:0140592 histone H3R8 methyltransferase activity
|
7
|
5.19e-01
|
-1.41e-01
|
8.35e-01
|
GO:0140903 histone H3R26 methyltransferase activity
|
7
|
5.19e-01
|
-1.41e-01
|
8.35e-01
|
GO:0033197 response to vitamin E
|
6
|
5.51e-01
|
-1.41e-01
|
8.49e-01
|
GO:0016887 ATP hydrolysis activity
|
322
|
1.52e-05
|
-1.41e-01
|
1.98e-03
|
GO:0046329 negative regulation of JNK cascade
|
23
|
2.43e-01
|
-1.41e-01
|
6.48e-01
|
GO:0016139 glycoside catabolic process
|
5
|
5.86e-01
|
-1.40e-01
|
8.68e-01
|
GO:0089701 U2AF complex
|
5
|
5.86e-01
|
-1.40e-01
|
8.68e-01
|
GO:0005851 eukaryotic translation initiation factor 2B complex
|
5
|
5.87e-01
|
-1.40e-01
|
8.68e-01
|
GO:0030506 ankyrin binding
|
11
|
4.20e-01
|
-1.40e-01
|
7.87e-01
|
GO:0001570 vasculogenesis
|
32
|
1.70e-01
|
-1.40e-01
|
5.75e-01
|
GO:1903427 negative regulation of reactive oxygen species biosynthetic process
|
11
|
4.20e-01
|
-1.40e-01
|
7.87e-01
|
GO:0001755 neural crest cell migration
|
23
|
2.44e-01
|
-1.40e-01
|
6.49e-01
|
GO:2000435 negative regulation of protein neddylation
|
5
|
5.87e-01
|
-1.40e-01
|
8.68e-01
|
GO:0030001 metal ion transport
|
6
|
5.52e-01
|
1.40e-01
|
8.49e-01
|
GO:0033044 regulation of chromosome organization
|
16
|
3.32e-01
|
-1.40e-01
|
7.21e-01
|
GO:0044327 dendritic spine head
|
5
|
5.87e-01
|
-1.40e-01
|
8.68e-01
|
GO:0006172 ADP biosynthetic process
|
5
|
5.88e-01
|
-1.40e-01
|
8.69e-01
|
GO:0033235 positive regulation of protein sumoylation
|
12
|
4.01e-01
|
-1.40e-01
|
7.77e-01
|
GO:0034620 cellular response to unfolded protein
|
14
|
3.65e-01
|
1.40e-01
|
7.48e-01
|
GO:0004865 protein serine/threonine phosphatase inhibitor activity
|
8
|
4.94e-01
|
-1.40e-01
|
8.25e-01
|
GO:0045830 positive regulation of isotype switching
|
13
|
3.83e-01
|
1.40e-01
|
7.60e-01
|
GO:0048038 quinone binding
|
10
|
4.44e-01
|
1.40e-01
|
7.97e-01
|
GO:0006006 glucose metabolic process
|
44
|
1.09e-01
|
-1.40e-01
|
4.69e-01
|
GO:1900271 regulation of long-term synaptic potentiation
|
8
|
4.94e-01
|
-1.40e-01
|
8.25e-01
|
GO:0038202 TORC1 signaling
|
20
|
2.80e-01
|
-1.39e-01
|
6.76e-01
|
GO:0044790 suppression of viral release by host
|
15
|
3.50e-01
|
-1.39e-01
|
7.35e-01
|
GO:0000281 mitotic cytokinesis
|
58
|
6.65e-02
|
-1.39e-01
|
3.82e-01
|
GO:0005178 integrin binding
|
91
|
2.20e-02
|
-1.39e-01
|
2.41e-01
|
GO:0036444 calcium import into the mitochondrion
|
13
|
3.85e-01
|
1.39e-01
|
7.63e-01
|
GO:0000166 nucleotide binding
|
53
|
8.01e-02
|
-1.39e-01
|
4.12e-01
|
GO:0006670 sphingosine metabolic process
|
7
|
5.24e-01
|
1.39e-01
|
8.37e-01
|
GO:0043522 leucine zipper domain binding
|
9
|
4.71e-01
|
-1.39e-01
|
8.13e-01
|
GO:0005635 nuclear envelope
|
175
|
1.58e-03
|
-1.39e-01
|
5.70e-02
|
GO:0007216 G protein-coupled glutamate receptor signaling pathway
|
5
|
5.91e-01
|
1.39e-01
|
8.71e-01
|
GO:0010457 centriole-centriole cohesion
|
13
|
3.87e-01
|
-1.39e-01
|
7.63e-01
|
GO:0006474 N-terminal protein amino acid acetylation
|
7
|
5.25e-01
|
1.39e-01
|
8.37e-01
|
GO:0017069 snRNA binding
|
9
|
4.72e-01
|
-1.39e-01
|
8.13e-01
|
GO:0006098 pentose-phosphate shunt
|
11
|
4.27e-01
|
1.38e-01
|
7.90e-01
|
GO:0032420 stereocilium
|
26
|
2.22e-01
|
-1.38e-01
|
6.21e-01
|
GO:0001944 vasculature development
|
8
|
4.98e-01
|
1.38e-01
|
8.27e-01
|
GO:0045134 UDP phosphatase activity
|
6
|
5.57e-01
|
-1.38e-01
|
8.53e-01
|
GO:0003690 double-stranded DNA binding
|
80
|
3.26e-02
|
-1.38e-01
|
2.87e-01
|
GO:1904659 D-glucose transmembrane transport
|
10
|
4.49e-01
|
-1.38e-01
|
8.00e-01
|
GO:0007141 male meiosis I
|
14
|
3.71e-01
|
1.38e-01
|
7.51e-01
|
GO:0008283 cell population proliferation
|
99
|
1.76e-02
|
-1.38e-01
|
2.23e-01
|
GO:0000423 mitophagy
|
47
|
1.02e-01
|
1.38e-01
|
4.55e-01
|
GO:0045663 positive regulation of myoblast differentiation
|
31
|
1.83e-01
|
-1.38e-01
|
5.85e-01
|
GO:0032509 endosome transport via multivesicular body sorting pathway
|
9
|
4.73e-01
|
1.38e-01
|
8.15e-01
|
GO:0043202 lysosomal lumen
|
70
|
4.60e-02
|
1.38e-01
|
3.36e-01
|
GO:0001706 endoderm formation
|
5
|
5.93e-01
|
1.38e-01
|
8.73e-01
|
GO:0140678 molecular function inhibitor activity
|
26
|
2.24e-01
|
1.38e-01
|
6.23e-01
|
GO:0060628 regulation of ER to Golgi vesicle-mediated transport
|
5
|
5.93e-01
|
1.38e-01
|
8.73e-01
|
GO:0006935 chemotaxis
|
63
|
5.85e-02
|
-1.38e-01
|
3.58e-01
|
GO:0008373 sialyltransferase activity
|
14
|
3.72e-01
|
-1.38e-01
|
7.51e-01
|
GO:0055075 potassium ion homeostasis
|
10
|
4.51e-01
|
-1.38e-01
|
8.02e-01
|
GO:0003184 pulmonary valve morphogenesis
|
10
|
4.51e-01
|
-1.38e-01
|
8.02e-01
|
GO:0021670 lateral ventricle development
|
8
|
5.01e-01
|
-1.38e-01
|
8.28e-01
|
GO:0016242 negative regulation of macroautophagy
|
13
|
3.91e-01
|
-1.38e-01
|
7.68e-01
|
GO:0008474 palmitoyl-(protein) hydrolase activity
|
13
|
3.91e-01
|
-1.37e-01
|
7.68e-01
|
GO:0048013 ephrin receptor signaling pathway
|
40
|
1.33e-01
|
-1.37e-01
|
5.12e-01
|
GO:0008582 regulation of synaptic assembly at neuromuscular junction
|
6
|
5.60e-01
|
-1.37e-01
|
8.55e-01
|
GO:0097431 mitotic spindle pole
|
36
|
1.54e-01
|
-1.37e-01
|
5.49e-01
|
GO:0052742 phosphatidylinositol kinase activity
|
5
|
5.95e-01
|
-1.37e-01
|
8.74e-01
|
GO:0032364 intracellular oxygen homeostasis
|
6
|
5.61e-01
|
-1.37e-01
|
8.55e-01
|
GO:0099524 postsynaptic cytosol
|
21
|
2.77e-01
|
-1.37e-01
|
6.73e-01
|
GO:0006813 potassium ion transport
|
29
|
2.02e-01
|
-1.37e-01
|
6.05e-01
|
GO:0009312 oligosaccharide biosynthetic process
|
13
|
3.93e-01
|
-1.37e-01
|
7.70e-01
|
GO:0098574 cytoplasmic side of lysosomal membrane
|
11
|
4.33e-01
|
1.37e-01
|
7.94e-01
|
GO:0071218 cellular response to misfolded protein
|
11
|
4.33e-01
|
1.37e-01
|
7.94e-01
|
GO:1902255 positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator
|
5
|
5.97e-01
|
1.37e-01
|
8.75e-01
|
GO:0106074 aminoacyl-tRNA metabolism involved in translational fidelity
|
8
|
5.04e-01
|
-1.36e-01
|
8.31e-01
|
GO:0032733 positive regulation of interleukin-10 production
|
28
|
2.12e-01
|
-1.36e-01
|
6.15e-01
|
GO:0071625 vocalization behavior
|
10
|
4.55e-01
|
-1.36e-01
|
8.03e-01
|
GO:0008237 metallopeptidase activity
|
30
|
1.96e-01
|
-1.36e-01
|
6.01e-01
|
GO:0043008 ATP-dependent protein binding
|
5
|
5.98e-01
|
-1.36e-01
|
8.76e-01
|
GO:0031463 Cul3-RING ubiquitin ligase complex
|
49
|
9.92e-02
|
-1.36e-01
|
4.51e-01
|
GO:0030031 cell projection assembly
|
16
|
3.46e-01
|
-1.36e-01
|
7.30e-01
|
GO:0044877 protein-containing complex binding
|
258
|
1.73e-04
|
-1.36e-01
|
1.34e-02
|
GO:0006888 endoplasmic reticulum to Golgi vesicle-mediated transport
|
109
|
1.42e-02
|
1.36e-01
|
2.07e-01
|
GO:0001953 negative regulation of cell-matrix adhesion
|
13
|
3.96e-01
|
-1.36e-01
|
7.71e-01
|
GO:0060285 cilium-dependent cell motility
|
7
|
5.33e-01
|
1.36e-01
|
8.43e-01
|
GO:0004176 ATP-dependent peptidase activity
|
7
|
5.33e-01
|
-1.36e-01
|
8.43e-01
|
GO:0008542 visual learning
|
28
|
2.13e-01
|
1.36e-01
|
6.15e-01
|
GO:0070509 calcium ion import
|
12
|
4.15e-01
|
-1.36e-01
|
7.87e-01
|
GO:1903077 negative regulation of protein localization to plasma membrane
|
17
|
3.32e-01
|
-1.36e-01
|
7.21e-01
|
GO:0030316 osteoclast differentiation
|
35
|
1.65e-01
|
-1.36e-01
|
5.67e-01
|
GO:0034098 VCP-NPL4-UFD1 AAA ATPase complex
|
8
|
5.06e-01
|
1.36e-01
|
8.33e-01
|
GO:0051693 actin filament capping
|
6
|
5.65e-01
|
-1.36e-01
|
8.56e-01
|
GO:0051649 establishment of localization in cell
|
46
|
1.11e-01
|
-1.36e-01
|
4.73e-01
|
GO:0140804 NAD+-protein-lysine ADP-ribosyltransferase activity
|
5
|
5.99e-01
|
-1.36e-01
|
8.76e-01
|
GO:0015986 proton motive force-driven ATP synthesis
|
21
|
2.82e-01
|
-1.36e-01
|
6.78e-01
|
GO:0098742 cell-cell adhesion via plasma-membrane adhesion molecules
|
8
|
5.07e-01
|
-1.35e-01
|
8.33e-01
|
GO:0061512 protein localization to cilium
|
27
|
2.23e-01
|
1.35e-01
|
6.22e-01
|
GO:0008469 histone arginine N-methyltransferase activity
|
5
|
6.00e-01
|
1.35e-01
|
8.76e-01
|
GO:0050679 positive regulation of epithelial cell proliferation
|
31
|
1.92e-01
|
-1.35e-01
|
5.97e-01
|
GO:0051900 regulation of mitochondrial depolarization
|
5
|
6.01e-01
|
-1.35e-01
|
8.77e-01
|
GO:0010507 negative regulation of autophagy
|
52
|
9.22e-02
|
-1.35e-01
|
4.37e-01
|
GO:0140672 ATAC complex
|
13
|
3.99e-01
|
-1.35e-01
|
7.75e-01
|
GO:0016712 oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
8
|
5.09e-01
|
-1.35e-01
|
8.34e-01
|
GO:0002357 defense response to tumor cell
|
11
|
4.39e-01
|
-1.35e-01
|
7.95e-01
|
GO:0005938 cell cortex
|
125
|
9.28e-03
|
-1.35e-01
|
1.72e-01
|
GO:0043162 ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway
|
29
|
2.09e-01
|
1.35e-01
|
6.12e-01
|
GO:0046777 protein autophosphorylation
|
100
|
2.00e-02
|
-1.35e-01
|
2.33e-01
|
GO:0042117 monocyte activation
|
7
|
5.37e-01
|
-1.35e-01
|
8.45e-01
|
GO:0043407 negative regulation of MAP kinase activity
|
19
|
3.09e-01
|
1.35e-01
|
7.00e-01
|
GO:0046856 phosphatidylinositol dephosphorylation
|
27
|
2.26e-01
|
-1.35e-01
|
6.26e-01
|
GO:0030620 U2 snRNA binding
|
6
|
5.68e-01
|
-1.35e-01
|
8.58e-01
|
GO:0019531 oxalate transmembrane transporter activity
|
5
|
6.03e-01
|
1.34e-01
|
8.78e-01
|
GO:0006851 mitochondrial calcium ion transmembrane transport
|
13
|
4.02e-01
|
1.34e-01
|
7.77e-01
|
GO:0032979 protein insertion into mitochondrial inner membrane from matrix
|
5
|
6.04e-01
|
-1.34e-01
|
8.78e-01
|
GO:0006878 intracellular copper ion homeostasis
|
15
|
3.69e-01
|
1.34e-01
|
7.50e-01
|
GO:0019731 antibacterial humoral response
|
16
|
3.54e-01
|
1.34e-01
|
7.38e-01
|
GO:0046835 carbohydrate phosphorylation
|
21
|
2.88e-01
|
-1.34e-01
|
6.82e-01
|
GO:0007249 canonical NF-kappaB signal transduction
|
33
|
1.83e-01
|
-1.34e-01
|
5.85e-01
|
GO:0040016 embryonic cleavage
|
7
|
5.40e-01
|
1.34e-01
|
8.45e-01
|
GO:0034379 very-low-density lipoprotein particle assembly
|
8
|
5.13e-01
|
-1.34e-01
|
8.34e-01
|
GO:0000463 maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
|
16
|
3.55e-01
|
-1.34e-01
|
7.39e-01
|
GO:0048012 hepatocyte growth factor receptor signaling pathway
|
21
|
2.89e-01
|
-1.34e-01
|
6.82e-01
|
GO:0030301 cholesterol transport
|
14
|
3.87e-01
|
-1.34e-01
|
7.63e-01
|
GO:0002686 negative regulation of leukocyte migration
|
6
|
5.71e-01
|
1.34e-01
|
8.60e-01
|
GO:0070168 negative regulation of biomineral tissue development
|
5
|
6.05e-01
|
-1.34e-01
|
8.79e-01
|
GO:0106072 negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway
|
5
|
6.05e-01
|
-1.34e-01
|
8.79e-01
|
GO:0043304 regulation of mast cell degranulation
|
7
|
5.41e-01
|
-1.33e-01
|
8.45e-01
|
GO:1902494 catalytic complex
|
16
|
3.55e-01
|
1.33e-01
|
7.39e-01
|
GO:0140759 histone H3K56 methyltransferase activity
|
8
|
5.13e-01
|
-1.33e-01
|
8.34e-01
|
GO:0008535 respiratory chain complex IV assembly
|
7
|
5.41e-01
|
-1.33e-01
|
8.45e-01
|
GO:0044387 negative regulation of protein kinase activity by regulation of protein phosphorylation
|
6
|
5.72e-01
|
-1.33e-01
|
8.60e-01
|
GO:0099151 regulation of postsynaptic density assembly
|
8
|
5.14e-01
|
-1.33e-01
|
8.34e-01
|
GO:0072577 endothelial cell apoptotic process
|
7
|
5.42e-01
|
-1.33e-01
|
8.45e-01
|
GO:0031047 regulatory ncRNA-mediated gene silencing
|
16
|
3.57e-01
|
-1.33e-01
|
7.40e-01
|
GO:0009650 UV protection
|
10
|
4.66e-01
|
1.33e-01
|
8.10e-01
|
GO:0042393 histone binding
|
149
|
5.14e-03
|
-1.33e-01
|
1.22e-01
|
GO:0044284 mitochondrial crista junction
|
8
|
5.15e-01
|
-1.33e-01
|
8.34e-01
|
GO:0001702 gastrulation with mouth forming second
|
13
|
4.07e-01
|
1.33e-01
|
7.82e-01
|
GO:0045785 positive regulation of cell adhesion
|
38
|
1.57e-01
|
-1.33e-01
|
5.54e-01
|
GO:1990498 mitotic spindle microtubule
|
15
|
3.73e-01
|
-1.33e-01
|
7.52e-01
|
GO:0030131 clathrin adaptor complex
|
6
|
5.73e-01
|
1.33e-01
|
8.61e-01
|
GO:2000373 positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity
|
5
|
6.08e-01
|
-1.33e-01
|
8.80e-01
|
GO:0003777 microtubule motor activity
|
35
|
1.75e-01
|
-1.33e-01
|
5.78e-01
|
GO:0016042 lipid catabolic process
|
33
|
1.88e-01
|
1.33e-01
|
5.90e-01
|
GO:0044857 plasma membrane raft organization
|
5
|
6.08e-01
|
-1.33e-01
|
8.80e-01
|
GO:0008509 monoatomic anion transmembrane transporter activity
|
5
|
6.08e-01
|
1.33e-01
|
8.80e-01
|
GO:0035725 sodium ion transmembrane transport
|
50
|
1.05e-01
|
1.32e-01
|
4.60e-01
|
GO:0035988 chondrocyte proliferation
|
5
|
6.08e-01
|
1.32e-01
|
8.80e-01
|
GO:0006388 tRNA splicing, via endonucleolytic cleavage and ligation
|
12
|
4.27e-01
|
1.32e-01
|
7.90e-01
|
GO:0097194 execution phase of apoptosis
|
18
|
3.31e-01
|
-1.32e-01
|
7.21e-01
|
GO:0005272 sodium channel activity
|
8
|
5.17e-01
|
-1.32e-01
|
8.34e-01
|
GO:0055085 transmembrane transport
|
112
|
1.57e-02
|
-1.32e-01
|
2.17e-01
|
GO:0022417 protein maturation by protein folding
|
8
|
5.17e-01
|
1.32e-01
|
8.34e-01
|
GO:0006782 protoporphyrinogen IX biosynthetic process
|
8
|
5.17e-01
|
-1.32e-01
|
8.34e-01
|
GO:1904949 ATPase complex
|
8
|
5.17e-01
|
-1.32e-01
|
8.34e-01
|
GO:0071639 positive regulation of monocyte chemotactic protein-1 production
|
11
|
4.48e-01
|
1.32e-01
|
8.00e-01
|
GO:0033116 endoplasmic reticulum-Golgi intermediate compartment membrane
|
68
|
5.97e-02
|
1.32e-01
|
3.62e-01
|
GO:0048704 embryonic skeletal system morphogenesis
|
14
|
3.92e-01
|
1.32e-01
|
7.69e-01
|
GO:0070161 anchoring junction
|
32
|
1.96e-01
|
-1.32e-01
|
6.01e-01
|
GO:0060306 regulation of membrane repolarization
|
9
|
4.93e-01
|
-1.32e-01
|
8.25e-01
|
GO:0006465 signal peptide processing
|
13
|
4.10e-01
|
-1.32e-01
|
7.83e-01
|
GO:0045730 respiratory burst
|
11
|
4.49e-01
|
1.32e-01
|
8.00e-01
|
GO:0045879 negative regulation of smoothened signaling pathway
|
24
|
2.64e-01
|
-1.32e-01
|
6.64e-01
|
GO:0043524 negative regulation of neuron apoptotic process
|
84
|
3.69e-02
|
-1.32e-01
|
2.99e-01
|
GO:1900076 regulation of cellular response to insulin stimulus
|
10
|
4.71e-01
|
1.32e-01
|
8.13e-01
|
GO:0010960 magnesium ion homeostasis
|
5
|
6.10e-01
|
-1.32e-01
|
8.81e-01
|
GO:0030666 endocytic vesicle membrane
|
51
|
1.04e-01
|
-1.32e-01
|
4.58e-01
|
GO:0070300 phosphatidic acid binding
|
18
|
3.34e-01
|
-1.31e-01
|
7.23e-01
|
GO:0051247 positive regulation of protein metabolic process
|
16
|
3.63e-01
|
-1.31e-01
|
7.45e-01
|
GO:0099509 regulation of presynaptic cytosolic calcium ion concentration
|
6
|
5.78e-01
|
1.31e-01
|
8.64e-01
|
GO:0006699 bile acid biosynthetic process
|
18
|
3.35e-01
|
-1.31e-01
|
7.23e-01
|
GO:0030949 positive regulation of vascular endothelial growth factor receptor signaling pathway
|
9
|
4.95e-01
|
1.31e-01
|
8.26e-01
|
GO:0015824 proline transport
|
7
|
5.48e-01
|
1.31e-01
|
8.49e-01
|
GO:1990841 promoter-specific chromatin binding
|
56
|
8.98e-02
|
-1.31e-01
|
4.33e-01
|
GO:0003746 translation elongation factor activity
|
18
|
3.36e-01
|
1.31e-01
|
7.23e-01
|
GO:0009409 response to cold
|
20
|
3.10e-01
|
1.31e-01
|
7.01e-01
|
GO:0048712 negative regulation of astrocyte differentiation
|
5
|
6.12e-01
|
-1.31e-01
|
8.81e-01
|
GO:0005229 intracellularly calcium-gated chloride channel activity
|
9
|
4.96e-01
|
1.31e-01
|
8.27e-01
|
GO:1990874 vascular associated smooth muscle cell proliferation
|
6
|
5.79e-01
|
1.31e-01
|
8.65e-01
|
GO:0035278 miRNA-mediated gene silencing by inhibition of translation
|
15
|
3.80e-01
|
-1.31e-01
|
7.58e-01
|
GO:0061635 regulation of protein complex stability
|
12
|
4.33e-01
|
-1.31e-01
|
7.94e-01
|
GO:0003203 endocardial cushion morphogenesis
|
10
|
4.74e-01
|
1.31e-01
|
8.15e-01
|
GO:0042171 lysophosphatidic acid acyltransferase activity
|
7
|
5.49e-01
|
-1.31e-01
|
8.49e-01
|
GO:0005815 microtubule organizing center
|
64
|
7.07e-02
|
-1.31e-01
|
3.90e-01
|
GO:0030522 intracellular receptor signaling pathway
|
19
|
3.24e-01
|
1.31e-01
|
7.16e-01
|
GO:0000184 nuclear-transcribed mRNA catabolic process, nonsense-mediated decay
|
35
|
1.81e-01
|
-1.31e-01
|
5.84e-01
|
GO:0005031 tumor necrosis factor receptor activity
|
7
|
5.50e-01
|
-1.31e-01
|
8.49e-01
|
GO:0016479 negative regulation of transcription by RNA polymerase I
|
7
|
5.50e-01
|
-1.31e-01
|
8.49e-01
|
GO:0005528 FK506 binding
|
9
|
4.98e-01
|
1.30e-01
|
8.27e-01
|
GO:0030426 growth cone
|
92
|
3.08e-02
|
-1.30e-01
|
2.79e-01
|
GO:0045216 cell-cell junction organization
|
15
|
3.82e-01
|
-1.30e-01
|
7.60e-01
|
GO:0060314 regulation of ryanodine-sensitive calcium-release channel activity
|
6
|
5.80e-01
|
1.30e-01
|
8.65e-01
|
GO:0000938 GARP complex
|
5
|
6.14e-01
|
-1.30e-01
|
8.81e-01
|
GO:0031499 TRAMP complex
|
5
|
6.14e-01
|
-1.30e-01
|
8.81e-01
|
GO:0048662 negative regulation of smooth muscle cell proliferation
|
15
|
3.83e-01
|
-1.30e-01
|
7.60e-01
|
GO:0048260 positive regulation of receptor-mediated endocytosis
|
14
|
4.00e-01
|
-1.30e-01
|
7.75e-01
|
GO:1905907 negative regulation of amyloid fibril formation
|
11
|
4.55e-01
|
1.30e-01
|
8.03e-01
|
GO:0002503 peptide antigen assembly with MHC class II protein complex
|
13
|
4.17e-01
|
-1.30e-01
|
7.87e-01
|
GO:1901379 regulation of potassium ion transmembrane transport
|
11
|
4.55e-01
|
1.30e-01
|
8.03e-01
|
GO:0060339 negative regulation of type I interferon-mediated signaling pathway
|
21
|
3.03e-01
|
-1.30e-01
|
6.93e-01
|
GO:0006397 mRNA processing
|
175
|
3.07e-03
|
-1.30e-01
|
8.97e-02
|
GO:0004672 protein kinase activity
|
171
|
3.44e-03
|
-1.30e-01
|
9.71e-02
|
GO:0038203 TORC2 signaling
|
9
|
5.00e-01
|
1.30e-01
|
8.28e-01
|
GO:0060563 neuroepithelial cell differentiation
|
6
|
5.82e-01
|
-1.30e-01
|
8.65e-01
|
GO:1903861 positive regulation of dendrite extension
|
14
|
4.01e-01
|
-1.30e-01
|
7.76e-01
|
GO:0099507 ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential
|
5
|
6.16e-01
|
1.30e-01
|
8.82e-01
|
GO:0097202 activation of cysteine-type endopeptidase activity
|
12
|
4.37e-01
|
1.29e-01
|
7.95e-01
|
GO:0061351 neural precursor cell proliferation
|
18
|
3.42e-01
|
-1.29e-01
|
7.27e-01
|
GO:0008063 Toll signaling pathway
|
6
|
5.83e-01
|
-1.29e-01
|
8.66e-01
|
GO:1900407 regulation of cellular response to oxidative stress
|
11
|
4.58e-01
|
1.29e-01
|
8.04e-01
|
GO:0071005 U2-type precatalytic spliceosome
|
50
|
1.14e-01
|
-1.29e-01
|
4.78e-01
|
GO:0042098 T cell proliferation
|
37
|
1.73e-01
|
-1.29e-01
|
5.78e-01
|
GO:0042908 xenobiotic transport
|
15
|
3.86e-01
|
-1.29e-01
|
7.63e-01
|
GO:0043330 response to exogenous dsRNA
|
14
|
4.02e-01
|
-1.29e-01
|
7.77e-01
|
GO:0001783 B cell apoptotic process
|
9
|
5.02e-01
|
-1.29e-01
|
8.30e-01
|
GO:0090168 Golgi reassembly
|
5
|
6.17e-01
|
1.29e-01
|
8.82e-01
|
GO:0050798 activated T cell proliferation
|
7
|
5.54e-01
|
1.29e-01
|
8.50e-01
|
GO:0097091 synaptic vesicle clustering
|
7
|
5.54e-01
|
-1.29e-01
|
8.50e-01
|
GO:1900226 negative regulation of NLRP3 inflammasome complex assembly
|
12
|
4.39e-01
|
1.29e-01
|
7.96e-01
|
GO:0060770 negative regulation of epithelial cell proliferation involved in prostate gland development
|
5
|
6.17e-01
|
-1.29e-01
|
8.82e-01
|
GO:0090336 positive regulation of brown fat cell differentiation
|
13
|
4.21e-01
|
-1.29e-01
|
7.87e-01
|
GO:0048246 macrophage chemotaxis
|
9
|
5.03e-01
|
-1.29e-01
|
8.30e-01
|
GO:1903140 regulation of establishment of endothelial barrier
|
10
|
4.80e-01
|
-1.29e-01
|
8.19e-01
|
GO:0006487 protein N-linked glycosylation
|
50
|
1.15e-01
|
1.29e-01
|
4.79e-01
|
GO:0080135 regulation of cellular response to stress
|
5
|
6.18e-01
|
-1.29e-01
|
8.82e-01
|
GO:0032783 super elongation complex
|
6
|
5.85e-01
|
-1.29e-01
|
8.67e-01
|
GO:0032228 regulation of synaptic transmission, GABAergic
|
8
|
5.28e-01
|
-1.29e-01
|
8.40e-01
|
GO:0001934 positive regulation of protein phosphorylation
|
86
|
3.93e-02
|
-1.29e-01
|
3.10e-01
|
GO:0000245 spliceosomal complex assembly
|
26
|
2.56e-01
|
-1.29e-01
|
6.58e-01
|
GO:0140767 enzyme-substrate adaptor activity
|
11
|
4.60e-01
|
-1.29e-01
|
8.06e-01
|
GO:0010975 regulation of neuron projection development
|
17
|
3.59e-01
|
-1.29e-01
|
7.41e-01
|
GO:0072583 clathrin-dependent endocytosis
|
25
|
2.66e-01
|
-1.29e-01
|
6.68e-01
|
GO:0097157 pre-mRNA intronic binding
|
9
|
5.05e-01
|
-1.28e-01
|
8.31e-01
|
GO:0001772 immunological synapse
|
39
|
1.66e-01
|
-1.28e-01
|
5.68e-01
|
GO:0071340 skeletal muscle acetylcholine-gated channel clustering
|
6
|
5.86e-01
|
-1.28e-01
|
8.68e-01
|
GO:0016791 phosphatase activity
|
32
|
2.09e-01
|
-1.28e-01
|
6.12e-01
|
GO:0045821 positive regulation of glycolytic process
|
19
|
3.33e-01
|
-1.28e-01
|
7.22e-01
|
GO:0048660 regulation of smooth muscle cell proliferation
|
7
|
5.57e-01
|
-1.28e-01
|
8.53e-01
|
GO:0000976 transcription cis-regulatory region binding
|
150
|
6.82e-03
|
-1.28e-01
|
1.45e-01
|
GO:0008543 fibroblast growth factor receptor signaling pathway
|
35
|
1.90e-01
|
-1.28e-01
|
5.94e-01
|
GO:0031274 positive regulation of pseudopodium assembly
|
8
|
5.30e-01
|
-1.28e-01
|
8.41e-01
|
GO:0010667 negative regulation of cardiac muscle cell apoptotic process
|
18
|
3.47e-01
|
1.28e-01
|
7.32e-01
|
GO:0019706 protein-cysteine S-palmitoyltransferase activity
|
20
|
3.22e-01
|
1.28e-01
|
7.13e-01
|
GO:0090160 Golgi to lysosome transport
|
11
|
4.63e-01
|
-1.28e-01
|
8.08e-01
|
GO:0004714 transmembrane receptor protein tyrosine kinase activity
|
9
|
5.06e-01
|
-1.28e-01
|
8.33e-01
|
GO:0006974 DNA damage response
|
277
|
2.62e-04
|
-1.28e-01
|
1.87e-02
|
GO:0002088 lens development in camera-type eye
|
12
|
4.43e-01
|
-1.28e-01
|
7.97e-01
|
GO:1901526 positive regulation of mitophagy
|
13
|
4.25e-01
|
-1.28e-01
|
7.90e-01
|
GO:0005911 cell-cell junction
|
107
|
2.27e-02
|
-1.28e-01
|
2.43e-01
|
GO:0002639 positive regulation of immunoglobulin production
|
20
|
3.23e-01
|
-1.28e-01
|
7.14e-01
|
GO:0045773 positive regulation of axon extension
|
22
|
3.00e-01
|
-1.28e-01
|
6.92e-01
|
GO:0005902 microvillus
|
41
|
1.58e-01
|
-1.28e-01
|
5.56e-01
|
GO:0006338 chromatin remodeling
|
718
|
7.65e-09
|
-1.28e-01
|
4.98e-06
|
GO:0048143 astrocyte activation
|
11
|
4.65e-01
|
-1.27e-01
|
8.09e-01
|
GO:0008757 S-adenosylmethionine-dependent methyltransferase activity
|
13
|
4.27e-01
|
-1.27e-01
|
7.90e-01
|
GO:0086091 regulation of heart rate by cardiac conduction
|
19
|
3.37e-01
|
-1.27e-01
|
7.24e-01
|
GO:0010880 regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
|
14
|
4.10e-01
|
1.27e-01
|
7.83e-01
|
GO:0071346 cellular response to type II interferon
|
58
|
9.42e-02
|
-1.27e-01
|
4.40e-01
|
GO:0030258 lipid modification
|
6
|
5.90e-01
|
-1.27e-01
|
8.70e-01
|
GO:0071421 manganese ion transmembrane transport
|
8
|
5.34e-01
|
-1.27e-01
|
8.43e-01
|
GO:0005546 phosphatidylinositol-4,5-bisphosphate binding
|
58
|
9.44e-02
|
-1.27e-01
|
4.40e-01
|
GO:0048644 muscle organ morphogenesis
|
5
|
6.23e-01
|
1.27e-01
|
8.84e-01
|
GO:0030968 endoplasmic reticulum unfolded protein response
|
46
|
1.36e-01
|
1.27e-01
|
5.16e-01
|
GO:0002544 chronic inflammatory response
|
7
|
5.61e-01
|
-1.27e-01
|
8.55e-01
|
GO:0042734 presynaptic membrane
|
65
|
7.70e-02
|
-1.27e-01
|
4.06e-01
|
GO:0030041 actin filament polymerization
|
30
|
2.29e-01
|
-1.27e-01
|
6.30e-01
|
GO:0048812 neuron projection morphogenesis
|
43
|
1.50e-01
|
-1.27e-01
|
5.43e-01
|
GO:0061436 establishment of skin barrier
|
15
|
3.95e-01
|
-1.27e-01
|
7.71e-01
|
GO:0005787 signal peptidase complex
|
5
|
6.23e-01
|
1.27e-01
|
8.84e-01
|
GO:0048265 response to pain
|
7
|
5.61e-01
|
-1.27e-01
|
8.55e-01
|
GO:0016604 nuclear body
|
290
|
2.15e-04
|
-1.27e-01
|
1.57e-02
|
GO:0045814 negative regulation of gene expression, epigenetic
|
30
|
2.30e-01
|
-1.27e-01
|
6.32e-01
|
GO:0009954 proximal/distal pattern formation
|
9
|
5.11e-01
|
-1.26e-01
|
8.34e-01
|
GO:0042813 Wnt receptor activity
|
10
|
4.89e-01
|
-1.26e-01
|
8.24e-01
|
GO:0006177 GMP biosynthetic process
|
9
|
5.12e-01
|
1.26e-01
|
8.34e-01
|
GO:0030318 melanocyte differentiation
|
10
|
4.90e-01
|
-1.26e-01
|
8.24e-01
|
GO:0032050 clathrin heavy chain binding
|
10
|
4.90e-01
|
-1.26e-01
|
8.24e-01
|
GO:0048702 embryonic neurocranium morphogenesis
|
7
|
5.64e-01
|
1.26e-01
|
8.56e-01
|
GO:0043220 Schmidt-Lanterman incisure
|
5
|
6.26e-01
|
-1.26e-01
|
8.85e-01
|
GO:0022615 protein to membrane docking
|
5
|
6.26e-01
|
1.26e-01
|
8.85e-01
|
GO:0034122 negative regulation of toll-like receptor signaling pathway
|
12
|
4.50e-01
|
-1.26e-01
|
8.02e-01
|
GO:0010666 positive regulation of cardiac muscle cell apoptotic process
|
10
|
4.91e-01
|
-1.26e-01
|
8.24e-01
|
GO:0050868 negative regulation of T cell activation
|
10
|
4.91e-01
|
-1.26e-01
|
8.24e-01
|
GO:0016579 protein deubiquitination
|
71
|
6.72e-02
|
-1.26e-01
|
3.83e-01
|
GO:1901653 cellular response to peptide
|
7
|
5.65e-01
|
-1.26e-01
|
8.56e-01
|
GO:0035520 monoubiquitinated protein deubiquitination
|
9
|
5.14e-01
|
-1.25e-01
|
8.34e-01
|
GO:0006868 glutamine transport
|
7
|
5.65e-01
|
1.25e-01
|
8.56e-01
|
GO:0015186 L-glutamine transmembrane transporter activity
|
7
|
5.65e-01
|
1.25e-01
|
8.56e-01
|
GO:0030321 transepithelial chloride transport
|
5
|
6.27e-01
|
1.25e-01
|
8.85e-01
|
GO:0004467 long-chain fatty acid-CoA ligase activity
|
9
|
5.15e-01
|
1.25e-01
|
8.34e-01
|
GO:0030119 AP-type membrane coat adaptor complex
|
7
|
5.66e-01
|
1.25e-01
|
8.56e-01
|
GO:0090385 phagosome-lysosome fusion
|
11
|
4.72e-01
|
-1.25e-01
|
8.13e-01
|
GO:0090263 positive regulation of canonical Wnt signaling pathway
|
71
|
6.81e-02
|
-1.25e-01
|
3.86e-01
|
GO:0033690 positive regulation of osteoblast proliferation
|
6
|
5.95e-01
|
-1.25e-01
|
8.74e-01
|
GO:0048715 negative regulation of oligodendrocyte differentiation
|
5
|
6.28e-01
|
-1.25e-01
|
8.85e-01
|
GO:0070585 protein localization to mitochondrion
|
10
|
4.94e-01
|
1.25e-01
|
8.25e-01
|
GO:1990391 DNA repair complex
|
14
|
4.18e-01
|
-1.25e-01
|
7.87e-01
|
GO:0044572 [4Fe-4S] cluster assembly
|
5
|
6.29e-01
|
-1.25e-01
|
8.85e-01
|
GO:0046931 pore complex assembly
|
9
|
5.17e-01
|
1.25e-01
|
8.34e-01
|
GO:1903377 negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway
|
10
|
4.95e-01
|
-1.25e-01
|
8.25e-01
|
GO:0008023 transcription elongation factor complex
|
20
|
3.35e-01
|
-1.25e-01
|
7.23e-01
|
GO:1904646 cellular response to amyloid-beta
|
32
|
2.23e-01
|
-1.25e-01
|
6.22e-01
|
GO:0097322 7SK snRNA binding
|
8
|
5.42e-01
|
1.25e-01
|
8.45e-01
|
GO:0071391 cellular response to estrogen stimulus
|
14
|
4.20e-01
|
-1.24e-01
|
7.87e-01
|
GO:0032757 positive regulation of interleukin-8 production
|
42
|
1.63e-01
|
-1.24e-01
|
5.65e-01
|
GO:0042102 positive regulation of T cell proliferation
|
44
|
1.54e-01
|
-1.24e-01
|
5.48e-01
|
GO:0005347 ATP transmembrane transporter activity
|
8
|
5.43e-01
|
-1.24e-01
|
8.47e-01
|
GO:0031083 BLOC-1 complex
|
14
|
4.22e-01
|
1.24e-01
|
7.87e-01
|
GO:0022409 positive regulation of cell-cell adhesion
|
9
|
5.19e-01
|
-1.24e-01
|
8.35e-01
|
GO:0043539 protein serine/threonine kinase activator activity
|
50
|
1.29e-01
|
-1.24e-01
|
5.06e-01
|
GO:0090156 intracellular sphingolipid homeostasis
|
5
|
6.31e-01
|
1.24e-01
|
8.86e-01
|
GO:0001656 metanephros development
|
14
|
4.22e-01
|
1.24e-01
|
7.87e-01
|
GO:1990544 mitochondrial ATP transmembrane transport
|
6
|
5.99e-01
|
1.24e-01
|
8.76e-01
|
GO:0006139 nucleobase-containing compound metabolic process
|
27
|
2.65e-01
|
1.24e-01
|
6.67e-01
|
GO:1903243 negative regulation of cardiac muscle hypertrophy in response to stress
|
5
|
6.32e-01
|
1.24e-01
|
8.86e-01
|
GO:1903608 protein localization to cytoplasmic stress granule
|
8
|
5.45e-01
|
-1.24e-01
|
8.47e-01
|
GO:0070412 R-SMAD binding
|
22
|
3.15e-01
|
-1.24e-01
|
7.07e-01
|
GO:1990456 mitochondrion-endoplasmic reticulum membrane tethering
|
8
|
5.45e-01
|
-1.24e-01
|
8.47e-01
|
GO:0019901 protein kinase binding
|
359
|
6.13e-05
|
-1.24e-01
|
6.20e-03
|
GO:0004252 serine-type endopeptidase activity
|
75
|
6.46e-02
|
1.24e-01
|
3.78e-01
|
GO:0097550 transcription preinitiation complex
|
13
|
4.41e-01
|
1.23e-01
|
7.96e-01
|
GO:2001140 positive regulation of phospholipid transport
|
5
|
6.33e-01
|
-1.23e-01
|
8.86e-01
|
GO:0090148 membrane fission
|
40
|
1.77e-01
|
1.23e-01
|
5.78e-01
|
GO:0000439 transcription factor TFIIH core complex
|
11
|
4.79e-01
|
1.23e-01
|
8.19e-01
|
GO:0060440 trachea formation
|
6
|
6.01e-01
|
-1.23e-01
|
8.77e-01
|
GO:0042311 vasodilation
|
20
|
3.40e-01
|
1.23e-01
|
7.26e-01
|
GO:0048026 positive regulation of mRNA splicing, via spliceosome
|
19
|
3.52e-01
|
-1.23e-01
|
7.37e-01
|
GO:0031418 L-ascorbic acid binding
|
15
|
4.09e-01
|
1.23e-01
|
7.82e-01
|
GO:0098554 cytoplasmic side of endoplasmic reticulum membrane
|
15
|
4.09e-01
|
-1.23e-01
|
7.82e-01
|
GO:0040029 epigenetic regulation of gene expression
|
29
|
2.51e-01
|
-1.23e-01
|
6.53e-01
|
GO:0051016 barbed-end actin filament capping
|
17
|
3.79e-01
|
-1.23e-01
|
7.58e-01
|
GO:0016446 somatic hypermutation of immunoglobulin genes
|
13
|
4.42e-01
|
-1.23e-01
|
7.96e-01
|
GO:0052548 regulation of endopeptidase activity
|
5
|
6.34e-01
|
1.23e-01
|
8.87e-01
|
GO:0051258 protein polymerization
|
9
|
5.22e-01
|
1.23e-01
|
8.37e-01
|
GO:0002821 positive regulation of adaptive immune response
|
8
|
5.47e-01
|
-1.23e-01
|
8.48e-01
|
GO:0050770 regulation of axonogenesis
|
11
|
4.80e-01
|
-1.23e-01
|
8.19e-01
|
GO:0097027 ubiquitin-protein transferase activator activity
|
6
|
6.02e-01
|
-1.23e-01
|
8.78e-01
|
GO:0080025 phosphatidylinositol-3,5-bisphosphate binding
|
23
|
3.08e-01
|
1.23e-01
|
6.99e-01
|
GO:0006734 NADH metabolic process
|
8
|
5.48e-01
|
1.23e-01
|
8.49e-01
|
GO:0051085 chaperone cofactor-dependent protein refolding
|
29
|
2.53e-01
|
1.23e-01
|
6.56e-01
|
GO:0030099 myeloid cell differentiation
|
23
|
3.09e-01
|
-1.22e-01
|
7.00e-01
|
GO:0021766 hippocampus development
|
45
|
1.55e-01
|
-1.22e-01
|
5.51e-01
|
GO:0048566 embryonic digestive tract development
|
7
|
5.75e-01
|
1.22e-01
|
8.63e-01
|
GO:1903898 negative regulation of PERK-mediated unfolded protein response
|
12
|
4.63e-01
|
-1.22e-01
|
8.08e-01
|
GO:0140839 RNA polymerase II CTD heptapeptide repeat P3 isomerase activity
|
27
|
2.71e-01
|
1.22e-01
|
6.70e-01
|
GO:0140840 RNA polymerase II CTD heptapeptide repeat P6 isomerase activity
|
27
|
2.71e-01
|
1.22e-01
|
6.70e-01
|
GO:0033120 positive regulation of RNA splicing
|
13
|
4.45e-01
|
-1.22e-01
|
7.98e-01
|
GO:2000641 regulation of early endosome to late endosome transport
|
8
|
5.49e-01
|
-1.22e-01
|
8.49e-01
|
GO:0043001 Golgi to plasma membrane protein transport
|
30
|
2.47e-01
|
1.22e-01
|
6.51e-01
|
GO:0006893 Golgi to plasma membrane transport
|
26
|
2.81e-01
|
1.22e-01
|
6.78e-01
|
GO:0051607 defense response to virus
|
176
|
5.29e-03
|
1.22e-01
|
1.24e-01
|
GO:0043273 CTPase activity
|
6
|
6.05e-01
|
-1.22e-01
|
8.79e-01
|
GO:0000812 Swr1 complex
|
13
|
4.46e-01
|
-1.22e-01
|
7.99e-01
|
GO:0005871 kinesin complex
|
33
|
2.25e-01
|
-1.22e-01
|
6.25e-01
|
GO:0016706 2-oxoglutarate-dependent dioxygenase activity
|
14
|
4.29e-01
|
1.22e-01
|
7.92e-01
|
GO:0006312 mitotic recombination
|
6
|
6.05e-01
|
-1.22e-01
|
8.79e-01
|
GO:0051930 regulation of sensory perception of pain
|
7
|
5.76e-01
|
1.22e-01
|
8.64e-01
|
GO:0042795 snRNA transcription by RNA polymerase II
|
10
|
5.04e-01
|
1.22e-01
|
8.31e-01
|
GO:0007566 embryo implantation
|
26
|
2.82e-01
|
1.22e-01
|
6.78e-01
|
GO:1904903 ESCRT III complex disassembly
|
10
|
5.05e-01
|
1.22e-01
|
8.31e-01
|
GO:0070187 shelterin complex
|
6
|
6.06e-01
|
1.22e-01
|
8.79e-01
|
GO:0101031 protein folding chaperone complex
|
30
|
2.49e-01
|
1.22e-01
|
6.52e-01
|
GO:0033276 transcription factor TFTC complex
|
18
|
3.72e-01
|
1.22e-01
|
7.51e-01
|
GO:0009435 NAD biosynthetic process
|
9
|
5.28e-01
|
1.22e-01
|
8.40e-01
|
GO:0006281 DNA repair
|
230
|
1.53e-03
|
-1.22e-01
|
5.70e-02
|
GO:0050905 neuromuscular process
|
19
|
3.59e-01
|
-1.22e-01
|
7.41e-01
|
GO:0001817 regulation of cytokine production
|
41
|
1.79e-01
|
-1.21e-01
|
5.81e-01
|
GO:0071285 cellular response to lithium ion
|
9
|
5.28e-01
|
-1.21e-01
|
8.40e-01
|
GO:0030893 meiotic cohesin complex
|
5
|
6.39e-01
|
-1.21e-01
|
8.88e-01
|
GO:2000601 positive regulation of Arp2/3 complex-mediated actin nucleation
|
7
|
5.79e-01
|
1.21e-01
|
8.65e-01
|
GO:1904044 response to aldosterone
|
8
|
5.53e-01
|
-1.21e-01
|
8.50e-01
|
GO:0034647 histone H3K4me/H3K4me2/H3K4me3 demethylase activity
|
5
|
6.40e-01
|
-1.21e-01
|
8.88e-01
|
GO:0002291 T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell
|
7
|
5.80e-01
|
-1.21e-01
|
8.65e-01
|
GO:0016328 lateral plasma membrane
|
42
|
1.76e-01
|
-1.21e-01
|
5.78e-01
|
GO:0030307 positive regulation of cell growth
|
61
|
1.03e-01
|
-1.21e-01
|
4.56e-01
|
GO:0045839 negative regulation of mitotic nuclear division
|
7
|
5.80e-01
|
1.21e-01
|
8.65e-01
|
GO:0032456 endocytic recycling
|
58
|
1.12e-01
|
-1.21e-01
|
4.75e-01
|
GO:0050884 neuromuscular process controlling posture
|
8
|
5.55e-01
|
1.21e-01
|
8.51e-01
|
GO:0045892 negative regulation of DNA-templated transcription
|
394
|
4.38e-05
|
-1.20e-01
|
5.04e-03
|
GO:0051443 positive regulation of ubiquitin-protein transferase activity
|
9
|
5.32e-01
|
1.20e-01
|
8.43e-01
|
GO:0061502 early endosome to recycling endosome transport
|
5
|
6.41e-01
|
1.20e-01
|
8.88e-01
|
GO:0097284 hepatocyte apoptotic process
|
14
|
4.36e-01
|
-1.20e-01
|
7.95e-01
|
GO:0061036 positive regulation of cartilage development
|
6
|
6.11e-01
|
1.20e-01
|
8.81e-01
|
GO:0021549 cerebellum development
|
28
|
2.72e-01
|
1.20e-01
|
6.70e-01
|
GO:0016180 snRNA processing
|
16
|
4.06e-01
|
-1.20e-01
|
7.81e-01
|
GO:0051881 regulation of mitochondrial membrane potential
|
25
|
2.99e-01
|
1.20e-01
|
6.91e-01
|
GO:0048488 synaptic vesicle endocytosis
|
28
|
2.72e-01
|
-1.20e-01
|
6.70e-01
|
GO:0004465 lipoprotein lipase activity
|
6
|
6.11e-01
|
-1.20e-01
|
8.81e-01
|
GO:0046929 negative regulation of neurotransmitter secretion
|
5
|
6.43e-01
|
-1.20e-01
|
8.89e-01
|
GO:0004181 metallocarboxypeptidase activity
|
11
|
4.92e-01
|
1.20e-01
|
8.25e-01
|
GO:0043195 terminal bouton
|
17
|
3.95e-01
|
-1.19e-01
|
7.71e-01
|
GO:0030223 neutrophil differentiation
|
6
|
6.13e-01
|
-1.19e-01
|
8.81e-01
|
GO:0050982 detection of mechanical stimulus
|
8
|
5.60e-01
|
-1.19e-01
|
8.55e-01
|
GO:0008380 RNA splicing
|
158
|
9.87e-03
|
-1.19e-01
|
1.75e-01
|
GO:0140052 cellular response to oxidised low-density lipoprotein particle stimulus
|
11
|
4.94e-01
|
-1.19e-01
|
8.25e-01
|
GO:0016327 apicolateral plasma membrane
|
10
|
5.14e-01
|
1.19e-01
|
8.34e-01
|
GO:0032281 AMPA glutamate receptor complex
|
6
|
6.13e-01
|
-1.19e-01
|
8.81e-01
|
GO:0005980 glycogen catabolic process
|
8
|
5.60e-01
|
-1.19e-01
|
8.55e-01
|
GO:0004869 cysteine-type endopeptidase inhibitor activity
|
14
|
4.41e-01
|
-1.19e-01
|
7.96e-01
|
GO:0043353 enucleate erythrocyte differentiation
|
5
|
6.45e-01
|
1.19e-01
|
8.91e-01
|
GO:0097484 dendrite extension
|
8
|
5.61e-01
|
1.19e-01
|
8.55e-01
|
GO:0007034 vacuolar transport
|
6
|
6.14e-01
|
1.19e-01
|
8.81e-01
|
GO:0051276 chromosome organization
|
20
|
3.58e-01
|
-1.19e-01
|
7.41e-01
|
GO:0045862 positive regulation of proteolysis
|
19
|
3.72e-01
|
-1.18e-01
|
7.51e-01
|
GO:0001556 oocyte maturation
|
12
|
4.78e-01
|
-1.18e-01
|
8.19e-01
|
GO:0009612 response to mechanical stimulus
|
37
|
2.13e-01
|
-1.18e-01
|
6.15e-01
|
GO:0098685 Schaffer collateral - CA1 synapse
|
54
|
1.33e-01
|
-1.18e-01
|
5.12e-01
|
GO:0071650 negative regulation of chemokine (C-C motif) ligand 5 production
|
6
|
6.16e-01
|
1.18e-01
|
8.82e-01
|
GO:0001878 response to yeast
|
10
|
5.18e-01
|
1.18e-01
|
8.34e-01
|
GO:0045541 negative regulation of cholesterol biosynthetic process
|
6
|
6.16e-01
|
-1.18e-01
|
8.82e-01
|
GO:0031087 deadenylation-independent decapping of nuclear-transcribed mRNA
|
5
|
6.48e-01
|
1.18e-01
|
8.92e-01
|
GO:0031435 mitogen-activated protein kinase kinase kinase binding
|
12
|
4.79e-01
|
-1.18e-01
|
8.19e-01
|
GO:0044390 ubiquitin-like protein conjugating enzyme binding
|
7
|
5.89e-01
|
1.18e-01
|
8.70e-01
|
GO:0060170 ciliary membrane
|
33
|
2.41e-01
|
1.18e-01
|
6.46e-01
|
GO:0006646 phosphatidylethanolamine biosynthetic process
|
9
|
5.41e-01
|
-1.18e-01
|
8.45e-01
|
GO:0061734 type 2 mitophagy
|
5
|
6.48e-01
|
-1.18e-01
|
8.93e-01
|
GO:0044294 dendritic growth cone
|
7
|
5.90e-01
|
-1.18e-01
|
8.70e-01
|
GO:0002092 positive regulation of receptor internalization
|
18
|
3.87e-01
|
1.18e-01
|
7.64e-01
|
GO:0005164 tumor necrosis factor receptor binding
|
26
|
2.99e-01
|
-1.18e-01
|
6.91e-01
|
GO:2000623 negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay
|
7
|
5.90e-01
|
-1.18e-01
|
8.70e-01
|
GO:0043010 camera-type eye development
|
21
|
3.51e-01
|
1.18e-01
|
7.36e-01
|
GO:0045046 protein import into peroxisome membrane
|
6
|
6.18e-01
|
1.18e-01
|
8.82e-01
|
GO:1990481 mRNA pseudouridine synthesis
|
10
|
5.20e-01
|
-1.17e-01
|
8.36e-01
|
GO:0012505 endomembrane system
|
115
|
2.98e-02
|
1.17e-01
|
2.75e-01
|
GO:0090303 positive regulation of wound healing
|
13
|
4.64e-01
|
-1.17e-01
|
8.09e-01
|
GO:0030140 trans-Golgi network transport vesicle
|
14
|
4.47e-01
|
1.17e-01
|
8.00e-01
|
GO:0004571 mannosyl-oligosaccharide 1,2-alpha-mannosidase activity
|
7
|
5.91e-01
|
1.17e-01
|
8.71e-01
|
GO:0018243 protein O-linked glycosylation via threonine
|
6
|
6.19e-01
|
-1.17e-01
|
8.83e-01
|
GO:0033499 galactose catabolic process via UDP-galactose
|
5
|
6.50e-01
|
1.17e-01
|
8.93e-01
|
GO:0071394 cellular response to testosterone stimulus
|
9
|
5.43e-01
|
-1.17e-01
|
8.47e-01
|
GO:2001014 regulation of skeletal muscle cell differentiation
|
5
|
6.50e-01
|
-1.17e-01
|
8.93e-01
|
GO:0045618 positive regulation of keratinocyte differentiation
|
12
|
4.83e-01
|
-1.17e-01
|
8.22e-01
|
GO:0120020 cholesterol transfer activity
|
14
|
4.49e-01
|
1.17e-01
|
8.00e-01
|
GO:0015886 heme transport
|
6
|
6.20e-01
|
-1.17e-01
|
8.84e-01
|
GO:0042594 response to starvation
|
24
|
3.22e-01
|
-1.17e-01
|
7.13e-01
|
GO:0035497 cAMP response element binding
|
10
|
5.22e-01
|
-1.17e-01
|
8.37e-01
|
GO:0031503 protein-containing complex localization
|
13
|
4.66e-01
|
-1.17e-01
|
8.10e-01
|
GO:0005516 calmodulin binding
|
130
|
2.16e-02
|
-1.17e-01
|
2.41e-01
|
GO:1990275 preribosome binding
|
6
|
6.21e-01
|
-1.17e-01
|
8.84e-01
|
GO:0016279 protein-lysine N-methyltransferase activity
|
23
|
3.33e-01
|
-1.17e-01
|
7.22e-01
|
GO:0031012 extracellular matrix
|
69
|
9.40e-02
|
-1.17e-01
|
4.40e-01
|
GO:0050860 negative regulation of T cell receptor signaling pathway
|
20
|
3.67e-01
|
-1.17e-01
|
7.49e-01
|
GO:0034644 cellular response to UV
|
52
|
1.46e-01
|
-1.17e-01
|
5.36e-01
|
GO:0032212 positive regulation of telomere maintenance via telomerase
|
26
|
3.03e-01
|
-1.17e-01
|
6.93e-01
|
GO:0050840 extracellular matrix binding
|
11
|
5.03e-01
|
-1.17e-01
|
8.30e-01
|
GO:0000979 RNA polymerase II core promoter sequence-specific DNA binding
|
15
|
4.35e-01
|
-1.17e-01
|
7.94e-01
|
GO:0007368 determination of left/right symmetry
|
37
|
2.20e-01
|
1.17e-01
|
6.20e-01
|
GO:0010269 response to selenium ion
|
7
|
5.94e-01
|
1.16e-01
|
8.73e-01
|
GO:0000956 nuclear-transcribed mRNA catabolic process
|
21
|
3.56e-01
|
-1.16e-01
|
7.39e-01
|
GO:0001657 ureteric bud development
|
18
|
3.93e-01
|
-1.16e-01
|
7.70e-01
|
GO:1990782 protein tyrosine kinase binding
|
28
|
2.87e-01
|
-1.16e-01
|
6.81e-01
|
GO:0044319 wound healing, spreading of cells
|
11
|
5.05e-01
|
-1.16e-01
|
8.31e-01
|
GO:0042622 photoreceptor outer segment membrane
|
10
|
5.25e-01
|
1.16e-01
|
8.37e-01
|
GO:0070728 L-leucine binding
|
6
|
6.23e-01
|
-1.16e-01
|
8.84e-01
|
GO:0036503 ERAD pathway
|
84
|
6.62e-02
|
1.16e-01
|
3.81e-01
|
GO:0030289 protein phosphatase 4 complex
|
5
|
6.53e-01
|
1.16e-01
|
8.94e-01
|
GO:0007369 gastrulation
|
18
|
3.95e-01
|
1.16e-01
|
7.71e-01
|
GO:0001503 ossification
|
38
|
2.17e-01
|
-1.16e-01
|
6.18e-01
|
GO:0071933 Arp2/3 complex binding
|
12
|
4.88e-01
|
-1.16e-01
|
8.24e-01
|
GO:0008250 oligosaccharyltransferase complex
|
12
|
4.88e-01
|
1.16e-01
|
8.24e-01
|
GO:0090575 RNA polymerase II transcription regulator complex
|
98
|
4.81e-02
|
-1.16e-01
|
3.39e-01
|
GO:0042405 nuclear inclusion body
|
12
|
4.88e-01
|
-1.16e-01
|
8.24e-01
|
GO:0010494 cytoplasmic stress granule
|
83
|
6.89e-02
|
-1.16e-01
|
3.87e-01
|
GO:0141163 positive regulation of cAMP/PKA signal transduction
|
5
|
6.54e-01
|
-1.16e-01
|
8.94e-01
|
GO:1900006 positive regulation of dendrite development
|
13
|
4.71e-01
|
-1.15e-01
|
8.13e-01
|
GO:0046638 positive regulation of alpha-beta T cell differentiation
|
7
|
5.97e-01
|
-1.15e-01
|
8.75e-01
|
GO:0019825 oxygen binding
|
5
|
6.55e-01
|
-1.15e-01
|
8.94e-01
|
GO:0015207 adenine transmembrane transporter activity
|
5
|
6.55e-01
|
-1.15e-01
|
8.94e-01
|
GO:0005777 peroxisome
|
96
|
5.13e-02
|
1.15e-01
|
3.44e-01
|
GO:0050910 detection of mechanical stimulus involved in sensory perception of sound
|
9
|
5.49e-01
|
-1.15e-01
|
8.49e-01
|
GO:0004222 metalloendopeptidase activity
|
55
|
1.40e-01
|
-1.15e-01
|
5.24e-01
|
GO:0070234 positive regulation of T cell apoptotic process
|
6
|
6.25e-01
|
1.15e-01
|
8.85e-01
|
GO:0005524 ATP binding
|
1130
|
1.18e-10
|
-1.15e-01
|
1.39e-07
|
GO:0002151 G-quadruplex RNA binding
|
7
|
5.98e-01
|
-1.15e-01
|
8.76e-01
|
GO:0072332 intrinsic apoptotic signaling pathway by p53 class mediator
|
22
|
3.51e-01
|
1.15e-01
|
7.36e-01
|
GO:0016655 oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor
|
7
|
5.99e-01
|
1.15e-01
|
8.76e-01
|
GO:0033674 positive regulation of kinase activity
|
11
|
5.10e-01
|
-1.15e-01
|
8.34e-01
|
GO:0090207 regulation of triglyceride metabolic process
|
5
|
6.57e-01
|
1.15e-01
|
8.95e-01
|
GO:0032780 negative regulation of ATP-dependent activity
|
8
|
5.74e-01
|
1.15e-01
|
8.62e-01
|
GO:0043279 response to alkaloid
|
9
|
5.51e-01
|
-1.15e-01
|
8.49e-01
|
GO:0031954 positive regulation of protein autophosphorylation
|
17
|
4.13e-01
|
-1.15e-01
|
7.85e-01
|
GO:0071108 protein K48-linked deubiquitination
|
21
|
3.63e-01
|
-1.15e-01
|
7.45e-01
|
GO:0036211 protein modification process
|
73
|
9.08e-02
|
1.15e-01
|
4.35e-01
|
GO:0005795 Golgi stack
|
29
|
2.86e-01
|
1.14e-01
|
6.81e-01
|
GO:0019538 protein metabolic process
|
5
|
6.58e-01
|
1.14e-01
|
8.95e-01
|
GO:0000381 regulation of alternative mRNA splicing, via spliceosome
|
43
|
1.94e-01
|
-1.14e-01
|
5.98e-01
|
GO:0071872 cellular response to epinephrine stimulus
|
9
|
5.53e-01
|
1.14e-01
|
8.50e-01
|
GO:0006351 DNA-templated transcription
|
57
|
1.36e-01
|
-1.14e-01
|
5.16e-01
|
GO:0034453 microtubule anchoring
|
8
|
5.76e-01
|
1.14e-01
|
8.63e-01
|
GO:0033299 secretion of lysosomal enzymes
|
5
|
6.58e-01
|
1.14e-01
|
8.95e-01
|
GO:0008312 7S RNA binding
|
7
|
6.01e-01
|
1.14e-01
|
8.77e-01
|
GO:0003007 heart morphogenesis
|
28
|
2.96e-01
|
-1.14e-01
|
6.90e-01
|
GO:0071986 Ragulator complex
|
6
|
6.29e-01
|
-1.14e-01
|
8.85e-01
|
GO:0051451 myoblast migration
|
5
|
6.59e-01
|
-1.14e-01
|
8.96e-01
|
GO:0035723 interleukin-15-mediated signaling pathway
|
8
|
5.77e-01
|
-1.14e-01
|
8.64e-01
|
GO:2000352 negative regulation of endothelial cell apoptotic process
|
15
|
4.45e-01
|
-1.14e-01
|
7.98e-01
|
GO:0045056 transcytosis
|
8
|
5.77e-01
|
-1.14e-01
|
8.64e-01
|
GO:0051924 regulation of calcium ion transport
|
15
|
4.46e-01
|
-1.14e-01
|
7.98e-01
|
GO:0044849 estrous cycle
|
10
|
5.34e-01
|
-1.14e-01
|
8.43e-01
|
GO:0006661 phosphatidylinositol biosynthetic process
|
41
|
2.08e-01
|
-1.14e-01
|
6.12e-01
|
GO:0031252 cell leading edge
|
40
|
2.14e-01
|
-1.14e-01
|
6.15e-01
|
GO:0070200 establishment of protein localization to telomere
|
6
|
6.31e-01
|
-1.13e-01
|
8.86e-01
|
GO:0016558 protein import into peroxisome matrix
|
12
|
4.97e-01
|
1.13e-01
|
8.27e-01
|
GO:0140664 ATP-dependent DNA damage sensor activity
|
14
|
4.64e-01
|
-1.13e-01
|
8.09e-01
|
GO:0006469 negative regulation of protein kinase activity
|
36
|
2.40e-01
|
-1.13e-01
|
6.46e-01
|
GO:0016442 RISC complex
|
14
|
4.64e-01
|
-1.13e-01
|
8.09e-01
|
GO:0005778 peroxisomal membrane
|
59
|
1.33e-01
|
1.13e-01
|
5.12e-01
|
GO:0017119 Golgi transport complex
|
10
|
5.36e-01
|
1.13e-01
|
8.44e-01
|
GO:0006730 one-carbon metabolic process
|
13
|
4.81e-01
|
-1.13e-01
|
8.19e-01
|
GO:0015279 store-operated calcium channel activity
|
5
|
6.62e-01
|
1.13e-01
|
8.98e-01
|
GO:0006027 glycosaminoglycan catabolic process
|
6
|
6.32e-01
|
-1.13e-01
|
8.86e-01
|
GO:0006954 inflammatory response
|
238
|
2.78e-03
|
-1.13e-01
|
8.49e-02
|
GO:2000096 positive regulation of Wnt signaling pathway, planar cell polarity pathway
|
6
|
6.32e-01
|
-1.13e-01
|
8.86e-01
|
GO:0050681 nuclear androgen receptor binding
|
23
|
3.49e-01
|
-1.13e-01
|
7.34e-01
|
GO:0046330 positive regulation of JNK cascade
|
70
|
1.03e-01
|
-1.13e-01
|
4.56e-01
|
GO:0034045 phagophore assembly site membrane
|
21
|
3.71e-01
|
1.13e-01
|
7.51e-01
|
GO:0070761 pre-snoRNP complex
|
7
|
6.06e-01
|
1.13e-01
|
8.79e-01
|
GO:0032781 positive regulation of ATP-dependent activity
|
17
|
4.22e-01
|
-1.13e-01
|
7.87e-01
|
GO:0005912 adherens junction
|
117
|
3.58e-02
|
-1.13e-01
|
2.97e-01
|
GO:0021987 cerebral cortex development
|
52
|
1.61e-01
|
-1.12e-01
|
5.61e-01
|
GO:0006002 fructose 6-phosphate metabolic process
|
10
|
5.38e-01
|
-1.12e-01
|
8.45e-01
|
GO:0060999 positive regulation of dendritic spine development
|
17
|
4.22e-01
|
-1.12e-01
|
7.87e-01
|
GO:0010793 regulation of mRNA export from nucleus
|
8
|
5.82e-01
|
-1.12e-01
|
8.65e-01
|
GO:0033152 immunoglobulin V(D)J recombination
|
6
|
6.34e-01
|
-1.12e-01
|
8.87e-01
|
GO:0015734 taurine transmembrane transport
|
6
|
6.34e-01
|
-1.12e-01
|
8.87e-01
|
GO:0008150 biological process
|
42
|
2.09e-01
|
-1.12e-01
|
6.12e-01
|
GO:0071204 histone pre-mRNA 3’end processing complex
|
6
|
6.34e-01
|
1.12e-01
|
8.87e-01
|
GO:0045124 regulation of bone resorption
|
8
|
5.83e-01
|
-1.12e-01
|
8.66e-01
|
GO:0048261 negative regulation of receptor-mediated endocytosis
|
6
|
6.35e-01
|
-1.12e-01
|
8.87e-01
|
GO:0071404 cellular response to low-density lipoprotein particle stimulus
|
15
|
4.53e-01
|
-1.12e-01
|
8.02e-01
|
GO:0006325 chromatin organization
|
125
|
3.10e-02
|
-1.12e-01
|
2.80e-01
|
GO:0009299 mRNA transcription
|
5
|
6.65e-01
|
1.12e-01
|
8.99e-01
|
GO:0006024 glycosaminoglycan biosynthetic process
|
13
|
4.85e-01
|
1.12e-01
|
8.23e-01
|
GO:0010792 DNA double-strand break processing involved in repair via single-strand annealing
|
6
|
6.35e-01
|
-1.12e-01
|
8.88e-01
|
GO:2000672 negative regulation of motor neuron apoptotic process
|
7
|
6.09e-01
|
1.12e-01
|
8.80e-01
|
GO:0046597 negative regulation of viral entry into host cell
|
18
|
4.12e-01
|
1.12e-01
|
7.85e-01
|
GO:0098655 monoatomic cation transmembrane transport
|
25
|
3.34e-01
|
-1.12e-01
|
7.22e-01
|
GO:0046827 positive regulation of protein export from nucleus
|
16
|
4.40e-01
|
-1.12e-01
|
7.96e-01
|
GO:0008135 translation factor activity, RNA binding
|
21
|
3.76e-01
|
-1.12e-01
|
7.56e-01
|
GO:0019852 L-ascorbic acid metabolic process
|
9
|
5.63e-01
|
-1.11e-01
|
8.56e-01
|
GO:0035329 hippo signaling
|
13
|
4.87e-01
|
-1.11e-01
|
8.24e-01
|
GO:1903232 melanosome assembly
|
19
|
4.00e-01
|
-1.11e-01
|
7.76e-01
|
GO:0038154 interleukin-11-mediated signaling pathway
|
5
|
6.66e-01
|
1.11e-01
|
8.99e-01
|
GO:0038095 Fc-epsilon receptor signaling pathway
|
23
|
3.55e-01
|
-1.11e-01
|
7.39e-01
|
GO:0006924 activation-induced cell death of T cells
|
6
|
6.37e-01
|
1.11e-01
|
8.88e-01
|
GO:0043303 mast cell degranulation
|
14
|
4.71e-01
|
-1.11e-01
|
8.13e-01
|
GO:0016593 Cdc73/Paf1 complex
|
6
|
6.37e-01
|
1.11e-01
|
8.88e-01
|
GO:0060644 mammary gland epithelial cell differentiation
|
9
|
5.63e-01
|
1.11e-01
|
8.56e-01
|
GO:0140939 histone H4 methyltransferase activity
|
5
|
6.67e-01
|
-1.11e-01
|
9.00e-01
|
GO:0045662 negative regulation of myoblast differentiation
|
15
|
4.56e-01
|
-1.11e-01
|
8.03e-01
|
GO:0031848 protection from non-homologous end joining at telomere
|
6
|
6.38e-01
|
1.11e-01
|
8.88e-01
|
GO:0000815 ESCRT III complex
|
11
|
5.24e-01
|
1.11e-01
|
8.37e-01
|
GO:0051469 vesicle fusion with vacuole
|
11
|
5.24e-01
|
1.11e-01
|
8.37e-01
|
GO:0061763 multivesicular body-lysosome fusion
|
11
|
5.24e-01
|
1.11e-01
|
8.37e-01
|
GO:1904930 amphisome membrane
|
11
|
5.24e-01
|
1.11e-01
|
8.37e-01
|
GO:0050861 positive regulation of B cell receptor signaling pathway
|
7
|
6.11e-01
|
1.11e-01
|
8.81e-01
|
GO:0032930 positive regulation of superoxide anion generation
|
15
|
4.57e-01
|
1.11e-01
|
8.04e-01
|
GO:0007413 axonal fasciculation
|
10
|
5.44e-01
|
-1.11e-01
|
8.47e-01
|
GO:0002456 T cell mediated immunity
|
9
|
5.65e-01
|
1.11e-01
|
8.56e-01
|
GO:0097186 amelogenesis
|
6
|
6.39e-01
|
1.11e-01
|
8.88e-01
|
GO:0001675 acrosome assembly
|
16
|
4.44e-01
|
1.11e-01
|
7.97e-01
|
GO:0043122 regulation of canonical NF-kappaB signal transduction
|
30
|
2.94e-01
|
1.11e-01
|
6.89e-01
|
GO:0030297 transmembrane receptor protein tyrosine kinase activator activity
|
9
|
5.66e-01
|
1.11e-01
|
8.56e-01
|
GO:0048786 presynaptic active zone
|
22
|
3.70e-01
|
1.10e-01
|
7.50e-01
|
GO:0035332 positive regulation of hippo signaling
|
9
|
5.66e-01
|
-1.10e-01
|
8.56e-01
|
GO:0022408 negative regulation of cell-cell adhesion
|
10
|
5.46e-01
|
-1.10e-01
|
8.47e-01
|
GO:1902624 positive regulation of neutrophil migration
|
5
|
6.69e-01
|
1.10e-01
|
9.01e-01
|
GO:0042692 muscle cell differentiation
|
13
|
4.91e-01
|
1.10e-01
|
8.24e-01
|
GO:0034605 cellular response to heat
|
39
|
2.33e-01
|
1.10e-01
|
6.35e-01
|
GO:0016070 RNA metabolic process
|
6
|
6.40e-01
|
-1.10e-01
|
8.88e-01
|
GO:0031462 Cul2-RING ubiquitin ligase complex
|
21
|
3.82e-01
|
-1.10e-01
|
7.60e-01
|
GO:0051495 positive regulation of cytoskeleton organization
|
6
|
6.41e-01
|
-1.10e-01
|
8.88e-01
|
GO:0044615 nuclear pore nuclear basket
|
13
|
4.92e-01
|
-1.10e-01
|
8.25e-01
|
GO:0019864 IgG binding
|
6
|
6.41e-01
|
1.10e-01
|
8.88e-01
|
GO:0035022 positive regulation of Rac protein signal transduction
|
11
|
5.27e-01
|
-1.10e-01
|
8.40e-01
|
GO:0050871 positive regulation of B cell activation
|
5
|
6.70e-01
|
1.10e-01
|
9.01e-01
|
GO:2000117 negative regulation of cysteine-type endopeptidase activity
|
32
|
2.82e-01
|
1.10e-01
|
6.78e-01
|
GO:0019068 virion assembly
|
7
|
6.15e-01
|
1.10e-01
|
8.81e-01
|
GO:0001508 action potential
|
17
|
4.33e-01
|
-1.10e-01
|
7.94e-01
|
GO:0097193 intrinsic apoptotic signaling pathway
|
41
|
2.24e-01
|
1.10e-01
|
6.23e-01
|
GO:0098780 response to mitochondrial depolarisation
|
6
|
6.41e-01
|
-1.10e-01
|
8.88e-01
|
GO:0016197 endosomal transport
|
51
|
1.75e-01
|
-1.10e-01
|
5.78e-01
|
GO:0097110 scaffold protein binding
|
50
|
1.80e-01
|
-1.10e-01
|
5.83e-01
|
GO:0070411 I-SMAD binding
|
13
|
4.94e-01
|
-1.10e-01
|
8.25e-01
|
GO:0140822 NAD+-histone H2BE35 glutamate ADP-ribosyltransferase activity
|
12
|
5.11e-01
|
1.09e-01
|
8.34e-01
|
GO:0140844 NAD+-histone H2BE2 glutamate ADP-ribosyltransferase activity
|
12
|
5.11e-01
|
1.09e-01
|
8.34e-01
|
GO:0140867 NAD+-histone H2BE18 glutamate ADP-ribosyltransferase activity
|
12
|
5.11e-01
|
1.09e-01
|
8.34e-01
|
GO:0008175 tRNA methyltransferase activity
|
9
|
5.70e-01
|
-1.09e-01
|
8.59e-01
|
GO:0031018 endocrine pancreas development
|
7
|
6.16e-01
|
-1.09e-01
|
8.82e-01
|
GO:0006446 regulation of translational initiation
|
33
|
2.78e-01
|
1.09e-01
|
6.75e-01
|
GO:0030100 regulation of endocytosis
|
24
|
3.55e-01
|
-1.09e-01
|
7.39e-01
|
GO:0034356 NAD biosynthesis via nicotinamide riboside salvage pathway
|
6
|
6.43e-01
|
-1.09e-01
|
8.89e-01
|
GO:0043083 synaptic cleft
|
9
|
5.71e-01
|
1.09e-01
|
8.60e-01
|
GO:0051645 Golgi localization
|
6
|
6.44e-01
|
1.09e-01
|
8.89e-01
|
GO:0070822 Sin3-type complex
|
22
|
3.76e-01
|
-1.09e-01
|
7.55e-01
|
GO:0070765 gamma-secretase complex
|
7
|
6.17e-01
|
1.09e-01
|
8.82e-01
|
GO:0042765 GPI-anchor transamidase complex
|
5
|
6.73e-01
|
-1.09e-01
|
9.02e-01
|
GO:1990379 lipid transport across blood-brain barrier
|
5
|
6.73e-01
|
1.09e-01
|
9.02e-01
|
GO:0008053 mitochondrial fusion
|
22
|
3.77e-01
|
-1.09e-01
|
7.56e-01
|
GO:0016234 inclusion body
|
14
|
4.80e-01
|
-1.09e-01
|
8.19e-01
|
GO:0051010 microtubule plus-end binding
|
20
|
3.99e-01
|
-1.09e-01
|
7.75e-01
|
GO:0150093 amyloid-beta clearance by transcytosis
|
7
|
6.18e-01
|
-1.09e-01
|
8.82e-01
|
GO:0007042 lysosomal lumen acidification
|
24
|
3.56e-01
|
1.09e-01
|
7.39e-01
|
GO:0055013 cardiac muscle cell development
|
16
|
4.51e-01
|
-1.09e-01
|
8.02e-01
|
GO:0043320 natural killer cell degranulation
|
6
|
6.45e-01
|
-1.09e-01
|
8.91e-01
|
GO:0034214 protein hexamerization
|
8
|
5.95e-01
|
-1.09e-01
|
8.74e-01
|
GO:0051090 regulation of DNA-binding transcription factor activity
|
11
|
5.33e-01
|
-1.08e-01
|
8.43e-01
|
GO:0044342 type B pancreatic cell proliferation
|
9
|
5.73e-01
|
-1.08e-01
|
8.61e-01
|
GO:0120009 intermembrane lipid transfer
|
27
|
3.30e-01
|
-1.08e-01
|
7.20e-01
|
GO:1990247 N6-methyladenosine-containing RNA reader activity
|
11
|
5.34e-01
|
-1.08e-01
|
8.43e-01
|
GO:0003713 transcription coactivator activity
|
226
|
5.16e-03
|
-1.08e-01
|
1.22e-01
|
GO:0034614 cellular response to reactive oxygen species
|
34
|
2.75e-01
|
-1.08e-01
|
6.71e-01
|
GO:0050829 defense response to Gram-negative bacterium
|
33
|
2.82e-01
|
1.08e-01
|
6.78e-01
|
GO:0070390 transcription export complex 2
|
5
|
6.75e-01
|
1.08e-01
|
9.03e-01
|
GO:0001669 acrosomal vesicle
|
55
|
1.65e-01
|
-1.08e-01
|
5.68e-01
|
GO:0010526 transposable element silencing
|
11
|
5.35e-01
|
1.08e-01
|
8.43e-01
|
GO:0004698 calcium,diacylglycerol-dependent serine/threonine kinase activity
|
11
|
5.35e-01
|
1.08e-01
|
8.43e-01
|
GO:0004699 diacylglycerol-dependent, calcium-independent serine/threonine kinase activity
|
11
|
5.35e-01
|
1.08e-01
|
8.43e-01
|
GO:0004867 serine-type endopeptidase inhibitor activity
|
40
|
2.37e-01
|
1.08e-01
|
6.42e-01
|
GO:0033089 positive regulation of T cell differentiation in thymus
|
5
|
6.76e-01
|
-1.08e-01
|
9.03e-01
|
GO:0048738 cardiac muscle tissue development
|
7
|
6.21e-01
|
1.08e-01
|
8.84e-01
|
GO:0015267 channel activity
|
13
|
5.00e-01
|
-1.08e-01
|
8.28e-01
|
GO:0090383 phagosome acidification
|
7
|
6.21e-01
|
-1.08e-01
|
8.84e-01
|
GO:0031089 platelet dense granule lumen
|
8
|
5.98e-01
|
1.08e-01
|
8.76e-01
|
GO:0006368 transcription elongation by RNA polymerase II
|
31
|
3.00e-01
|
1.08e-01
|
6.91e-01
|
GO:0016308 1-phosphatidylinositol-4-phosphate 5-kinase activity
|
7
|
6.22e-01
|
-1.07e-01
|
8.84e-01
|
GO:0140861 DNA repair-dependent chromatin remodeling
|
23
|
3.73e-01
|
1.07e-01
|
7.52e-01
|
GO:0030534 adult behavior
|
19
|
4.18e-01
|
1.07e-01
|
7.87e-01
|
GO:0097001 ceramide binding
|
9
|
5.78e-01
|
1.07e-01
|
8.64e-01
|
GO:0030422 siRNA processing
|
7
|
6.24e-01
|
1.07e-01
|
8.84e-01
|
GO:0005802 trans-Golgi network
|
152
|
2.29e-02
|
1.07e-01
|
2.45e-01
|
GO:0048679 regulation of axon regeneration
|
5
|
6.78e-01
|
-1.07e-01
|
9.04e-01
|
GO:0090330 regulation of platelet aggregation
|
5
|
6.78e-01
|
-1.07e-01
|
9.04e-01
|
GO:0036159 inner dynein arm assembly
|
6
|
6.50e-01
|
1.07e-01
|
8.93e-01
|
GO:1990229 iron-sulfur cluster assembly complex
|
11
|
5.39e-01
|
-1.07e-01
|
8.45e-01
|
GO:0034450 ubiquitin-ubiquitin ligase activity
|
16
|
4.59e-01
|
-1.07e-01
|
8.05e-01
|
GO:0050808 synapse organization
|
19
|
4.19e-01
|
-1.07e-01
|
7.87e-01
|
GO:0141198 protein branched polyubiquitination
|
19
|
4.19e-01
|
-1.07e-01
|
7.87e-01
|
GO:0045039 protein insertion into mitochondrial inner membrane
|
13
|
5.05e-01
|
-1.07e-01
|
8.31e-01
|
GO:0048251 elastic fiber assembly
|
7
|
6.25e-01
|
1.07e-01
|
8.84e-01
|
GO:0004596 peptide alpha-N-acetyltransferase activity
|
6
|
6.51e-01
|
-1.07e-01
|
8.93e-01
|
GO:0038133 ERBB2-ERBB3 signaling pathway
|
6
|
6.51e-01
|
-1.07e-01
|
8.93e-01
|
GO:0071356 cellular response to tumor necrosis factor
|
74
|
1.13e-01
|
-1.07e-01
|
4.75e-01
|
GO:0015889 cobalamin transport
|
5
|
6.79e-01
|
-1.07e-01
|
9.05e-01
|
GO:0050859 negative regulation of B cell receptor signaling pathway
|
8
|
6.01e-01
|
-1.07e-01
|
8.77e-01
|
GO:0140268 endoplasmic reticulum-plasma membrane contact site
|
8
|
6.02e-01
|
1.07e-01
|
8.77e-01
|
GO:0097440 apical dendrite
|
11
|
5.41e-01
|
-1.06e-01
|
8.45e-01
|
GO:0035791 platelet-derived growth factor receptor-beta signaling pathway
|
17
|
4.48e-01
|
-1.06e-01
|
8.00e-01
|
GO:0035020 regulation of Rac protein signal transduction
|
10
|
5.61e-01
|
-1.06e-01
|
8.55e-01
|
GO:0015386 potassium:proton antiporter activity
|
7
|
6.26e-01
|
1.06e-01
|
8.85e-01
|
GO:0005643 nuclear pore
|
75
|
1.12e-01
|
-1.06e-01
|
4.75e-01
|
GO:0000785 chromatin
|
640
|
5.34e-06
|
-1.06e-01
|
9.49e-04
|
GO:0005041 low-density lipoprotein particle receptor activity
|
12
|
5.24e-01
|
-1.06e-01
|
8.37e-01
|
GO:0045296 cadherin binding
|
257
|
3.48e-03
|
-1.06e-01
|
9.71e-02
|
GO:1904874 positive regulation of telomerase RNA localization to Cajal body
|
9
|
5.82e-01
|
-1.06e-01
|
8.65e-01
|
GO:0019370 leukotriene biosynthetic process
|
7
|
6.27e-01
|
1.06e-01
|
8.85e-01
|
GO:0034979 NAD-dependent protein lysine deacetylase activity
|
7
|
6.27e-01
|
-1.06e-01
|
8.85e-01
|
GO:0007268 chemical synaptic transmission
|
76
|
1.10e-01
|
-1.06e-01
|
4.72e-01
|
GO:0043011 myeloid dendritic cell differentiation
|
11
|
5.43e-01
|
-1.06e-01
|
8.47e-01
|
GO:0090158 endoplasmic reticulum membrane organization
|
5
|
6.82e-01
|
-1.06e-01
|
9.05e-01
|
GO:0015935 small ribosomal subunit
|
14
|
4.93e-01
|
1.06e-01
|
8.25e-01
|
GO:0047044 androstan-3-alpha,17-beta-diol dehydrogenase activity
|
5
|
6.82e-01
|
1.06e-01
|
9.05e-01
|
GO:0006307 DNA alkylation repair
|
11
|
5.44e-01
|
1.06e-01
|
8.47e-01
|
GO:0036021 endolysosome lumen
|
5
|
6.83e-01
|
1.06e-01
|
9.05e-01
|
GO:0005095 GTPase inhibitor activity
|
11
|
5.44e-01
|
-1.06e-01
|
8.47e-01
|
GO:0032480 negative regulation of type I interferon production
|
26
|
3.52e-01
|
1.06e-01
|
7.37e-01
|
GO:1990535 neuron projection maintenance
|
8
|
6.06e-01
|
1.05e-01
|
8.79e-01
|
GO:0098586 cellular response to virus
|
47
|
2.12e-01
|
-1.05e-01
|
6.15e-01
|
GO:0001578 microtubule bundle formation
|
21
|
4.03e-01
|
-1.05e-01
|
7.79e-01
|
GO:0008217 regulation of blood pressure
|
37
|
2.68e-01
|
1.05e-01
|
6.68e-01
|
GO:0003674 molecular function
|
41
|
2.44e-01
|
-1.05e-01
|
6.48e-01
|
GO:0042953 lipoprotein transport
|
16
|
4.66e-01
|
1.05e-01
|
8.10e-01
|
GO:1990508 CKM complex
|
5
|
6.84e-01
|
-1.05e-01
|
9.05e-01
|
GO:0000380 alternative mRNA splicing, via spliceosome
|
24
|
3.73e-01
|
-1.05e-01
|
7.52e-01
|
GO:0033617 mitochondrial cytochrome c oxidase assembly
|
23
|
3.84e-01
|
-1.05e-01
|
7.61e-01
|
GO:0019897 extrinsic component of plasma membrane
|
7
|
6.31e-01
|
-1.05e-01
|
8.86e-01
|
GO:0071169 establishment of protein localization to chromatin
|
5
|
6.85e-01
|
-1.05e-01
|
9.05e-01
|
GO:0035252 UDP-xylosyltransferase activity
|
6
|
6.57e-01
|
-1.05e-01
|
8.95e-01
|
GO:0032497 detection of lipopolysaccharide
|
5
|
6.85e-01
|
1.05e-01
|
9.05e-01
|
GO:1902166 negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator
|
12
|
5.30e-01
|
-1.05e-01
|
8.41e-01
|
GO:1901223 negative regulation of non-canonical NF-kappaB signal transduction
|
21
|
4.06e-01
|
1.05e-01
|
7.81e-01
|
GO:0001655 urogenital system development
|
6
|
6.57e-01
|
-1.05e-01
|
8.95e-01
|
GO:0009314 response to radiation
|
10
|
5.67e-01
|
-1.05e-01
|
8.57e-01
|
GO:0044853 plasma membrane raft
|
20
|
4.18e-01
|
-1.05e-01
|
7.87e-01
|
GO:0016024 CDP-diacylglycerol biosynthetic process
|
13
|
5.14e-01
|
1.05e-01
|
8.34e-01
|
GO:1901731 positive regulation of platelet aggregation
|
9
|
5.87e-01
|
-1.05e-01
|
8.68e-01
|
GO:1900118 negative regulation of execution phase of apoptosis
|
8
|
6.09e-01
|
-1.05e-01
|
8.80e-01
|
GO:0002281 macrophage activation involved in immune response
|
11
|
5.48e-01
|
1.05e-01
|
8.49e-01
|
GO:0015036 disulfide oxidoreductase activity
|
6
|
6.58e-01
|
1.04e-01
|
8.95e-01
|
GO:0106222 lncRNA binding
|
17
|
4.56e-01
|
-1.04e-01
|
8.03e-01
|
GO:0008201 heparin binding
|
69
|
1.34e-01
|
1.04e-01
|
5.13e-01
|
GO:0005637 nuclear inner membrane
|
43
|
2.37e-01
|
-1.04e-01
|
6.42e-01
|
GO:0051298 centrosome duplication
|
15
|
4.84e-01
|
-1.04e-01
|
8.22e-01
|
GO:0007173 epidermal growth factor receptor signaling pathway
|
47
|
2.17e-01
|
-1.04e-01
|
6.18e-01
|
GO:0140608 cysteine-type endopeptidase activator activity
|
6
|
6.58e-01
|
1.04e-01
|
8.96e-01
|
GO:0030136 clathrin-coated vesicle
|
55
|
1.82e-01
|
-1.04e-01
|
5.85e-01
|
GO:0007269 neurotransmitter secretion
|
14
|
5.00e-01
|
-1.04e-01
|
8.28e-01
|
GO:0070424 regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway
|
5
|
6.87e-01
|
-1.04e-01
|
9.06e-01
|
GO:0060324 face development
|
14
|
5.00e-01
|
-1.04e-01
|
8.28e-01
|
GO:0051020 GTPase binding
|
28
|
3.41e-01
|
1.04e-01
|
7.27e-01
|
GO:0035166 post-embryonic hemopoiesis
|
5
|
6.87e-01
|
-1.04e-01
|
9.06e-01
|
GO:0070971 endoplasmic reticulum exit site
|
27
|
3.50e-01
|
1.04e-01
|
7.35e-01
|
GO:0009749 response to glucose
|
41
|
2.50e-01
|
-1.04e-01
|
6.53e-01
|
GO:0030578 PML body organization
|
6
|
6.60e-01
|
1.04e-01
|
8.96e-01
|
GO:0010038 response to metal ion
|
7
|
6.35e-01
|
-1.04e-01
|
8.87e-01
|
GO:0007596 blood coagulation
|
50
|
2.05e-01
|
1.04e-01
|
6.10e-01
|
GO:0071339 MLL1 complex
|
30
|
3.26e-01
|
-1.04e-01
|
7.18e-01
|
GO:0048535 lymph node development
|
13
|
5.18e-01
|
-1.04e-01
|
8.35e-01
|
GO:0006906 vesicle fusion
|
24
|
3.80e-01
|
1.04e-01
|
7.58e-01
|
GO:0030177 positive regulation of Wnt signaling pathway
|
24
|
3.80e-01
|
1.03e-01
|
7.58e-01
|
GO:0007033 vacuole organization
|
8
|
6.12e-01
|
-1.03e-01
|
8.81e-01
|
GO:0034604 pyruvate dehydrogenase (NAD+) activity
|
5
|
6.89e-01
|
-1.03e-01
|
9.06e-01
|
GO:0051117 ATPase binding
|
63
|
1.56e-01
|
1.03e-01
|
5.53e-01
|
GO:0006970 response to osmotic stress
|
10
|
5.72e-01
|
-1.03e-01
|
8.60e-01
|
GO:0048854 brain morphogenesis
|
15
|
4.89e-01
|
1.03e-01
|
8.24e-01
|
GO:2000772 regulation of cellular senescence
|
10
|
5.72e-01
|
-1.03e-01
|
8.61e-01
|
GO:0009636 response to toxic substance
|
50
|
2.07e-01
|
-1.03e-01
|
6.11e-01
|
GO:1990130 GATOR1 complex
|
5
|
6.90e-01
|
-1.03e-01
|
9.06e-01
|
GO:1905564 positive regulation of vascular endothelial cell proliferation
|
12
|
5.37e-01
|
-1.03e-01
|
8.45e-01
|
GO:0034224 cellular response to zinc ion starvation
|
7
|
6.37e-01
|
-1.03e-01
|
8.88e-01
|
GO:0008287 protein serine/threonine phosphatase complex
|
5
|
6.90e-01
|
1.03e-01
|
9.06e-01
|
GO:1901987 regulation of cell cycle phase transition
|
7
|
6.38e-01
|
-1.03e-01
|
8.88e-01
|
GO:0030911 TPR domain binding
|
7
|
6.38e-01
|
1.03e-01
|
8.88e-01
|
GO:0016607 nuclear speck
|
364
|
8.06e-04
|
-1.03e-01
|
3.63e-02
|
GO:0001217 DNA-binding transcription repressor activity
|
11
|
5.56e-01
|
-1.03e-01
|
8.52e-01
|
GO:0015075 monoatomic ion transmembrane transporter activity
|
10
|
5.74e-01
|
-1.03e-01
|
8.62e-01
|
GO:0060544 regulation of necroptotic process
|
9
|
5.94e-01
|
-1.03e-01
|
8.74e-01
|
GO:0016310 phosphorylation
|
20
|
4.28e-01
|
-1.03e-01
|
7.90e-01
|
GO:0032374 regulation of cholesterol transport
|
6
|
6.64e-01
|
-1.02e-01
|
8.98e-01
|
GO:0071383 cellular response to steroid hormone stimulus
|
11
|
5.57e-01
|
1.02e-01
|
8.53e-01
|
GO:0071224 cellular response to peptidoglycan
|
5
|
6.92e-01
|
1.02e-01
|
9.07e-01
|
GO:0006488 dolichol-linked oligosaccharide biosynthetic process
|
18
|
4.53e-01
|
1.02e-01
|
8.02e-01
|
GO:0042584 chromaffin granule membrane
|
7
|
6.39e-01
|
-1.02e-01
|
8.88e-01
|
GO:0032481 positive regulation of type I interferon production
|
34
|
3.02e-01
|
-1.02e-01
|
6.93e-01
|
GO:0006820 monoatomic anion transport
|
7
|
6.39e-01
|
-1.02e-01
|
8.88e-01
|
GO:0002076 osteoblast development
|
9
|
5.96e-01
|
-1.02e-01
|
8.74e-01
|
GO:0001894 tissue homeostasis
|
13
|
5.24e-01
|
-1.02e-01
|
8.37e-01
|
GO:1904322 cellular response to forskolin
|
6
|
6.65e-01
|
-1.02e-01
|
8.99e-01
|
GO:0043325 phosphatidylinositol-3,4-bisphosphate binding
|
23
|
3.98e-01
|
-1.02e-01
|
7.73e-01
|
GO:0044458 motile cilium assembly
|
16
|
4.81e-01
|
1.02e-01
|
8.19e-01
|
GO:0040008 regulation of growth
|
12
|
5.41e-01
|
1.02e-01
|
8.45e-01
|
GO:0060402 calcium ion transport into cytosol
|
6
|
6.66e-01
|
1.02e-01
|
8.99e-01
|
GO:0008210 estrogen metabolic process
|
11
|
5.59e-01
|
-1.02e-01
|
8.55e-01
|
GO:0006657 CDP-choline pathway
|
6
|
6.66e-01
|
1.02e-01
|
8.99e-01
|
GO:0009411 response to UV
|
41
|
2.60e-01
|
-1.02e-01
|
6.61e-01
|
GO:1905691 lipid droplet disassembly
|
6
|
6.66e-01
|
-1.02e-01
|
8.99e-01
|
GO:0050750 low-density lipoprotein particle receptor binding
|
21
|
4.20e-01
|
1.02e-01
|
7.87e-01
|
GO:0097729 9+2 motile cilium
|
9
|
5.98e-01
|
1.02e-01
|
8.76e-01
|
GO:0035194 regulatory ncRNA-mediated post-transcriptional gene silencing
|
13
|
5.26e-01
|
-1.01e-01
|
8.38e-01
|
GO:1900016 negative regulation of cytokine production involved in inflammatory response
|
17
|
4.69e-01
|
-1.01e-01
|
8.13e-01
|
GO:1902018 negative regulation of cilium assembly
|
19
|
4.44e-01
|
-1.01e-01
|
7.97e-01
|
GO:0050852 T cell receptor signaling pathway
|
81
|
1.15e-01
|
-1.01e-01
|
4.79e-01
|
GO:0005021 vascular endothelial growth factor receptor activity
|
16
|
4.83e-01
|
-1.01e-01
|
8.22e-01
|
GO:0031468 nuclear membrane reassembly
|
17
|
4.70e-01
|
1.01e-01
|
8.13e-01
|
GO:0000800 lateral element
|
9
|
5.99e-01
|
-1.01e-01
|
8.76e-01
|
GO:0004180 carboxypeptidase activity
|
11
|
5.61e-01
|
-1.01e-01
|
8.55e-01
|
GO:0050773 regulation of dendrite development
|
11
|
5.61e-01
|
-1.01e-01
|
8.55e-01
|
GO:0019838 growth factor binding
|
16
|
4.83e-01
|
-1.01e-01
|
8.22e-01
|
GO:0006099 tricarboxylic acid cycle
|
29
|
3.46e-01
|
-1.01e-01
|
7.30e-01
|
GO:0008017 microtubule binding
|
201
|
1.36e-02
|
-1.01e-01
|
2.04e-01
|
GO:0032426 stereocilium tip
|
11
|
5.62e-01
|
1.01e-01
|
8.55e-01
|
GO:0005161 platelet-derived growth factor receptor binding
|
12
|
5.45e-01
|
-1.01e-01
|
8.47e-01
|
GO:0015914 phospholipid transport
|
25
|
3.82e-01
|
-1.01e-01
|
7.60e-01
|
GO:0016540 protein autoprocessing
|
16
|
4.84e-01
|
1.01e-01
|
8.22e-01
|
GO:0070828 heterochromatin organization
|
8
|
6.21e-01
|
1.01e-01
|
8.84e-01
|
GO:0005261 monoatomic cation channel activity
|
16
|
4.85e-01
|
-1.01e-01
|
8.23e-01
|
GO:0019228 neuronal action potential
|
15
|
4.99e-01
|
-1.01e-01
|
8.27e-01
|
GO:0044354 macropinosome
|
6
|
6.70e-01
|
-1.01e-01
|
9.01e-01
|
GO:0015101 organic cation transmembrane transporter activity
|
5
|
6.97e-01
|
1.01e-01
|
9.11e-01
|
GO:0006415 translational termination
|
6
|
6.70e-01
|
-1.01e-01
|
9.01e-01
|
GO:0051879 Hsp90 protein binding
|
34
|
3.11e-01
|
-1.00e-01
|
7.01e-01
|
GO:1901525 negative regulation of mitophagy
|
7
|
6.45e-01
|
1.00e-01
|
8.91e-01
|
GO:0030178 negative regulation of Wnt signaling pathway
|
18
|
4.61e-01
|
1.00e-01
|
8.06e-01
|
GO:0046710 GDP metabolic process
|
8
|
6.23e-01
|
1.00e-01
|
8.84e-01
|
GO:0009755 hormone-mediated signaling pathway
|
21
|
4.26e-01
|
1.00e-01
|
7.90e-01
|
GO:0072089 stem cell proliferation
|
20
|
4.38e-01
|
1.00e-01
|
7.95e-01
|
GO:0090103 cochlea morphogenesis
|
8
|
6.24e-01
|
-1.00e-01
|
8.84e-01
|
GO:0051123 RNA polymerase II preinitiation complex assembly
|
47
|
2.35e-01
|
1.00e-01
|
6.39e-01
|
GO:0051170 import into nucleus
|
6
|
6.71e-01
|
-1.00e-01
|
9.01e-01
|
GO:2000234 positive regulation of rRNA processing
|
10
|
5.84e-01
|
1.00e-01
|
8.66e-01
|
GO:0046332 SMAD binding
|
39
|
2.80e-01
|
-1.00e-01
|
6.76e-01
|
GO:0000038 very long-chain fatty acid metabolic process
|
13
|
5.33e-01
|
-9.99e-02
|
8.43e-01
|
GO:0044829 positive regulation by host of viral genome replication
|
10
|
5.84e-01
|
9.99e-02
|
8.67e-01
|
GO:0007289 spermatid nucleus differentiation
|
9
|
6.04e-01
|
9.99e-02
|
8.78e-01
|
GO:0016787 hydrolase activity
|
52
|
2.14e-01
|
9.96e-02
|
6.15e-01
|
GO:0006886 intracellular protein transport
|
227
|
9.93e-03
|
9.96e-02
|
1.76e-01
|
GO:0003729 mRNA binding
|
193
|
1.73e-02
|
-9.96e-02
|
2.21e-01
|
GO:0006370 7-methylguanosine mRNA capping
|
7
|
6.49e-01
|
9.94e-02
|
8.93e-01
|
GO:0071498 cellular response to fluid shear stress
|
12
|
5.51e-01
|
-9.94e-02
|
8.49e-01
|
GO:0098869 cellular oxidant detoxification
|
49
|
2.29e-01
|
9.94e-02
|
6.30e-01
|
GO:0015693 magnesium ion transport
|
13
|
5.35e-01
|
-9.94e-02
|
8.44e-01
|
GO:2000377 regulation of reactive oxygen species metabolic process
|
20
|
4.42e-01
|
9.93e-02
|
7.96e-01
|
GO:0006520 amino acid metabolic process
|
11
|
5.68e-01
|
9.93e-02
|
8.58e-01
|
GO:0003334 keratinocyte development
|
5
|
7.01e-01
|
-9.92e-02
|
9.13e-01
|
GO:0042759 long-chain fatty acid biosynthetic process
|
6
|
6.74e-01
|
-9.92e-02
|
9.02e-01
|
GO:0032720 negative regulation of tumor necrosis factor production
|
46
|
2.45e-01
|
-9.92e-02
|
6.49e-01
|
GO:0016461 unconventional myosin complex
|
6
|
6.74e-01
|
-9.92e-02
|
9.02e-01
|
GO:0030742 GTP-dependent protein binding
|
18
|
4.67e-01
|
9.92e-02
|
8.10e-01
|
GO:0034220 monoatomic ion transmembrane transport
|
53
|
2.12e-01
|
-9.91e-02
|
6.15e-01
|
GO:0043388 positive regulation of DNA binding
|
14
|
5.21e-01
|
9.90e-02
|
8.37e-01
|
GO:0009925 basal plasma membrane
|
43
|
2.62e-01
|
-9.90e-02
|
6.62e-01
|
GO:0051726 regulation of cell cycle
|
197
|
1.69e-02
|
-9.89e-02
|
2.20e-01
|
GO:0004526 ribonuclease P activity
|
11
|
5.70e-01
|
-9.89e-02
|
8.59e-01
|
GO:0038113 interleukin-9-mediated signaling pathway
|
6
|
6.75e-01
|
-9.89e-02
|
9.03e-01
|
GO:0000407 phagophore assembly site
|
29
|
3.57e-01
|
9.89e-02
|
7.40e-01
|
GO:0046323 D-glucose import
|
12
|
5.53e-01
|
9.88e-02
|
8.50e-01
|
GO:0005776 autophagosome
|
72
|
1.48e-01
|
9.88e-02
|
5.38e-01
|
GO:0017166 vinculin binding
|
9
|
6.08e-01
|
-9.88e-02
|
8.80e-01
|
GO:0039536 negative regulation of RIG-I signaling pathway
|
8
|
6.29e-01
|
-9.87e-02
|
8.85e-01
|
GO:0012507 ER to Golgi transport vesicle membrane
|
50
|
2.28e-01
|
9.86e-02
|
6.28e-01
|
GO:0043297 apical junction assembly
|
7
|
6.52e-01
|
-9.85e-02
|
8.94e-01
|
GO:0060136 embryonic process involved in female pregnancy
|
6
|
6.76e-01
|
9.84e-02
|
9.03e-01
|
GO:0015074 DNA integration
|
6
|
6.76e-01
|
-9.84e-02
|
9.03e-01
|
GO:0007163 establishment or maintenance of cell polarity
|
30
|
3.51e-01
|
-9.84e-02
|
7.36e-01
|
GO:0031581 hemidesmosome assembly
|
5
|
7.03e-01
|
-9.84e-02
|
9.14e-01
|
GO:0045907 positive regulation of vasoconstriction
|
14
|
5.24e-01
|
-9.84e-02
|
8.37e-01
|
GO:0017136 histone deacetylase activity, NAD-dependent
|
6
|
6.76e-01
|
-9.84e-02
|
9.03e-01
|
GO:0043030 regulation of macrophage activation
|
10
|
5.90e-01
|
-9.84e-02
|
8.70e-01
|
GO:0097680 double-strand break repair via classical nonhomologous end joining
|
9
|
6.10e-01
|
9.83e-02
|
8.81e-01
|
GO:0032886 regulation of microtubule-based process
|
9
|
6.10e-01
|
-9.83e-02
|
8.81e-01
|
GO:1901741 positive regulation of myoblast fusion
|
11
|
5.72e-01
|
9.83e-02
|
8.61e-01
|
GO:0001676 long-chain fatty acid metabolic process
|
16
|
4.96e-01
|
-9.83e-02
|
8.27e-01
|
GO:0005925 focal adhesion
|
355
|
1.54e-03
|
-9.82e-02
|
5.70e-02
|
GO:0031264 death-inducing signaling complex
|
7
|
6.53e-01
|
9.81e-02
|
8.94e-01
|
GO:0045047 protein targeting to ER
|
15
|
5.11e-01
|
9.81e-02
|
8.34e-01
|
GO:0071392 cellular response to estradiol stimulus
|
25
|
3.96e-01
|
-9.81e-02
|
7.72e-01
|
GO:0000290 deadenylation-dependent decapping of nuclear-transcribed mRNA
|
10
|
5.92e-01
|
9.80e-02
|
8.72e-01
|
GO:0030219 megakaryocyte differentiation
|
6
|
6.78e-01
|
-9.80e-02
|
9.04e-01
|
GO:0051861 glycolipid binding
|
5
|
7.04e-01
|
9.79e-02
|
9.15e-01
|
GO:0035912 dorsal aorta morphogenesis
|
6
|
6.78e-01
|
-9.79e-02
|
9.04e-01
|
GO:0035627 ceramide transport
|
8
|
6.32e-01
|
9.79e-02
|
8.86e-01
|
GO:0001541 ovarian follicle development
|
26
|
3.88e-01
|
9.78e-02
|
7.65e-01
|
GO:0071577 zinc ion transmembrane transport
|
19
|
4.61e-01
|
-9.78e-02
|
8.06e-01
|
GO:2000146 negative regulation of cell motility
|
8
|
6.32e-01
|
-9.78e-02
|
8.86e-01
|
GO:0015293 symporter activity
|
23
|
4.17e-01
|
9.78e-02
|
7.87e-01
|
GO:0010757 negative regulation of plasminogen activation
|
7
|
6.54e-01
|
9.77e-02
|
8.94e-01
|
GO:0004385 guanylate kinase activity
|
9
|
6.12e-01
|
9.76e-02
|
8.81e-01
|
GO:0004713 protein tyrosine kinase activity
|
56
|
2.07e-01
|
-9.76e-02
|
6.11e-01
|
GO:0005548 phospholipid transporter activity
|
6
|
6.79e-01
|
9.76e-02
|
9.04e-01
|
GO:0032926 negative regulation of activin receptor signaling pathway
|
9
|
6.12e-01
|
-9.76e-02
|
8.81e-01
|
GO:0005684 U2-type spliceosomal complex
|
27
|
3.81e-01
|
-9.74e-02
|
7.58e-01
|
GO:0030915 Smc5-Smc6 complex
|
9
|
6.13e-01
|
9.74e-02
|
8.81e-01
|
GO:0051683 establishment of Golgi localization
|
7
|
6.56e-01
|
9.73e-02
|
8.94e-01
|
GO:0043087 regulation of GTPase activity
|
28
|
3.73e-01
|
-9.73e-02
|
7.52e-01
|
GO:0072593 reactive oxygen species metabolic process
|
28
|
3.73e-01
|
9.73e-02
|
7.52e-01
|
GO:0031965 nuclear membrane
|
225
|
1.22e-02
|
-9.72e-02
|
1.96e-01
|
GO:0005245 voltage-gated calcium channel activity
|
17
|
4.88e-01
|
9.72e-02
|
8.24e-01
|
GO:0180010 co-transcriptional mRNA 3’-end processing, cleavage and polyadenylation pathway
|
9
|
6.14e-01
|
-9.71e-02
|
8.81e-01
|
GO:0002605 negative regulation of dendritic cell antigen processing and presentation
|
5
|
7.07e-01
|
-9.71e-02
|
9.16e-01
|
GO:0009165 nucleotide biosynthetic process
|
6
|
6.81e-01
|
-9.71e-02
|
9.05e-01
|
GO:0016342 catenin complex
|
8
|
6.35e-01
|
-9.70e-02
|
8.87e-01
|
GO:2001028 positive regulation of endothelial cell chemotaxis
|
9
|
6.14e-01
|
-9.70e-02
|
8.81e-01
|
GO:0044389 ubiquitin-like protein ligase binding
|
21
|
4.42e-01
|
-9.70e-02
|
7.96e-01
|
GO:0004439 phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity
|
9
|
6.15e-01
|
-9.70e-02
|
8.81e-01
|
GO:0031267 small GTPase binding
|
249
|
8.61e-03
|
-9.70e-02
|
1.63e-01
|
GO:0033192 calmodulin-dependent protein phosphatase activity
|
63
|
1.84e-01
|
-9.69e-02
|
5.85e-01
|
GO:0140791 histone H2AXS140 phosphatase activity
|
63
|
1.84e-01
|
-9.69e-02
|
5.85e-01
|
GO:0180004 RNA polymerase II CTD heptapeptide repeat Y1 phosphatase activity
|
63
|
1.84e-01
|
-9.69e-02
|
5.85e-01
|
GO:0180005 RNA polymerase II CTD heptapeptide repeat T4 phosphatase activity
|
63
|
1.84e-01
|
-9.69e-02
|
5.85e-01
|
GO:0180006 RNA polymerase II CTD heptapeptide repeat S2 phosphatase activity
|
63
|
1.84e-01
|
-9.69e-02
|
5.85e-01
|
GO:0180007 RNA polymerase II CTD heptapeptide repeat S5 phosphatase activity
|
63
|
1.84e-01
|
-9.69e-02
|
5.85e-01
|
GO:0180008 RNA polymerase II CTD heptapeptide repeat S7 phosphatase activity
|
63
|
1.84e-01
|
-9.69e-02
|
5.85e-01
|
GO:1990439 MAP kinase serine/threonine phosphatase activity
|
63
|
1.84e-01
|
-9.69e-02
|
5.85e-01
|
GO:1902554 serine/threonine protein kinase complex
|
11
|
5.78e-01
|
9.69e-02
|
8.64e-01
|
GO:0031175 neuron projection development
|
85
|
1.23e-01
|
9.68e-02
|
4.96e-01
|
GO:0006413 translational initiation
|
53
|
2.23e-01
|
9.68e-02
|
6.22e-01
|
GO:0035591 signaling adaptor activity
|
65
|
1.78e-01
|
-9.67e-02
|
5.79e-01
|
GO:0060539 diaphragm development
|
5
|
7.08e-01
|
9.67e-02
|
9.17e-01
|
GO:0008028 monocarboxylic acid transmembrane transporter activity
|
8
|
6.36e-01
|
9.67e-02
|
8.88e-01
|
GO:0033762 response to glucagon
|
8
|
6.36e-01
|
-9.67e-02
|
8.88e-01
|
GO:0098719 sodium ion import across plasma membrane
|
8
|
6.36e-01
|
-9.67e-02
|
8.88e-01
|
GO:0048711 positive regulation of astrocyte differentiation
|
8
|
6.36e-01
|
-9.66e-02
|
8.88e-01
|
GO:0038027 apolipoprotein A-I-mediated signaling pathway
|
5
|
7.08e-01
|
9.66e-02
|
9.17e-01
|
GO:0042552 myelination
|
44
|
2.68e-01
|
-9.65e-02
|
6.69e-01
|
GO:0097527 necroptotic signaling pathway
|
7
|
6.59e-01
|
-9.65e-02
|
8.96e-01
|
GO:0033673 negative regulation of kinase activity
|
6
|
6.82e-01
|
9.64e-02
|
9.05e-01
|
GO:0005504 fatty acid binding
|
17
|
4.91e-01
|
9.64e-02
|
8.25e-01
|
GO:0046475 glycerophospholipid catabolic process
|
10
|
5.98e-01
|
9.64e-02
|
8.76e-01
|
GO:0030336 negative regulation of cell migration
|
96
|
1.03e-01
|
-9.63e-02
|
4.56e-01
|
GO:0043615 astrocyte cell migration
|
5
|
7.09e-01
|
9.63e-02
|
9.17e-01
|
GO:0043235 receptor complex
|
99
|
9.84e-02
|
-9.62e-02
|
4.50e-01
|
GO:0005540 hyaluronic acid binding
|
10
|
5.99e-01
|
-9.62e-02
|
8.76e-01
|
GO:0005604 basement membrane
|
41
|
2.87e-01
|
-9.61e-02
|
6.81e-01
|
GO:2001234 negative regulation of apoptotic signaling pathway
|
17
|
4.93e-01
|
9.61e-02
|
8.25e-01
|
GO:0003747 translation release factor activity
|
5
|
7.10e-01
|
9.61e-02
|
9.17e-01
|
GO:0030574 collagen catabolic process
|
21
|
4.46e-01
|
-9.60e-02
|
7.99e-01
|
GO:0032355 response to estradiol
|
48
|
2.50e-01
|
-9.60e-02
|
6.53e-01
|
GO:0001947 heart looping
|
36
|
3.20e-01
|
-9.59e-02
|
7.10e-01
|
GO:0045725 positive regulation of glycogen biosynthetic process
|
11
|
5.82e-01
|
-9.59e-02
|
8.65e-01
|
GO:0018345 protein palmitoylation
|
17
|
4.94e-01
|
9.58e-02
|
8.25e-01
|
GO:0010891 negative regulation of sequestering of triglyceride
|
6
|
6.85e-01
|
9.58e-02
|
9.05e-01
|
GO:0019213 deacetylase activity
|
7
|
6.61e-01
|
9.57e-02
|
8.97e-01
|
GO:0010596 negative regulation of endothelial cell migration
|
12
|
5.66e-01
|
9.57e-02
|
8.56e-01
|
GO:1903826 L-arginine transmembrane transport
|
10
|
6.01e-01
|
9.56e-02
|
8.77e-01
|
GO:0004519 endonuclease activity
|
27
|
3.90e-01
|
-9.56e-02
|
7.68e-01
|
GO:0005201 extracellular matrix structural constituent
|
44
|
2.73e-01
|
-9.55e-02
|
6.70e-01
|
GO:0070417 cellular response to cold
|
10
|
6.01e-01
|
9.55e-02
|
8.77e-01
|
GO:0001671 ATPase activator activity
|
24
|
4.18e-01
|
9.55e-02
|
7.87e-01
|
GO:0070233 negative regulation of T cell apoptotic process
|
7
|
6.62e-01
|
-9.54e-02
|
8.98e-01
|
GO:0036342 post-anal tail morphogenesis
|
8
|
6.41e-01
|
-9.53e-02
|
8.88e-01
|
GO:0042592 homeostatic process
|
8
|
6.41e-01
|
9.53e-02
|
8.88e-01
|
GO:0008286 insulin receptor signaling pathway
|
69
|
1.71e-01
|
-9.53e-02
|
5.77e-01
|
GO:0060384 innervation
|
6
|
6.86e-01
|
9.52e-02
|
9.06e-01
|
GO:0006633 fatty acid biosynthetic process
|
29
|
3.75e-01
|
-9.52e-02
|
7.54e-01
|
GO:0031333 negative regulation of protein-containing complex assembly
|
28
|
3.83e-01
|
9.52e-02
|
7.60e-01
|
GO:0042127 regulation of cell population proliferation
|
93
|
1.13e-01
|
-9.52e-02
|
4.76e-01
|
GO:0002283 neutrophil activation involved in immune response
|
7
|
6.63e-01
|
-9.50e-02
|
8.98e-01
|
GO:0005905 clathrin-coated pit
|
51
|
2.41e-01
|
-9.50e-02
|
6.46e-01
|
GO:0003016 respiratory system process
|
13
|
5.53e-01
|
-9.49e-02
|
8.50e-01
|
GO:0030308 negative regulation of cell growth
|
82
|
1.38e-01
|
-9.49e-02
|
5.18e-01
|
GO:0017148 negative regulation of translation
|
73
|
1.61e-01
|
-9.49e-02
|
5.62e-01
|
GO:0004090 carbonyl reductase (NADPH) activity
|
9
|
6.22e-01
|
9.48e-02
|
8.84e-01
|
GO:0060078 regulation of postsynaptic membrane potential
|
8
|
6.44e-01
|
9.45e-02
|
8.89e-01
|
GO:0019904 protein domain specific binding
|
167
|
3.60e-02
|
-9.42e-02
|
2.97e-01
|
GO:0006569 tryptophan catabolic process
|
5
|
7.15e-01
|
9.42e-02
|
9.20e-01
|
GO:0038145 macrophage colony-stimulating factor signaling pathway
|
16
|
5.14e-01
|
-9.42e-02
|
8.34e-01
|
GO:0003677 DNA binding
|
694
|
2.73e-05
|
-9.42e-02
|
3.34e-03
|
GO:1990000 amyloid fibril formation
|
22
|
4.45e-01
|
9.41e-02
|
7.98e-01
|
GO:0090394 negative regulation of excitatory postsynaptic potential
|
6
|
6.90e-01
|
9.40e-02
|
9.06e-01
|
GO:0001701 in utero embryonic development
|
155
|
4.37e-02
|
-9.40e-02
|
3.28e-01
|
GO:0031419 cobalamin binding
|
8
|
6.45e-01
|
-9.40e-02
|
8.91e-01
|
GO:0032007 negative regulation of TOR signaling
|
25
|
4.17e-01
|
-9.39e-02
|
7.87e-01
|
GO:0002042 cell migration involved in sprouting angiogenesis
|
11
|
5.90e-01
|
9.38e-02
|
8.70e-01
|
GO:0035267 NuA4 histone acetyltransferase complex
|
23
|
4.36e-01
|
-9.38e-02
|
7.95e-01
|
GO:0038066 p38MAPK cascade
|
15
|
5.30e-01
|
-9.37e-02
|
8.41e-01
|
GO:0070131 positive regulation of mitochondrial translation
|
18
|
4.92e-01
|
-9.35e-02
|
8.25e-01
|
GO:0097150 neuronal stem cell population maintenance
|
19
|
4.81e-01
|
-9.35e-02
|
8.19e-01
|
GO:0045580 regulation of T cell differentiation
|
9
|
6.28e-01
|
-9.34e-02
|
8.85e-01
|
GO:0002682 regulation of immune system process
|
25
|
4.19e-01
|
-9.34e-02
|
7.87e-01
|
GO:0007175 negative regulation of epidermal growth factor-activated receptor activity
|
9
|
6.28e-01
|
-9.33e-02
|
8.85e-01
|
GO:0001501 skeletal system development
|
50
|
2.54e-01
|
9.33e-02
|
6.56e-01
|
GO:0070534 protein K63-linked ubiquitination
|
53
|
2.41e-01
|
-9.32e-02
|
6.46e-01
|
GO:0006816 calcium ion transport
|
53
|
2.41e-01
|
9.32e-02
|
6.46e-01
|
GO:0098978 glutamatergic synapse
|
367
|
2.28e-03
|
-9.31e-02
|
7.31e-02
|
GO:0034134 toll-like receptor 2 signaling pathway
|
7
|
6.70e-01
|
-9.30e-02
|
9.01e-01
|
GO:0033093 Weibel-Palade body
|
6
|
6.93e-01
|
-9.30e-02
|
9.08e-01
|
GO:0006282 regulation of DNA repair
|
59
|
2.17e-01
|
-9.30e-02
|
6.18e-01
|
GO:0061578 K63-linked deubiquitinase activity
|
14
|
5.48e-01
|
9.28e-02
|
8.49e-01
|
GO:0006367 transcription initiation at RNA polymerase II promoter
|
43
|
2.93e-01
|
9.27e-02
|
6.87e-01
|
GO:0032825 positive regulation of natural killer cell differentiation
|
5
|
7.20e-01
|
-9.27e-02
|
9.22e-01
|
GO:0002248 connective tissue replacement involved in inflammatory response wound healing
|
5
|
7.20e-01
|
9.27e-02
|
9.22e-01
|
GO:0071542 dopaminergic neuron differentiation
|
7
|
6.71e-01
|
9.27e-02
|
9.01e-01
|
GO:0030877 beta-catenin destruction complex
|
9
|
6.31e-01
|
9.26e-02
|
8.86e-01
|
GO:0002062 chondrocyte differentiation
|
28
|
3.97e-01
|
-9.25e-02
|
7.72e-01
|
GO:1990825 sequence-specific mRNA binding
|
9
|
6.31e-01
|
-9.25e-02
|
8.86e-01
|
GO:0006376 mRNA splice site recognition
|
18
|
4.97e-01
|
-9.25e-02
|
8.27e-01
|
GO:0004722 protein serine/threonine phosphatase activity
|
43
|
2.95e-01
|
-9.24e-02
|
6.89e-01
|
GO:0007056 spindle assembly involved in female meiosis
|
5
|
7.21e-01
|
9.24e-02
|
9.22e-01
|
GO:0015095 magnesium ion transmembrane transporter activity
|
15
|
5.36e-01
|
-9.24e-02
|
8.44e-01
|
GO:0002949 tRNA threonylcarbamoyladenosine modification
|
5
|
7.21e-01
|
9.23e-02
|
9.22e-01
|
GO:0043209 myelin sheath
|
18
|
4.98e-01
|
-9.23e-02
|
8.27e-01
|
GO:0010637 negative regulation of mitochondrial fusion
|
8
|
6.51e-01
|
9.23e-02
|
8.93e-01
|
GO:0007219 Notch signaling pathway
|
60
|
2.17e-01
|
9.22e-02
|
6.18e-01
|
GO:0097165 nuclear stress granule
|
7
|
6.73e-01
|
9.21e-02
|
9.02e-01
|
GO:0034727 piecemeal microautophagy of the nucleus
|
18
|
4.99e-01
|
9.20e-02
|
8.27e-01
|
GO:0070317 negative regulation of G0 to G1 transition
|
5
|
7.22e-01
|
-9.19e-02
|
9.23e-01
|
GO:0001525 angiogenesis
|
157
|
4.74e-02
|
-9.19e-02
|
3.39e-01
|
GO:0045582 positive regulation of T cell differentiation
|
28
|
4.01e-01
|
-9.18e-02
|
7.76e-01
|
GO:0047496 vesicle transport along microtubule
|
15
|
5.39e-01
|
-9.17e-02
|
8.45e-01
|
GO:0030292 protein tyrosine kinase inhibitor activity
|
5
|
7.23e-01
|
9.16e-02
|
9.24e-01
|
GO:0036094 small molecule binding
|
10
|
6.16e-01
|
9.16e-02
|
8.82e-01
|
GO:0006879 intracellular iron ion homeostasis
|
51
|
2.59e-01
|
-9.15e-02
|
6.60e-01
|
GO:0030141 secretory granule
|
43
|
3.00e-01
|
9.15e-02
|
6.91e-01
|
GO:0030166 proteoglycan biosynthetic process
|
13
|
5.68e-01
|
9.14e-02
|
8.58e-01
|
GO:0032731 positive regulation of interleukin-1 beta production
|
50
|
2.64e-01
|
9.14e-02
|
6.65e-01
|
GO:0030326 embryonic limb morphogenesis
|
17
|
5.14e-01
|
9.13e-02
|
8.34e-01
|
GO:0098794 postsynapse
|
130
|
7.26e-02
|
-9.13e-02
|
3.93e-01
|
GO:0035102 PRC1 complex
|
15
|
5.41e-01
|
-9.13e-02
|
8.45e-01
|
GO:0061523 cilium disassembly
|
5
|
7.24e-01
|
-9.13e-02
|
9.24e-01
|
GO:0016562 protein import into peroxisome matrix, receptor recycling
|
7
|
6.76e-01
|
9.13e-02
|
9.03e-01
|
GO:0035338 long-chain fatty-acyl-CoA biosynthetic process
|
13
|
5.69e-01
|
9.12e-02
|
8.59e-01
|
GO:0004843 cysteine-type deubiquitinase activity
|
82
|
1.54e-01
|
-9.12e-02
|
5.48e-01
|
GO:0030073 insulin secretion
|
18
|
5.03e-01
|
9.11e-02
|
8.30e-01
|
GO:0008203 cholesterol metabolic process
|
51
|
2.61e-01
|
-9.10e-02
|
6.62e-01
|
GO:0042273 ribosomal large subunit biogenesis
|
33
|
3.66e-01
|
9.10e-02
|
7.49e-01
|
GO:0043518 negative regulation of DNA damage response, signal transduction by p53 class mediator
|
12
|
5.86e-01
|
-9.09e-02
|
8.68e-01
|
GO:0046488 phosphatidylinositol metabolic process
|
13
|
5.71e-01
|
-9.08e-02
|
8.60e-01
|
GO:0072675 osteoclast fusion
|
6
|
7.00e-01
|
9.08e-02
|
9.13e-01
|
GO:0005654 nucleoplasm
|
3278
|
2.01e-15
|
-9.08e-02
|
1.18e-11
|
GO:0044331 cell-cell adhesion mediated by cadherin
|
9
|
6.38e-01
|
9.06e-02
|
8.88e-01
|
GO:0061744 motor behavior
|
20
|
4.83e-01
|
-9.06e-02
|
8.22e-01
|
GO:0034452 dynactin binding
|
10
|
6.20e-01
|
-9.05e-02
|
8.84e-01
|
GO:0035999 tetrahydrofolate interconversion
|
9
|
6.39e-01
|
9.04e-02
|
8.88e-01
|
GO:0051932 synaptic transmission, GABAergic
|
10
|
6.21e-01
|
9.04e-02
|
8.84e-01
|
GO:0010669 epithelial structure maintenance
|
9
|
6.39e-01
|
-9.04e-02
|
8.88e-01
|
GO:0045893 positive regulation of DNA-templated transcription
|
513
|
4.99e-04
|
-9.03e-02
|
2.97e-02
|
GO:0036057 slit diaphragm
|
5
|
7.27e-01
|
-9.03e-02
|
9.25e-01
|
GO:0051602 response to electrical stimulus
|
18
|
5.08e-01
|
9.02e-02
|
8.33e-01
|
GO:0008021 synaptic vesicle
|
80
|
1.63e-01
|
9.02e-02
|
5.65e-01
|
GO:0140416 transcription regulator inhibitor activity
|
23
|
4.54e-01
|
-9.02e-02
|
8.03e-01
|
GO:0031623 receptor internalization
|
44
|
3.01e-01
|
-9.02e-02
|
6.92e-01
|
GO:0048469 cell maturation
|
11
|
6.05e-01
|
9.01e-02
|
8.79e-01
|
GO:0034695 response to prostaglandin E
|
10
|
6.22e-01
|
-9.01e-02
|
8.84e-01
|
GO:0040014 regulation of multicellular organism growth
|
18
|
5.08e-01
|
-9.01e-02
|
8.34e-01
|
GO:0006090 pyruvate metabolic process
|
9
|
6.40e-01
|
9.01e-02
|
8.88e-01
|
GO:0001886 endothelial cell morphogenesis
|
5
|
7.27e-01
|
9.01e-02
|
9.25e-01
|
GO:0030262 apoptotic nuclear changes
|
5
|
7.27e-01
|
-9.00e-02
|
9.25e-01
|
GO:0051145 smooth muscle cell differentiation
|
5
|
7.27e-01
|
-9.00e-02
|
9.25e-01
|
GO:0034982 mitochondrial protein processing
|
6
|
7.03e-01
|
-9.00e-02
|
9.14e-01
|
GO:0060716 labyrinthine layer blood vessel development
|
15
|
5.46e-01
|
-9.00e-02
|
8.48e-01
|
GO:0097623 potassium ion export across plasma membrane
|
5
|
7.28e-01
|
8.99e-02
|
9.25e-01
|
GO:0032237 activation of store-operated calcium channel activity
|
5
|
7.28e-01
|
-8.97e-02
|
9.25e-01
|
GO:0043236 laminin binding
|
17
|
5.23e-01
|
8.95e-02
|
8.37e-01
|
GO:0031953 negative regulation of protein autophosphorylation
|
5
|
7.29e-01
|
8.93e-02
|
9.25e-01
|
GO:0017156 calcium-ion regulated exocytosis
|
12
|
5.93e-01
|
-8.92e-02
|
8.73e-01
|
GO:0009083 branched-chain amino acid catabolic process
|
13
|
5.78e-01
|
8.92e-02
|
8.64e-01
|
GO:0016491 oxidoreductase activity
|
64
|
2.18e-01
|
8.92e-02
|
6.18e-01
|
GO:0018026 peptidyl-lysine monomethylation
|
7
|
6.83e-01
|
8.91e-02
|
9.05e-01
|
GO:0097345 mitochondrial outer membrane permeabilization
|
8
|
6.63e-01
|
-8.91e-02
|
8.98e-01
|
GO:0046889 positive regulation of lipid biosynthetic process
|
14
|
5.64e-01
|
8.91e-02
|
8.56e-01
|
GO:0006904 vesicle docking involved in exocytosis
|
22
|
4.70e-01
|
8.90e-02
|
8.13e-01
|
GO:0042149 cellular response to glucose starvation
|
46
|
2.97e-01
|
-8.90e-02
|
6.90e-01
|
GO:0046676 negative regulation of insulin secretion
|
12
|
5.94e-01
|
-8.90e-02
|
8.73e-01
|
GO:0045259 proton-transporting ATP synthase complex
|
15
|
5.51e-01
|
-8.89e-02
|
8.49e-01
|
GO:2000045 regulation of G1/S transition of mitotic cell cycle
|
48
|
2.87e-01
|
-8.89e-02
|
6.81e-01
|
GO:0017018 myosin phosphatase activity
|
64
|
2.19e-01
|
-8.89e-02
|
6.20e-01
|
GO:0010968 regulation of microtubule nucleation
|
10
|
6.26e-01
|
8.89e-02
|
8.85e-01
|
GO:0036016 cellular response to interleukin-3
|
7
|
6.84e-01
|
8.89e-02
|
9.05e-01
|
GO:0051592 response to calcium ion
|
36
|
3.56e-01
|
-8.89e-02
|
7.39e-01
|
GO:0034975 protein folding in endoplasmic reticulum
|
11
|
6.10e-01
|
8.88e-02
|
8.81e-01
|
GO:0045263 proton-transporting ATP synthase complex, coupling factor F(o)
|
13
|
5.79e-01
|
-8.88e-02
|
8.65e-01
|
GO:0009062 fatty acid catabolic process
|
10
|
6.27e-01
|
8.88e-02
|
8.85e-01
|
GO:0045054 constitutive secretory pathway
|
5
|
7.31e-01
|
8.88e-02
|
9.26e-01
|
GO:0097398 cellular response to interleukin-17
|
5
|
7.31e-01
|
-8.86e-02
|
9.26e-01
|
GO:0010591 regulation of lamellipodium assembly
|
7
|
6.85e-01
|
8.86e-02
|
9.05e-01
|
GO:0060117 auditory receptor cell development
|
7
|
6.85e-01
|
-8.86e-02
|
9.05e-01
|
GO:0050699 WW domain binding
|
18
|
5.16e-01
|
8.85e-02
|
8.34e-01
|
GO:0000408 EKC/KEOPS complex
|
5
|
7.32e-01
|
8.85e-02
|
9.27e-01
|
GO:0042532 negative regulation of tyrosine phosphorylation of STAT protein
|
5
|
7.32e-01
|
8.84e-02
|
9.27e-01
|
GO:0051561 positive regulation of mitochondrial calcium ion concentration
|
9
|
6.46e-01
|
8.83e-02
|
8.92e-01
|
GO:0045579 positive regulation of B cell differentiation
|
13
|
5.82e-01
|
-8.83e-02
|
8.65e-01
|
GO:1903955 positive regulation of protein targeting to mitochondrion
|
32
|
3.88e-01
|
-8.82e-02
|
7.65e-01
|
GO:0034765 regulation of monoatomic ion transmembrane transport
|
9
|
6.47e-01
|
-8.81e-02
|
8.92e-01
|
GO:0008432 JUN kinase binding
|
9
|
6.48e-01
|
8.79e-02
|
8.93e-01
|
GO:0005158 insulin receptor binding
|
16
|
5.44e-01
|
-8.77e-02
|
8.47e-01
|
GO:0002827 positive regulation of T-helper 1 type immune response
|
6
|
7.10e-01
|
8.77e-02
|
9.17e-01
|
GO:0035556 intracellular signal transduction
|
304
|
8.81e-03
|
-8.76e-02
|
1.66e-01
|
GO:0040019 positive regulation of embryonic development
|
9
|
6.49e-01
|
8.76e-02
|
8.93e-01
|
GO:1903169 regulation of calcium ion transmembrane transport
|
5
|
7.35e-01
|
8.75e-02
|
9.28e-01
|
GO:0035197 siRNA binding
|
8
|
6.69e-01
|
-8.74e-02
|
9.01e-01
|
GO:0019899 enzyme binding
|
284
|
1.16e-02
|
-8.74e-02
|
1.90e-01
|
GO:0099149 regulation of postsynaptic neurotransmitter receptor internalization
|
18
|
5.21e-01
|
8.73e-02
|
8.37e-01
|
GO:0005783 endoplasmic reticulum
|
822
|
2.54e-05
|
8.73e-02
|
3.16e-03
|
GO:0035255 ionotropic glutamate receptor binding
|
17
|
5.34e-01
|
-8.72e-02
|
8.43e-01
|
GO:0016239 positive regulation of macroautophagy
|
24
|
4.60e-01
|
-8.72e-02
|
8.06e-01
|
GO:0017146 NMDA selective glutamate receptor complex
|
5
|
7.36e-01
|
8.71e-02
|
9.29e-01
|
GO:0035115 embryonic forelimb morphogenesis
|
13
|
5.87e-01
|
8.71e-02
|
8.68e-01
|
GO:0002064 epithelial cell development
|
7
|
6.90e-01
|
-8.70e-02
|
9.06e-01
|
GO:0019076 viral release from host cell
|
18
|
5.23e-01
|
8.70e-02
|
8.37e-01
|
GO:0009247 glycolipid biosynthetic process
|
7
|
6.90e-01
|
8.69e-02
|
9.06e-01
|
GO:0035024 negative regulation of Rho protein signal transduction
|
19
|
5.12e-01
|
-8.69e-02
|
8.34e-01
|
GO:0008219 cell death
|
5
|
7.37e-01
|
-8.68e-02
|
9.29e-01
|
GO:0046339 diacylglycerol metabolic process
|
12
|
6.03e-01
|
8.67e-02
|
8.78e-01
|
GO:0021983 pituitary gland development
|
9
|
6.52e-01
|
8.67e-02
|
8.94e-01
|
GO:0006259 DNA metabolic process
|
17
|
5.36e-01
|
-8.67e-02
|
8.44e-01
|
GO:0038163 thrombopoietin-mediated signaling pathway
|
5
|
7.37e-01
|
-8.66e-02
|
9.29e-01
|
GO:0051147 regulation of muscle cell differentiation
|
5
|
7.38e-01
|
-8.65e-02
|
9.29e-01
|
GO:0019903 protein phosphatase binding
|
71
|
2.08e-01
|
-8.65e-02
|
6.12e-01
|
GO:2000622 regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay
|
5
|
7.38e-01
|
-8.65e-02
|
9.29e-01
|
GO:0010632 regulation of epithelial cell migration
|
6
|
7.14e-01
|
-8.64e-02
|
9.19e-01
|
GO:0030130 clathrin coat of trans-Golgi network vesicle
|
6
|
7.14e-01
|
-8.64e-02
|
9.19e-01
|
GO:0071425 hematopoietic stem cell proliferation
|
17
|
5.37e-01
|
8.64e-02
|
8.45e-01
|
GO:1902749 regulation of cell cycle G2/M phase transition
|
7
|
6.93e-01
|
-8.63e-02
|
9.08e-01
|
GO:1900242 regulation of synaptic vesicle endocytosis
|
16
|
5.50e-01
|
-8.63e-02
|
8.49e-01
|
GO:0048384 retinoic acid receptor signaling pathway
|
16
|
5.50e-01
|
-8.63e-02
|
8.49e-01
|
GO:1900426 positive regulation of defense response to bacterium
|
5
|
7.38e-01
|
-8.62e-02
|
9.29e-01
|
GO:0006897 endocytosis
|
134
|
8.53e-02
|
-8.62e-02
|
4.24e-01
|
GO:0006302 double-strand break repair
|
70
|
2.13e-01
|
-8.62e-02
|
6.15e-01
|
GO:0030518 nuclear receptor-mediated steroid hormone signaling pathway
|
7
|
6.93e-01
|
-8.61e-02
|
9.08e-01
|
GO:0007214 gamma-aminobutyric acid signaling pathway
|
9
|
6.55e-01
|
-8.61e-02
|
8.94e-01
|
GO:0030224 monocyte differentiation
|
16
|
5.52e-01
|
-8.60e-02
|
8.49e-01
|
GO:0043434 response to peptide hormone
|
30
|
4.15e-01
|
8.59e-02
|
7.87e-01
|
GO:0035567 non-canonical Wnt signaling pathway
|
13
|
5.92e-01
|
-8.59e-02
|
8.72e-01
|
GO:0005768 endosome
|
220
|
2.85e-02
|
8.59e-02
|
2.70e-01
|
GO:0042448 progesterone metabolic process
|
5
|
7.40e-01
|
8.59e-02
|
9.29e-01
|
GO:0060395 SMAD protein signal transduction
|
21
|
4.96e-01
|
-8.58e-02
|
8.27e-01
|
GO:0006515 protein quality control for misfolded or incompletely synthesized proteins
|
17
|
5.41e-01
|
8.57e-02
|
8.45e-01
|
GO:0051292 nuclear pore complex assembly
|
11
|
6.22e-01
|
-8.57e-02
|
8.84e-01
|
GO:0031490 chromatin DNA binding
|
54
|
2.76e-01
|
-8.57e-02
|
6.71e-01
|
GO:0005575 cellular component
|
31
|
4.09e-01
|
-8.57e-02
|
7.82e-01
|
GO:0060391 positive regulation of SMAD protein signal transduction
|
27
|
4.41e-01
|
8.57e-02
|
7.96e-01
|
GO:0030854 positive regulation of granulocyte differentiation
|
5
|
7.40e-01
|
-8.57e-02
|
9.29e-01
|
GO:0001974 blood vessel remodeling
|
20
|
5.07e-01
|
-8.57e-02
|
8.33e-01
|
GO:0016188 synaptic vesicle maturation
|
8
|
6.75e-01
|
-8.56e-02
|
9.03e-01
|
GO:1904706 negative regulation of vascular associated smooth muscle cell proliferation
|
16
|
5.53e-01
|
-8.56e-02
|
8.50e-01
|
GO:0021756 striatum development
|
12
|
6.08e-01
|
8.56e-02
|
8.80e-01
|
GO:0071901 negative regulation of protein serine/threonine kinase activity
|
11
|
6.24e-01
|
-8.54e-02
|
8.84e-01
|
GO:0007169 cell surface receptor protein tyrosine kinase signaling pathway
|
46
|
3.17e-01
|
-8.53e-02
|
7.09e-01
|
GO:0032009 early phagosome
|
8
|
6.77e-01
|
-8.50e-02
|
9.04e-01
|
GO:0001881 receptor recycling
|
11
|
6.25e-01
|
8.50e-02
|
8.85e-01
|
GO:0046836 glycolipid transport
|
6
|
7.18e-01
|
-8.50e-02
|
9.22e-01
|
GO:1990116 ribosome-associated ubiquitin-dependent protein catabolic process
|
7
|
6.97e-01
|
-8.49e-02
|
9.11e-01
|
GO:0000242 pericentriolar material
|
20
|
5.11e-01
|
8.49e-02
|
8.34e-01
|
GO:0000122 negative regulation of transcription by RNA polymerase II
|
617
|
3.49e-04
|
-8.49e-02
|
2.20e-02
|
GO:0034976 response to endoplasmic reticulum stress
|
87
|
1.72e-01
|
8.47e-02
|
5.77e-01
|
GO:0045494 photoreceptor cell maintenance
|
26
|
4.55e-01
|
8.46e-02
|
8.03e-01
|
GO:0071499 cellular response to laminar fluid shear stress
|
7
|
6.99e-01
|
-8.44e-02
|
9.12e-01
|
GO:0000172 ribonuclease MRP complex
|
9
|
6.61e-01
|
-8.44e-02
|
8.97e-01
|
GO:0005828 kinetochore microtubule
|
19
|
5.25e-01
|
-8.43e-02
|
8.37e-01
|
GO:1904263 positive regulation of TORC1 signaling
|
51
|
2.98e-01
|
-8.43e-02
|
6.91e-01
|
GO:0050729 positive regulation of inflammatory response
|
71
|
2.20e-01
|
-8.43e-02
|
6.20e-01
|
GO:0033137 negative regulation of peptidyl-serine phosphorylation
|
12
|
6.13e-01
|
-8.43e-02
|
8.81e-01
|
GO:0010649 regulation of cell communication by electrical coupling
|
5
|
7.45e-01
|
8.42e-02
|
9.32e-01
|
GO:0015385 sodium:proton antiporter activity
|
7
|
7.00e-01
|
8.41e-02
|
9.13e-01
|
GO:0019065 receptor-mediated endocytosis of virus by host cell
|
7
|
7.00e-01
|
8.41e-02
|
9.13e-01
|
GO:0007029 endoplasmic reticulum organization
|
34
|
3.97e-01
|
8.40e-02
|
7.72e-01
|
GO:0042391 regulation of membrane potential
|
19
|
5.26e-01
|
-8.40e-02
|
8.38e-01
|
GO:0035580 specific granule lumen
|
47
|
3.19e-01
|
8.40e-02
|
7.10e-01
|
GO:0070830 bicellular tight junction assembly
|
23
|
4.86e-01
|
8.40e-02
|
8.23e-01
|
GO:0001824 blastocyst development
|
17
|
5.49e-01
|
8.40e-02
|
8.49e-01
|
GO:0060052 neurofilament cytoskeleton organization
|
8
|
6.81e-01
|
8.40e-02
|
9.05e-01
|
GO:0055117 regulation of cardiac muscle contraction
|
11
|
6.30e-01
|
8.39e-02
|
8.86e-01
|
GO:0004497 monooxygenase activity
|
12
|
6.15e-01
|
-8.39e-02
|
8.82e-01
|
GO:0031214 biomineral tissue development
|
10
|
6.46e-01
|
8.39e-02
|
8.91e-01
|
GO:0001786 phosphatidylserine binding
|
37
|
3.78e-01
|
-8.38e-02
|
7.57e-01
|
GO:0002830 positive regulation of type 2 immune response
|
5
|
7.46e-01
|
8.38e-02
|
9.32e-01
|
GO:0070863 positive regulation of protein exit from endoplasmic reticulum
|
5
|
7.46e-01
|
8.38e-02
|
9.32e-01
|
GO:0042573 retinoic acid metabolic process
|
6
|
7.23e-01
|
8.37e-02
|
9.24e-01
|
GO:0003151 outflow tract morphogenesis
|
27
|
4.52e-01
|
-8.36e-02
|
8.02e-01
|
GO:0010804 negative regulation of tumor necrosis factor-mediated signaling pathway
|
16
|
5.63e-01
|
8.35e-02
|
8.56e-01
|
GO:0045254 pyruvate dehydrogenase complex
|
7
|
7.02e-01
|
-8.34e-02
|
9.14e-01
|
GO:0001843 neural tube closure
|
63
|
2.52e-01
|
-8.34e-02
|
6.55e-01
|
GO:0098909 regulation of cardiac muscle cell action potential involved in regulation of contraction
|
5
|
7.47e-01
|
8.34e-02
|
9.32e-01
|
GO:0008134 transcription factor binding
|
16
|
5.64e-01
|
8.33e-02
|
8.56e-01
|
GO:0070301 cellular response to hydrogen peroxide
|
52
|
2.99e-01
|
-8.33e-02
|
6.91e-01
|
GO:0032526 response to retinoic acid
|
30
|
4.30e-01
|
8.32e-02
|
7.92e-01
|
GO:0045070 positive regulation of viral genome replication
|
27
|
4.54e-01
|
8.32e-02
|
8.03e-01
|
GO:0043525 positive regulation of neuron apoptotic process
|
48
|
3.19e-01
|
8.32e-02
|
7.10e-01
|
GO:0048168 regulation of neuronal synaptic plasticity
|
15
|
5.77e-01
|
-8.31e-02
|
8.64e-01
|
GO:0042060 wound healing
|
44
|
3.41e-01
|
-8.31e-02
|
7.27e-01
|
GO:0005506 iron ion binding
|
59
|
2.70e-01
|
-8.31e-02
|
6.70e-01
|
GO:1904862 inhibitory synapse assembly
|
5
|
7.48e-01
|
8.30e-02
|
9.32e-01
|
GO:0051259 protein complex oligomerization
|
20
|
5.21e-01
|
8.29e-02
|
8.37e-01
|
GO:0006468 protein phosphorylation
|
235
|
2.91e-02
|
-8.29e-02
|
2.71e-01
|
GO:0007155 cell adhesion
|
216
|
3.64e-02
|
-8.28e-02
|
2.97e-01
|
GO:0005758 mitochondrial intermembrane space
|
79
|
2.04e-01
|
-8.28e-02
|
6.09e-01
|
GO:0030901 midbrain development
|
13
|
6.06e-01
|
-8.27e-02
|
8.79e-01
|
GO:0031672 A band
|
6
|
7.26e-01
|
8.27e-02
|
9.25e-01
|
GO:0006978 DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator
|
9
|
6.68e-01
|
8.26e-02
|
9.00e-01
|
GO:0072344 rescue of stalled ribosome
|
30
|
4.34e-01
|
8.26e-02
|
7.94e-01
|
GO:0031625 ubiquitin protein ligase binding
|
264
|
2.12e-02
|
-8.26e-02
|
2.40e-01
|
GO:0008083 growth factor activity
|
53
|
2.99e-01
|
-8.26e-02
|
6.91e-01
|
GO:0048814 regulation of dendrite morphogenesis
|
12
|
6.21e-01
|
8.25e-02
|
8.84e-01
|
GO:0005975 carbohydrate metabolic process
|
84
|
1.92e-01
|
8.25e-02
|
5.96e-01
|
GO:0036151 phosphatidylcholine acyl-chain remodeling
|
13
|
6.07e-01
|
-8.24e-02
|
8.80e-01
|
GO:0008344 adult locomotory behavior
|
27
|
4.59e-01
|
8.23e-02
|
8.05e-01
|
GO:0030983 mismatched DNA binding
|
8
|
6.87e-01
|
-8.23e-02
|
9.06e-01
|
GO:0045732 positive regulation of protein catabolic process
|
65
|
2.51e-01
|
-8.23e-02
|
6.53e-01
|
GO:0032039 integrator complex
|
18
|
5.46e-01
|
-8.23e-02
|
8.47e-01
|
GO:0042982 amyloid precursor protein metabolic process
|
9
|
6.69e-01
|
8.22e-02
|
9.01e-01
|
GO:0031103 axon regeneration
|
10
|
6.53e-01
|
8.21e-02
|
8.94e-01
|
GO:0030122 AP-2 adaptor complex
|
8
|
6.87e-01
|
8.21e-02
|
9.06e-01
|
GO:0048010 vascular endothelial growth factor receptor signaling pathway
|
19
|
5.35e-01
|
-8.21e-02
|
8.44e-01
|
GO:0004383 guanylate cyclase activity
|
6
|
7.28e-01
|
8.21e-02
|
9.25e-01
|
GO:0006182 cGMP biosynthetic process
|
6
|
7.28e-01
|
8.21e-02
|
9.25e-01
|
GO:0042780 tRNA 3’-end processing
|
5
|
7.51e-01
|
8.21e-02
|
9.33e-01
|
GO:0016192 vesicle-mediated transport
|
144
|
8.99e-02
|
8.20e-02
|
4.33e-01
|
GO:0048714 positive regulation of oligodendrocyte differentiation
|
12
|
6.23e-01
|
-8.20e-02
|
8.84e-01
|
GO:0051536 iron-sulfur cluster binding
|
9
|
6.70e-01
|
-8.20e-02
|
9.01e-01
|
GO:0008821 crossover junction DNA endonuclease activity
|
7
|
7.08e-01
|
-8.18e-02
|
9.17e-01
|
GO:0007032 endosome organization
|
35
|
4.02e-01
|
-8.18e-02
|
7.77e-01
|
GO:0046761 viral budding from plasma membrane
|
13
|
6.10e-01
|
8.18e-02
|
8.81e-01
|
GO:0035459 vesicle cargo loading
|
6
|
7.29e-01
|
8.18e-02
|
9.25e-01
|
GO:0007608 sensory perception of smell
|
17
|
5.60e-01
|
8.17e-02
|
8.55e-01
|
GO:0016684 oxidoreductase activity, acting on peroxide as acceptor
|
5
|
7.52e-01
|
-8.17e-02
|
9.34e-01
|
GO:0048839 inner ear development
|
24
|
4.89e-01
|
8.15e-02
|
8.24e-01
|
GO:0032874 positive regulation of stress-activated MAPK cascade
|
19
|
5.39e-01
|
8.15e-02
|
8.45e-01
|
GO:0015630 microtubule cytoskeleton
|
153
|
8.24e-02
|
-8.15e-02
|
4.17e-01
|
GO:0016529 sarcoplasmic reticulum
|
24
|
4.90e-01
|
-8.15e-02
|
8.24e-01
|
GO:0007250 activation of NF-kappaB-inducing kinase activity
|
9
|
6.72e-01
|
-8.14e-02
|
9.02e-01
|
GO:0007631 feeding behavior
|
8
|
6.90e-01
|
8.13e-02
|
9.06e-01
|
GO:0048703 embryonic viscerocranium morphogenesis
|
7
|
7.09e-01
|
-8.13e-02
|
9.17e-01
|
GO:0016973 poly(A)+ mRNA export from nucleus
|
19
|
5.40e-01
|
-8.12e-02
|
8.45e-01
|
GO:0045776 negative regulation of blood pressure
|
14
|
5.99e-01
|
8.12e-02
|
8.76e-01
|
GO:2001240 negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
21
|
5.20e-01
|
8.12e-02
|
8.35e-01
|
GO:0048169 regulation of long-term neuronal synaptic plasticity
|
13
|
6.12e-01
|
8.12e-02
|
8.81e-01
|
GO:0030532 small nuclear ribonucleoprotein complex
|
14
|
5.99e-01
|
8.11e-02
|
8.76e-01
|
GO:0038092 nodal signaling pathway
|
5
|
7.54e-01
|
8.11e-02
|
9.34e-01
|
GO:0002218 activation of innate immune response
|
31
|
4.35e-01
|
-8.11e-02
|
7.94e-01
|
GO:0042834 peptidoglycan binding
|
7
|
7.10e-01
|
-8.10e-02
|
9.17e-01
|
GO:0005353 fructose transmembrane transporter activity
|
6
|
7.31e-01
|
-8.10e-02
|
9.26e-01
|
GO:1903438 positive regulation of mitotic cytokinetic process
|
7
|
7.11e-01
|
-8.09e-02
|
9.18e-01
|
GO:0090141 positive regulation of mitochondrial fission
|
17
|
5.64e-01
|
8.09e-02
|
8.56e-01
|
GO:0006869 lipid transport
|
44
|
3.54e-01
|
-8.08e-02
|
7.38e-01
|
GO:0044818 mitotic G2/M transition checkpoint
|
20
|
5.32e-01
|
-8.08e-02
|
8.43e-01
|
GO:0035578 azurophil granule lumen
|
74
|
2.30e-01
|
8.08e-02
|
6.31e-01
|
GO:0060613 fat pad development
|
8
|
6.93e-01
|
8.06e-02
|
9.08e-01
|
GO:0050709 negative regulation of protein secretion
|
12
|
6.29e-01
|
8.05e-02
|
8.85e-01
|
GO:0004177 aminopeptidase activity
|
27
|
4.69e-01
|
-8.05e-02
|
8.13e-01
|
GO:0007154 cell communication
|
6
|
7.33e-01
|
8.05e-02
|
9.27e-01
|
GO:0060348 bone development
|
39
|
3.85e-01
|
8.04e-02
|
7.62e-01
|
GO:0060252 positive regulation of glial cell proliferation
|
14
|
6.03e-01
|
8.04e-02
|
8.78e-01
|
GO:0038155 interleukin-23-mediated signaling pathway
|
5
|
7.56e-01
|
-8.04e-02
|
9.35e-01
|
GO:0060071 Wnt signaling pathway, planar cell polarity pathway
|
21
|
5.24e-01
|
-8.03e-02
|
8.37e-01
|
GO:0048701 embryonic cranial skeleton morphogenesis
|
14
|
6.04e-01
|
8.02e-02
|
8.78e-01
|
GO:0097250 mitochondrial respirasome assembly
|
6
|
7.34e-01
|
8.00e-02
|
9.28e-01
|
GO:1901524 regulation of mitophagy
|
13
|
6.18e-01
|
-8.00e-02
|
8.82e-01
|
GO:0140374 antiviral innate immune response
|
48
|
3.38e-01
|
7.99e-02
|
7.25e-01
|
GO:0045471 response to ethanol
|
58
|
2.93e-01
|
-7.99e-02
|
6.87e-01
|
GO:0071318 cellular response to ATP
|
14
|
6.05e-01
|
7.98e-02
|
8.79e-01
|
GO:0035726 common myeloid progenitor cell proliferation
|
6
|
7.35e-01
|
-7.97e-02
|
9.29e-01
|
GO:0008076 voltage-gated potassium channel complex
|
34
|
4.22e-01
|
-7.96e-02
|
7.87e-01
|
GO:0015232 heme transmembrane transporter activity
|
7
|
7.16e-01
|
-7.95e-02
|
9.20e-01
|
GO:0060041 retina development in camera-type eye
|
34
|
4.22e-01
|
7.95e-02
|
7.87e-01
|
GO:1990830 cellular response to leukemia inhibitory factor
|
74
|
2.37e-01
|
-7.95e-02
|
6.42e-01
|
GO:0035790 platelet-derived growth factor receptor-alpha signaling pathway
|
15
|
5.94e-01
|
-7.94e-02
|
8.74e-01
|
GO:1902774 late endosome to lysosome transport
|
17
|
5.71e-01
|
7.94e-02
|
8.60e-01
|
GO:0000014 single-stranded DNA endodeoxyribonuclease activity
|
10
|
6.64e-01
|
7.94e-02
|
8.98e-01
|
GO:0044725 epigenetic programming in the zygotic pronuclei
|
7
|
7.17e-01
|
7.92e-02
|
9.21e-01
|
GO:0048872 homeostasis of number of cells
|
15
|
5.96e-01
|
7.92e-02
|
8.74e-01
|
GO:0030851 granulocyte differentiation
|
12
|
6.35e-01
|
7.92e-02
|
8.87e-01
|
GO:0000413 protein peptidyl-prolyl isomerization
|
5
|
7.59e-01
|
-7.91e-02
|
9.35e-01
|
GO:0001654 eye development
|
20
|
5.40e-01
|
7.91e-02
|
8.45e-01
|
GO:0106310 protein serine kinase activity
|
290
|
2.09e-02
|
-7.91e-02
|
2.38e-01
|
GO:0032527 protein exit from endoplasmic reticulum
|
8
|
6.98e-01
|
7.91e-02
|
9.12e-01
|
GO:0001958 endochondral ossification
|
13
|
6.21e-01
|
7.91e-02
|
8.84e-01
|
GO:0043034 costamere
|
14
|
6.08e-01
|
-7.91e-02
|
8.80e-01
|
GO:0009303 rRNA transcription
|
11
|
6.50e-01
|
-7.90e-02
|
8.93e-01
|
GO:0050807 regulation of synapse organization
|
18
|
5.62e-01
|
-7.90e-02
|
8.56e-01
|
GO:0001818 negative regulation of cytokine production
|
28
|
4.70e-01
|
-7.89e-02
|
8.13e-01
|
GO:0003925 G protein activity
|
43
|
3.71e-01
|
-7.89e-02
|
7.51e-01
|
GO:0030674 protein-macromolecule adaptor activity
|
136
|
1.13e-01
|
-7.89e-02
|
4.75e-01
|
GO:0006489 dolichyl diphosphate biosynthetic process
|
5
|
7.60e-01
|
-7.88e-02
|
9.35e-01
|
GO:0061045 negative regulation of wound healing
|
6
|
7.38e-01
|
-7.88e-02
|
9.29e-01
|
GO:0051897 positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
|
107
|
1.61e-01
|
-7.86e-02
|
5.61e-01
|
GO:0005765 lysosomal membrane
|
336
|
1.36e-02
|
-7.86e-02
|
2.04e-01
|
GO:0042255 ribosome assembly
|
8
|
7.00e-01
|
7.86e-02
|
9.13e-01
|
GO:0033588 elongator holoenzyme complex
|
6
|
7.39e-01
|
7.84e-02
|
9.29e-01
|
GO:0000124 SAGA complex
|
25
|
4.97e-01
|
-7.84e-02
|
8.27e-01
|
GO:0060055 angiogenesis involved in wound healing
|
7
|
7.20e-01
|
7.84e-02
|
9.22e-01
|
GO:0140900 chloride:bicarbonate antiporter activity
|
6
|
7.40e-01
|
7.83e-02
|
9.29e-01
|
GO:0042826 histone deacetylase binding
|
93
|
1.92e-01
|
-7.83e-02
|
5.97e-01
|
GO:0008284 positive regulation of cell population proliferation
|
270
|
2.72e-02
|
-7.83e-02
|
2.66e-01
|
GO:1900227 positive regulation of NLRP3 inflammasome complex assembly
|
25
|
4.98e-01
|
-7.83e-02
|
8.27e-01
|
GO:0099159 regulation of modification of postsynaptic structure
|
9
|
6.85e-01
|
7.82e-02
|
9.05e-01
|
GO:0019905 syntaxin binding
|
38
|
4.04e-01
|
7.82e-02
|
7.79e-01
|
GO:0042288 MHC class I protein binding
|
14
|
6.13e-01
|
-7.82e-02
|
8.81e-01
|
GO:0005375 copper ion transmembrane transporter activity
|
6
|
7.40e-01
|
-7.82e-02
|
9.29e-01
|
GO:0008611 ether lipid biosynthetic process
|
7
|
7.20e-01
|
7.81e-02
|
9.22e-01
|
GO:0035176 social behavior
|
29
|
4.67e-01
|
-7.80e-02
|
8.11e-01
|
GO:0008234 cysteine-type peptidase activity
|
26
|
4.91e-01
|
7.80e-02
|
8.25e-01
|
GO:0015755 fructose transmembrane transport
|
7
|
7.21e-01
|
-7.80e-02
|
9.22e-01
|
GO:0003707 nuclear steroid receptor activity
|
14
|
6.14e-01
|
-7.78e-02
|
8.81e-01
|
GO:0034113 heterotypic cell-cell adhesion
|
20
|
5.47e-01
|
-7.78e-02
|
8.48e-01
|
GO:0036064 ciliary basal body
|
136
|
1.18e-01
|
7.78e-02
|
4.84e-01
|
GO:0030496 midbody
|
172
|
7.94e-02
|
-7.77e-02
|
4.11e-01
|
GO:0044029 positive regulation of gene expression via chromosomal CpG island demethylation
|
11
|
6.56e-01
|
-7.77e-02
|
8.94e-01
|
GO:0019886 antigen processing and presentation of exogenous peptide antigen via MHC class II
|
27
|
4.85e-01
|
-7.76e-02
|
8.23e-01
|
GO:0001006 RNA polymerase III type 3 promoter sequence-specific DNA binding
|
6
|
7.42e-01
|
-7.75e-02
|
9.30e-01
|
GO:0010698 acetyltransferase activator activity
|
8
|
7.05e-01
|
7.73e-02
|
9.15e-01
|
GO:0009311 oligosaccharide metabolic process
|
11
|
6.57e-01
|
-7.73e-02
|
8.95e-01
|
GO:0034709 methylosome
|
12
|
6.43e-01
|
-7.73e-02
|
8.89e-01
|
GO:0015116 sulfate transmembrane transporter activity
|
7
|
7.24e-01
|
-7.72e-02
|
9.24e-01
|
GO:0009897 external side of plasma membrane
|
192
|
6.59e-02
|
7.71e-02
|
3.79e-01
|
GO:0032332 positive regulation of chondrocyte differentiation
|
7
|
7.24e-01
|
-7.70e-02
|
9.25e-01
|
GO:0045178 basal part of cell
|
7
|
7.24e-01
|
-7.70e-02
|
9.25e-01
|
GO:0070578 RISC-loading complex
|
8
|
7.06e-01
|
-7.69e-02
|
9.16e-01
|
GO:0000900 mRNA regulatory element binding translation repressor activity
|
16
|
5.94e-01
|
-7.69e-02
|
8.74e-01
|
GO:0030593 neutrophil chemotaxis
|
34
|
4.38e-01
|
-7.69e-02
|
7.95e-01
|
GO:0055007 cardiac muscle cell differentiation
|
14
|
6.19e-01
|
-7.68e-02
|
8.83e-01
|
GO:0032410 negative regulation of transporter activity
|
5
|
7.66e-01
|
7.68e-02
|
9.37e-01
|
GO:0019367 fatty acid elongation, saturated fatty acid
|
5
|
7.67e-01
|
-7.67e-02
|
9.37e-01
|
GO:0061676 importin-alpha family protein binding
|
8
|
7.08e-01
|
-7.65e-02
|
9.17e-01
|
GO:0051018 protein kinase A binding
|
15
|
6.08e-01
|
-7.65e-02
|
8.80e-01
|
GO:0055037 recycling endosome
|
100
|
1.87e-01
|
-7.65e-02
|
5.89e-01
|
GO:0098793 presynapse
|
125
|
1.40e-01
|
-7.65e-02
|
5.25e-01
|
GO:0048468 cell development
|
5
|
7.68e-01
|
-7.63e-02
|
9.37e-01
|
GO:0031547 brain-derived neurotrophic factor receptor signaling pathway
|
16
|
5.97e-01
|
7.63e-02
|
8.76e-01
|
GO:1903241 U2-type prespliceosome assembly
|
25
|
5.09e-01
|
-7.63e-02
|
8.34e-01
|
GO:0140806 NAD+-protein-aspartate ADP-ribosyltransferase activity
|
13
|
6.34e-01
|
-7.62e-02
|
8.87e-01
|
GO:0035654 clathrin-coated vesicle cargo loading, AP-3-mediated
|
7
|
7.27e-01
|
-7.62e-02
|
9.25e-01
|
GO:0043031 negative regulation of macrophage activation
|
7
|
7.27e-01
|
7.62e-02
|
9.25e-01
|
GO:0010314 phosphatidylinositol-5-phosphate binding
|
18
|
5.76e-01
|
7.61e-02
|
8.64e-01
|
GO:1905337 positive regulation of aggrephagy
|
5
|
7.68e-01
|
-7.61e-02
|
9.37e-01
|
GO:0099572 postsynaptic specialization
|
6
|
7.47e-01
|
-7.61e-02
|
9.32e-01
|
GO:0045540 regulation of cholesterol biosynthetic process
|
10
|
6.77e-01
|
-7.60e-02
|
9.04e-01
|
GO:0005977 glycogen metabolic process
|
24
|
5.19e-01
|
-7.60e-02
|
8.35e-01
|
GO:0150052 regulation of postsynapse assembly
|
30
|
4.72e-01
|
-7.60e-02
|
8.13e-01
|
GO:0001504 neurotransmitter uptake
|
5
|
7.69e-01
|
7.60e-02
|
9.37e-01
|
GO:0032289 central nervous system myelin formation
|
5
|
7.69e-01
|
7.60e-02
|
9.37e-01
|
GO:0005513 detection of calcium ion
|
10
|
6.78e-01
|
-7.59e-02
|
9.04e-01
|
GO:0009404 toxin metabolic process
|
5
|
7.69e-01
|
7.59e-02
|
9.37e-01
|
GO:0030325 adrenal gland development
|
12
|
6.49e-01
|
-7.59e-02
|
8.93e-01
|
GO:0042730 fibrinolysis
|
9
|
6.94e-01
|
7.58e-02
|
9.08e-01
|
GO:0003254 regulation of membrane depolarization
|
5
|
7.69e-01
|
7.58e-02
|
9.37e-01
|
GO:0070198 protein localization to chromosome, telomeric region
|
11
|
6.64e-01
|
7.57e-02
|
8.98e-01
|
GO:0033553 rDNA heterochromatin
|
5
|
7.70e-01
|
-7.56e-02
|
9.37e-01
|
GO:0019212 phosphatase inhibitor activity
|
6
|
7.49e-01
|
-7.56e-02
|
9.32e-01
|
GO:0031122 cytoplasmic microtubule organization
|
38
|
4.21e-01
|
-7.55e-02
|
7.87e-01
|
GO:0010569 regulation of double-strand break repair via homologous recombination
|
15
|
6.13e-01
|
-7.54e-02
|
8.81e-01
|
GO:0015833 peptide transport
|
5
|
7.70e-01
|
7.54e-02
|
9.37e-01
|
GO:0045944 positive regulation of transcription by RNA polymerase II
|
804
|
3.22e-04
|
-7.53e-02
|
2.12e-02
|
GO:0030007 intracellular potassium ion homeostasis
|
8
|
7.12e-01
|
7.53e-02
|
9.19e-01
|
GO:0090084 negative regulation of inclusion body assembly
|
8
|
7.12e-01
|
7.53e-02
|
9.19e-01
|
GO:0016174 NAD(P)H oxidase H2O2-forming activity
|
6
|
7.50e-01
|
7.52e-02
|
9.33e-01
|
GO:0005882 intermediate filament
|
25
|
5.15e-01
|
-7.52e-02
|
8.34e-01
|
GO:0008146 sulfotransferase activity
|
13
|
6.39e-01
|
-7.52e-02
|
8.88e-01
|
GO:0032588 trans-Golgi network membrane
|
92
|
2.13e-01
|
-7.51e-02
|
6.15e-01
|
GO:0030850 prostate gland development
|
5
|
7.71e-01
|
-7.51e-02
|
9.38e-01
|
GO:0034499 late endosome to Golgi transport
|
6
|
7.50e-01
|
-7.50e-02
|
9.33e-01
|
GO:0045669 positive regulation of osteoblast differentiation
|
39
|
4.18e-01
|
-7.50e-02
|
7.87e-01
|
GO:0004674 protein serine/threonine kinase activity
|
278
|
3.20e-02
|
-7.50e-02
|
2.85e-01
|
GO:0097191 extrinsic apoptotic signaling pathway
|
43
|
3.96e-01
|
7.49e-02
|
7.71e-01
|
GO:0071225 cellular response to muramyl dipeptide
|
8
|
7.14e-01
|
7.49e-02
|
9.19e-01
|
GO:0007565 female pregnancy
|
41
|
4.07e-01
|
-7.48e-02
|
7.82e-01
|
GO:0002221 pattern recognition receptor signaling pathway
|
12
|
6.54e-01
|
7.48e-02
|
8.94e-01
|
GO:0045668 negative regulation of osteoblast differentiation
|
30
|
4.79e-01
|
-7.47e-02
|
8.19e-01
|
GO:0004117 calmodulin-activated dual specificity 3’,5’-cyclic-GMP, 3’,5’-cyclic-AMP phosphodiesterase activity
|
6
|
7.51e-01
|
-7.47e-02
|
9.34e-01
|
GO:0048101 calmodulin-activated 3’,5’-cyclic-GMP phosphodiesterase activity
|
6
|
7.51e-01
|
-7.47e-02
|
9.34e-01
|
GO:0016592 mediator complex
|
36
|
4.38e-01
|
-7.47e-02
|
7.95e-01
|
GO:0007420 brain development
|
113
|
1.71e-01
|
-7.47e-02
|
5.76e-01
|
GO:0048842 positive regulation of axon extension involved in axon guidance
|
5
|
7.73e-01
|
-7.47e-02
|
9.38e-01
|
GO:0048185 activin binding
|
10
|
6.83e-01
|
7.46e-02
|
9.05e-01
|
GO:0060020 Bergmann glial cell differentiation
|
8
|
7.15e-01
|
-7.46e-02
|
9.20e-01
|
GO:0015918 sterol transport
|
11
|
6.69e-01
|
7.46e-02
|
9.01e-01
|
GO:0071007 U2-type catalytic step 2 spliceosome
|
30
|
4.80e-01
|
-7.45e-02
|
8.19e-01
|
GO:0007265 Ras protein signal transduction
|
66
|
2.96e-01
|
-7.45e-02
|
6.90e-01
|
GO:0035773 insulin secretion involved in cellular response to glucose stimulus
|
10
|
6.83e-01
|
7.45e-02
|
9.05e-01
|
GO:0003723 RNA binding
|
1246
|
1.32e-05
|
-7.45e-02
|
1.89e-03
|
GO:0033194 response to hydroperoxide
|
7
|
7.33e-01
|
7.45e-02
|
9.27e-01
|
GO:0070314 G1 to G0 transition
|
8
|
7.15e-01
|
-7.45e-02
|
9.20e-01
|
GO:0000109 nucleotide-excision repair complex
|
6
|
7.52e-01
|
7.44e-02
|
9.34e-01
|
GO:0038156 interleukin-3-mediated signaling pathway
|
6
|
7.53e-01
|
-7.42e-02
|
9.34e-01
|
GO:0005891 voltage-gated calcium channel complex
|
11
|
6.70e-01
|
-7.42e-02
|
9.01e-01
|
GO:0033574 response to testosterone
|
18
|
5.86e-01
|
-7.42e-02
|
8.68e-01
|
GO:0019673 GDP-mannose metabolic process
|
5
|
7.74e-01
|
-7.41e-02
|
9.39e-01
|
GO:0019432 triglyceride biosynthetic process
|
16
|
6.08e-01
|
7.41e-02
|
8.80e-01
|
GO:0046470 phosphatidylcholine metabolic process
|
6
|
7.53e-01
|
-7.41e-02
|
9.34e-01
|
GO:1901673 regulation of mitotic spindle assembly
|
24
|
5.30e-01
|
7.40e-02
|
8.41e-01
|
GO:0030215 semaphorin receptor binding
|
14
|
6.32e-01
|
-7.39e-02
|
8.86e-01
|
GO:0001975 response to amphetamine
|
19
|
5.77e-01
|
-7.39e-02
|
8.64e-01
|
GO:0045165 cell fate commitment
|
14
|
6.32e-01
|
-7.39e-02
|
8.86e-01
|
GO:0032465 regulation of cytokinesis
|
36
|
4.43e-01
|
-7.39e-02
|
7.97e-01
|
GO:0005160 transforming growth factor beta receptor binding
|
8
|
7.17e-01
|
7.39e-02
|
9.21e-01
|
GO:0097546 ciliary base
|
28
|
5.00e-01
|
7.36e-02
|
8.28e-01
|
GO:0010506 regulation of autophagy
|
61
|
3.20e-01
|
7.36e-02
|
7.11e-01
|
GO:0050764 regulation of phagocytosis
|
8
|
7.19e-01
|
-7.36e-02
|
9.22e-01
|
GO:0046479 glycosphingolipid catabolic process
|
9
|
7.03e-01
|
-7.35e-02
|
9.14e-01
|
GO:0045335 phagocytic vesicle
|
65
|
3.06e-01
|
-7.35e-02
|
6.96e-01
|
GO:0022829 wide pore channel activity
|
7
|
7.37e-01
|
7.34e-02
|
9.29e-01
|
GO:0010718 positive regulation of epithelial to mesenchymal transition
|
33
|
4.66e-01
|
7.34e-02
|
8.10e-01
|
GO:0048705 skeletal system morphogenesis
|
24
|
5.34e-01
|
7.34e-02
|
8.43e-01
|
GO:0016226 iron-sulfur cluster assembly
|
27
|
5.10e-01
|
7.33e-02
|
8.34e-01
|
GO:0071051 poly(A)-dependent snoRNA 3’-end processing
|
8
|
7.20e-01
|
-7.33e-02
|
9.22e-01
|
GO:1902004 positive regulation of amyloid-beta formation
|
15
|
6.23e-01
|
-7.33e-02
|
8.84e-01
|
GO:0045630 positive regulation of T-helper 2 cell differentiation
|
6
|
7.56e-01
|
7.33e-02
|
9.35e-01
|
GO:1902176 negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway
|
12
|
6.60e-01
|
7.33e-02
|
8.97e-01
|
GO:0140296 general transcription initiation factor binding
|
10
|
6.89e-01
|
-7.32e-02
|
9.06e-01
|
GO:0010628 positive regulation of gene expression
|
247
|
4.83e-02
|
-7.32e-02
|
3.39e-01
|
GO:0010510 regulation of acetyl-CoA biosynthetic process from pyruvate
|
6
|
7.57e-01
|
7.30e-02
|
9.35e-01
|
GO:0032869 cellular response to insulin stimulus
|
67
|
3.02e-01
|
-7.30e-02
|
6.93e-01
|
GO:2001199 negative regulation of dendritic cell differentiation
|
7
|
7.38e-01
|
7.30e-02
|
9.29e-01
|
GO:0060612 adipose tissue development
|
29
|
4.97e-01
|
7.29e-02
|
8.27e-01
|
GO:0051725 protein de-ADP-ribosylation
|
5
|
7.79e-01
|
7.26e-02
|
9.42e-01
|
GO:0048254 snoRNA localization
|
6
|
7.58e-01
|
7.25e-02
|
9.35e-01
|
GO:0004435 phosphatidylinositol phospholipase C activity
|
14
|
6.39e-01
|
-7.25e-02
|
8.88e-01
|
GO:2000637 positive regulation of miRNA-mediated gene silencing
|
6
|
7.59e-01
|
7.25e-02
|
9.35e-01
|
GO:0003183 mitral valve morphogenesis
|
7
|
7.40e-01
|
7.24e-02
|
9.29e-01
|
GO:0043029 T cell homeostasis
|
27
|
5.16e-01
|
-7.23e-02
|
8.34e-01
|
GO:0097504 Gemini of coiled bodies
|
11
|
6.78e-01
|
7.23e-02
|
9.04e-01
|
GO:0046513 ceramide biosynthetic process
|
24
|
5.40e-01
|
7.22e-02
|
8.45e-01
|
GO:0010951 negative regulation of endopeptidase activity
|
16
|
6.17e-01
|
-7.21e-02
|
8.82e-01
|
GO:0098656 monoatomic anion transmembrane transport
|
25
|
5.34e-01
|
-7.20e-02
|
8.43e-01
|
GO:0043589 skin morphogenesis
|
9
|
7.09e-01
|
-7.20e-02
|
9.17e-01
|
GO:0016255 attachment of GPI anchor to protein
|
6
|
7.61e-01
|
7.17e-02
|
9.35e-01
|
GO:0045211 postsynaptic membrane
|
79
|
2.71e-01
|
-7.17e-02
|
6.70e-01
|
GO:0005764 lysosome
|
244
|
5.46e-02
|
7.16e-02
|
3.53e-01
|
GO:0016600 flotillin complex
|
7
|
7.43e-01
|
-7.16e-02
|
9.30e-01
|
GO:0000302 response to reactive oxygen species
|
11
|
6.81e-01
|
-7.16e-02
|
9.05e-01
|
GO:0070979 protein K11-linked ubiquitination
|
37
|
4.52e-01
|
-7.15e-02
|
8.02e-01
|
GO:1900181 negative regulation of protein localization to nucleus
|
17
|
6.10e-01
|
-7.15e-02
|
8.81e-01
|
GO:0006103 2-oxoglutarate metabolic process
|
14
|
6.43e-01
|
-7.15e-02
|
8.89e-01
|
GO:0016525 negative regulation of angiogenesis
|
58
|
3.47e-01
|
-7.15e-02
|
7.31e-01
|
GO:0007018 microtubule-based movement
|
39
|
4.40e-01
|
-7.14e-02
|
7.96e-01
|
GO:0005381 iron ion transmembrane transporter activity
|
7
|
7.44e-01
|
-7.14e-02
|
9.31e-01
|
GO:0031146 SCF-dependent proteasomal ubiquitin-dependent protein catabolic process
|
34
|
4.72e-01
|
7.14e-02
|
8.13e-01
|
GO:0004128 cytochrome-b5 reductase activity, acting on NAD(P)H
|
5
|
7.82e-01
|
7.14e-02
|
9.44e-01
|
GO:0006784 heme A biosynthetic process
|
10
|
6.96e-01
|
-7.13e-02
|
9.10e-01
|
GO:0045807 positive regulation of endocytosis
|
15
|
6.34e-01
|
-7.10e-02
|
8.87e-01
|
GO:0034774 secretory granule lumen
|
100
|
2.22e-01
|
-7.08e-02
|
6.21e-01
|
GO:0032689 negative regulation of type II interferon production
|
22
|
5.66e-01
|
-7.08e-02
|
8.56e-01
|
GO:0060173 limb development
|
26
|
5.33e-01
|
7.07e-02
|
8.43e-01
|
GO:0035035 histone acetyltransferase binding
|
21
|
5.75e-01
|
-7.06e-02
|
8.63e-01
|
GO:0043565 sequence-specific DNA binding
|
144
|
1.44e-01
|
-7.06e-02
|
5.33e-01
|
GO:0042119 neutrophil activation
|
11
|
6.86e-01
|
7.05e-02
|
9.05e-01
|
GO:0044539 long-chain fatty acid import into cell
|
7
|
7.47e-01
|
-7.04e-02
|
9.32e-01
|
GO:0030168 platelet activation
|
40
|
4.42e-01
|
-7.02e-02
|
7.96e-01
|
GO:0034451 centriolar satellite
|
103
|
2.19e-01
|
7.02e-02
|
6.20e-01
|
GO:0030897 HOPS complex
|
13
|
6.61e-01
|
7.02e-02
|
8.98e-01
|
GO:0000077 DNA damage checkpoint signaling
|
38
|
4.55e-01
|
-7.01e-02
|
8.03e-01
|
GO:0030681 multimeric ribonuclease P complex
|
10
|
7.01e-01
|
-7.01e-02
|
9.13e-01
|
GO:0033204 ribonuclease P RNA binding
|
10
|
7.01e-01
|
-7.01e-02
|
9.13e-01
|
GO:0006366 transcription by RNA polymerase II
|
157
|
1.31e-01
|
-7.00e-02
|
5.07e-01
|
GO:0001222 transcription corepressor binding
|
44
|
4.23e-01
|
-6.99e-02
|
7.87e-01
|
GO:0045778 positive regulation of ossification
|
7
|
7.49e-01
|
-6.99e-02
|
9.33e-01
|
GO:0043194 axon initial segment
|
11
|
6.88e-01
|
-6.99e-02
|
9.06e-01
|
GO:0014032 neural crest cell development
|
10
|
7.03e-01
|
6.95e-02
|
9.14e-01
|
GO:0030332 cyclin binding
|
32
|
4.96e-01
|
6.95e-02
|
8.27e-01
|
GO:0051539 4 iron, 4 sulfur cluster binding
|
44
|
4.26e-01
|
-6.94e-02
|
7.90e-01
|
GO:0042627 chylomicron
|
6
|
7.68e-01
|
6.94e-02
|
9.37e-01
|
GO:0032695 negative regulation of interleukin-12 production
|
14
|
6.53e-01
|
-6.94e-02
|
8.94e-01
|
GO:0045198 establishment of epithelial cell apical/basal polarity
|
11
|
6.91e-01
|
6.93e-02
|
9.06e-01
|
GO:0010608 post-transcriptional regulation of gene expression
|
23
|
5.65e-01
|
-6.93e-02
|
8.56e-01
|
GO:0042551 neuron maturation
|
11
|
6.91e-01
|
-6.92e-02
|
9.06e-01
|
GO:0016798 hydrolase activity, acting on glycosyl bonds
|
5
|
7.89e-01
|
-6.92e-02
|
9.48e-01
|
GO:0005179 hormone activity
|
23
|
5.66e-01
|
6.92e-02
|
8.56e-01
|
GO:0005254 chloride channel activity
|
26
|
5.42e-01
|
6.91e-02
|
8.45e-01
|
GO:1900015 regulation of cytokine production involved in inflammatory response
|
7
|
7.52e-01
|
-6.90e-02
|
9.34e-01
|
GO:0038134 ERBB2-EGFR signaling pathway
|
5
|
7.89e-01
|
-6.90e-02
|
9.48e-01
|
GO:1990935 splicing factor binding
|
5
|
7.89e-01
|
-6.90e-02
|
9.48e-01
|
GO:0050714 positive regulation of protein secretion
|
35
|
4.80e-01
|
-6.89e-02
|
8.19e-01
|
GO:0003774 cytoskeletal motor activity
|
14
|
6.55e-01
|
-6.89e-02
|
8.94e-01
|
GO:0033017 sarcoplasmic reticulum membrane
|
24
|
5.60e-01
|
6.88e-02
|
8.55e-01
|
GO:0097422 tubular endosome
|
5
|
7.90e-01
|
6.88e-02
|
9.48e-01
|
GO:0035196 miRNA processing
|
14
|
6.56e-01
|
-6.88e-02
|
8.94e-01
|
GO:0031594 neuromuscular junction
|
52
|
3.92e-01
|
-6.87e-02
|
7.68e-01
|
GO:0005319 lipid transporter activity
|
10
|
7.07e-01
|
6.87e-02
|
9.16e-01
|
GO:0001913 T cell mediated cytotoxicity
|
13
|
6.68e-01
|
6.87e-02
|
9.00e-01
|
GO:0006665 sphingolipid metabolic process
|
7
|
7.53e-01
|
6.86e-02
|
9.34e-01
|
GO:0005634 nucleus
|
4213
|
7.29e-11
|
-6.86e-02
|
1.07e-07
|
GO:0007612 learning
|
37
|
4.71e-01
|
6.85e-02
|
8.13e-01
|
GO:0008544 epidermis development
|
27
|
5.38e-01
|
6.84e-02
|
8.45e-01
|
GO:0031069 hair follicle morphogenesis
|
12
|
6.82e-01
|
6.84e-02
|
9.05e-01
|
GO:0008654 phospholipid biosynthetic process
|
20
|
5.97e-01
|
-6.84e-02
|
8.75e-01
|
GO:0060261 positive regulation of transcription initiation by RNA polymerase II
|
55
|
3.81e-01
|
6.84e-02
|
7.58e-01
|
GO:1901985 positive regulation of protein acetylation
|
7
|
7.54e-01
|
6.83e-02
|
9.34e-01
|
GO:0003198 epithelial to mesenchymal transition involved in endocardial cushion formation
|
6
|
7.72e-01
|
-6.82e-02
|
9.38e-01
|
GO:0002931 response to ischemia
|
46
|
4.24e-01
|
-6.81e-02
|
7.89e-01
|
GO:0006958 complement activation, classical pathway
|
17
|
6.27e-01
|
6.80e-02
|
8.85e-01
|
GO:0031640 killing of cells of another organism
|
24
|
5.64e-01
|
6.80e-02
|
8.56e-01
|
GO:0045787 positive regulation of cell cycle
|
24
|
5.64e-01
|
6.80e-02
|
8.56e-01
|
GO:0016071 mRNA metabolic process
|
8
|
7.39e-01
|
-6.80e-02
|
9.29e-01
|
GO:0033077 T cell differentiation in thymus
|
28
|
5.34e-01
|
6.79e-02
|
8.43e-01
|
GO:0050869 negative regulation of B cell activation
|
5
|
7.93e-01
|
-6.79e-02
|
9.48e-01
|
GO:0051918 negative regulation of fibrinolysis
|
7
|
7.56e-01
|
6.78e-02
|
9.35e-01
|
GO:0140326 ATPase-coupled intramembrane lipid transporter activity
|
12
|
6.84e-01
|
-6.78e-02
|
9.05e-01
|
GO:0034987 immunoglobulin receptor binding
|
6
|
7.74e-01
|
-6.76e-02
|
9.39e-01
|
GO:1902074 response to salt
|
5
|
7.93e-01
|
-6.76e-02
|
9.49e-01
|
GO:0002162 dystroglycan binding
|
8
|
7.41e-01
|
-6.76e-02
|
9.29e-01
|
GO:0005874 microtubule
|
220
|
8.48e-02
|
-6.76e-02
|
4.23e-01
|
GO:0048339 paraxial mesoderm development
|
5
|
7.94e-01
|
6.76e-02
|
9.49e-01
|
GO:0032590 dendrite membrane
|
9
|
7.26e-01
|
-6.76e-02
|
9.25e-01
|
GO:0016363 nuclear matrix
|
114
|
2.13e-01
|
-6.76e-02
|
6.15e-01
|
GO:0045954 positive regulation of natural killer cell mediated cytotoxicity
|
12
|
6.86e-01
|
-6.75e-02
|
9.05e-01
|
GO:0090314 positive regulation of protein targeting to membrane
|
20
|
6.02e-01
|
-6.74e-02
|
8.77e-01
|
GO:0031334 positive regulation of protein-containing complex assembly
|
40
|
4.61e-01
|
-6.74e-02
|
8.06e-01
|
GO:0001819 positive regulation of cytokine production
|
43
|
4.45e-01
|
-6.74e-02
|
7.98e-01
|
GO:0051412 response to corticosterone
|
7
|
7.58e-01
|
-6.73e-02
|
9.35e-01
|
GO:1990907 beta-catenin-TCF complex
|
12
|
6.86e-01
|
-6.73e-02
|
9.06e-01
|
GO:0006754 ATP biosynthetic process
|
14
|
6.63e-01
|
-6.73e-02
|
8.98e-01
|
GO:0007405 neuroblast proliferation
|
18
|
6.21e-01
|
-6.73e-02
|
8.84e-01
|
GO:0006164 purine nucleotide biosynthetic process
|
12
|
6.87e-01
|
6.73e-02
|
9.06e-01
|
GO:0005521 lamin binding
|
14
|
6.63e-01
|
6.73e-02
|
8.98e-01
|
GO:0010521 telomerase inhibitor activity
|
7
|
7.58e-01
|
-6.72e-02
|
9.35e-01
|
GO:0031527 filopodium membrane
|
13
|
6.75e-01
|
-6.72e-02
|
9.03e-01
|
GO:0034046 poly(G) binding
|
8
|
7.43e-01
|
-6.71e-02
|
9.30e-01
|
GO:0002053 positive regulation of mesenchymal cell proliferation
|
12
|
6.88e-01
|
-6.69e-02
|
9.06e-01
|
GO:0051963 regulation of synapse assembly
|
14
|
6.65e-01
|
-6.69e-02
|
8.99e-01
|
GO:0043023 ribosomal large subunit binding
|
13
|
6.76e-01
|
-6.69e-02
|
9.03e-01
|
GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process
|
250
|
6.93e-02
|
6.69e-02
|
3.88e-01
|
GO:0006590 thyroid hormone generation
|
7
|
7.59e-01
|
-6.69e-02
|
9.35e-01
|
GO:0030511 positive regulation of transforming growth factor beta receptor signaling pathway
|
24
|
5.71e-01
|
-6.68e-02
|
8.60e-01
|
GO:0016236 macroautophagy
|
67
|
3.45e-01
|
6.68e-02
|
7.30e-01
|
GO:0008081 phosphoric diester hydrolase activity
|
7
|
7.60e-01
|
-6.67e-02
|
9.35e-01
|
GO:0120283 protein serine/threonine kinase binding
|
15
|
6.55e-01
|
-6.67e-02
|
8.94e-01
|
GO:0004520 DNA endonuclease activity
|
12
|
6.89e-01
|
6.67e-02
|
9.06e-01
|
GO:2000134 negative regulation of G1/S transition of mitotic cell cycle
|
35
|
4.95e-01
|
-6.67e-02
|
8.25e-01
|
GO:2000379 positive regulation of reactive oxygen species metabolic process
|
24
|
5.72e-01
|
-6.67e-02
|
8.60e-01
|
GO:0090050 positive regulation of cell migration involved in sprouting angiogenesis
|
13
|
6.78e-01
|
6.66e-02
|
9.04e-01
|
GO:0006228 UTP biosynthetic process
|
8
|
7.45e-01
|
-6.65e-02
|
9.32e-01
|
GO:0098641 cadherin binding involved in cell-cell adhesion
|
12
|
6.90e-01
|
6.64e-02
|
9.06e-01
|
GO:0007253 cytoplasmic sequestering of NF-kappaB
|
6
|
7.78e-01
|
-6.64e-02
|
9.42e-01
|
GO:0001779 natural killer cell differentiation
|
12
|
6.91e-01
|
6.63e-02
|
9.06e-01
|
GO:0090571 RNA polymerase II transcription repressor complex
|
6
|
7.79e-01
|
-6.62e-02
|
9.42e-01
|
GO:0034380 high-density lipoprotein particle assembly
|
7
|
7.62e-01
|
-6.61e-02
|
9.36e-01
|
GO:0016528 sarcoplasm
|
13
|
6.80e-01
|
-6.61e-02
|
9.05e-01
|
GO:0015949 nucleobase-containing small molecule interconversion
|
8
|
7.46e-01
|
6.61e-02
|
9.32e-01
|
GO:0071896 protein localization to adherens junction
|
5
|
7.98e-01
|
6.60e-02
|
9.49e-01
|
GO:0044344 cellular response to fibroblast growth factor stimulus
|
18
|
6.28e-01
|
-6.59e-02
|
8.85e-01
|
GO:1990904 ribonucleoprotein complex
|
146
|
1.70e-01
|
-6.59e-02
|
5.76e-01
|
GO:0006937 regulation of muscle contraction
|
5
|
7.99e-01
|
6.58e-02
|
9.49e-01
|
GO:0032206 positive regulation of telomere maintenance
|
30
|
5.33e-01
|
-6.58e-02
|
8.43e-01
|
GO:0017022 myosin binding
|
16
|
6.49e-01
|
6.58e-02
|
8.93e-01
|
GO:0005614 interstitial matrix
|
6
|
7.81e-01
|
-6.57e-02
|
9.43e-01
|
GO:0006939 smooth muscle contraction
|
11
|
7.06e-01
|
-6.56e-02
|
9.16e-01
|
GO:0009966 regulation of signal transduction
|
40
|
4.73e-01
|
-6.56e-02
|
8.15e-01
|
GO:0045008 depyrimidination
|
8
|
7.48e-01
|
6.55e-02
|
9.32e-01
|
GO:0035254 glutamate receptor binding
|
7
|
7.64e-01
|
6.55e-02
|
9.37e-01
|
GO:0019233 sensory perception of pain
|
18
|
6.31e-01
|
-6.54e-02
|
8.86e-01
|
GO:0005955 calcineurin complex
|
5
|
8.00e-01
|
-6.53e-02
|
9.49e-01
|
GO:0007166 cell surface receptor signaling pathway
|
135
|
1.91e-01
|
-6.53e-02
|
5.95e-01
|
GO:0044388 small protein activating enzyme binding
|
5
|
8.01e-01
|
6.52e-02
|
9.49e-01
|
GO:0007212 G protein-coupled dopamine receptor signaling pathway
|
8
|
7.49e-01
|
-6.52e-02
|
9.33e-01
|
GO:0005114 type II transforming growth factor beta receptor binding
|
8
|
7.49e-01
|
6.52e-02
|
9.33e-01
|
GO:0048011 neurotrophin TRK receptor signaling pathway
|
13
|
6.84e-01
|
-6.52e-02
|
9.05e-01
|
GO:0030123 AP-3 adaptor complex
|
11
|
7.08e-01
|
-6.51e-02
|
9.17e-01
|
GO:0005388 P-type calcium transporter activity
|
7
|
7.65e-01
|
-6.51e-02
|
9.37e-01
|
GO:0099171 presynaptic modulation of chemical synaptic transmission
|
14
|
6.74e-01
|
-6.50e-02
|
9.02e-01
|
GO:0042104 positive regulation of activated T cell proliferation
|
16
|
6.53e-01
|
-6.50e-02
|
8.94e-01
|
GO:0060325 face morphogenesis
|
20
|
6.15e-01
|
-6.49e-02
|
8.82e-01
|
GO:0015701 bicarbonate transport
|
19
|
6.24e-01
|
6.49e-02
|
8.84e-01
|
GO:1904115 axon cytoplasm
|
50
|
4.28e-01
|
6.49e-02
|
7.90e-01
|
GO:0099041 vesicle tethering to Golgi
|
5
|
8.02e-01
|
6.48e-02
|
9.49e-01
|
GO:0032868 response to insulin
|
52
|
4.19e-01
|
-6.48e-02
|
7.87e-01
|
GO:0006790 sulfur compound metabolic process
|
5
|
8.02e-01
|
-6.48e-02
|
9.49e-01
|
GO:0005667 transcription regulator complex
|
117
|
2.27e-01
|
-6.48e-02
|
6.27e-01
|
GO:0012506 vesicle membrane
|
27
|
5.61e-01
|
-6.47e-02
|
8.55e-01
|
GO:0045475 locomotor rhythm
|
9
|
7.38e-01
|
-6.43e-02
|
9.29e-01
|
GO:1901289 succinyl-CoA catabolic process
|
6
|
7.85e-01
|
-6.43e-02
|
9.45e-01
|
GO:0030619 U1 snRNA binding
|
8
|
7.53e-01
|
-6.42e-02
|
9.34e-01
|
GO:0050768 negative regulation of neurogenesis
|
15
|
6.67e-01
|
6.42e-02
|
9.00e-01
|
GO:0036499 PERK-mediated unfolded protein response
|
8
|
7.53e-01
|
6.42e-02
|
9.34e-01
|
GO:0061298 retina vasculature development in camera-type eye
|
8
|
7.53e-01
|
-6.41e-02
|
9.34e-01
|
GO:0007252 I-kappaB phosphorylation
|
6
|
7.86e-01
|
6.40e-02
|
9.45e-01
|
GO:0050680 negative regulation of epithelial cell proliferation
|
32
|
5.31e-01
|
-6.40e-02
|
8.42e-01
|
GO:0003714 transcription corepressor activity
|
165
|
1.57e-01
|
-6.40e-02
|
5.54e-01
|
GO:0044545 NSL complex
|
11
|
7.14e-01
|
-6.39e-02
|
9.19e-01
|
GO:0050435 amyloid-beta metabolic process
|
8
|
7.54e-01
|
6.39e-02
|
9.34e-01
|
GO:0005681 spliceosomal complex
|
110
|
2.48e-01
|
-6.38e-02
|
6.52e-01
|
GO:0007584 response to nutrient
|
35
|
5.14e-01
|
-6.38e-02
|
8.34e-01
|
GO:0005875 microtubule associated complex
|
25
|
5.81e-01
|
-6.37e-02
|
8.65e-01
|
GO:0001228 DNA-binding transcription activator activity, RNA polymerase II-specific
|
269
|
7.29e-02
|
-6.37e-02
|
3.94e-01
|
GO:0004143 ATP-dependent diacylglycerol kinase activity
|
9
|
7.41e-01
|
6.37e-02
|
9.29e-01
|
GO:0046834 lipid phosphorylation
|
9
|
7.41e-01
|
6.37e-02
|
9.29e-01
|
GO:0051302 regulation of cell division
|
17
|
6.50e-01
|
6.37e-02
|
8.93e-01
|
GO:0002764 immune response-regulating signaling pathway
|
17
|
6.50e-01
|
-6.36e-02
|
8.93e-01
|
GO:0071492 cellular response to UV-A
|
6
|
7.87e-01
|
6.36e-02
|
9.47e-01
|
GO:0004559 alpha-mannosidase activity
|
7
|
7.71e-01
|
6.35e-02
|
9.38e-01
|
GO:0061795 Golgi lumen acidification
|
10
|
7.28e-01
|
-6.35e-02
|
9.25e-01
|
GO:0005085 guanyl-nucleotide exchange factor activity
|
192
|
1.31e-01
|
-6.34e-02
|
5.07e-01
|
GO:0010842 retina layer formation
|
12
|
7.04e-01
|
6.34e-02
|
9.14e-01
|
GO:0002199 zona pellucida receptor complex
|
6
|
7.88e-01
|
6.34e-02
|
9.47e-01
|
GO:0007519 skeletal muscle tissue development
|
29
|
5.55e-01
|
6.33e-02
|
8.51e-01
|
GO:0032454 histone H3K9 demethylase activity
|
11
|
7.16e-01
|
6.33e-02
|
9.21e-01
|
GO:0008545 JUN kinase kinase activity
|
8
|
7.57e-01
|
-6.32e-02
|
9.35e-01
|
GO:0006400 tRNA modification
|
25
|
5.85e-01
|
6.31e-02
|
8.67e-01
|
GO:0071949 FAD binding
|
32
|
5.39e-01
|
6.28e-02
|
8.45e-01
|
GO:2000171 negative regulation of dendrite development
|
5
|
8.08e-01
|
6.28e-02
|
9.53e-01
|
GO:0150104 transport across blood-brain barrier
|
48
|
4.52e-01
|
-6.28e-02
|
8.02e-01
|
GO:0030235 nitric-oxide synthase regulator activity
|
5
|
8.08e-01
|
-6.28e-02
|
9.53e-01
|
GO:0015908 fatty acid transport
|
18
|
6.45e-01
|
-6.28e-02
|
8.91e-01
|
GO:0001889 liver development
|
59
|
4.05e-01
|
-6.27e-02
|
7.80e-01
|
GO:0048490 anterograde synaptic vesicle transport
|
17
|
6.55e-01
|
6.26e-02
|
8.94e-01
|
GO:0001664 G protein-coupled receptor binding
|
37
|
5.11e-01
|
-6.25e-02
|
8.34e-01
|
GO:0045600 positive regulation of fat cell differentiation
|
33
|
5.35e-01
|
-6.25e-02
|
8.43e-01
|
GO:0004550 nucleoside diphosphate kinase activity
|
15
|
6.76e-01
|
6.24e-02
|
9.03e-01
|
GO:0044232 organelle membrane contact site
|
9
|
7.46e-01
|
6.24e-02
|
9.32e-01
|
GO:2000059 negative regulation of ubiquitin-dependent protein catabolic process
|
18
|
6.47e-01
|
6.23e-02
|
8.92e-01
|
GO:0045019 negative regulation of nitric oxide biosynthetic process
|
9
|
7.46e-01
|
-6.22e-02
|
9.32e-01
|
GO:0035650 AP-1 adaptor complex binding
|
5
|
8.10e-01
|
6.22e-02
|
9.53e-01
|
GO:0005515 protein binding
|
9496
|
4.26e-10
|
-6.22e-02
|
3.57e-07
|
GO:0019787 ubiquitin-like protein transferase activity
|
8
|
7.61e-01
|
6.22e-02
|
9.35e-01
|
GO:0050918 positive chemotaxis
|
23
|
6.06e-01
|
-6.21e-02
|
8.79e-01
|
GO:0071474 cellular hyperosmotic response
|
9
|
7.47e-01
|
-6.20e-02
|
9.32e-01
|
GO:1904888 cranial skeletal system development
|
10
|
7.34e-01
|
6.20e-02
|
9.28e-01
|
GO:0099604 ligand-gated calcium channel activity
|
5
|
8.11e-01
|
6.19e-02
|
9.54e-01
|
GO:2001243 negative regulation of intrinsic apoptotic signaling pathway
|
18
|
6.50e-01
|
-6.18e-02
|
8.93e-01
|
GO:0006805 xenobiotic metabolic process
|
44
|
4.78e-01
|
6.18e-02
|
8.19e-01
|
GO:0010824 regulation of centrosome duplication
|
19
|
6.41e-01
|
-6.18e-02
|
8.88e-01
|
GO:0002098 tRNA wobble uridine modification
|
14
|
6.89e-01
|
-6.18e-02
|
9.06e-01
|
GO:0003094 glomerular filtration
|
5
|
8.11e-01
|
-6.18e-02
|
9.54e-01
|
GO:0101005 deubiquitinase activity
|
16
|
6.69e-01
|
-6.17e-02
|
9.01e-01
|
GO:0001938 positive regulation of endothelial cell proliferation
|
43
|
4.84e-01
|
6.17e-02
|
8.22e-01
|
GO:0006486 protein glycosylation
|
61
|
4.05e-01
|
6.17e-02
|
7.80e-01
|
GO:0006119 oxidative phosphorylation
|
12
|
7.12e-01
|
6.16e-02
|
9.18e-01
|
GO:0007158 neuron cell-cell adhesion
|
7
|
7.78e-01
|
6.16e-02
|
9.42e-01
|
GO:0032784 regulation of DNA-templated transcription elongation
|
6
|
7.94e-01
|
6.16e-02
|
9.49e-01
|
GO:0005641 nuclear envelope lumen
|
8
|
7.63e-01
|
6.16e-02
|
9.36e-01
|
GO:0098609 cell-cell adhesion
|
100
|
2.87e-01
|
-6.16e-02
|
6.81e-01
|
GO:0051019 mitogen-activated protein kinase binding
|
22
|
6.17e-01
|
-6.16e-02
|
8.82e-01
|
GO:0005829 cytosol
|
4318
|
3.79e-09
|
-6.16e-02
|
2.78e-06
|
GO:0097320 plasma membrane tubulation
|
11
|
7.24e-01
|
-6.15e-02
|
9.24e-01
|
GO:0043495 protein-membrane adaptor activity
|
28
|
5.73e-01
|
-6.15e-02
|
8.61e-01
|
GO:0001965 G-protein alpha-subunit binding
|
20
|
6.34e-01
|
6.14e-02
|
8.87e-01
|
GO:0019532 oxalate transport
|
6
|
7.95e-01
|
6.13e-02
|
9.49e-01
|
GO:0019216 regulation of lipid metabolic process
|
24
|
6.03e-01
|
6.13e-02
|
8.78e-01
|
GO:0001574 ganglioside biosynthetic process
|
7
|
7.79e-01
|
-6.13e-02
|
9.42e-01
|
GO:0000974 Prp19 complex
|
14
|
6.91e-01
|
-6.13e-02
|
9.07e-01
|
GO:0042246 tissue regeneration
|
10
|
7.37e-01
|
6.12e-02
|
9.29e-01
|
GO:0055010 ventricular cardiac muscle tissue morphogenesis
|
8
|
7.65e-01
|
-6.11e-02
|
9.37e-01
|
GO:0006362 transcription elongation by RNA polymerase I
|
6
|
7.96e-01
|
6.11e-02
|
9.49e-01
|
GO:0003684 damaged DNA binding
|
62
|
4.06e-01
|
-6.11e-02
|
7.81e-01
|
GO:0004705 JUN kinase activity
|
10
|
7.38e-01
|
-6.10e-02
|
9.29e-01
|
GO:0005685 U1 snRNP
|
18
|
6.55e-01
|
-6.09e-02
|
8.94e-01
|
GO:0071560 cellular response to transforming growth factor beta stimulus
|
38
|
5.16e-01
|
-6.09e-02
|
8.34e-01
|
GO:0010629 negative regulation of gene expression
|
176
|
1.65e-01
|
-6.08e-02
|
5.67e-01
|
GO:0001960 negative regulation of cytokine-mediated signaling pathway
|
7
|
7.81e-01
|
6.08e-02
|
9.43e-01
|
GO:0009086 methionine biosynthetic process
|
5
|
8.14e-01
|
-6.08e-02
|
9.55e-01
|
GO:0090162 establishment of epithelial cell polarity
|
11
|
7.27e-01
|
6.07e-02
|
9.25e-01
|
GO:1990531 phospholipid-translocating ATPase complex
|
11
|
7.28e-01
|
-6.07e-02
|
9.25e-01
|
GO:0060322 head development
|
9
|
7.53e-01
|
6.05e-02
|
9.34e-01
|
GO:0098553 lumenal side of endoplasmic reticulum membrane
|
31
|
5.60e-01
|
-6.05e-02
|
8.55e-01
|
GO:0060039 pericardium development
|
6
|
7.97e-01
|
-6.05e-02
|
9.49e-01
|
GO:0061462 protein localization to lysosome
|
13
|
7.06e-01
|
-6.05e-02
|
9.16e-01
|
GO:0004888 transmembrane signaling receptor activity
|
80
|
3.50e-01
|
-6.04e-02
|
7.35e-01
|
GO:0001833 inner cell mass cell proliferation
|
14
|
6.95e-01
|
6.04e-02
|
9.09e-01
|
GO:1902230 negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage
|
11
|
7.29e-01
|
6.04e-02
|
9.25e-01
|
GO:1904645 response to amyloid-beta
|
8
|
7.67e-01
|
6.04e-02
|
9.37e-01
|
GO:0006020 inositol metabolic process
|
6
|
7.98e-01
|
-6.04e-02
|
9.49e-01
|
GO:0060509 type I pneumocyte differentiation
|
6
|
7.98e-01
|
6.04e-02
|
9.49e-01
|
GO:0071782 endoplasmic reticulum tubular network
|
20
|
6.40e-01
|
6.04e-02
|
8.88e-01
|
GO:0016209 antioxidant activity
|
13
|
7.07e-01
|
6.03e-02
|
9.16e-01
|
GO:0140857 histone H3T45 kinase activity
|
195
|
1.48e-01
|
-6.02e-02
|
5.39e-01
|
GO:0031115 negative regulation of microtubule polymerization
|
8
|
7.68e-01
|
6.01e-02
|
9.37e-01
|
GO:0071141 SMAD protein complex
|
5
|
8.16e-01
|
-6.01e-02
|
9.56e-01
|
GO:0004679 AMP-activated protein kinase activity
|
197
|
1.48e-01
|
-6.00e-02
|
5.38e-01
|
GO:0030976 thiamine pyrophosphate binding
|
5
|
8.16e-01
|
6.00e-02
|
9.56e-01
|
GO:1905665 positive regulation of calcium ion import across plasma membrane
|
6
|
7.99e-01
|
-6.00e-02
|
9.49e-01
|
GO:0099523 presynaptic cytosol
|
23
|
6.19e-01
|
-5.99e-02
|
8.83e-01
|
GO:0042417 dopamine metabolic process
|
6
|
7.99e-01
|
5.99e-02
|
9.49e-01
|
GO:0005198 structural molecule activity
|
83
|
3.46e-01
|
5.99e-02
|
7.30e-01
|
GO:0061154 endothelial tube morphogenesis
|
8
|
7.69e-01
|
5.99e-02
|
9.37e-01
|
GO:0070129 regulation of mitochondrial translation
|
8
|
7.69e-01
|
5.99e-02
|
9.37e-01
|
GO:0009235 cobalamin metabolic process
|
8
|
7.70e-01
|
-5.97e-02
|
9.37e-01
|
GO:0070050 neuron cellular homeostasis
|
22
|
6.28e-01
|
-5.96e-02
|
8.85e-01
|
GO:0007165 signal transduction
|
696
|
7.81e-03
|
-5.96e-02
|
1.55e-01
|
GO:0030670 phagocytic vesicle membrane
|
70
|
3.89e-01
|
5.96e-02
|
7.66e-01
|
GO:2000210 positive regulation of anoikis
|
5
|
8.17e-01
|
5.96e-02
|
9.56e-01
|
GO:0000002 mitochondrial genome maintenance
|
12
|
7.21e-01
|
5.96e-02
|
9.22e-01
|
GO:0008191 metalloendopeptidase inhibitor activity
|
9
|
7.57e-01
|
5.96e-02
|
9.35e-01
|
GO:1904841 TORC2 complex binding
|
5
|
8.18e-01
|
-5.94e-02
|
9.56e-01
|
GO:1990405 protein antigen binding
|
5
|
8.18e-01
|
-5.94e-02
|
9.56e-01
|
GO:0032154 cleavage furrow
|
46
|
4.86e-01
|
-5.93e-02
|
8.24e-01
|
GO:0007040 lysosome organization
|
44
|
4.98e-01
|
5.90e-02
|
8.27e-01
|
GO:0035401 histone H3Y41 kinase activity
|
69
|
3.97e-01
|
-5.90e-02
|
7.72e-01
|
GO:0140801 histone H2AXY142 kinase activity
|
69
|
3.97e-01
|
-5.90e-02
|
7.72e-01
|
GO:2001235 positive regulation of apoptotic signaling pathway
|
22
|
6.32e-01
|
5.90e-02
|
8.86e-01
|
GO:0032266 phosphatidylinositol-3-phosphate binding
|
44
|
4.99e-01
|
5.89e-02
|
8.27e-01
|
GO:0030016 myofibril
|
16
|
6.83e-01
|
5.89e-02
|
9.05e-01
|
GO:0015459 potassium channel regulator activity
|
24
|
6.18e-01
|
5.89e-02
|
8.82e-01
|
GO:0042177 negative regulation of protein catabolic process
|
32
|
5.65e-01
|
-5.89e-02
|
8.56e-01
|
GO:0045786 negative regulation of cell cycle
|
39
|
5.26e-01
|
-5.87e-02
|
8.38e-01
|
GO:0097242 amyloid-beta clearance
|
16
|
6.84e-01
|
-5.87e-02
|
9.05e-01
|
GO:0030033 microvillus assembly
|
14
|
7.04e-01
|
-5.87e-02
|
9.14e-01
|
GO:0043401 steroid hormone receptor signaling pathway
|
15
|
6.94e-01
|
-5.87e-02
|
9.08e-01
|
GO:0050804 modulation of chemical synaptic transmission
|
41
|
5.16e-01
|
5.87e-02
|
8.34e-01
|
GO:0031982 vesicle
|
107
|
2.96e-01
|
5.86e-02
|
6.90e-01
|
GO:0000387 spliceosomal snRNP assembly
|
27
|
5.99e-01
|
-5.85e-02
|
8.76e-01
|
GO:0048617 embryonic foregut morphogenesis
|
5
|
8.21e-01
|
5.85e-02
|
9.57e-01
|
GO:2000773 negative regulation of cellular senescence
|
16
|
6.86e-01
|
5.84e-02
|
9.05e-01
|
GO:0098556 cytoplasmic side of rough endoplasmic reticulum membrane
|
6
|
8.04e-01
|
-5.84e-02
|
9.51e-01
|
GO:0008277 regulation of G protein-coupled receptor signaling pathway
|
31
|
5.74e-01
|
5.83e-02
|
8.62e-01
|
GO:0140537 transcription regulator activator activity
|
11
|
7.38e-01
|
5.83e-02
|
9.29e-01
|
GO:0060828 regulation of canonical Wnt signaling pathway
|
22
|
6.36e-01
|
-5.83e-02
|
8.88e-01
|
GO:2000058 regulation of ubiquitin-dependent protein catabolic process
|
5
|
8.22e-01
|
-5.82e-02
|
9.57e-01
|
GO:0060304 regulation of phosphatidylinositol dephosphorylation
|
5
|
8.22e-01
|
-5.82e-02
|
9.57e-01
|
GO:0071397 cellular response to cholesterol
|
10
|
7.50e-01
|
5.81e-02
|
9.33e-01
|
GO:0008093 cytoskeletal anchor activity
|
15
|
6.97e-01
|
-5.81e-02
|
9.10e-01
|
GO:0070410 co-SMAD binding
|
8
|
7.76e-01
|
-5.81e-02
|
9.41e-01
|
GO:0045794 negative regulation of cell volume
|
5
|
8.22e-01
|
5.81e-02
|
9.57e-01
|
GO:0051393 alpha-actinin binding
|
7
|
7.90e-01
|
5.81e-02
|
9.48e-01
|
GO:0004806 triacylglycerol lipase activity
|
11
|
7.39e-01
|
5.81e-02
|
9.29e-01
|
GO:0032591 dendritic spine membrane
|
6
|
8.06e-01
|
5.79e-02
|
9.52e-01
|
GO:0071895 odontoblast differentiation
|
5
|
8.23e-01
|
-5.79e-02
|
9.57e-01
|
GO:0051880 G-quadruplex DNA binding
|
10
|
7.51e-01
|
5.79e-02
|
9.34e-01
|
GO:0031509 subtelomeric heterochromatin formation
|
8
|
7.77e-01
|
-5.78e-02
|
9.42e-01
|
GO:2000378 negative regulation of reactive oxygen species metabolic process
|
17
|
6.80e-01
|
5.78e-02
|
9.05e-01
|
GO:0006450 regulation of translational fidelity
|
5
|
8.23e-01
|
5.78e-02
|
9.57e-01
|
GO:0030644 intracellular chloride ion homeostasis
|
7
|
7.91e-01
|
5.78e-02
|
9.48e-01
|
GO:0030278 regulation of ossification
|
12
|
7.29e-01
|
-5.78e-02
|
9.25e-01
|
GO:0030137 COPI-coated vesicle
|
6
|
8.07e-01
|
5.77e-02
|
9.52e-01
|
GO:0030234 enzyme regulator activity
|
22
|
6.39e-01
|
-5.77e-02
|
8.88e-01
|
GO:0051131 chaperone-mediated protein complex assembly
|
19
|
6.63e-01
|
5.77e-02
|
8.98e-01
|
GO:0004861 cyclin-dependent protein serine/threonine kinase inhibitor activity
|
13
|
7.19e-01
|
-5.77e-02
|
9.22e-01
|
GO:2000110 negative regulation of macrophage apoptotic process
|
6
|
8.07e-01
|
-5.77e-02
|
9.52e-01
|
GO:0005689 U12-type spliceosomal complex
|
26
|
6.11e-01
|
-5.76e-02
|
8.81e-01
|
GO:0006930 substrate-dependent cell migration, cell extension
|
7
|
7.92e-01
|
-5.76e-02
|
9.48e-01
|
GO:0008233 peptidase activity
|
58
|
4.49e-01
|
5.75e-02
|
8.00e-01
|
GO:0009982 pseudouridine synthase activity
|
13
|
7.20e-01
|
-5.75e-02
|
9.22e-01
|
GO:0019395 fatty acid oxidation
|
8
|
7.78e-01
|
5.74e-02
|
9.42e-01
|
GO:0005677 chromatin silencing complex
|
10
|
7.53e-01
|
-5.74e-02
|
9.34e-01
|
GO:0048009 insulin-like growth factor receptor signaling pathway
|
40
|
5.30e-01
|
-5.74e-02
|
8.41e-01
|
GO:0035235 ionotropic glutamate receptor signaling pathway
|
12
|
7.31e-01
|
5.74e-02
|
9.26e-01
|
GO:0046933 proton-transporting ATP synthase activity, rotational mechanism
|
17
|
6.82e-01
|
-5.74e-02
|
9.05e-01
|
GO:0004879 nuclear receptor activity
|
32
|
5.76e-01
|
-5.72e-02
|
8.63e-01
|
GO:0002028 regulation of sodium ion transport
|
11
|
7.43e-01
|
5.71e-02
|
9.30e-01
|
GO:0004677 DNA-dependent protein kinase activity
|
195
|
1.70e-01
|
-5.71e-02
|
5.76e-01
|
GO:0003700 DNA-binding transcription factor activity
|
292
|
9.52e-02
|
-5.70e-02
|
4.42e-01
|
GO:0005794 Golgi apparatus
|
781
|
7.32e-03
|
5.69e-02
|
1.53e-01
|
GO:0010883 regulation of lipid storage
|
6
|
8.09e-01
|
-5.69e-02
|
9.53e-01
|
GO:0016051 carbohydrate biosynthetic process
|
9
|
7.68e-01
|
-5.69e-02
|
9.37e-01
|
GO:0004708 MAP kinase kinase activity
|
12
|
7.33e-01
|
5.69e-02
|
9.27e-01
|
GO:0090150 establishment of protein localization to membrane
|
8
|
7.81e-01
|
5.69e-02
|
9.43e-01
|
GO:0005811 lipid droplet
|
83
|
3.71e-01
|
-5.68e-02
|
7.51e-01
|
GO:0043537 negative regulation of blood vessel endothelial cell migration
|
17
|
6.86e-01
|
5.67e-02
|
9.05e-01
|
GO:0004630 phospholipase D activity
|
5
|
8.26e-01
|
5.67e-02
|
9.59e-01
|
GO:0032367 intracellular cholesterol transport
|
11
|
7.45e-01
|
5.66e-02
|
9.32e-01
|
GO:0006289 nucleotide-excision repair
|
39
|
5.42e-01
|
-5.65e-02
|
8.45e-01
|
GO:0031210 phosphatidylcholine binding
|
19
|
6.70e-01
|
-5.65e-02
|
9.01e-01
|
GO:0016567 protein ubiquitination
|
331
|
7.87e-02
|
-5.64e-02
|
4.10e-01
|
GO:0030101 natural killer cell activation
|
13
|
7.25e-01
|
5.64e-02
|
9.25e-01
|
GO:0000139 Golgi membrane
|
546
|
2.50e-02
|
5.64e-02
|
2.58e-01
|
GO:0004676 3-phosphoinositide-dependent protein kinase activity
|
194
|
1.76e-01
|
-5.64e-02
|
5.78e-01
|
GO:0004711 ribosomal protein S6 kinase activity
|
194
|
1.76e-01
|
-5.64e-02
|
5.78e-01
|
GO:0035175 histone H3S10 kinase activity
|
194
|
1.76e-01
|
-5.64e-02
|
5.78e-01
|
GO:0035979 histone H2AXS139 kinase activity
|
194
|
1.76e-01
|
-5.64e-02
|
5.78e-01
|
GO:0044022 histone H3S28 kinase activity
|
194
|
1.76e-01
|
-5.64e-02
|
5.78e-01
|
GO:0044023 histone H4S1 kinase activity
|
194
|
1.76e-01
|
-5.64e-02
|
5.78e-01
|
GO:0044024 histone H2AS1 kinase activity
|
194
|
1.76e-01
|
-5.64e-02
|
5.78e-01
|
GO:0044025 histone H2BS14 kinase activity
|
194
|
1.76e-01
|
-5.64e-02
|
5.78e-01
|
GO:0072354 histone H3T3 kinase activity
|
194
|
1.76e-01
|
-5.64e-02
|
5.78e-01
|
GO:0072371 histone H2AS121 kinase activity
|
194
|
1.76e-01
|
-5.64e-02
|
5.78e-01
|
GO:0072518 Rho-dependent protein serine/threonine kinase activity
|
194
|
1.76e-01
|
-5.64e-02
|
5.78e-01
|
GO:0140823 histone H2BS36 kinase activity
|
194
|
1.76e-01
|
-5.64e-02
|
5.78e-01
|
GO:0140855 histone H3S57 kinase activity
|
194
|
1.76e-01
|
-5.64e-02
|
5.78e-01
|
GO:1990244 histone H2AT120 kinase activity
|
194
|
1.76e-01
|
-5.64e-02
|
5.78e-01
|
GO:0021702 cerebellar Purkinje cell differentiation
|
9
|
7.70e-01
|
-5.63e-02
|
9.37e-01
|
GO:0009416 response to light stimulus
|
14
|
7.16e-01
|
-5.63e-02
|
9.20e-01
|
GO:0007099 centriole replication
|
21
|
6.56e-01
|
-5.63e-02
|
8.94e-01
|
GO:0043523 regulation of neuron apoptotic process
|
16
|
6.97e-01
|
-5.62e-02
|
9.11e-01
|
GO:0035403 histone H3T6 kinase activity
|
196
|
1.77e-01
|
-5.60e-02
|
5.78e-01
|
GO:0015813 L-glutamate transmembrane transport
|
16
|
6.98e-01
|
-5.60e-02
|
9.12e-01
|
GO:0002903 negative regulation of B cell apoptotic process
|
8
|
7.84e-01
|
-5.59e-02
|
9.45e-01
|
GO:0089718 amino acid import across plasma membrane
|
7
|
7.98e-01
|
5.59e-02
|
9.49e-01
|
GO:0051219 phosphoprotein binding
|
31
|
5.90e-01
|
-5.59e-02
|
8.70e-01
|
GO:0035402 histone H3T11 kinase activity
|
196
|
1.78e-01
|
-5.59e-02
|
5.79e-01
|
GO:0097009 energy homeostasis
|
38
|
5.51e-01
|
-5.59e-02
|
8.49e-01
|
GO:0005769 early endosome
|
249
|
1.30e-01
|
-5.58e-02
|
5.07e-01
|
GO:0016004 phospholipase activator activity
|
10
|
7.60e-01
|
-5.58e-02
|
9.35e-01
|
GO:0005638 lamin filament
|
5
|
8.29e-01
|
-5.57e-02
|
9.60e-01
|
GO:0071353 cellular response to interleukin-4
|
20
|
6.66e-01
|
-5.57e-02
|
8.99e-01
|
GO:0070085 glycosylation
|
19
|
6.74e-01
|
5.57e-02
|
9.03e-01
|
GO:0005452 solute:inorganic anion antiporter activity
|
10
|
7.60e-01
|
-5.57e-02
|
9.35e-01
|
GO:0048745 smooth muscle tissue development
|
6
|
8.14e-01
|
5.56e-02
|
9.55e-01
|
GO:0005743 mitochondrial inner membrane
|
426
|
5.05e-02
|
-5.55e-02
|
3.42e-01
|
GO:0008584 male gonad development
|
51
|
4.93e-01
|
5.55e-02
|
8.25e-01
|
GO:0042130 negative regulation of T cell proliferation
|
32
|
5.87e-01
|
-5.55e-02
|
8.68e-01
|
GO:0005102 signaling receptor binding
|
194
|
1.85e-01
|
5.53e-02
|
5.88e-01
|
GO:0007098 centrosome cycle
|
42
|
5.36e-01
|
-5.53e-02
|
8.44e-01
|
GO:0050727 regulation of inflammatory response
|
57
|
4.71e-01
|
5.52e-02
|
8.13e-01
|
GO:0005675 transcription factor TFIIH holo complex
|
12
|
7.41e-01
|
5.52e-02
|
9.29e-01
|
GO:1904813 ficolin-1-rich granule lumen
|
118
|
3.01e-01
|
5.52e-02
|
6.92e-01
|
GO:0070847 core mediator complex
|
26
|
6.27e-01
|
5.51e-02
|
8.85e-01
|
GO:0140467 integrated stress response signaling
|
23
|
6.47e-01
|
-5.51e-02
|
8.92e-01
|
GO:0043403 skeletal muscle tissue regeneration
|
12
|
7.41e-01
|
5.51e-02
|
9.29e-01
|
GO:0030315 T-tubule
|
26
|
6.28e-01
|
-5.49e-02
|
8.85e-01
|
GO:0030057 desmosome
|
12
|
7.42e-01
|
5.49e-02
|
9.30e-01
|
GO:0048678 response to axon injury
|
20
|
6.71e-01
|
5.49e-02
|
9.01e-01
|
GO:0004791 thioredoxin-disulfide reductase (NADPH) activity
|
6
|
8.16e-01
|
-5.49e-02
|
9.56e-01
|
GO:1903078 positive regulation of protein localization to plasma membrane
|
39
|
5.54e-01
|
5.48e-02
|
8.50e-01
|
GO:0032489 regulation of Cdc42 protein signal transduction
|
5
|
8.32e-01
|
-5.48e-02
|
9.61e-01
|
GO:1905606 regulation of presynapse assembly
|
15
|
7.14e-01
|
-5.47e-02
|
9.19e-01
|
GO:0007007 inner mitochondrial membrane organization
|
17
|
6.96e-01
|
-5.47e-02
|
9.10e-01
|
GO:0018023 peptidyl-lysine trimethylation
|
7
|
8.02e-01
|
-5.46e-02
|
9.49e-01
|
GO:0006506 GPI anchor biosynthetic process
|
29
|
6.11e-01
|
-5.46e-02
|
8.81e-01
|
GO:0001649 osteoblast differentiation
|
71
|
4.27e-01
|
-5.46e-02
|
7.90e-01
|
GO:0006283 transcription-coupled nucleotide-excision repair
|
10
|
7.65e-01
|
5.46e-02
|
9.37e-01
|
GO:0004706 JUN kinase kinase kinase activity
|
16
|
7.06e-01
|
-5.45e-02
|
9.16e-01
|
GO:0030199 collagen fibril organization
|
28
|
6.18e-01
|
-5.45e-02
|
8.82e-01
|
GO:0070564 positive regulation of vitamin D receptor signaling pathway
|
6
|
8.17e-01
|
-5.44e-02
|
9.56e-01
|
GO:0015108 chloride transmembrane transporter activity
|
11
|
7.55e-01
|
-5.44e-02
|
9.34e-01
|
GO:0070498 interleukin-1-mediated signaling pathway
|
21
|
6.66e-01
|
-5.44e-02
|
8.99e-01
|
GO:0034612 response to tumor necrosis factor
|
26
|
6.32e-01
|
5.43e-02
|
8.86e-01
|
GO:0035253 ciliary rootlet
|
10
|
7.66e-01
|
5.43e-02
|
9.37e-01
|
GO:0050892 intestinal absorption
|
9
|
7.78e-01
|
-5.43e-02
|
9.42e-01
|
GO:0062023 collagen-containing extracellular matrix
|
169
|
2.24e-01
|
-5.43e-02
|
6.24e-01
|
GO:1904669 ATP export
|
6
|
8.18e-01
|
5.43e-02
|
9.56e-01
|
GO:0043021 ribonucleoprotein complex binding
|
35
|
5.79e-01
|
5.43e-02
|
8.65e-01
|
GO:0022617 extracellular matrix disassembly
|
28
|
6.19e-01
|
-5.43e-02
|
8.83e-01
|
GO:0004694 eukaryotic translation initiation factor 2alpha kinase activity
|
192
|
1.97e-01
|
-5.41e-02
|
6.01e-01
|
GO:0048681 negative regulation of axon regeneration
|
6
|
8.19e-01
|
-5.41e-02
|
9.56e-01
|
GO:0005267 potassium channel activity
|
14
|
7.26e-01
|
-5.41e-02
|
9.25e-01
|
GO:0008637 apoptotic mitochondrial changes
|
15
|
7.17e-01
|
5.41e-02
|
9.21e-01
|
GO:0046902 regulation of mitochondrial membrane permeability
|
11
|
7.57e-01
|
-5.40e-02
|
9.35e-01
|
GO:0072542 protein phosphatase activator activity
|
16
|
7.09e-01
|
5.39e-02
|
9.17e-01
|
GO:0070062 extracellular exosome
|
1450
|
7.31e-04
|
5.39e-02
|
3.48e-02
|
GO:0001650 fibrillar center
|
130
|
2.89e-01
|
-5.39e-02
|
6.82e-01
|
GO:0005184 neuropeptide hormone activity
|
9
|
7.80e-01
|
5.39e-02
|
9.42e-01
|
GO:0070652 HAUS complex
|
8
|
7.92e-01
|
5.38e-02
|
9.48e-01
|
GO:0043015 gamma-tubulin binding
|
31
|
6.04e-01
|
-5.38e-02
|
8.79e-01
|
GO:0060392 negative regulation of SMAD protein signal transduction
|
18
|
6.93e-01
|
5.37e-02
|
9.08e-01
|
GO:0006955 immune response
|
199
|
1.94e-01
|
-5.36e-02
|
5.98e-01
|
GO:0035259 nuclear glucocorticoid receptor binding
|
11
|
7.59e-01
|
5.35e-02
|
9.35e-01
|
GO:0035666 TRIF-dependent toll-like receptor signaling pathway
|
11
|
7.59e-01
|
5.34e-02
|
9.35e-01
|
GO:1900223 positive regulation of amyloid-beta clearance
|
6
|
8.21e-01
|
5.34e-02
|
9.57e-01
|
GO:0050862 positive regulation of T cell receptor signaling pathway
|
14
|
7.30e-01
|
-5.34e-02
|
9.25e-01
|
GO:0032092 positive regulation of protein binding
|
32
|
6.01e-01
|
5.34e-02
|
8.77e-01
|
GO:0072384 organelle transport along microtubule
|
13
|
7.39e-01
|
5.33e-02
|
9.29e-01
|
GO:0032981 mitochondrial respiratory chain complex I assembly
|
62
|
4.68e-01
|
5.33e-02
|
8.11e-01
|
GO:0005834 heterotrimeric G-protein complex
|
20
|
6.80e-01
|
5.32e-02
|
9.05e-01
|
GO:0019955 cytokine binding
|
24
|
6.52e-01
|
-5.32e-02
|
8.94e-01
|
GO:0060546 negative regulation of necroptotic process
|
12
|
7.50e-01
|
-5.32e-02
|
9.33e-01
|
GO:0007215 glutamate receptor signaling pathway
|
8
|
7.95e-01
|
-5.31e-02
|
9.49e-01
|
GO:0004697 diacylglycerol-dependent serine/threonine kinase activity
|
11
|
7.61e-01
|
5.29e-02
|
9.35e-01
|
GO:0098842 postsynaptic early endosome
|
6
|
8.22e-01
|
5.29e-02
|
9.57e-01
|
GO:0006629 lipid metabolic process
|
114
|
3.30e-01
|
-5.29e-02
|
7.20e-01
|
GO:1904358 positive regulation of telomere maintenance via telomere lengthening
|
6
|
8.23e-01
|
-5.28e-02
|
9.57e-01
|
GO:1902600 proton transmembrane transport
|
137
|
2.86e-01
|
-5.28e-02
|
6.81e-01
|
GO:0006417 regulation of translation
|
68
|
4.52e-01
|
-5.28e-02
|
8.02e-01
|
GO:0036465 synaptic vesicle recycling
|
11
|
7.62e-01
|
-5.28e-02
|
9.36e-01
|
GO:0031397 negative regulation of protein ubiquitination
|
51
|
5.15e-01
|
5.27e-02
|
8.34e-01
|
GO:1990757 ubiquitin ligase activator activity
|
8
|
7.96e-01
|
5.27e-02
|
9.49e-01
|
GO:0045648 positive regulation of erythrocyte differentiation
|
25
|
6.49e-01
|
-5.27e-02
|
8.93e-01
|
GO:0060627 regulation of vesicle-mediated transport
|
11
|
7.62e-01
|
-5.27e-02
|
9.36e-01
|
GO:0010907 positive regulation of glucose metabolic process
|
7
|
8.10e-01
|
-5.26e-02
|
9.53e-01
|
GO:0060090 molecular adaptor activity
|
153
|
2.62e-01
|
-5.26e-02
|
6.63e-01
|
GO:0007613 memory
|
46
|
5.38e-01
|
5.26e-02
|
8.45e-01
|
GO:0007035 vacuolar acidification
|
21
|
6.77e-01
|
-5.26e-02
|
9.03e-01
|
GO:0030145 manganese ion binding
|
57
|
4.93e-01
|
-5.25e-02
|
8.25e-01
|
GO:0014009 glial cell proliferation
|
11
|
7.63e-01
|
5.25e-02
|
9.36e-01
|
GO:1900273 positive regulation of long-term synaptic potentiation
|
12
|
7.53e-01
|
5.25e-02
|
9.34e-01
|
GO:0030943 mitochondrion targeting sequence binding
|
5
|
8.39e-01
|
-5.24e-02
|
9.65e-01
|
GO:0007281 germ cell development
|
22
|
6.71e-01
|
5.24e-02
|
9.01e-01
|
GO:0007156 homophilic cell adhesion via plasma membrane adhesion molecules
|
36
|
5.87e-01
|
-5.24e-02
|
8.68e-01
|
GO:0005744 TIM23 mitochondrial import inner membrane translocase complex
|
16
|
7.17e-01
|
-5.24e-02
|
9.21e-01
|
GO:0051560 mitochondrial calcium ion homeostasis
|
15
|
7.26e-01
|
5.23e-02
|
9.25e-01
|
GO:0030182 neuron differentiation
|
79
|
4.22e-01
|
-5.23e-02
|
7.87e-01
|
GO:0030501 positive regulation of bone mineralization
|
25
|
6.51e-01
|
5.23e-02
|
8.93e-01
|
GO:0006605 protein targeting
|
36
|
5.87e-01
|
5.23e-02
|
8.68e-01
|
GO:0005247 voltage-gated chloride channel activity
|
6
|
8.25e-01
|
5.22e-02
|
9.58e-01
|
GO:0045048 protein insertion into ER membrane
|
8
|
7.98e-01
|
5.22e-02
|
9.49e-01
|
GO:0016589 NURF complex
|
6
|
8.25e-01
|
-5.22e-02
|
9.58e-01
|
GO:0036122 BMP binding
|
6
|
8.25e-01
|
-5.22e-02
|
9.58e-01
|
GO:1990776 response to angiotensin
|
7
|
8.11e-01
|
5.21e-02
|
9.54e-01
|
GO:0034205 amyloid-beta formation
|
9
|
7.87e-01
|
-5.21e-02
|
9.46e-01
|
GO:0031670 cellular response to nutrient
|
8
|
7.99e-01
|
5.20e-02
|
9.49e-01
|
GO:0060441 epithelial tube branching involved in lung morphogenesis
|
8
|
7.99e-01
|
-5.20e-02
|
9.49e-01
|
GO:0090102 cochlea development
|
16
|
7.19e-01
|
-5.19e-02
|
9.22e-01
|
GO:0006355 regulation of DNA-templated transcription
|
418
|
7.01e-02
|
-5.19e-02
|
3.89e-01
|
GO:0019003 GDP binding
|
61
|
4.84e-01
|
5.19e-02
|
8.22e-01
|
GO:0045739 positive regulation of DNA repair
|
41
|
5.66e-01
|
-5.19e-02
|
8.56e-01
|
GO:0045332 phospholipid translocation
|
21
|
6.81e-01
|
5.19e-02
|
9.05e-01
|
GO:0090611 ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway
|
5
|
8.41e-01
|
5.18e-02
|
9.66e-01
|
GO:0003215 cardiac right ventricle morphogenesis
|
5
|
8.41e-01
|
-5.17e-02
|
9.66e-01
|
GO:0032510 endosome to lysosome transport via multivesicular body sorting pathway
|
5
|
8.42e-01
|
5.15e-02
|
9.66e-01
|
GO:0050830 defense response to Gram-positive bacterium
|
51
|
5.25e-01
|
5.15e-02
|
8.37e-01
|
GO:0046785 microtubule polymerization
|
13
|
7.48e-01
|
-5.15e-02
|
9.32e-01
|
GO:0032801 receptor catabolic process
|
14
|
7.39e-01
|
5.14e-02
|
9.29e-01
|
GO:0001932 regulation of protein phosphorylation
|
21
|
6.83e-01
|
5.14e-02
|
9.05e-01
|
GO:0060674 placenta blood vessel development
|
10
|
7.78e-01
|
-5.14e-02
|
9.42e-01
|
GO:0070531 BRCA1-A complex
|
8
|
8.02e-01
|
5.13e-02
|
9.49e-01
|
GO:0035579 specific granule membrane
|
76
|
4.40e-01
|
-5.13e-02
|
7.96e-01
|
GO:0000228 nuclear chromosome
|
23
|
6.71e-01
|
-5.13e-02
|
9.01e-01
|
GO:0021799 cerebral cortex radially oriented cell migration
|
5
|
8.43e-01
|
-5.12e-02
|
9.66e-01
|
GO:0010324 membrane invagination
|
6
|
8.29e-01
|
-5.10e-02
|
9.60e-01
|
GO:0006983 ER overload response
|
11
|
7.70e-01
|
5.09e-02
|
9.37e-01
|
GO:0009395 phospholipid catabolic process
|
9
|
7.91e-01
|
5.09e-02
|
9.48e-01
|
GO:0015030 Cajal body
|
51
|
5.30e-01
|
-5.09e-02
|
8.41e-01
|
GO:0070269 pyroptotic inflammatory response
|
23
|
6.73e-01
|
5.09e-02
|
9.02e-01
|
GO:0008296 3’-5’-DNA exonuclease activity
|
6
|
8.30e-01
|
-5.08e-02
|
9.60e-01
|
GO:0046599 regulation of centriole replication
|
7
|
8.16e-01
|
5.07e-02
|
9.56e-01
|
GO:0036148 phosphatidylglycerol acyl-chain remodeling
|
6
|
8.30e-01
|
5.07e-02
|
9.60e-01
|
GO:0044828 negative regulation by host of viral genome replication
|
11
|
7.72e-01
|
-5.06e-02
|
9.38e-01
|
GO:0006826 iron ion transport
|
14
|
7.43e-01
|
-5.06e-02
|
9.31e-01
|
GO:2000114 regulation of establishment of cell polarity
|
13
|
7.53e-01
|
5.05e-02
|
9.34e-01
|
GO:0051177 meiotic sister chromatid cohesion
|
6
|
8.30e-01
|
-5.05e-02
|
9.61e-01
|
GO:0071889 14-3-3 protein binding
|
29
|
6.38e-01
|
5.05e-02
|
8.88e-01
|
GO:0038173 interleukin-17A-mediated signaling pathway
|
5
|
8.45e-01
|
-5.05e-02
|
9.67e-01
|
GO:0007399 nervous system development
|
189
|
2.33e-01
|
-5.04e-02
|
6.35e-01
|
GO:0032991 protein-containing complex
|
495
|
5.62e-02
|
-5.04e-02
|
3.53e-01
|
GO:0061668 mitochondrial ribosome assembly
|
7
|
8.17e-01
|
-5.04e-02
|
9.56e-01
|
GO:0042445 hormone metabolic process
|
7
|
8.18e-01
|
5.02e-02
|
9.56e-01
|
GO:0001558 regulation of cell growth
|
57
|
5.12e-01
|
-5.02e-02
|
8.34e-01
|
GO:0033146 regulation of intracellular estrogen receptor signaling pathway
|
9
|
7.94e-01
|
-5.02e-02
|
9.49e-01
|
GO:0071805 potassium ion transmembrane transport
|
50
|
5.40e-01
|
-5.01e-02
|
8.45e-01
|
GO:0031410 cytoplasmic vesicle
|
206
|
2.16e-01
|
-5.01e-02
|
6.18e-01
|
GO:0071223 cellular response to lipoteichoic acid
|
9
|
7.95e-01
|
-5.01e-02
|
9.49e-01
|
GO:0016485 protein processing
|
60
|
5.03e-01
|
-5.00e-02
|
8.30e-01
|
GO:0046622 positive regulation of organ growth
|
6
|
8.32e-01
|
5.00e-02
|
9.61e-01
|
GO:0060396 growth hormone receptor signaling pathway
|
6
|
8.32e-01
|
5.00e-02
|
9.61e-01
|
GO:1904996 positive regulation of leukocyte adhesion to vascular endothelial cell
|
9
|
7.95e-01
|
-5.00e-02
|
9.49e-01
|
GO:0008285 negative regulation of cell population proliferation
|
260
|
1.67e-01
|
-4.99e-02
|
5.71e-01
|
GO:0000395 mRNA 5’-splice site recognition
|
5
|
8.47e-01
|
-4.99e-02
|
9.68e-01
|
GO:0044346 fibroblast apoptotic process
|
10
|
7.85e-01
|
-4.98e-02
|
9.45e-01
|
GO:0005770 late endosome
|
129
|
3.30e-01
|
4.98e-02
|
7.20e-01
|
GO:1902476 chloride transmembrane transport
|
48
|
5.51e-01
|
-4.97e-02
|
8.49e-01
|
GO:0046328 regulation of JNK cascade
|
12
|
7.66e-01
|
4.97e-02
|
9.37e-01
|
GO:0042113 B cell activation
|
26
|
6.61e-01
|
-4.97e-02
|
8.97e-01
|
GO:0006914 autophagy
|
132
|
3.25e-01
|
4.97e-02
|
7.18e-01
|
GO:0120212 sperm head-tail coupling apparatus
|
10
|
7.86e-01
|
4.96e-02
|
9.45e-01
|
GO:0048665 neuron fate specification
|
5
|
8.48e-01
|
4.96e-02
|
9.68e-01
|
GO:0045429 positive regulation of nitric oxide biosynthetic process
|
33
|
6.22e-01
|
4.96e-02
|
8.84e-01
|
GO:0043123 positive regulation of canonical NF-kappaB signal transduction
|
178
|
2.57e-01
|
-4.93e-02
|
6.58e-01
|
GO:0010882 regulation of cardiac muscle contraction by calcium ion signaling
|
5
|
8.49e-01
|
4.93e-02
|
9.68e-01
|
GO:0032045 guanyl-nucleotide exchange factor complex
|
9
|
7.98e-01
|
4.92e-02
|
9.49e-01
|
GO:0001227 DNA-binding transcription repressor activity, RNA polymerase II-specific
|
167
|
2.74e-01
|
-4.92e-02
|
6.71e-01
|
GO:0060993 kidney morphogenesis
|
8
|
8.10e-01
|
-4.92e-02
|
9.53e-01
|
GO:0002021 response to dietary excess
|
8
|
8.10e-01
|
-4.91e-02
|
9.53e-01
|
GO:0035925 mRNA 3’-UTR AU-rich region binding
|
27
|
6.59e-01
|
-4.91e-02
|
8.96e-01
|
GO:0007601 visual perception
|
86
|
4.33e-01
|
4.90e-02
|
7.94e-01
|
GO:0007507 heart development
|
128
|
3.39e-01
|
-4.90e-02
|
7.26e-01
|
GO:0070885 negative regulation of calcineurin-NFAT signaling cascade
|
12
|
7.69e-01
|
-4.89e-02
|
9.37e-01
|
GO:0120162 positive regulation of cold-induced thermogenesis
|
68
|
4.87e-01
|
-4.88e-02
|
8.24e-01
|
GO:1903136 cuprous ion binding
|
6
|
8.36e-01
|
-4.88e-02
|
9.65e-01
|
GO:0032182 ubiquitin-like protein binding
|
5
|
8.50e-01
|
-4.88e-02
|
9.68e-01
|
GO:2000436 positive regulation of protein neddylation
|
5
|
8.50e-01
|
-4.88e-02
|
9.68e-01
|
GO:0046940 nucleoside monophosphate phosphorylation
|
10
|
7.90e-01
|
4.87e-02
|
9.48e-01
|
GO:0010595 positive regulation of endothelial cell migration
|
38
|
6.04e-01
|
-4.87e-02
|
8.78e-01
|
GO:0038023 signaling receptor activity
|
113
|
3.72e-01
|
4.87e-02
|
7.51e-01
|
GO:0042306 regulation of protein import into nucleus
|
5
|
8.51e-01
|
-4.86e-02
|
9.68e-01
|
GO:0016323 basolateral plasma membrane
|
155
|
2.97e-01
|
-4.86e-02
|
6.90e-01
|
GO:0005576 extracellular region
|
823
|
1.91e-02
|
4.85e-02
|
2.28e-01
|
GO:0043559 insulin binding
|
5
|
8.51e-01
|
4.85e-02
|
9.68e-01
|
GO:0004693 cyclin-dependent protein serine/threonine kinase activity
|
27
|
6.63e-01
|
-4.85e-02
|
8.98e-01
|
GO:1904823 purine nucleobase transmembrane transport
|
5
|
8.51e-01
|
4.85e-02
|
9.68e-01
|
GO:0061052 negative regulation of cell growth involved in cardiac muscle cell development
|
8
|
8.13e-01
|
-4.84e-02
|
9.54e-01
|
GO:0046326 positive regulation of D-glucose import
|
23
|
6.88e-01
|
4.84e-02
|
9.06e-01
|
GO:0005827 polar microtubule
|
5
|
8.51e-01
|
-4.84e-02
|
9.68e-01
|
GO:1903980 positive regulation of microglial cell activation
|
6
|
8.37e-01
|
4.84e-02
|
9.65e-01
|
GO:0005741 mitochondrial outer membrane
|
186
|
2.56e-01
|
4.84e-02
|
6.58e-01
|
GO:0016079 synaptic vesicle exocytosis
|
13
|
7.63e-01
|
4.83e-02
|
9.36e-01
|
GO:0006055 CMP-N-acetylneuraminate biosynthetic process
|
5
|
8.52e-01
|
4.82e-02
|
9.68e-01
|
GO:0009986 cell surface
|
341
|
1.28e-01
|
-4.82e-02
|
5.05e-01
|
GO:0070242 thymocyte apoptotic process
|
9
|
8.03e-01
|
4.81e-02
|
9.49e-01
|
GO:0051151 negative regulation of smooth muscle cell differentiation
|
7
|
8.26e-01
|
-4.81e-02
|
9.58e-01
|
GO:0043114 regulation of vascular permeability
|
7
|
8.26e-01
|
-4.80e-02
|
9.58e-01
|
GO:0071345 cellular response to cytokine stimulus
|
17
|
7.32e-01
|
-4.79e-02
|
9.27e-01
|
GO:0055089 fatty acid homeostasis
|
11
|
7.83e-01
|
-4.79e-02
|
9.45e-01
|
GO:0019209 kinase activator activity
|
9
|
8.04e-01
|
-4.79e-02
|
9.50e-01
|
GO:0000470 maturation of LSU-rRNA
|
9
|
8.04e-01
|
4.78e-02
|
9.50e-01
|
GO:0001764 neuron migration
|
76
|
4.71e-01
|
-4.78e-02
|
8.13e-01
|
GO:0031093 platelet alpha granule lumen
|
44
|
5.84e-01
|
4.78e-02
|
8.66e-01
|
GO:0008324 monoatomic cation transmembrane transporter activity
|
5
|
8.53e-01
|
-4.78e-02
|
9.69e-01
|
GO:0097237 cellular response to toxic substance
|
7
|
8.27e-01
|
-4.77e-02
|
9.59e-01
|
GO:0015269 calcium-activated potassium channel activity
|
6
|
8.40e-01
|
4.76e-02
|
9.65e-01
|
GO:0008290 F-actin capping protein complex
|
6
|
8.40e-01
|
-4.76e-02
|
9.65e-01
|
GO:0001401 SAM complex
|
13
|
7.66e-01
|
-4.76e-02
|
9.37e-01
|
GO:0140275 MIB complex
|
13
|
7.66e-01
|
-4.76e-02
|
9.37e-01
|
GO:0032580 Golgi cisterna membrane
|
56
|
5.39e-01
|
-4.75e-02
|
8.45e-01
|
GO:0048144 fibroblast proliferation
|
29
|
6.58e-01
|
4.75e-02
|
8.95e-01
|
GO:0006956 complement activation
|
10
|
7.95e-01
|
-4.75e-02
|
9.49e-01
|
GO:0006493 protein O-linked glycosylation
|
45
|
5.82e-01
|
-4.75e-02
|
8.65e-01
|
GO:0140042 lipid droplet formation
|
12
|
7.76e-01
|
-4.74e-02
|
9.41e-01
|
GO:0002753 cytoplasmic pattern recognition receptor signaling pathway
|
16
|
7.43e-01
|
4.74e-02
|
9.30e-01
|
GO:0030673 axolemma
|
8
|
8.16e-01
|
4.74e-02
|
9.56e-01
|
GO:0042796 snRNA transcription by RNA polymerase III
|
9
|
8.06e-01
|
4.74e-02
|
9.52e-01
|
GO:0017075 syntaxin-1 binding
|
11
|
7.86e-01
|
-4.74e-02
|
9.45e-01
|
GO:0071723 lipopeptide binding
|
5
|
8.55e-01
|
-4.73e-02
|
9.70e-01
|
GO:0043627 response to estrogen
|
30
|
6.54e-01
|
-4.73e-02
|
8.94e-01
|
GO:0032963 collagen metabolic process
|
10
|
7.96e-01
|
-4.73e-02
|
9.49e-01
|
GO:0030425 dendrite
|
251
|
1.99e-01
|
-4.72e-02
|
6.02e-01
|
GO:0008568 microtubule severing ATPase activity
|
5
|
8.55e-01
|
-4.72e-02
|
9.70e-01
|
GO:0042542 response to hydrogen peroxide
|
25
|
6.83e-01
|
-4.71e-02
|
9.05e-01
|
GO:0032729 positive regulation of type II interferon production
|
52
|
5.57e-01
|
-4.71e-02
|
8.53e-01
|
GO:2000178 negative regulation of neural precursor cell proliferation
|
6
|
8.42e-01
|
4.71e-02
|
9.66e-01
|
GO:0001046 core promoter sequence-specific DNA binding
|
16
|
7.45e-01
|
-4.70e-02
|
9.32e-01
|
GO:0071875 adrenergic receptor signaling pathway
|
7
|
8.29e-01
|
-4.70e-02
|
9.60e-01
|
GO:0051287 NAD binding
|
32
|
6.46e-01
|
4.69e-02
|
8.91e-01
|
GO:0008352 katanin complex
|
5
|
8.56e-01
|
-4.68e-02
|
9.70e-01
|
GO:0032753 positive regulation of interleukin-4 production
|
17
|
7.38e-01
|
-4.68e-02
|
9.29e-01
|
GO:1903830 magnesium ion transmembrane transport
|
14
|
7.62e-01
|
-4.68e-02
|
9.36e-01
|
GO:0015026 coreceptor activity
|
34
|
6.37e-01
|
-4.68e-02
|
8.88e-01
|
GO:0007611 learning or memory
|
39
|
6.13e-01
|
-4.68e-02
|
8.81e-01
|
GO:0004017 adenylate kinase activity
|
7
|
8.30e-01
|
4.68e-02
|
9.61e-01
|
GO:0070883 pre-miRNA binding
|
8
|
8.19e-01
|
4.67e-02
|
9.56e-01
|
GO:0036498 IRE1-mediated unfolded protein response
|
6
|
8.43e-01
|
4.67e-02
|
9.67e-01
|
GO:0030286 dynein complex
|
14
|
7.63e-01
|
4.66e-02
|
9.36e-01
|
GO:0031023 microtubule organizing center organization
|
10
|
7.99e-01
|
-4.66e-02
|
9.49e-01
|
GO:0015827 tryptophan transport
|
5
|
8.57e-01
|
4.65e-02
|
9.70e-01
|
GO:0098826 endoplasmic reticulum tubular network membrane
|
5
|
8.57e-01
|
4.64e-02
|
9.70e-01
|
GO:0072659 protein localization to plasma membrane
|
101
|
4.21e-01
|
-4.64e-02
|
7.87e-01
|
GO:0006874 intracellular calcium ion homeostasis
|
57
|
5.45e-01
|
-4.64e-02
|
8.47e-01
|
GO:0005886 plasma membrane
|
2616
|
1.97e-04
|
-4.63e-02
|
1.48e-02
|
GO:0031526 brush border membrane
|
31
|
6.55e-01
|
4.63e-02
|
8.94e-01
|
GO:0050661 NADP binding
|
28
|
6.72e-01
|
4.63e-02
|
9.01e-01
|
GO:0120293 dynein axonemal particle
|
10
|
8.00e-01
|
4.63e-02
|
9.49e-01
|
GO:0030324 lung development
|
44
|
5.96e-01
|
4.62e-02
|
8.75e-01
|
GO:0097035 regulation of membrane lipid distribution
|
6
|
8.45e-01
|
4.61e-02
|
9.67e-01
|
GO:0030311 poly-N-acetyllactosamine biosynthetic process
|
5
|
8.58e-01
|
4.61e-02
|
9.70e-01
|
GO:0007605 sensory perception of sound
|
88
|
4.56e-01
|
-4.61e-02
|
8.03e-01
|
GO:1904354 negative regulation of telomere capping
|
5
|
8.59e-01
|
-4.60e-02
|
9.70e-01
|
GO:0006809 nitric oxide biosynthetic process
|
15
|
7.58e-01
|
-4.60e-02
|
9.35e-01
|
GO:0034362 low-density lipoprotein particle
|
11
|
7.92e-01
|
4.59e-02
|
9.48e-01
|
GO:0097192 extrinsic apoptotic signaling pathway in absence of ligand
|
23
|
7.03e-01
|
-4.59e-02
|
9.14e-01
|
GO:0032736 positive regulation of interleukin-13 production
|
9
|
8.12e-01
|
-4.59e-02
|
9.54e-01
|
GO:0032593 insulin-responsive compartment
|
6
|
8.46e-01
|
4.59e-02
|
9.68e-01
|
GO:0048487 beta-tubulin binding
|
35
|
6.39e-01
|
4.58e-02
|
8.88e-01
|
GO:1905323 telomerase holoenzyme complex assembly
|
6
|
8.46e-01
|
4.57e-02
|
9.68e-01
|
GO:0009060 aerobic respiration
|
68
|
5.15e-01
|
4.57e-02
|
8.34e-01
|
GO:0062196 regulation of lysosome size
|
9
|
8.13e-01
|
-4.56e-02
|
9.54e-01
|
GO:0002191 cap-dependent translational initiation
|
6
|
8.46e-01
|
-4.56e-02
|
9.68e-01
|
GO:0005665 RNA polymerase II, core complex
|
15
|
7.60e-01
|
-4.56e-02
|
9.35e-01
|
GO:0043296 apical junction complex
|
18
|
7.38e-01
|
4.56e-02
|
9.29e-01
|
GO:0038180 nerve growth factor signaling pathway
|
9
|
8.13e-01
|
4.55e-02
|
9.54e-01
|
GO:0031005 filamin binding
|
8
|
8.24e-01
|
-4.55e-02
|
9.58e-01
|
GO:0005856 cytoskeleton
|
272
|
1.98e-01
|
-4.55e-02
|
6.02e-01
|
GO:0005384 manganese ion transmembrane transporter activity
|
5
|
8.60e-01
|
4.55e-02
|
9.70e-01
|
GO:0070821 tertiary granule membrane
|
61
|
5.40e-01
|
-4.54e-02
|
8.45e-01
|
GO:1903779 regulation of cardiac conduction
|
12
|
7.86e-01
|
-4.52e-02
|
9.45e-01
|
GO:0030056 hemidesmosome
|
6
|
8.48e-01
|
-4.52e-02
|
9.68e-01
|
GO:0099175 regulation of postsynapse organization
|
20
|
7.26e-01
|
-4.52e-02
|
9.25e-01
|
GO:0003148 outflow tract septum morphogenesis
|
16
|
7.54e-01
|
-4.52e-02
|
9.34e-01
|
GO:0099505 regulation of presynaptic membrane potential
|
9
|
8.15e-01
|
-4.51e-02
|
9.55e-01
|
GO:1990837 sequence-specific double-stranded DNA binding
|
257
|
2.15e-01
|
-4.51e-02
|
6.16e-01
|
GO:1902523 positive regulation of protein K63-linked ubiquitination
|
8
|
8.25e-01
|
-4.51e-02
|
9.58e-01
|
GO:0010807 regulation of synaptic vesicle priming
|
7
|
8.37e-01
|
4.49e-02
|
9.65e-01
|
GO:0046903 secretion
|
6
|
8.49e-01
|
-4.49e-02
|
9.68e-01
|
GO:0071539 protein localization to centrosome
|
24
|
7.04e-01
|
-4.48e-02
|
9.14e-01
|
GO:0015174 basic amino acid transmembrane transporter activity
|
7
|
8.38e-01
|
4.47e-02
|
9.65e-01
|
GO:0016266 O-glycan processing
|
30
|
6.72e-01
|
-4.47e-02
|
9.01e-01
|
GO:0061891 calcium ion sensor activity
|
8
|
8.27e-01
|
-4.47e-02
|
9.59e-01
|
GO:0030512 negative regulation of transforming growth factor beta receptor signaling pathway
|
74
|
5.07e-01
|
-4.47e-02
|
8.33e-01
|
GO:0051262 protein tetramerization
|
22
|
7.17e-01
|
4.46e-02
|
9.21e-01
|
GO:0043312 neutrophil degranulation
|
6
|
8.50e-01
|
-4.46e-02
|
9.68e-01
|
GO:0070922 RISC complex assembly
|
10
|
8.07e-01
|
-4.46e-02
|
9.52e-01
|
GO:0006953 acute-phase response
|
16
|
7.58e-01
|
-4.46e-02
|
9.35e-01
|
GO:0033210 leptin-mediated signaling pathway
|
5
|
8.63e-01
|
-4.45e-02
|
9.70e-01
|
GO:0009597 detection of virus
|
5
|
8.63e-01
|
4.45e-02
|
9.70e-01
|
GO:0019992 diacylglycerol binding
|
11
|
7.98e-01
|
-4.45e-02
|
9.49e-01
|
GO:0008289 lipid binding
|
104
|
4.35e-01
|
-4.44e-02
|
7.94e-01
|
GO:0007095 mitotic G2 DNA damage checkpoint signaling
|
35
|
6.51e-01
|
4.42e-02
|
8.93e-01
|
GO:0032288 myelin assembly
|
6
|
8.51e-01
|
-4.42e-02
|
9.68e-01
|
GO:0046983 protein dimerization activity
|
87
|
4.76e-01
|
-4.42e-02
|
8.18e-01
|
GO:1902807 negative regulation of cell cycle G1/S phase transition
|
5
|
8.64e-01
|
4.42e-02
|
9.70e-01
|
GO:0002523 leukocyte migration involved in inflammatory response
|
7
|
8.40e-01
|
4.41e-02
|
9.65e-01
|
GO:0014069 postsynaptic density
|
172
|
3.20e-01
|
-4.40e-02
|
7.11e-01
|
GO:0045499 chemorepellent activity
|
14
|
7.76e-01
|
-4.40e-02
|
9.41e-01
|
GO:0006942 regulation of striated muscle contraction
|
5
|
8.65e-01
|
4.40e-02
|
9.70e-01
|
GO:0005640 nuclear outer membrane
|
22
|
7.21e-01
|
-4.40e-02
|
9.22e-01
|
GO:0014704 intercalated disc
|
32
|
6.68e-01
|
-4.39e-02
|
9.00e-01
|
GO:0035264 multicellular organism growth
|
74
|
5.15e-01
|
-4.38e-02
|
8.34e-01
|
GO:1903543 positive regulation of exosomal secretion
|
13
|
7.84e-01
|
-4.38e-02
|
9.45e-01
|
GO:0008340 determination of adult lifespan
|
26
|
6.99e-01
|
4.38e-02
|
9.12e-01
|
GO:0140318 protein transporter activity
|
11
|
8.02e-01
|
-4.37e-02
|
9.49e-01
|
GO:0002040 sprouting angiogenesis
|
20
|
7.35e-01
|
-4.37e-02
|
9.29e-01
|
GO:0010008 endosome membrane
|
219
|
2.67e-01
|
-4.37e-02
|
6.68e-01
|
GO:0046966 nuclear thyroid hormone receptor binding
|
27
|
6.95e-01
|
-4.37e-02
|
9.09e-01
|
GO:0033314 mitotic DNA replication checkpoint signaling
|
8
|
8.31e-01
|
-4.36e-02
|
9.61e-01
|
GO:0007339 binding of sperm to zona pellucida
|
16
|
7.63e-01
|
-4.36e-02
|
9.36e-01
|
GO:0032008 positive regulation of TOR signaling
|
25
|
7.06e-01
|
4.36e-02
|
9.16e-01
|
GO:0046620 regulation of organ growth
|
5
|
8.66e-01
|
-4.36e-02
|
9.71e-01
|
GO:0106002 mCRD-mediated mRNA stability complex
|
5
|
8.66e-01
|
-4.35e-02
|
9.71e-01
|
GO:0098792 xenophagy
|
9
|
8.21e-01
|
4.35e-02
|
9.57e-01
|
GO:0010508 positive regulation of autophagy
|
59
|
5.65e-01
|
-4.34e-02
|
8.56e-01
|
GO:0051491 positive regulation of filopodium assembly
|
21
|
7.31e-01
|
4.33e-02
|
9.26e-01
|
GO:0005125 cytokine activity
|
63
|
5.52e-01
|
4.33e-02
|
8.50e-01
|
GO:0072520 seminiferous tubule development
|
12
|
7.95e-01
|
4.33e-02
|
9.49e-01
|
GO:0008408 3’-5’ exonuclease activity
|
16
|
7.64e-01
|
4.33e-02
|
9.37e-01
|
GO:1990404 NAD+-protein ADP-ribosyltransferase activity
|
22
|
7.26e-01
|
4.32e-02
|
9.25e-01
|
GO:1990606 membrane scission GTPase motor activity
|
36
|
6.55e-01
|
4.31e-02
|
8.94e-01
|
GO:0007030 Golgi organization
|
96
|
4.66e-01
|
4.31e-02
|
8.10e-01
|
GO:0030206 chondroitin sulfate biosynthetic process
|
17
|
7.60e-01
|
4.29e-02
|
9.35e-01
|
GO:0060444 branching involved in mammary gland duct morphogenesis
|
6
|
8.56e-01
|
-4.27e-02
|
9.70e-01
|
GO:1903146 regulation of autophagy of mitochondrion
|
6
|
8.56e-01
|
4.27e-02
|
9.70e-01
|
GO:0007193 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway
|
21
|
7.35e-01
|
-4.27e-02
|
9.28e-01
|
GO:0006821 chloride transport
|
18
|
7.54e-01
|
-4.27e-02
|
9.34e-01
|
GO:0060992 response to fungicide
|
6
|
8.56e-01
|
4.27e-02
|
9.70e-01
|
GO:0050778 positive regulation of immune response
|
19
|
7.47e-01
|
4.27e-02
|
9.32e-01
|
GO:0010469 regulation of signaling receptor activity
|
5
|
8.69e-01
|
4.27e-02
|
9.72e-01
|
GO:0071375 cellular response to peptide hormone stimulus
|
7
|
8.45e-01
|
-4.26e-02
|
9.67e-01
|
GO:0140361 cyclic-GMP-AMP transmembrane import across plasma membrane
|
7
|
8.45e-01
|
4.25e-02
|
9.67e-01
|
GO:2001242 regulation of intrinsic apoptotic signaling pathway
|
6
|
8.57e-01
|
4.25e-02
|
9.70e-01
|
GO:0010996 response to auditory stimulus
|
12
|
7.99e-01
|
4.24e-02
|
9.49e-01
|
GO:0006911 phagocytosis, engulfment
|
22
|
7.31e-01
|
-4.24e-02
|
9.26e-01
|
GO:0098703 calcium ion import across plasma membrane
|
13
|
7.91e-01
|
4.24e-02
|
9.48e-01
|
GO:0098632 cell-cell adhesion mediator activity
|
11
|
8.08e-01
|
4.23e-02
|
9.53e-01
|
GO:0140713 histone chaperone activity
|
10
|
8.17e-01
|
4.23e-02
|
9.56e-01
|
GO:0008610 lipid biosynthetic process
|
13
|
7.92e-01
|
-4.23e-02
|
9.48e-01
|
GO:0015631 tubulin binding
|
44
|
6.28e-01
|
-4.22e-02
|
8.85e-01
|
GO:0001955 blood vessel maturation
|
6
|
8.58e-01
|
-4.22e-02
|
9.70e-01
|
GO:0005248 voltage-gated sodium channel activity
|
7
|
8.47e-01
|
4.21e-02
|
9.68e-01
|
GO:0006691 leukotriene metabolic process
|
7
|
8.47e-01
|
4.21e-02
|
9.68e-01
|
GO:0007186 G protein-coupled receptor signaling pathway
|
173
|
3.41e-01
|
-4.21e-02
|
7.27e-01
|
GO:0001658 branching involved in ureteric bud morphogenesis
|
13
|
7.93e-01
|
4.20e-02
|
9.49e-01
|
GO:0097746 blood vessel diameter maintenance
|
11
|
8.09e-01
|
4.20e-02
|
9.53e-01
|
GO:0034315 regulation of Arp2/3 complex-mediated actin nucleation
|
14
|
7.86e-01
|
-4.20e-02
|
9.45e-01
|
GO:0005005 transmembrane-ephrin receptor activity
|
16
|
7.72e-01
|
-4.19e-02
|
9.38e-01
|
GO:0006491 N-glycan processing
|
15
|
7.79e-01
|
-4.19e-02
|
9.42e-01
|
GO:0050660 flavin adenine dinucleotide binding
|
44
|
6.31e-01
|
-4.18e-02
|
8.86e-01
|
GO:0005737 cytoplasm
|
3796
|
1.24e-04
|
-4.18e-02
|
1.05e-02
|
GO:0008333 endosome to lysosome transport
|
41
|
6.44e-01
|
4.17e-02
|
8.90e-01
|
GO:0045746 negative regulation of Notch signaling pathway
|
27
|
7.08e-01
|
-4.16e-02
|
9.17e-01
|
GO:0034198 cellular response to amino acid starvation
|
46
|
6.26e-01
|
-4.15e-02
|
8.85e-01
|
GO:0018146 keratan sulfate biosynthetic process
|
11
|
8.12e-01
|
-4.15e-02
|
9.54e-01
|
GO:0005262 calcium channel activity
|
47
|
6.23e-01
|
4.14e-02
|
8.84e-01
|
GO:0033268 node of Ranvier
|
9
|
8.30e-01
|
4.14e-02
|
9.60e-01
|
GO:0002115 store-operated calcium entry
|
8
|
8.39e-01
|
4.14e-02
|
9.65e-01
|
GO:1903358 regulation of Golgi organization
|
11
|
8.12e-01
|
-4.14e-02
|
9.54e-01
|
GO:0045197 establishment or maintenance of epithelial cell apical/basal polarity
|
18
|
7.61e-01
|
4.14e-02
|
9.35e-01
|
GO:0051537 2 iron, 2 sulfur cluster binding
|
24
|
7.26e-01
|
4.14e-02
|
9.25e-01
|
GO:0070125 mitochondrial translational elongation
|
5
|
8.73e-01
|
4.14e-02
|
9.73e-01
|
GO:1902527 positive regulation of protein monoubiquitination
|
5
|
8.73e-01
|
4.12e-02
|
9.73e-01
|
GO:0010460 positive regulation of heart rate
|
9
|
8.31e-01
|
-4.12e-02
|
9.61e-01
|
GO:0090090 negative regulation of canonical Wnt signaling pathway
|
83
|
5.18e-01
|
4.11e-02
|
8.34e-01
|
GO:0021542 dentate gyrus development
|
13
|
7.98e-01
|
4.11e-02
|
9.49e-01
|
GO:0005789 endoplasmic reticulum membrane
|
837
|
4.59e-02
|
4.10e-02
|
3.36e-01
|
GO:0045861 negative regulation of proteolysis
|
15
|
7.83e-01
|
4.10e-02
|
9.45e-01
|
GO:0070166 enamel mineralization
|
10
|
8.23e-01
|
-4.10e-02
|
9.57e-01
|
GO:0042589 zymogen granule membrane
|
7
|
8.51e-01
|
4.10e-02
|
9.68e-01
|
GO:0060216 definitive hemopoiesis
|
10
|
8.23e-01
|
-4.08e-02
|
9.58e-01
|
GO:0071014 post-mRNA release spliceosomal complex
|
7
|
8.52e-01
|
4.08e-02
|
9.68e-01
|
GO:0016241 regulation of macroautophagy
|
51
|
6.15e-01
|
-4.07e-02
|
8.82e-01
|
GO:0005958 DNA-dependent protein kinase-DNA ligase 4 complex
|
7
|
8.52e-01
|
-4.07e-02
|
9.68e-01
|
GO:0003730 mRNA 3’-UTR binding
|
71
|
5.54e-01
|
-4.06e-02
|
8.50e-01
|
GO:0007004 telomere maintenance via telomerase
|
21
|
7.48e-01
|
4.06e-02
|
9.32e-01
|
GO:0032040 small-subunit processome
|
70
|
5.58e-01
|
4.05e-02
|
8.54e-01
|
GO:0001942 hair follicle development
|
18
|
7.66e-01
|
-4.05e-02
|
9.37e-01
|
GO:0005796 Golgi lumen
|
39
|
6.62e-01
|
-4.05e-02
|
8.98e-01
|
GO:0060736 prostate gland growth
|
5
|
8.75e-01
|
-4.05e-02
|
9.73e-01
|
GO:0033151 V(D)J recombination
|
9
|
8.34e-01
|
-4.04e-02
|
9.63e-01
|
GO:0005730 nucleolus
|
786
|
5.68e-02
|
-4.03e-02
|
3.54e-01
|
GO:0051281 positive regulation of release of sequestered calcium ion into cytosol
|
12
|
8.09e-01
|
4.03e-02
|
9.53e-01
|
GO:0030216 keratinocyte differentiation
|
35
|
6.80e-01
|
4.03e-02
|
9.05e-01
|
GO:0071467 cellular response to pH
|
6
|
8.64e-01
|
4.02e-02
|
9.70e-01
|
GO:0048306 calcium-dependent protein binding
|
51
|
6.19e-01
|
4.02e-02
|
8.83e-01
|
GO:0048227 plasma membrane to endosome transport
|
8
|
8.44e-01
|
-4.02e-02
|
9.67e-01
|
GO:0034497 protein localization to phagophore assembly site
|
16
|
7.81e-01
|
4.02e-02
|
9.43e-01
|
GO:0045176 apical protein localization
|
8
|
8.44e-01
|
4.01e-02
|
9.67e-01
|
GO:0009266 response to temperature stimulus
|
6
|
8.65e-01
|
-4.01e-02
|
9.70e-01
|
GO:0003950 NAD+-protein poly-ADP-ribosyltransferase activity
|
24
|
7.34e-01
|
4.00e-02
|
9.28e-01
|
GO:0042645 mitochondrial nucleoid
|
45
|
6.42e-01
|
-4.00e-02
|
8.89e-01
|
GO:0070016 armadillo repeat domain binding
|
7
|
8.55e-01
|
3.98e-02
|
9.70e-01
|
GO:0007409 axonogenesis
|
54
|
6.14e-01
|
3.98e-02
|
8.81e-01
|
GO:0071944 cell periphery
|
39
|
6.68e-01
|
3.97e-02
|
9.00e-01
|
GO:0031295 T cell costimulation
|
25
|
7.31e-01
|
-3.97e-02
|
9.26e-01
|
GO:0030117 membrane coat
|
7
|
8.56e-01
|
3.97e-02
|
9.70e-01
|
GO:0004198 calcium-dependent cysteine-type endopeptidase activity
|
10
|
8.28e-01
|
3.96e-02
|
9.60e-01
|
GO:0005771 multivesicular body
|
31
|
7.03e-01
|
3.96e-02
|
9.14e-01
|
GO:2000318 positive regulation of T-helper 17 type immune response
|
9
|
8.37e-01
|
-3.95e-02
|
9.65e-01
|
GO:0048471 perinuclear region of cytoplasm
|
532
|
1.21e-01
|
-3.95e-02
|
4.92e-01
|
GO:0051026 chiasma assembly
|
5
|
8.79e-01
|
-3.93e-02
|
9.74e-01
|
GO:0004521 RNA endonuclease activity
|
29
|
7.14e-01
|
-3.93e-02
|
9.19e-01
|
GO:0045765 regulation of angiogenesis
|
22
|
7.50e-01
|
-3.93e-02
|
9.33e-01
|
GO:0006183 GTP biosynthetic process
|
9
|
8.39e-01
|
-3.92e-02
|
9.65e-01
|
GO:0048667 cell morphogenesis involved in neuron differentiation
|
8
|
8.48e-01
|
3.91e-02
|
9.68e-01
|
GO:0097094 craniofacial suture morphogenesis
|
6
|
8.68e-01
|
3.91e-02
|
9.72e-01
|
GO:0045159 myosin II binding
|
6
|
8.69e-01
|
3.89e-02
|
9.72e-01
|
GO:1904871 positive regulation of protein localization to Cajal body
|
10
|
8.31e-01
|
-3.89e-02
|
9.61e-01
|
GO:0021762 substantia nigra development
|
35
|
6.91e-01
|
-3.89e-02
|
9.06e-01
|
GO:0039529 RIG-I signaling pathway
|
6
|
8.69e-01
|
-3.88e-02
|
9.72e-01
|
GO:0006071 glycerol metabolic process
|
7
|
8.59e-01
|
3.87e-02
|
9.70e-01
|
GO:0050731 positive regulation of peptidyl-tyrosine phosphorylation
|
54
|
6.24e-01
|
-3.86e-02
|
8.84e-01
|
GO:0032205 negative regulation of telomere maintenance
|
5
|
8.81e-01
|
-3.86e-02
|
9.74e-01
|
GO:0005847 mRNA cleavage and polyadenylation specificity factor complex
|
17
|
7.84e-01
|
-3.85e-02
|
9.45e-01
|
GO:0002063 chondrocyte development
|
7
|
8.61e-01
|
3.83e-02
|
9.70e-01
|
GO:0036089 cleavage furrow formation
|
7
|
8.61e-01
|
-3.83e-02
|
9.70e-01
|
GO:0008270 zinc ion binding
|
596
|
1.15e-01
|
-3.81e-02
|
4.78e-01
|
GO:0050766 positive regulation of phagocytosis
|
32
|
7.10e-01
|
-3.80e-02
|
9.17e-01
|
GO:0001662 behavioral fear response
|
18
|
7.80e-01
|
-3.80e-02
|
9.43e-01
|
GO:0015106 bicarbonate transmembrane transporter activity
|
8
|
8.53e-01
|
-3.80e-02
|
9.68e-01
|
GO:1990380 K48-linked deubiquitinase activity
|
16
|
7.93e-01
|
3.79e-02
|
9.49e-01
|
GO:0006694 steroid biosynthetic process
|
13
|
8.14e-01
|
-3.77e-02
|
9.55e-01
|
GO:0008589 regulation of smoothened signaling pathway
|
14
|
8.07e-01
|
3.77e-02
|
9.52e-01
|
GO:0048311 mitochondrion distribution
|
6
|
8.73e-01
|
-3.77e-02
|
9.73e-01
|
GO:0046688 response to copper ion
|
7
|
8.63e-01
|
-3.77e-02
|
9.70e-01
|
GO:0007267 cell-cell signaling
|
77
|
5.68e-01
|
-3.77e-02
|
8.58e-01
|
GO:0005496 steroid binding
|
15
|
8.01e-01
|
3.76e-02
|
9.49e-01
|
GO:0010498 proteasomal protein catabolic process
|
16
|
7.95e-01
|
3.76e-02
|
9.49e-01
|
GO:0016240 autophagosome membrane docking
|
7
|
8.64e-01
|
3.73e-02
|
9.70e-01
|
GO:0042824 MHC class I peptide loading complex
|
8
|
8.55e-01
|
3.73e-02
|
9.70e-01
|
GO:0070934 CRD-mediated mRNA stabilization
|
10
|
8.38e-01
|
-3.73e-02
|
9.65e-01
|
GO:0006123 mitochondrial electron transport, cytochrome c to oxygen
|
17
|
7.91e-01
|
-3.72e-02
|
9.48e-01
|
GO:2001069 glycogen binding
|
7
|
8.65e-01
|
-3.71e-02
|
9.70e-01
|
GO:0000287 magnesium ion binding
|
190
|
3.79e-01
|
-3.71e-02
|
7.58e-01
|
GO:0071479 cellular response to ionizing radiation
|
38
|
6.93e-01
|
3.70e-02
|
9.08e-01
|
GO:0043647 inositol phosphate metabolic process
|
12
|
8.25e-01
|
-3.70e-02
|
9.58e-01
|
GO:1904019 epithelial cell apoptotic process
|
12
|
8.25e-01
|
3.69e-02
|
9.58e-01
|
GO:0071558 histone H3K27me2/H3K27me3 demethylase activity
|
5
|
8.87e-01
|
3.67e-02
|
9.75e-01
|
GO:0071682 endocytic vesicle lumen
|
8
|
8.57e-01
|
-3.67e-02
|
9.70e-01
|
GO:0017162 aryl hydrocarbon receptor binding
|
6
|
8.77e-01
|
3.66e-02
|
9.73e-01
|
GO:0070097 delta-catenin binding
|
5
|
8.88e-01
|
-3.63e-02
|
9.76e-01
|
GO:0098911 regulation of ventricular cardiac muscle cell action potential
|
5
|
8.88e-01
|
3.63e-02
|
9.76e-01
|
GO:0044721 protein import into peroxisome matrix, substrate release
|
5
|
8.88e-01
|
-3.62e-02
|
9.76e-01
|
GO:0099170 postsynaptic modulation of chemical synaptic transmission
|
12
|
8.29e-01
|
3.61e-02
|
9.60e-01
|
GO:0014075 response to amine
|
8
|
8.60e-01
|
-3.61e-02
|
9.70e-01
|
GO:0030054 cell junction
|
113
|
5.08e-01
|
-3.61e-02
|
8.34e-01
|
GO:0000425 pexophagy
|
12
|
8.29e-01
|
-3.61e-02
|
9.60e-01
|
GO:0071363 cellular response to growth factor stimulus
|
41
|
6.91e-01
|
3.59e-02
|
9.06e-01
|
GO:0005761 mitochondrial ribosome
|
22
|
7.71e-01
|
3.59e-02
|
9.38e-01
|
GO:0007276 gamete generation
|
12
|
8.30e-01
|
-3.59e-02
|
9.60e-01
|
GO:0045629 negative regulation of T-helper 2 cell differentiation
|
5
|
8.90e-01
|
-3.58e-02
|
9.76e-01
|
GO:0001778 plasma membrane repair
|
21
|
7.78e-01
|
-3.56e-02
|
9.42e-01
|
GO:0036464 cytoplasmic ribonucleoprotein granule
|
63
|
6.26e-01
|
-3.55e-02
|
8.85e-01
|
GO:0051898 negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
|
45
|
6.80e-01
|
3.55e-02
|
9.05e-01
|
GO:0007131 reciprocal meiotic recombination
|
19
|
7.89e-01
|
-3.55e-02
|
9.48e-01
|
GO:0031072 heat shock protein binding
|
49
|
6.68e-01
|
3.54e-02
|
9.00e-01
|
GO:0045202 synapse
|
251
|
3.37e-01
|
3.53e-02
|
7.25e-01
|
GO:0042742 defense response to bacterium
|
82
|
5.82e-01
|
-3.52e-02
|
8.65e-01
|
GO:0002224 toll-like receptor signaling pathway
|
23
|
7.70e-01
|
-3.52e-02
|
9.37e-01
|
GO:0070327 thyroid hormone transport
|
6
|
8.81e-01
|
-3.52e-02
|
9.74e-01
|
GO:0051489 regulation of filopodium assembly
|
11
|
8.40e-01
|
-3.52e-02
|
9.65e-01
|
GO:1990266 neutrophil migration
|
7
|
8.72e-01
|
3.51e-02
|
9.73e-01
|
GO:0009791 post-embryonic development
|
55
|
6.53e-01
|
-3.51e-02
|
8.94e-01
|
GO:0019896 axonal transport of mitochondrion
|
7
|
8.73e-01
|
-3.50e-02
|
9.73e-01
|
GO:0030061 mitochondrial crista
|
6
|
8.82e-01
|
-3.50e-02
|
9.74e-01
|
GO:0010867 positive regulation of triglyceride biosynthetic process
|
11
|
8.42e-01
|
-3.48e-02
|
9.66e-01
|
GO:0007162 negative regulation of cell adhesion
|
26
|
7.59e-01
|
-3.48e-02
|
9.35e-01
|
GO:1903573 negative regulation of response to endoplasmic reticulum stress
|
7
|
8.74e-01
|
-3.47e-02
|
9.73e-01
|
GO:0032357 oxidized purine DNA binding
|
6
|
8.83e-01
|
3.47e-02
|
9.74e-01
|
GO:0030170 pyridoxal phosphate binding
|
34
|
7.27e-01
|
3.46e-02
|
9.25e-01
|
GO:0043197 dendritic spine
|
85
|
5.82e-01
|
-3.46e-02
|
8.65e-01
|
GO:0060291 long-term synaptic potentiation
|
18
|
7.99e-01
|
3.46e-02
|
9.49e-01
|
GO:0048029 monosaccharide binding
|
5
|
8.93e-01
|
-3.46e-02
|
9.77e-01
|
GO:0000340 RNA 7-methylguanosine cap binding
|
12
|
8.36e-01
|
-3.46e-02
|
9.64e-01
|
GO:0005092 GDP-dissociation inhibitor activity
|
11
|
8.43e-01
|
3.46e-02
|
9.66e-01
|
GO:0019898 extrinsic component of membrane
|
9
|
8.58e-01
|
3.45e-02
|
9.70e-01
|
GO:0004857 enzyme inhibitor activity
|
29
|
7.48e-01
|
3.45e-02
|
9.32e-01
|
GO:0010719 negative regulation of epithelial to mesenchymal transition
|
20
|
7.90e-01
|
-3.44e-02
|
9.48e-01
|
GO:0000783 nuclear telomere cap complex
|
8
|
8.67e-01
|
3.43e-02
|
9.71e-01
|
GO:0043392 negative regulation of DNA binding
|
13
|
8.30e-01
|
3.43e-02
|
9.61e-01
|
GO:0043433 negative regulation of DNA-binding transcription factor activity
|
39
|
7.12e-01
|
3.42e-02
|
9.18e-01
|
GO:0055129 L-proline biosynthetic process
|
5
|
8.95e-01
|
3.42e-02
|
9.77e-01
|
GO:0097300 programmed necrotic cell death
|
8
|
8.67e-01
|
3.42e-02
|
9.72e-01
|
GO:0030154 cell differentiation
|
285
|
3.23e-01
|
-3.41e-02
|
7.14e-01
|
GO:0051480 regulation of cytosolic calcium ion concentration
|
19
|
7.97e-01
|
3.41e-02
|
9.49e-01
|
GO:0019372 lipoxygenase pathway
|
5
|
8.95e-01
|
3.40e-02
|
9.77e-01
|
GO:0042491 inner ear auditory receptor cell differentiation
|
6
|
8.86e-01
|
3.39e-02
|
9.75e-01
|
GO:0050900 leukocyte migration
|
16
|
8.15e-01
|
-3.39e-02
|
9.55e-01
|
GO:0017015 regulation of transforming growth factor beta receptor signaling pathway
|
16
|
8.15e-01
|
3.38e-02
|
9.55e-01
|
GO:0000149 SNARE binding
|
42
|
7.05e-01
|
3.38e-02
|
9.15e-01
|
GO:0006068 ethanol catabolic process
|
6
|
8.86e-01
|
-3.38e-02
|
9.75e-01
|
GO:0007283 spermatogenesis
|
229
|
3.81e-01
|
-3.37e-02
|
7.58e-01
|
GO:0045271 respiratory chain complex I
|
44
|
7.00e-01
|
3.36e-02
|
9.13e-01
|
GO:0009298 GDP-mannose biosynthetic process
|
6
|
8.87e-01
|
-3.35e-02
|
9.75e-01
|
GO:0000056 ribosomal small subunit export from nucleus
|
7
|
8.78e-01
|
3.35e-02
|
9.73e-01
|
GO:1900745 positive regulation of p38MAPK cascade
|
21
|
7.91e-01
|
-3.35e-02
|
9.48e-01
|
GO:0031528 microvillus membrane
|
18
|
8.06e-01
|
-3.35e-02
|
9.52e-01
|
GO:0008625 extrinsic apoptotic signaling pathway via death domain receptors
|
38
|
7.22e-01
|
-3.34e-02
|
9.23e-01
|
GO:0071679 commissural neuron axon guidance
|
8
|
8.71e-01
|
3.33e-02
|
9.73e-01
|
GO:0051604 protein maturation
|
41
|
7.12e-01
|
-3.33e-02
|
9.19e-01
|
GO:0060048 cardiac muscle contraction
|
19
|
8.02e-01
|
3.32e-02
|
9.49e-01
|
GO:0030010 establishment of cell polarity
|
29
|
7.57e-01
|
3.32e-02
|
9.35e-01
|
GO:0090119 vesicle-mediated cholesterol transport
|
5
|
8.98e-01
|
3.32e-02
|
9.78e-01
|
GO:1904153 negative regulation of retrograde protein transport, ER to cytosol
|
9
|
8.63e-01
|
-3.32e-02
|
9.70e-01
|
GO:0048754 branching morphogenesis of an epithelial tube
|
10
|
8.56e-01
|
3.31e-02
|
9.70e-01
|
GO:0061844 antimicrobial humoral immune response mediated by antimicrobial peptide
|
38
|
7.25e-01
|
-3.30e-02
|
9.25e-01
|
GO:0035924 cellular response to vascular endothelial growth factor stimulus
|
21
|
7.93e-01
|
3.30e-02
|
9.49e-01
|
GO:0036033 mediator complex binding
|
5
|
8.98e-01
|
3.30e-02
|
9.78e-01
|
GO:0019005 SCF ubiquitin ligase complex
|
51
|
6.86e-01
|
-3.27e-02
|
9.05e-01
|
GO:0030904 retromer complex
|
20
|
8.01e-01
|
-3.25e-02
|
9.49e-01
|
GO:0006357 regulation of transcription by RNA polymerase II
|
1108
|
7.13e-02
|
-3.25e-02
|
3.91e-01
|
GO:1904315 transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential
|
11
|
8.52e-01
|
3.25e-02
|
9.68e-01
|
GO:0097049 motor neuron apoptotic process
|
11
|
8.52e-01
|
3.25e-02
|
9.68e-01
|
GO:0046974 histone H3K9 methyltransferase activity
|
9
|
8.66e-01
|
-3.24e-02
|
9.71e-01
|
GO:0032402 melanosome transport
|
19
|
8.07e-01
|
-3.24e-02
|
9.52e-01
|
GO:0016020 membrane
|
2262
|
1.43e-02
|
-3.23e-02
|
2.07e-01
|
GO:0001510 RNA methylation
|
11
|
8.53e-01
|
3.23e-02
|
9.68e-01
|
GO:1905719 protein localization to perinuclear region of cytoplasm
|
5
|
9.01e-01
|
-3.23e-02
|
9.78e-01
|
GO:0048863 stem cell differentiation
|
31
|
7.56e-01
|
-3.22e-02
|
9.35e-01
|
GO:0045744 negative regulation of G protein-coupled receptor signaling pathway
|
11
|
8.53e-01
|
3.22e-02
|
9.69e-01
|
GO:0035515 oxidative RNA demethylase activity
|
5
|
9.01e-01
|
-3.22e-02
|
9.78e-01
|
GO:0097225 sperm midpiece
|
28
|
7.69e-01
|
-3.21e-02
|
9.37e-01
|
GO:0005788 endoplasmic reticulum lumen
|
175
|
4.64e-01
|
3.21e-02
|
8.09e-01
|
GO:0048018 receptor ligand activity
|
48
|
7.01e-01
|
3.21e-02
|
9.13e-01
|
GO:0050848 regulation of calcium-mediated signaling
|
10
|
8.61e-01
|
-3.21e-02
|
9.70e-01
|
GO:0001711 endodermal cell fate commitment
|
6
|
8.92e-01
|
3.20e-02
|
9.77e-01
|
GO:0010634 positive regulation of epithelial cell migration
|
27
|
7.74e-01
|
3.20e-02
|
9.39e-01
|
GO:0006518 peptide metabolic process
|
9
|
8.68e-01
|
-3.19e-02
|
9.72e-01
|
GO:0008374 O-acyltransferase activity
|
7
|
8.84e-01
|
3.19e-02
|
9.75e-01
|
GO:0030282 bone mineralization
|
29
|
7.67e-01
|
3.18e-02
|
9.37e-01
|
GO:0000339 RNA cap binding
|
12
|
8.49e-01
|
3.17e-02
|
9.68e-01
|
GO:0033119 negative regulation of RNA splicing
|
6
|
8.93e-01
|
3.16e-02
|
9.77e-01
|
GO:0006479 protein methylation
|
13
|
8.44e-01
|
-3.16e-02
|
9.67e-01
|
GO:0008271 secondary active sulfate transmembrane transporter activity
|
7
|
8.85e-01
|
3.16e-02
|
9.75e-01
|
GO:0019509 L-methionine salvage from methylthioadenosine
|
5
|
9.03e-01
|
3.15e-02
|
9.78e-01
|
GO:0048172 regulation of short-term neuronal synaptic plasticity
|
9
|
8.70e-01
|
-3.14e-02
|
9.73e-01
|
GO:0006622 protein targeting to lysosome
|
24
|
7.91e-01
|
-3.13e-02
|
9.48e-01
|
GO:0098802 plasma membrane signaling receptor complex
|
6
|
8.94e-01
|
-3.13e-02
|
9.77e-01
|
GO:0019957 C-C chemokine binding
|
6
|
8.95e-01
|
3.12e-02
|
9.77e-01
|
GO:0030259 lipid glycosylation
|
5
|
9.04e-01
|
-3.12e-02
|
9.78e-01
|
GO:0042789 mRNA transcription by RNA polymerase II
|
45
|
7.18e-01
|
-3.12e-02
|
9.21e-01
|
GO:0008645 hexose transmembrane transport
|
9
|
8.72e-01
|
-3.11e-02
|
9.73e-01
|
GO:1990050 phosphatidic acid transfer activity
|
7
|
8.87e-01
|
-3.11e-02
|
9.75e-01
|
GO:0141039 phosphatidylinositol 3-kinase inhibitor activity
|
6
|
8.95e-01
|
-3.10e-02
|
9.77e-01
|
GO:0008190 eukaryotic initiation factor 4E binding
|
9
|
8.72e-01
|
-3.10e-02
|
9.73e-01
|
GO:0048147 negative regulation of fibroblast proliferation
|
27
|
7.81e-01
|
3.10e-02
|
9.43e-01
|
GO:0051209 release of sequestered calcium ion into cytosol
|
26
|
7.86e-01
|
3.08e-02
|
9.45e-01
|
GO:0032967 positive regulation of collagen biosynthetic process
|
14
|
8.42e-01
|
3.08e-02
|
9.66e-01
|
GO:0008266 poly(U) RNA binding
|
19
|
8.16e-01
|
3.08e-02
|
9.56e-01
|
GO:0016324 apical plasma membrane
|
199
|
4.55e-01
|
3.08e-02
|
8.03e-01
|
GO:0086003 cardiac muscle cell contraction
|
6
|
8.96e-01
|
3.08e-02
|
9.77e-01
|
GO:0072562 blood microparticle
|
51
|
7.05e-01
|
3.07e-02
|
9.15e-01
|
GO:0097028 dendritic cell differentiation
|
9
|
8.73e-01
|
3.07e-02
|
9.73e-01
|
GO:0042326 negative regulation of phosphorylation
|
12
|
8.54e-01
|
3.06e-02
|
9.69e-01
|
GO:0036513 Derlin-1 retrotranslocation complex
|
8
|
8.81e-01
|
-3.06e-02
|
9.74e-01
|
GO:0032183 SUMO binding
|
11
|
8.61e-01
|
-3.05e-02
|
9.70e-01
|
GO:0042721 TIM22 mitochondrial import inner membrane insertion complex
|
7
|
8.89e-01
|
-3.04e-02
|
9.76e-01
|
GO:0006836 neurotransmitter transport
|
19
|
8.19e-01
|
-3.04e-02
|
9.56e-01
|
GO:0045190 isotype switching
|
18
|
8.24e-01
|
3.03e-02
|
9.58e-01
|
GO:0030200 heparan sulfate proteoglycan catabolic process
|
9
|
8.75e-01
|
-3.03e-02
|
9.73e-01
|
GO:0030218 erythrocyte differentiation
|
40
|
7.40e-01
|
-3.03e-02
|
9.29e-01
|
GO:0043124 negative regulation of canonical NF-kappaB signal transduction
|
56
|
6.96e-01
|
3.02e-02
|
9.10e-01
|
GO:0048545 response to steroid hormone
|
15
|
8.40e-01
|
3.01e-02
|
9.65e-01
|
GO:0090023 positive regulation of neutrophil chemotaxis
|
19
|
8.20e-01
|
-3.01e-02
|
9.57e-01
|
GO:0042383 sarcolemma
|
62
|
6.83e-01
|
3.00e-02
|
9.05e-01
|
GO:0043113 receptor clustering
|
21
|
8.12e-01
|
3.00e-02
|
9.54e-01
|
GO:0010575 positive regulation of vascular endothelial growth factor production
|
22
|
8.08e-01
|
-2.99e-02
|
9.53e-01
|
GO:0007517 muscle organ development
|
58
|
6.94e-01
|
2.99e-02
|
9.08e-01
|
GO:0035033 histone deacetylase regulator activity
|
5
|
9.08e-01
|
-2.99e-02
|
9.79e-01
|
GO:0001933 negative regulation of protein phosphorylation
|
36
|
7.57e-01
|
2.98e-02
|
9.35e-01
|
GO:0030424 axon
|
199
|
4.71e-01
|
-2.97e-02
|
8.13e-01
|
GO:0099560 synaptic membrane adhesion
|
8
|
8.85e-01
|
2.96e-02
|
9.75e-01
|
GO:0003727 single-stranded RNA binding
|
34
|
7.65e-01
|
2.96e-02
|
9.37e-01
|
GO:0098830 presynaptic endosome
|
7
|
8.92e-01
|
-2.96e-02
|
9.77e-01
|
GO:0034504 protein localization to nucleus
|
33
|
7.70e-01
|
-2.94e-02
|
9.37e-01
|
GO:0042981 regulation of apoptotic process
|
143
|
5.44e-01
|
-2.94e-02
|
8.47e-01
|
GO:0001964 startle response
|
8
|
8.86e-01
|
2.94e-02
|
9.75e-01
|
GO:0036438 maintenance of lens transparency
|
6
|
9.01e-01
|
-2.94e-02
|
9.78e-01
|
GO:0005791 rough endoplasmic reticulum
|
26
|
7.96e-01
|
-2.93e-02
|
9.49e-01
|
GO:0005249 voltage-gated potassium channel activity
|
14
|
8.50e-01
|
-2.93e-02
|
9.68e-01
|
GO:0032727 positive regulation of interferon-alpha production
|
21
|
8.17e-01
|
-2.92e-02
|
9.56e-01
|
GO:0043024 ribosomal small subunit binding
|
20
|
8.21e-01
|
-2.92e-02
|
9.57e-01
|
GO:0098688 parallel fiber to Purkinje cell synapse
|
12
|
8.61e-01
|
-2.92e-02
|
9.70e-01
|
GO:0030659 cytoplasmic vesicle membrane
|
76
|
6.62e-01
|
2.91e-02
|
8.98e-01
|
GO:0006105 succinate metabolic process
|
5
|
9.10e-01
|
2.90e-02
|
9.80e-01
|
GO:0038060 nitric oxide-cGMP-mediated signaling
|
6
|
9.02e-01
|
2.90e-02
|
9.78e-01
|
GO:0043027 cysteine-type endopeptidase inhibitor activity involved in apoptotic process
|
14
|
8.51e-01
|
-2.90e-02
|
9.68e-01
|
GO:0008156 negative regulation of DNA replication
|
14
|
8.51e-01
|
2.90e-02
|
9.68e-01
|
GO:0030239 myofibril assembly
|
9
|
8.80e-01
|
-2.90e-02
|
9.74e-01
|
GO:0007264 small GTPase-mediated signal transduction
|
72
|
6.71e-01
|
-2.90e-02
|
9.01e-01
|
GO:0021522 spinal cord motor neuron differentiation
|
7
|
8.95e-01
|
-2.88e-02
|
9.77e-01
|
GO:0015485 cholesterol binding
|
36
|
7.65e-01
|
-2.88e-02
|
9.37e-01
|
GO:2000766 negative regulation of cytoplasmic translation
|
8
|
8.88e-01
|
-2.88e-02
|
9.76e-01
|
GO:0019433 triglyceride catabolic process
|
9
|
8.81e-01
|
2.87e-02
|
9.74e-01
|
GO:0032760 positive regulation of tumor necrosis factor production
|
84
|
6.50e-01
|
-2.87e-02
|
8.93e-01
|
GO:0006915 apoptotic process
|
420
|
3.16e-01
|
2.87e-02
|
7.08e-01
|
GO:0098797 plasma membrane protein complex
|
9
|
8.82e-01
|
-2.86e-02
|
9.74e-01
|
GO:0010288 response to lead ion
|
12
|
8.64e-01
|
-2.85e-02
|
9.70e-01
|
GO:0016922 nuclear receptor binding
|
33
|
7.77e-01
|
2.85e-02
|
9.42e-01
|
GO:0004715 non-membrane spanning protein tyrosine kinase activity
|
34
|
7.74e-01
|
-2.84e-02
|
9.39e-01
|
GO:0010890 positive regulation of sequestering of triglyceride
|
6
|
9.04e-01
|
2.84e-02
|
9.78e-01
|
GO:0032543 mitochondrial translation
|
93
|
6.37e-01
|
-2.84e-02
|
8.88e-01
|
GO:0006729 tetrahydrobiopterin biosynthetic process
|
7
|
8.97e-01
|
2.84e-02
|
9.77e-01
|
GO:0070925 organelle assembly
|
6
|
9.04e-01
|
-2.83e-02
|
9.78e-01
|
GO:0005832 chaperonin-containing T-complex
|
9
|
8.83e-01
|
2.83e-02
|
9.74e-01
|
GO:1904894 positive regulation of receptor signaling pathway via STAT
|
6
|
9.04e-01
|
-2.83e-02
|
9.78e-01
|
GO:1902564 negative regulation of neutrophil activation
|
7
|
8.97e-01
|
2.83e-02
|
9.77e-01
|
GO:1990381 ubiquitin-specific protease binding
|
16
|
8.45e-01
|
-2.83e-02
|
9.67e-01
|
GO:0050847 progesterone receptor signaling pathway
|
10
|
8.77e-01
|
2.82e-02
|
9.73e-01
|
GO:1903076 regulation of protein localization to plasma membrane
|
22
|
8.19e-01
|
-2.81e-02
|
9.56e-01
|
GO:0030490 maturation of SSU-rRNA
|
21
|
8.23e-01
|
2.81e-02
|
9.58e-01
|
GO:0017059 serine palmitoyltransferase complex
|
7
|
8.98e-01
|
2.81e-02
|
9.78e-01
|
GO:0042274 ribosomal small subunit biogenesis
|
72
|
6.81e-01
|
2.81e-02
|
9.05e-01
|
GO:0001659 temperature homeostasis
|
10
|
8.78e-01
|
2.81e-02
|
9.73e-01
|
GO:0031293 membrane protein intracellular domain proteolysis
|
13
|
8.61e-01
|
2.80e-02
|
9.70e-01
|
GO:0030488 tRNA methylation
|
29
|
7.95e-01
|
-2.79e-02
|
9.49e-01
|
GO:0002862 negative regulation of inflammatory response to antigenic stimulus
|
18
|
8.38e-01
|
2.79e-02
|
9.65e-01
|
GO:0033300 dehydroascorbic acid transmembrane transporter activity
|
5
|
9.14e-01
|
-2.79e-02
|
9.81e-01
|
GO:0007127 meiosis I
|
6
|
9.06e-01
|
2.78e-02
|
9.79e-01
|
GO:0140658 ATP-dependent chromatin remodeler activity
|
15
|
8.52e-01
|
-2.77e-02
|
9.68e-01
|
GO:0043171 peptide catabolic process
|
12
|
8.68e-01
|
2.76e-02
|
9.72e-01
|
GO:0090402 oncogene-induced cell senescence
|
5
|
9.15e-01
|
-2.76e-02
|
9.81e-01
|
GO:0005687 U4 snRNP
|
10
|
8.80e-01
|
-2.75e-02
|
9.74e-01
|
GO:0045654 positive regulation of megakaryocyte differentiation
|
9
|
8.86e-01
|
2.75e-02
|
9.75e-01
|
GO:0010874 regulation of cholesterol efflux
|
5
|
9.15e-01
|
-2.75e-02
|
9.82e-01
|
GO:0010636 positive regulation of mitochondrial fusion
|
6
|
9.07e-01
|
2.74e-02
|
9.79e-01
|
GO:0001516 prostaglandin biosynthetic process
|
13
|
8.64e-01
|
2.74e-02
|
9.70e-01
|
GO:0004190 aspartic-type endopeptidase activity
|
8
|
8.93e-01
|
-2.74e-02
|
9.77e-01
|
GO:0031648 protein destabilization
|
46
|
7.48e-01
|
-2.73e-02
|
9.32e-01
|
GO:0042776 proton motive force-driven mitochondrial ATP synthesis
|
63
|
7.09e-01
|
2.72e-02
|
9.17e-01
|
GO:0016605 PML body
|
98
|
6.43e-01
|
-2.71e-02
|
8.89e-01
|
GO:0042167 heme catabolic process
|
7
|
9.01e-01
|
-2.71e-02
|
9.78e-01
|
GO:0042995 cell projection
|
103
|
6.35e-01
|
-2.71e-02
|
8.88e-01
|
GO:0031663 lipopolysaccharide-mediated signaling pathway
|
34
|
7.86e-01
|
-2.69e-02
|
9.45e-01
|
GO:0051896 regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
|
20
|
8.35e-01
|
-2.69e-02
|
9.64e-01
|
GO:0010468 regulation of gene expression
|
121
|
6.10e-01
|
-2.69e-02
|
8.81e-01
|
GO:0043548 phosphatidylinositol 3-kinase binding
|
9
|
8.89e-01
|
2.69e-02
|
9.76e-01
|
GO:0042802 identical protein binding
|
1239
|
1.19e-01
|
-2.67e-02
|
4.84e-01
|
GO:0016081 synaptic vesicle docking
|
6
|
9.10e-01
|
2.67e-02
|
9.79e-01
|
GO:0045121 membrane raft
|
137
|
5.90e-01
|
-2.67e-02
|
8.70e-01
|
GO:0050687 negative regulation of defense response to virus
|
11
|
8.78e-01
|
-2.66e-02
|
9.74e-01
|
GO:0007411 axon guidance
|
88
|
6.66e-01
|
-2.66e-02
|
8.99e-01
|
GO:0048388 endosomal lumen acidification
|
13
|
8.68e-01
|
2.65e-02
|
9.72e-01
|
GO:0097401 synaptic vesicle lumen acidification
|
14
|
8.64e-01
|
-2.65e-02
|
9.70e-01
|
GO:0051721 protein phosphatase 2A binding
|
26
|
8.16e-01
|
2.64e-02
|
9.56e-01
|
GO:0032418 lysosome localization
|
31
|
7.99e-01
|
-2.64e-02
|
9.49e-01
|
GO:0006739 NADP metabolic process
|
9
|
8.91e-01
|
2.64e-02
|
9.77e-01
|
GO:1901203 positive regulation of extracellular matrix assembly
|
7
|
9.04e-01
|
2.64e-02
|
9.78e-01
|
GO:1904293 negative regulation of ERAD pathway
|
7
|
9.04e-01
|
2.63e-02
|
9.78e-01
|
GO:0007005 mitochondrion organization
|
94
|
6.60e-01
|
-2.63e-02
|
8.96e-01
|
GO:0031054 pre-miRNA processing
|
12
|
8.75e-01
|
2.63e-02
|
9.73e-01
|
GO:0045022 early endosome to late endosome transport
|
22
|
8.31e-01
|
2.62e-02
|
9.61e-01
|
GO:2000767 positive regulation of cytoplasmic translation
|
12
|
8.75e-01
|
2.62e-02
|
9.73e-01
|
GO:0043065 positive regulation of apoptotic process
|
237
|
4.88e-01
|
-2.62e-02
|
8.24e-01
|
GO:0038111 interleukin-7-mediated signaling pathway
|
6
|
9.12e-01
|
-2.62e-02
|
9.80e-01
|
GO:0072656 maintenance of protein location in mitochondrion
|
5
|
9.19e-01
|
2.61e-02
|
9.83e-01
|
GO:0016272 prefoldin complex
|
7
|
9.05e-01
|
2.61e-02
|
9.78e-01
|
GO:0008631 intrinsic apoptotic signaling pathway in response to oxidative stress
|
15
|
8.62e-01
|
2.60e-02
|
9.70e-01
|
GO:0016486 peptide hormone processing
|
11
|
8.81e-01
|
2.60e-02
|
9.74e-01
|
GO:0045766 positive regulation of angiogenesis
|
93
|
6.65e-01
|
-2.60e-02
|
8.99e-01
|
GO:0019082 viral protein processing
|
30
|
8.06e-01
|
-2.60e-02
|
9.52e-01
|
GO:0006511 ubiquitin-dependent protein catabolic process
|
193
|
5.37e-01
|
2.58e-02
|
8.45e-01
|
GO:0051216 cartilage development
|
31
|
8.04e-01
|
2.57e-02
|
9.50e-01
|
GO:0050885 neuromuscular process controlling balance
|
27
|
8.17e-01
|
2.57e-02
|
9.56e-01
|
GO:0031901 early endosome membrane
|
147
|
5.93e-01
|
2.56e-02
|
8.73e-01
|
GO:0017046 peptide hormone binding
|
7
|
9.07e-01
|
2.56e-02
|
9.79e-01
|
GO:0006536 glutamate metabolic process
|
10
|
8.89e-01
|
2.55e-02
|
9.76e-01
|
GO:0051036 regulation of endosome size
|
11
|
8.84e-01
|
-2.55e-02
|
9.75e-01
|
GO:0051434 BH3 domain binding
|
5
|
9.22e-01
|
2.54e-02
|
9.83e-01
|
GO:0070837 dehydroascorbic acid transport
|
8
|
9.01e-01
|
-2.54e-02
|
9.78e-01
|
GO:0035265 organ growth
|
12
|
8.79e-01
|
2.53e-02
|
9.74e-01
|
GO:0051453 regulation of intracellular pH
|
16
|
8.61e-01
|
2.53e-02
|
9.70e-01
|
GO:0034719 SMN-Sm protein complex
|
16
|
8.61e-01
|
-2.52e-02
|
9.70e-01
|
GO:2000786 positive regulation of autophagosome assembly
|
19
|
8.49e-01
|
2.52e-02
|
9.68e-01
|
GO:0032794 GTPase activating protein binding
|
10
|
8.90e-01
|
-2.52e-02
|
9.76e-01
|
GO:0005814 centriole
|
134
|
6.15e-01
|
-2.52e-02
|
8.82e-01
|
GO:0031932 TORC2 complex
|
9
|
8.96e-01
|
-2.52e-02
|
9.77e-01
|
GO:0015031 protein transport
|
318
|
4.44e-01
|
2.51e-02
|
7.97e-01
|
GO:0042475 odontogenesis of dentin-containing tooth
|
26
|
8.26e-01
|
2.50e-02
|
9.58e-01
|
GO:0005525 GTP binding
|
290
|
4.66e-01
|
2.49e-02
|
8.10e-01
|
GO:0034067 protein localization to Golgi apparatus
|
19
|
8.51e-01
|
-2.48e-02
|
9.68e-01
|
GO:0045040 protein insertion into mitochondrial outer membrane
|
14
|
8.72e-01
|
2.48e-02
|
9.73e-01
|
GO:0009792 embryo development ending in birth or egg hatching
|
12
|
8.82e-01
|
-2.48e-02
|
9.74e-01
|
GO:0046677 response to antibiotic
|
18
|
8.56e-01
|
2.47e-02
|
9.70e-01
|
GO:0071333 cellular response to glucose stimulus
|
43
|
7.80e-01
|
-2.47e-02
|
9.42e-01
|
GO:1990090 cellular response to nerve growth factor stimulus
|
28
|
8.21e-01
|
-2.46e-02
|
9.57e-01
|
GO:0010001 glial cell differentiation
|
7
|
9.10e-01
|
-2.46e-02
|
9.79e-01
|
GO:0006750 glutathione biosynthetic process
|
9
|
8.98e-01
|
2.46e-02
|
9.78e-01
|
GO:0010906 regulation of glucose metabolic process
|
16
|
8.65e-01
|
-2.46e-02
|
9.70e-01
|
GO:0042462 eye photoreceptor cell development
|
9
|
8.99e-01
|
2.45e-02
|
9.78e-01
|
GO:0055056 D-glucose transmembrane transporter activity
|
10
|
8.93e-01
|
2.45e-02
|
9.77e-01
|
GO:0007259 cell surface receptor signaling pathway via JAK-STAT
|
35
|
8.03e-01
|
-2.44e-02
|
9.49e-01
|
GO:0071222 cellular response to lipopolysaccharide
|
121
|
6.43e-01
|
-2.44e-02
|
8.89e-01
|
GO:0070254 mucus secretion
|
9
|
8.99e-01
|
-2.44e-02
|
9.78e-01
|
GO:0051086 chaperone mediated protein folding independent of cofactor
|
8
|
9.05e-01
|
-2.44e-02
|
9.78e-01
|
GO:0060545 positive regulation of necroptotic process
|
5
|
9.25e-01
|
-2.42e-02
|
9.83e-01
|
GO:0099072 regulation of postsynaptic membrane neurotransmitter receptor levels
|
22
|
8.45e-01
|
2.41e-02
|
9.67e-01
|
GO:0045277 respiratory chain complex IV
|
16
|
8.68e-01
|
2.41e-02
|
9.72e-01
|
GO:0005004 GPI-linked ephrin receptor activity
|
14
|
8.76e-01
|
-2.41e-02
|
9.73e-01
|
GO:0005006 epidermal growth factor receptor activity
|
14
|
8.76e-01
|
-2.41e-02
|
9.73e-01
|
GO:0005008 hepatocyte growth factor receptor activity
|
14
|
8.76e-01
|
-2.41e-02
|
9.73e-01
|
GO:0005009 insulin receptor activity
|
14
|
8.76e-01
|
-2.41e-02
|
9.73e-01
|
GO:0005011 macrophage colony-stimulating factor receptor activity
|
14
|
8.76e-01
|
-2.41e-02
|
9.73e-01
|
GO:0005018 platelet-derived growth factor alpha-receptor activity
|
14
|
8.76e-01
|
-2.41e-02
|
9.73e-01
|
GO:0005019 platelet-derived growth factor beta-receptor activity
|
14
|
8.76e-01
|
-2.41e-02
|
9.73e-01
|
GO:0005020 stem cell factor receptor activity
|
14
|
8.76e-01
|
-2.41e-02
|
9.73e-01
|
GO:0008288 boss receptor activity
|
14
|
8.76e-01
|
-2.41e-02
|
9.73e-01
|
GO:0036323 vascular endothelial growth factor receptor-1 signaling pathway
|
14
|
8.76e-01
|
-2.41e-02
|
9.73e-01
|
GO:0036332 placental growth factor receptor activity
|
14
|
8.76e-01
|
-2.41e-02
|
9.73e-01
|
GO:0038062 protein tyrosine kinase collagen receptor activity
|
14
|
8.76e-01
|
-2.41e-02
|
9.73e-01
|
GO:0060175 brain-derived neurotrophic factor receptor activity
|
14
|
8.76e-01
|
-2.41e-02
|
9.73e-01
|
GO:0003924 GTPase activity
|
241
|
5.22e-01
|
2.40e-02
|
8.37e-01
|
GO:0000977 RNA polymerase II transcription regulatory region sequence-specific DNA binding
|
192
|
5.67e-01
|
-2.40e-02
|
8.57e-01
|
GO:0048771 tissue remodeling
|
10
|
8.96e-01
|
-2.40e-02
|
9.77e-01
|
GO:0001405 PAM complex, Tim23 associated import motor
|
5
|
9.26e-01
|
-2.39e-02
|
9.83e-01
|
GO:0071480 cellular response to gamma radiation
|
23
|
8.43e-01
|
-2.39e-02
|
9.66e-01
|
GO:0008033 tRNA processing
|
17
|
8.65e-01
|
-2.38e-02
|
9.70e-01
|
GO:2001034 positive regulation of double-strand break repair via nonhomologous end joining
|
17
|
8.65e-01
|
2.38e-02
|
9.70e-01
|
GO:0140947 histone H3K9me2 methyltransferase activity
|
6
|
9.20e-01
|
2.38e-02
|
9.83e-01
|
GO:0043517 positive regulation of DNA damage response, signal transduction by p53 class mediator
|
9
|
9.02e-01
|
-2.37e-02
|
9.78e-01
|
GO:0008519 ammonium channel activity
|
5
|
9.27e-01
|
-2.36e-02
|
9.83e-01
|
GO:0072488 ammonium transmembrane transport
|
5
|
9.27e-01
|
-2.36e-02
|
9.83e-01
|
GO:0042056 chemoattractant activity
|
15
|
8.75e-01
|
2.35e-02
|
9.73e-01
|
GO:0031016 pancreas development
|
11
|
8.93e-01
|
2.35e-02
|
9.77e-01
|
GO:0009653 anatomical structure morphogenesis
|
45
|
7.85e-01
|
-2.35e-02
|
9.45e-01
|
GO:0034715 pICln-Sm protein complex
|
6
|
9.21e-01
|
2.35e-02
|
9.83e-01
|
GO:0045777 positive regulation of blood pressure
|
5
|
9.28e-01
|
2.35e-02
|
9.83e-01
|
GO:0042593 glucose homeostasis
|
68
|
7.39e-01
|
2.34e-02
|
9.29e-01
|
GO:0002020 protease binding
|
76
|
7.25e-01
|
-2.34e-02
|
9.25e-01
|
GO:2000737 negative regulation of stem cell differentiation
|
15
|
8.76e-01
|
-2.34e-02
|
9.73e-01
|
GO:0006614 SRP-dependent cotranslational protein targeting to membrane
|
8
|
9.09e-01
|
2.34e-02
|
9.79e-01
|
GO:0043516 regulation of DNA damage response, signal transduction by p53 class mediator
|
5
|
9.28e-01
|
-2.33e-02
|
9.84e-01
|
GO:0035091 phosphatidylinositol binding
|
83
|
7.14e-01
|
-2.33e-02
|
9.19e-01
|
GO:0032094 response to food
|
14
|
8.80e-01
|
-2.33e-02
|
9.74e-01
|
GO:0070555 response to interleukin-1
|
27
|
8.35e-01
|
-2.32e-02
|
9.63e-01
|
GO:0070382 exocytic vesicle
|
13
|
8.85e-01
|
-2.32e-02
|
9.75e-01
|
GO:0005901 caveola
|
46
|
7.86e-01
|
-2.32e-02
|
9.45e-01
|
GO:0002286 T cell activation involved in immune response
|
6
|
9.22e-01
|
2.31e-02
|
9.83e-01
|
GO:0071493 cellular response to UV-B
|
10
|
8.99e-01
|
-2.31e-02
|
9.78e-01
|
GO:0045324 late endosome to vacuole transport
|
8
|
9.10e-01
|
2.31e-02
|
9.79e-01
|
GO:0035019 somatic stem cell population maintenance
|
37
|
8.08e-01
|
2.30e-02
|
9.53e-01
|
GO:0016358 dendrite development
|
25
|
8.42e-01
|
-2.30e-02
|
9.66e-01
|
GO:0007417 central nervous system development
|
68
|
7.43e-01
|
-2.30e-02
|
9.31e-01
|
GO:0043204 perikaryon
|
74
|
7.33e-01
|
2.29e-02
|
9.27e-01
|
GO:0071300 cellular response to retinoic acid
|
27
|
8.37e-01
|
-2.29e-02
|
9.65e-01
|
GO:0044830 modulation by host of viral RNA genome replication
|
5
|
9.30e-01
|
2.28e-02
|
9.84e-01
|
GO:0008047 enzyme activator activity
|
51
|
7.80e-01
|
2.26e-02
|
9.42e-01
|
GO:0008353 RNA polymerase II CTD heptapeptide repeat kinase activity
|
9
|
9.06e-01
|
-2.26e-02
|
9.79e-01
|
GO:0060070 canonical Wnt signaling pathway
|
54
|
7.74e-01
|
2.26e-02
|
9.39e-01
|
GO:0110011 regulation of basement membrane organization
|
6
|
9.24e-01
|
-2.26e-02
|
9.83e-01
|
GO:0061077 chaperone-mediated protein folding
|
38
|
8.10e-01
|
2.26e-02
|
9.53e-01
|
GO:0099558 maintenance of synapse structure
|
6
|
9.24e-01
|
-2.26e-02
|
9.83e-01
|
GO:0042176 regulation of protein catabolic process
|
14
|
8.84e-01
|
2.24e-02
|
9.75e-01
|
GO:0001822 kidney development
|
69
|
7.48e-01
|
-2.24e-02
|
9.32e-01
|
GO:0030509 BMP signaling pathway
|
43
|
8.00e-01
|
2.24e-02
|
9.49e-01
|
GO:0015718 monocarboxylic acid transport
|
8
|
9.13e-01
|
-2.23e-02
|
9.80e-01
|
GO:0000930 gamma-tubulin complex
|
10
|
9.03e-01
|
-2.22e-02
|
9.78e-01
|
GO:0097718 disordered domain specific binding
|
25
|
8.48e-01
|
-2.22e-02
|
9.68e-01
|
GO:0140662 ATP-dependent protein folding chaperone
|
29
|
8.37e-01
|
2.21e-02
|
9.65e-01
|
GO:0019369 arachidonate metabolic process
|
16
|
8.78e-01
|
2.21e-02
|
9.73e-01
|
GO:0002082 regulation of oxidative phosphorylation
|
11
|
8.99e-01
|
2.21e-02
|
9.78e-01
|
GO:0006241 CTP biosynthetic process
|
9
|
9.09e-01
|
2.20e-02
|
9.79e-01
|
GO:0008569 minus-end-directed microtubule motor activity
|
9
|
9.09e-01
|
-2.20e-02
|
9.79e-01
|
GO:1904861 excitatory synapse assembly
|
5
|
9.32e-01
|
-2.20e-02
|
9.84e-01
|
GO:1902387 ceramide 1-phosphate binding
|
5
|
9.32e-01
|
2.20e-02
|
9.84e-01
|
GO:0032880 regulation of protein localization
|
58
|
7.72e-01
|
2.20e-02
|
9.38e-01
|
GO:0070742 C2H2 zinc finger domain binding
|
9
|
9.09e-01
|
-2.19e-02
|
9.79e-01
|
GO:0008331 high voltage-gated calcium channel activity
|
6
|
9.26e-01
|
-2.19e-02
|
9.83e-01
|
GO:0035589 G protein-coupled purinergic nucleotide receptor signaling pathway
|
7
|
9.20e-01
|
2.18e-02
|
9.83e-01
|
GO:0031996 thioesterase binding
|
9
|
9.10e-01
|
2.18e-02
|
9.79e-01
|
GO:0055001 muscle cell development
|
10
|
9.05e-01
|
-2.18e-02
|
9.78e-01
|
GO:0001568 blood vessel development
|
21
|
8.63e-01
|
2.17e-02
|
9.70e-01
|
GO:0000795 synaptonemal complex
|
12
|
8.97e-01
|
2.17e-02
|
9.77e-01
|
GO:0097602 cullin family protein binding
|
24
|
8.55e-01
|
2.15e-02
|
9.70e-01
|
GO:0043508 negative regulation of JUN kinase activity
|
9
|
9.11e-01
|
-2.15e-02
|
9.80e-01
|
GO:0008180 COP9 signalosome
|
32
|
8.34e-01
|
-2.15e-02
|
9.63e-01
|
GO:0030021 extracellular matrix structural constituent conferring compression resistance
|
6
|
9.28e-01
|
-2.14e-02
|
9.83e-01
|
GO:0016460 myosin II complex
|
11
|
9.02e-01
|
-2.14e-02
|
9.78e-01
|
GO:0060340 positive regulation of type I interferon-mediated signaling pathway
|
16
|
8.82e-01
|
-2.14e-02
|
9.74e-01
|
GO:1903428 positive regulation of reactive oxygen species biosynthetic process
|
12
|
8.98e-01
|
2.14e-02
|
9.78e-01
|
GO:0051402 neuron apoptotic process
|
61
|
7.73e-01
|
2.14e-02
|
9.39e-01
|
GO:0009100 glycoprotein metabolic process
|
8
|
9.17e-01
|
-2.14e-02
|
9.82e-01
|
GO:0007626 locomotory behavior
|
39
|
8.18e-01
|
-2.13e-02
|
9.56e-01
|
GO:0035234 ectopic germ cell programmed cell death
|
12
|
8.98e-01
|
-2.13e-02
|
9.78e-01
|
GO:0006672 ceramide metabolic process
|
13
|
8.95e-01
|
2.12e-02
|
9.77e-01
|
GO:0038109 Kit signaling pathway
|
16
|
8.83e-01
|
-2.12e-02
|
9.74e-01
|
GO:0044183 protein folding chaperone
|
47
|
8.02e-01
|
2.12e-02
|
9.49e-01
|
GO:0000226 microtubule cytoskeleton organization
|
99
|
7.16e-01
|
-2.12e-02
|
9.21e-01
|
GO:0043085 positive regulation of catalytic activity
|
9
|
9.12e-01
|
-2.12e-02
|
9.80e-01
|
GO:0071011 precatalytic spliceosome
|
19
|
8.74e-01
|
-2.11e-02
|
9.73e-01
|
GO:0042632 cholesterol homeostasis
|
56
|
7.85e-01
|
2.11e-02
|
9.45e-01
|
GO:0015194 L-serine transmembrane transporter activity
|
7
|
9.23e-01
|
-2.10e-02
|
9.83e-01
|
GO:0015825 L-serine transport
|
7
|
9.23e-01
|
-2.10e-02
|
9.83e-01
|
GO:0030246 carbohydrate binding
|
96
|
7.23e-01
|
2.09e-02
|
9.24e-01
|
GO:0000151 ubiquitin ligase complex
|
104
|
7.12e-01
|
-2.09e-02
|
9.19e-01
|
GO:0045747 positive regulation of Notch signaling pathway
|
31
|
8.40e-01
|
-2.09e-02
|
9.65e-01
|
GO:0003725 double-stranded RNA binding
|
64
|
7.72e-01
|
-2.09e-02
|
9.38e-01
|
GO:0044297 cell body
|
48
|
8.02e-01
|
2.09e-02
|
9.49e-01
|
GO:0150105 protein localization to cell-cell junction
|
6
|
9.29e-01
|
2.09e-02
|
9.84e-01
|
GO:0097084 vascular associated smooth muscle cell development
|
5
|
9.36e-01
|
-2.09e-02
|
9.84e-01
|
GO:0051096 positive regulation of helicase activity
|
5
|
9.36e-01
|
-2.09e-02
|
9.84e-01
|
GO:0035658 Mon1-Ccz1 complex
|
5
|
9.36e-01
|
2.09e-02
|
9.84e-01
|
GO:0000145 exocyst
|
13
|
8.97e-01
|
2.08e-02
|
9.77e-01
|
GO:0045820 negative regulation of glycolytic process
|
13
|
8.97e-01
|
-2.08e-02
|
9.77e-01
|
GO:0048598 embryonic morphogenesis
|
8
|
9.19e-01
|
2.08e-02
|
9.83e-01
|
GO:0140639 positive regulation of pyroptotic inflammatory response
|
7
|
9.24e-01
|
2.08e-02
|
9.83e-01
|
GO:0046825 regulation of protein export from nucleus
|
12
|
9.01e-01
|
-2.07e-02
|
9.78e-01
|
GO:0001961 positive regulation of cytokine-mediated signaling pathway
|
8
|
9.19e-01
|
-2.07e-02
|
9.83e-01
|
GO:0005813 centrosome
|
546
|
4.12e-01
|
-2.07e-02
|
7.85e-01
|
GO:1901165 positive regulation of trophoblast cell migration
|
5
|
9.37e-01
|
-2.05e-02
|
9.84e-01
|
GO:0018279 protein N-linked glycosylation via asparagine
|
20
|
8.74e-01
|
-2.05e-02
|
9.73e-01
|
GO:0120163 negative regulation of cold-induced thermogenesis
|
33
|
8.40e-01
|
-2.04e-02
|
9.65e-01
|
GO:0031090 organelle membrane
|
18
|
8.82e-01
|
2.03e-02
|
9.74e-01
|
GO:2000300 regulation of synaptic vesicle exocytosis
|
20
|
8.75e-01
|
2.03e-02
|
9.73e-01
|
GO:0015297 antiporter activity
|
38
|
8.30e-01
|
2.01e-02
|
9.61e-01
|
GO:0030552 cAMP binding
|
15
|
8.93e-01
|
-2.01e-02
|
9.77e-01
|
GO:0005686 U2 snRNP
|
26
|
8.59e-01
|
-2.01e-02
|
9.70e-01
|
GO:0043022 ribosome binding
|
73
|
7.67e-01
|
-2.01e-02
|
9.37e-01
|
GO:0000993 RNA polymerase II complex binding
|
31
|
8.47e-01
|
2.00e-02
|
9.68e-01
|
GO:0034244 negative regulation of transcription elongation by RNA polymerase II
|
18
|
8.84e-01
|
1.99e-02
|
9.75e-01
|
GO:0006541 glutamine metabolic process
|
10
|
9.14e-01
|
-1.98e-02
|
9.81e-01
|
GO:0070633 transepithelial transport
|
7
|
9.28e-01
|
-1.97e-02
|
9.84e-01
|
GO:0051225 spindle assembly
|
34
|
8.42e-01
|
-1.97e-02
|
9.66e-01
|
GO:1904504 positive regulation of lipophagy
|
5
|
9.39e-01
|
1.97e-02
|
9.84e-01
|
GO:0043657 host cell
|
8
|
9.23e-01
|
-1.97e-02
|
9.83e-01
|
GO:1902017 regulation of cilium assembly
|
44
|
8.22e-01
|
-1.96e-02
|
9.57e-01
|
GO:1902950 regulation of dendritic spine maintenance
|
5
|
9.39e-01
|
1.96e-02
|
9.84e-01
|
GO:0002087 regulation of respiratory gaseous exchange by nervous system process
|
6
|
9.34e-01
|
1.96e-02
|
9.84e-01
|
GO:0051290 protein heterotetramerization
|
13
|
9.03e-01
|
-1.95e-02
|
9.78e-01
|
GO:0030194 positive regulation of blood coagulation
|
13
|
9.03e-01
|
-1.95e-02
|
9.78e-01
|
GO:0070542 response to fatty acid
|
13
|
9.04e-01
|
-1.94e-02
|
9.78e-01
|
GO:0043231 intracellular membrane-bounded organelle
|
658
|
4.00e-01
|
1.94e-02
|
7.75e-01
|
GO:0033592 RNA strand annealing activity
|
5
|
9.40e-01
|
1.93e-02
|
9.84e-01
|
GO:0042910 xenobiotic transmembrane transporter activity
|
16
|
8.94e-01
|
1.93e-02
|
9.77e-01
|
GO:1901224 positive regulation of non-canonical NF-kappaB signal transduction
|
51
|
8.12e-01
|
-1.93e-02
|
9.54e-01
|
GO:0014033 neural crest cell differentiation
|
7
|
9.30e-01
|
1.93e-02
|
9.84e-01
|
GO:0035374 chondroitin sulfate binding
|
6
|
9.35e-01
|
1.92e-02
|
9.84e-01
|
GO:0001782 B cell homeostasis
|
22
|
8.77e-01
|
-1.91e-02
|
9.73e-01
|
GO:0070102 interleukin-6-mediated signaling pathway
|
12
|
9.09e-01
|
-1.91e-02
|
9.79e-01
|
GO:2001056 positive regulation of cysteine-type endopeptidase activity
|
59
|
8.00e-01
|
1.91e-02
|
9.49e-01
|
GO:0009898 cytoplasmic side of plasma membrane
|
87
|
7.59e-01
|
-1.90e-02
|
9.35e-01
|
GO:0019348 dolichol metabolic process
|
6
|
9.37e-01
|
1.88e-02
|
9.84e-01
|
GO:0001892 embryonic placenta development
|
15
|
9.00e-01
|
-1.87e-02
|
9.78e-01
|
GO:0034329 cell junction assembly
|
7
|
9.32e-01
|
-1.87e-02
|
9.84e-01
|
GO:2001214 positive regulation of vasculogenesis
|
7
|
9.32e-01
|
1.87e-02
|
9.84e-01
|
GO:0006402 mRNA catabolic process
|
28
|
8.64e-01
|
1.87e-02
|
9.70e-01
|
GO:0035303 regulation of dephosphorylation
|
5
|
9.42e-01
|
-1.87e-02
|
9.84e-01
|
GO:0140115 export across plasma membrane
|
6
|
9.37e-01
|
-1.87e-02
|
9.84e-01
|
GO:0017128 phospholipid scramblase activity
|
12
|
9.11e-01
|
-1.86e-02
|
9.80e-01
|
GO:0005979 regulation of glycogen biosynthetic process
|
7
|
9.32e-01
|
1.86e-02
|
9.84e-01
|
GO:0044325 transmembrane transporter binding
|
91
|
7.60e-01
|
-1.86e-02
|
9.35e-01
|
GO:0019855 calcium channel inhibitor activity
|
10
|
9.19e-01
|
-1.85e-02
|
9.83e-01
|
GO:0060574 intestinal epithelial cell maturation
|
5
|
9.43e-01
|
1.84e-02
|
9.84e-01
|
GO:1901029 negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway
|
12
|
9.12e-01
|
-1.84e-02
|
9.80e-01
|
GO:0071407 cellular response to organic cyclic compound
|
22
|
8.82e-01
|
1.83e-02
|
9.74e-01
|
GO:0051246 regulation of protein metabolic process
|
5
|
9.44e-01
|
1.82e-02
|
9.84e-01
|
GO:0060042 retina morphogenesis in camera-type eye
|
5
|
9.44e-01
|
1.82e-02
|
9.84e-01
|
GO:0031209 SCAR complex
|
10
|
9.21e-01
|
1.81e-02
|
9.83e-01
|
GO:0045723 positive regulation of fatty acid biosynthetic process
|
10
|
9.21e-01
|
-1.81e-02
|
9.83e-01
|
GO:0099078 BORC complex
|
8
|
9.29e-01
|
1.81e-02
|
9.84e-01
|
GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific
|
714
|
4.16e-01
|
-1.80e-02
|
7.87e-01
|
GO:0006457 protein folding
|
133
|
7.22e-01
|
1.79e-02
|
9.23e-01
|
GO:0001666 response to hypoxia
|
111
|
7.46e-01
|
1.79e-02
|
9.32e-01
|
GO:0018230 peptidyl-L-cysteine S-palmitoylation
|
12
|
9.15e-01
|
1.78e-02
|
9.81e-01
|
GO:0033138 positive regulation of peptidyl-serine phosphorylation
|
33
|
8.60e-01
|
-1.78e-02
|
9.70e-01
|
GO:0048170 positive regulation of long-term neuronal synaptic plasticity
|
7
|
9.35e-01
|
1.77e-02
|
9.84e-01
|
GO:0006361 transcription initiation at RNA polymerase I promoter
|
6
|
9.40e-01
|
1.76e-02
|
9.84e-01
|
GO:0032259 methylation
|
75
|
7.92e-01
|
-1.76e-02
|
9.48e-01
|
GO:0004620 phospholipase activity
|
11
|
9.20e-01
|
1.76e-02
|
9.83e-01
|
GO:0051899 membrane depolarization
|
8
|
9.31e-01
|
-1.76e-02
|
9.84e-01
|
GO:0019843 rRNA binding
|
39
|
8.50e-01
|
1.75e-02
|
9.68e-01
|
GO:1904380 endoplasmic reticulum mannose trimming
|
12
|
9.17e-01
|
1.75e-02
|
9.82e-01
|
GO:0034498 early endosome to Golgi transport
|
16
|
9.04e-01
|
-1.74e-02
|
9.78e-01
|
GO:0001502 cartilage condensation
|
5
|
9.46e-01
|
1.74e-02
|
9.85e-01
|
GO:0005923 bicellular tight junction
|
72
|
7.99e-01
|
1.74e-02
|
9.49e-01
|
GO:0030148 sphingolipid biosynthetic process
|
33
|
8.63e-01
|
1.74e-02
|
9.70e-01
|
GO:0044794 positive regulation by host of viral process
|
12
|
9.17e-01
|
-1.74e-02
|
9.82e-01
|
GO:1902570 protein localization to nucleolus
|
11
|
9.21e-01
|
1.73e-02
|
9.83e-01
|
GO:0031091 platelet alpha granule
|
10
|
9.25e-01
|
1.72e-02
|
9.83e-01
|
GO:0071902 positive regulation of protein serine/threonine kinase activity
|
22
|
8.89e-01
|
-1.71e-02
|
9.76e-01
|
GO:0006814 sodium ion transport
|
22
|
8.89e-01
|
-1.71e-02
|
9.76e-01
|
GO:0010875 positive regulation of cholesterol efflux
|
18
|
9.00e-01
|
1.71e-02
|
9.78e-01
|
GO:1903561 extracellular vesicle
|
37
|
8.58e-01
|
-1.70e-02
|
9.70e-01
|
GO:0052658 inositol-1,4,5-trisphosphate 5-phosphatase activity
|
6
|
9.42e-01
|
-1.70e-02
|
9.84e-01
|
GO:0046982 protein heterodimerization activity
|
188
|
6.88e-01
|
-1.70e-02
|
9.06e-01
|
GO:0048844 artery morphogenesis
|
16
|
9.07e-01
|
1.70e-02
|
9.79e-01
|
GO:0045348 positive regulation of MHC class II biosynthetic process
|
12
|
9.19e-01
|
1.69e-02
|
9.83e-01
|
GO:0051452 intracellular pH reduction
|
13
|
9.16e-01
|
1.68e-02
|
9.82e-01
|
GO:0097371 MDM2/MDM4 family protein binding
|
10
|
9.27e-01
|
1.68e-02
|
9.83e-01
|
GO:0033540 fatty acid beta-oxidation using acyl-CoA oxidase
|
11
|
9.23e-01
|
1.68e-02
|
9.83e-01
|
GO:0032870 cellular response to hormone stimulus
|
14
|
9.14e-01
|
1.67e-02
|
9.81e-01
|
GO:0006611 protein export from nucleus
|
30
|
8.75e-01
|
-1.67e-02
|
9.73e-01
|
GO:0070262 peptidyl-serine dephosphorylation
|
7
|
9.39e-01
|
-1.67e-02
|
9.84e-01
|
GO:0031076 embryonic camera-type eye development
|
8
|
9.35e-01
|
1.66e-02
|
9.84e-01
|
GO:0140677 molecular function activator activity
|
19
|
9.00e-01
|
-1.66e-02
|
9.78e-01
|
GO:0001708 cell fate specification
|
6
|
9.44e-01
|
1.66e-02
|
9.84e-01
|
GO:0061952 midbody abscission
|
22
|
8.93e-01
|
-1.65e-02
|
9.77e-01
|
GO:0051149 positive regulation of muscle cell differentiation
|
11
|
9.25e-01
|
-1.64e-02
|
9.83e-01
|
GO:0035360 positive regulation of peroxisome proliferator activated receptor signaling pathway
|
5
|
9.49e-01
|
1.64e-02
|
9.87e-01
|
GO:0006936 muscle contraction
|
34
|
8.69e-01
|
1.64e-02
|
9.72e-01
|
GO:0000175 3’-5’-RNA exonuclease activity
|
29
|
8.79e-01
|
1.63e-02
|
9.74e-01
|
GO:0042770 signal transduction in response to DNA damage
|
15
|
9.13e-01
|
1.63e-02
|
9.80e-01
|
GO:0006012 galactose metabolic process
|
6
|
9.45e-01
|
1.63e-02
|
9.85e-01
|
GO:0005915 zonula adherens
|
7
|
9.40e-01
|
1.63e-02
|
9.84e-01
|
GO:0001890 placenta development
|
22
|
8.95e-01
|
1.63e-02
|
9.77e-01
|
GO:0046512 sphingosine biosynthetic process
|
11
|
9.26e-01
|
1.63e-02
|
9.83e-01
|
GO:0014029 neural crest formation
|
7
|
9.41e-01
|
-1.62e-02
|
9.84e-01
|
GO:0031369 translation initiation factor binding
|
21
|
8.98e-01
|
-1.62e-02
|
9.78e-01
|
GO:1902808 positive regulation of cell cycle G1/S phase transition
|
9
|
9.33e-01
|
1.61e-02
|
9.84e-01
|
GO:0050839 cell adhesion molecule binding
|
37
|
8.66e-01
|
-1.61e-02
|
9.71e-01
|
GO:0043014 alpha-tubulin binding
|
33
|
8.74e-01
|
1.60e-02
|
9.73e-01
|
GO:0017151 DEAD/H-box RNA helicase binding
|
7
|
9.42e-01
|
-1.60e-02
|
9.84e-01
|
GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding
|
720
|
4.70e-01
|
-1.59e-02
|
8.13e-01
|
GO:0019894 kinesin binding
|
32
|
8.76e-01
|
-1.59e-02
|
9.73e-01
|
GO:0006513 protein monoubiquitination
|
43
|
8.57e-01
|
1.59e-02
|
9.70e-01
|
GO:0043547 positive regulation of GTPase activity
|
67
|
8.23e-01
|
1.58e-02
|
9.57e-01
|
GO:0034707 chloride channel complex
|
18
|
9.08e-01
|
1.58e-02
|
9.79e-01
|
GO:0035973 aggrephagy
|
9
|
9.35e-01
|
1.58e-02
|
9.84e-01
|
GO:0048873 homeostasis of number of cells within a tissue
|
23
|
8.96e-01
|
-1.57e-02
|
9.77e-01
|
GO:0008239 dipeptidyl-peptidase activity
|
7
|
9.43e-01
|
-1.56e-02
|
9.84e-01
|
GO:0071439 clathrin complex
|
7
|
9.43e-01
|
-1.56e-02
|
9.84e-01
|
GO:0008080 N-acetyltransferase activity
|
9
|
9.36e-01
|
1.55e-02
|
9.84e-01
|
GO:0030953 astral microtubule organization
|
9
|
9.36e-01
|
1.55e-02
|
9.84e-01
|
GO:0060292 long-term synaptic depression
|
10
|
9.32e-01
|
1.55e-02
|
9.84e-01
|
GO:0140206 dipeptide import across plasma membrane
|
5
|
9.52e-01
|
1.55e-02
|
9.88e-01
|
GO:0042605 peptide antigen binding
|
29
|
8.86e-01
|
1.54e-02
|
9.75e-01
|
GO:0032691 negative regulation of interleukin-1 beta production
|
20
|
9.05e-01
|
1.54e-02
|
9.78e-01
|
GO:0007528 neuromuscular junction development
|
24
|
8.96e-01
|
1.54e-02
|
9.77e-01
|
GO:0030030 cell projection organization
|
31
|
8.82e-01
|
1.54e-02
|
9.74e-01
|
GO:0007492 endoderm development
|
12
|
9.27e-01
|
1.54e-02
|
9.83e-01
|
GO:0009048 dosage compensation by inactivation of X chromosome
|
8
|
9.40e-01
|
-1.53e-02
|
9.84e-01
|
GO:0000062 fatty-acyl-CoA binding
|
12
|
9.27e-01
|
1.53e-02
|
9.83e-01
|
GO:0034185 apolipoprotein binding
|
11
|
9.30e-01
|
-1.53e-02
|
9.84e-01
|
GO:0006265 DNA topological change
|
10
|
9.33e-01
|
1.53e-02
|
9.84e-01
|
GO:0001707 mesoderm formation
|
22
|
9.02e-01
|
-1.52e-02
|
9.78e-01
|
GO:0098686 hippocampal mossy fiber to CA3 synapse
|
32
|
8.82e-01
|
1.52e-02
|
9.74e-01
|
GO:0004622 lysophospholipase activity
|
20
|
9.08e-01
|
-1.50e-02
|
9.79e-01
|
GO:0042803 protein homodimerization activity
|
538
|
5.55e-01
|
-1.50e-02
|
8.51e-01
|
GO:0051791 medium-chain fatty acid metabolic process
|
5
|
9.54e-01
|
1.49e-02
|
9.88e-01
|
GO:0001673 male germ cell nucleus
|
37
|
8.75e-01
|
-1.49e-02
|
9.73e-01
|
GO:0010977 negative regulation of neuron projection development
|
42
|
8.68e-01
|
1.49e-02
|
9.72e-01
|
GO:0005668 RNA polymerase transcription factor SL1 complex
|
5
|
9.54e-01
|
1.48e-02
|
9.88e-01
|
GO:1905461 positive regulation of vascular associated smooth muscle cell apoptotic process
|
8
|
9.43e-01
|
-1.47e-02
|
9.84e-01
|
GO:0000729 DNA double-strand break processing
|
11
|
9.33e-01
|
-1.47e-02
|
9.84e-01
|
GO:0042470 melanosome
|
90
|
8.11e-01
|
-1.46e-02
|
9.54e-01
|
GO:2000353 positive regulation of endothelial cell apoptotic process
|
17
|
9.17e-01
|
1.46e-02
|
9.82e-01
|
GO:0048536 spleen development
|
27
|
8.96e-01
|
-1.46e-02
|
9.77e-01
|
GO:0098693 regulation of synaptic vesicle cycle
|
12
|
9.31e-01
|
1.45e-02
|
9.84e-01
|
GO:0032835 glomerulus development
|
5
|
9.56e-01
|
1.44e-02
|
9.88e-01
|
GO:0032148 activation of protein kinase B activity
|
7
|
9.48e-01
|
1.43e-02
|
9.86e-01
|
GO:0032438 melanosome organization
|
22
|
9.08e-01
|
1.43e-02
|
9.79e-01
|
GO:0035751 regulation of lysosomal lumen pH
|
5
|
9.56e-01
|
1.42e-02
|
9.88e-01
|
GO:0010838 positive regulation of keratinocyte proliferation
|
6
|
9.52e-01
|
1.42e-02
|
9.88e-01
|
GO:0007286 spermatid development
|
45
|
8.70e-01
|
-1.41e-02
|
9.73e-01
|
GO:0032897 negative regulation of viral transcription
|
16
|
9.22e-01
|
1.41e-02
|
9.83e-01
|
GO:0101003 ficolin-1-rich granule membrane
|
51
|
8.62e-01
|
-1.40e-02
|
9.70e-01
|
GO:0006508 proteolysis
|
276
|
6.89e-01
|
1.40e-02
|
9.06e-01
|
GO:0046872 metal ion binding
|
1809
|
3.38e-01
|
-1.39e-02
|
7.25e-01
|
GO:0002502 peptide antigen assembly with MHC class I protein complex
|
6
|
9.53e-01
|
-1.39e-02
|
9.88e-01
|
GO:0045055 regulated exocytosis
|
14
|
9.28e-01
|
-1.39e-02
|
9.84e-01
|
GO:0006641 triglyceride metabolic process
|
18
|
9.19e-01
|
1.38e-02
|
9.83e-01
|
GO:0043687 post-translational protein modification
|
36
|
8.86e-01
|
-1.38e-02
|
9.75e-01
|
GO:0003158 endothelium development
|
8
|
9.46e-01
|
1.37e-02
|
9.85e-01
|
GO:0032740 positive regulation of interleukin-17 production
|
19
|
9.18e-01
|
1.37e-02
|
9.83e-01
|
GO:0005010 insulin-like growth factor receptor activity
|
16
|
9.25e-01
|
-1.35e-02
|
9.83e-01
|
GO:2000036 regulation of stem cell population maintenance
|
9
|
9.44e-01
|
1.34e-02
|
9.84e-01
|
GO:0016045 detection of bacterium
|
8
|
9.48e-01
|
1.34e-02
|
9.86e-01
|
GO:0009408 response to heat
|
26
|
9.06e-01
|
-1.33e-02
|
9.79e-01
|
GO:0046976 histone H3K27 methyltransferase activity
|
5
|
9.59e-01
|
-1.33e-02
|
9.89e-01
|
GO:0006654 phosphatidic acid biosynthetic process
|
30
|
9.00e-01
|
-1.33e-02
|
9.78e-01
|
GO:0140948 histone H3K9 monomethyltransferase activity
|
5
|
9.59e-01
|
-1.33e-02
|
9.89e-01
|
GO:0140313 molecular sequestering activity
|
12
|
9.37e-01
|
1.33e-02
|
9.84e-01
|
GO:0019902 phosphatase binding
|
39
|
8.86e-01
|
1.33e-02
|
9.75e-01
|
GO:0035722 interleukin-12-mediated signaling pathway
|
7
|
9.52e-01
|
-1.32e-02
|
9.88e-01
|
GO:0003149 membranous septum morphogenesis
|
5
|
9.59e-01
|
1.32e-02
|
9.89e-01
|
GO:0005109 frizzled binding
|
13
|
9.35e-01
|
1.31e-02
|
9.84e-01
|
GO:0034399 nuclear periphery
|
15
|
9.30e-01
|
-1.31e-02
|
9.84e-01
|
GO:0005615 extracellular space
|
652
|
5.73e-01
|
1.30e-02
|
8.61e-01
|
GO:0035800 deubiquitinase activator activity
|
7
|
9.53e-01
|
-1.30e-02
|
9.88e-01
|
GO:0017147 Wnt-protein binding
|
14
|
9.33e-01
|
1.30e-02
|
9.84e-01
|
GO:0051965 positive regulation of synapse assembly
|
20
|
9.20e-01
|
1.30e-02
|
9.83e-01
|
GO:0045453 bone resorption
|
19
|
9.22e-01
|
-1.30e-02
|
9.83e-01
|
GO:0031748 D1 dopamine receptor binding
|
6
|
9.57e-01
|
-1.28e-02
|
9.89e-01
|
GO:0036435 K48-linked polyubiquitin modification-dependent protein binding
|
10
|
9.44e-01
|
1.28e-02
|
9.84e-01
|
GO:0032570 response to progesterone
|
24
|
9.14e-01
|
-1.28e-02
|
9.81e-01
|
GO:1990403 embryonic brain development
|
12
|
9.39e-01
|
-1.28e-02
|
9.84e-01
|
GO:0051279 regulation of release of sequestered calcium ion into cytosol
|
14
|
9.34e-01
|
-1.27e-02
|
9.84e-01
|
GO:2000647 negative regulation of stem cell proliferation
|
11
|
9.42e-01
|
1.27e-02
|
9.84e-01
|
GO:0033162 melanosome membrane
|
15
|
9.32e-01
|
-1.27e-02
|
9.84e-01
|
GO:0014070 response to organic cyclic compound
|
35
|
8.97e-01
|
-1.27e-02
|
9.77e-01
|
GO:0071456 cellular response to hypoxia
|
87
|
8.38e-01
|
1.27e-02
|
9.65e-01
|
GO:0009437 carnitine metabolic process
|
5
|
9.61e-01
|
1.27e-02
|
9.90e-01
|
GO:0031985 Golgi cisterna
|
8
|
9.51e-01
|
-1.26e-02
|
9.87e-01
|
GO:1990877 FNIP-folliculin RagC/D GAP
|
10
|
9.45e-01
|
1.26e-02
|
9.85e-01
|
GO:0017121 plasma membrane phospholipid scrambling
|
11
|
9.42e-01
|
-1.26e-02
|
9.84e-01
|
GO:0006301 postreplication repair
|
11
|
9.43e-01
|
-1.25e-02
|
9.84e-01
|
GO:0006266 DNA ligation
|
7
|
9.54e-01
|
-1.25e-02
|
9.88e-01
|
GO:0010803 regulation of tumor necrosis factor-mediated signaling pathway
|
22
|
9.20e-01
|
-1.24e-02
|
9.83e-01
|
GO:0004415 hyalurononglucosaminidase activity
|
5
|
9.62e-01
|
-1.23e-02
|
9.90e-01
|
GO:0000462 maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
|
22
|
9.21e-01
|
1.23e-02
|
9.83e-01
|
GO:0034993 meiotic nuclear membrane microtubule tethering complex
|
7
|
9.56e-01
|
-1.21e-02
|
9.88e-01
|
GO:0046427 positive regulation of receptor signaling pathway via JAK-STAT
|
20
|
9.25e-01
|
1.21e-02
|
9.83e-01
|
GO:0031290 retinal ganglion cell axon guidance
|
10
|
9.47e-01
|
1.21e-02
|
9.86e-01
|
GO:0005149 interleukin-1 receptor binding
|
7
|
9.56e-01
|
1.21e-02
|
9.88e-01
|
GO:0006623 protein targeting to vacuole
|
12
|
9.42e-01
|
-1.20e-02
|
9.84e-01
|
GO:0051895 negative regulation of focal adhesion assembly
|
13
|
9.40e-01
|
1.20e-02
|
9.84e-01
|
GO:0006303 double-strand break repair via nonhomologous end joining
|
38
|
8.98e-01
|
1.20e-02
|
9.78e-01
|
GO:0045953 negative regulation of natural killer cell mediated cytotoxicity
|
16
|
9.34e-01
|
-1.20e-02
|
9.84e-01
|
GO:0006952 defense response
|
44
|
8.91e-01
|
1.19e-02
|
9.77e-01
|
GO:0032815 negative regulation of natural killer cell activation
|
7
|
9.57e-01
|
1.19e-02
|
9.89e-01
|
GO:0006744 ubiquinone biosynthetic process
|
15
|
9.36e-01
|
-1.19e-02
|
9.84e-01
|
GO:2000785 regulation of autophagosome assembly
|
16
|
9.35e-01
|
-1.18e-02
|
9.84e-01
|
GO:0090543 Flemming body
|
31
|
9.09e-01
|
-1.18e-02
|
9.79e-01
|
GO:0071621 granulocyte chemotaxis
|
5
|
9.64e-01
|
1.18e-02
|
9.90e-01
|
GO:0099645 neurotransmitter receptor localization to postsynaptic specialization membrane
|
9
|
9.51e-01
|
1.18e-02
|
9.88e-01
|
GO:0043005 neuron projection
|
160
|
7.97e-01
|
1.18e-02
|
9.49e-01
|
GO:0097067 cellular response to thyroid hormone stimulus
|
8
|
9.54e-01
|
-1.18e-02
|
9.88e-01
|
GO:0008168 methyltransferase activity
|
27
|
9.17e-01
|
1.16e-02
|
9.82e-01
|
GO:0004860 protein kinase inhibitor activity
|
32
|
9.11e-01
|
1.15e-02
|
9.80e-01
|
GO:0042308 negative regulation of protein import into nucleus
|
12
|
9.45e-01
|
-1.15e-02
|
9.85e-01
|
GO:0065003 protein-containing complex assembly
|
108
|
8.37e-01
|
-1.14e-02
|
9.65e-01
|
GO:2000010 positive regulation of protein localization to cell surface
|
16
|
9.37e-01
|
1.14e-02
|
9.84e-01
|
GO:0043069 negative regulation of programmed cell death
|
19
|
9.31e-01
|
-1.14e-02
|
9.84e-01
|
GO:0044754 autolysosome
|
11
|
9.48e-01
|
1.14e-02
|
9.86e-01
|
GO:1902237 positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway
|
8
|
9.56e-01
|
-1.13e-02
|
9.88e-01
|
GO:0006631 fatty acid metabolic process
|
57
|
8.83e-01
|
1.12e-02
|
9.74e-01
|
GO:0160063 multi-pass transmembrane protein insertion into ER membrane
|
9
|
9.53e-01
|
-1.12e-02
|
9.88e-01
|
GO:0160064 multi-pass translocon complex
|
9
|
9.53e-01
|
-1.12e-02
|
9.88e-01
|
GO:0060134 prepulse inhibition
|
6
|
9.62e-01
|
-1.12e-02
|
9.90e-01
|
GO:0030018 Z disc
|
78
|
8.64e-01
|
1.12e-02
|
9.70e-01
|
GO:0048538 thymus development
|
35
|
9.09e-01
|
-1.12e-02
|
9.79e-01
|
GO:2000660 negative regulation of interleukin-1-mediated signaling pathway
|
6
|
9.62e-01
|
1.12e-02
|
9.90e-01
|
GO:0000902 cell morphogenesis
|
59
|
8.83e-01
|
1.11e-02
|
9.74e-01
|
GO:0004197 cysteine-type endopeptidase activity
|
56
|
8.86e-01
|
-1.11e-02
|
9.75e-01
|
GO:0006688 glycosphingolipid biosynthetic process
|
15
|
9.41e-01
|
-1.11e-02
|
9.84e-01
|
GO:0008137 NADH dehydrogenase (ubiquinone) activity
|
41
|
9.02e-01
|
1.11e-02
|
9.78e-01
|
GO:0004842 ubiquitin-protein transferase activity
|
194
|
7.91e-01
|
-1.11e-02
|
9.48e-01
|
GO:0001774 microglial cell activation
|
21
|
9.30e-01
|
1.11e-02
|
9.84e-01
|
GO:0070294 renal sodium ion absorption
|
6
|
9.63e-01
|
-1.09e-02
|
9.90e-01
|
GO:0097120 receptor localization to synapse
|
5
|
9.66e-01
|
1.09e-02
|
9.92e-01
|
GO:0010042 response to manganese ion
|
7
|
9.60e-01
|
1.09e-02
|
9.90e-01
|
GO:0005762 mitochondrial large ribosomal subunit
|
56
|
8.88e-01
|
-1.09e-02
|
9.76e-01
|
GO:0050431 transforming growth factor beta binding
|
17
|
9.38e-01
|
1.08e-02
|
9.84e-01
|
GO:0140105 interleukin-10-mediated signaling pathway
|
11
|
9.51e-01
|
-1.08e-02
|
9.87e-01
|
GO:0002376 immune system process
|
29
|
9.20e-01
|
-1.08e-02
|
9.83e-01
|
GO:0034751 aryl hydrocarbon receptor complex
|
5
|
9.67e-01
|
-1.08e-02
|
9.92e-01
|
GO:0006620 post-translational protein targeting to endoplasmic reticulum membrane
|
9
|
9.56e-01
|
1.07e-02
|
9.88e-01
|
GO:0003281 ventricular septum development
|
20
|
9.34e-01
|
1.07e-02
|
9.84e-01
|
GO:0006364 rRNA processing
|
115
|
8.44e-01
|
1.07e-02
|
9.67e-01
|
GO:0006284 base-excision repair
|
28
|
9.22e-01
|
-1.07e-02
|
9.83e-01
|
GO:0032585 multivesicular body membrane
|
23
|
9.30e-01
|
1.06e-02
|
9.84e-01
|
GO:0030521 androgen receptor signaling pathway
|
18
|
9.38e-01
|
1.06e-02
|
9.84e-01
|
GO:0048741 skeletal muscle fiber development
|
17
|
9.40e-01
|
1.06e-02
|
9.84e-01
|
GO:0051092 positive regulation of NF-kappaB transcription factor activity
|
97
|
8.59e-01
|
-1.05e-02
|
9.70e-01
|
GO:0045599 negative regulation of fat cell differentiation
|
28
|
9.24e-01
|
-1.04e-02
|
9.83e-01
|
GO:0060416 response to growth hormone
|
5
|
9.68e-01
|
1.04e-02
|
9.92e-01
|
GO:0070273 phosphatidylinositol-4-phosphate binding
|
28
|
9.24e-01
|
-1.04e-02
|
9.83e-01
|
GO:0031624 ubiquitin conjugating enzyme binding
|
24
|
9.30e-01
|
1.03e-02
|
9.84e-01
|
GO:0090656 t-circle formation
|
11
|
9.53e-01
|
-1.03e-02
|
9.88e-01
|
GO:0086002 cardiac muscle cell action potential involved in contraction
|
9
|
9.58e-01
|
1.03e-02
|
9.89e-01
|
GO:0061053 somite development
|
6
|
9.65e-01
|
-1.02e-02
|
9.91e-01
|
GO:0051865 protein autoubiquitination
|
59
|
8.92e-01
|
1.02e-02
|
9.77e-01
|
GO:0099122 RNA polymerase II C-terminal domain binding
|
7
|
9.63e-01
|
-1.02e-02
|
9.90e-01
|
GO:0050776 regulation of immune response
|
20
|
9.37e-01
|
1.02e-02
|
9.84e-01
|
GO:0005543 phospholipid binding
|
73
|
8.81e-01
|
-1.01e-02
|
9.74e-01
|
GO:0036295 cellular response to increased oxygen levels
|
7
|
9.63e-01
|
-1.01e-02
|
9.90e-01
|
GO:0098901 regulation of cardiac muscle cell action potential
|
5
|
9.69e-01
|
1.01e-02
|
9.93e-01
|
GO:0032496 response to lipopolysaccharide
|
85
|
8.73e-01
|
-1.00e-02
|
9.73e-01
|
GO:0086036 regulation of cardiac muscle cell membrane potential
|
5
|
9.69e-01
|
-1.00e-02
|
9.93e-01
|
GO:1904294 positive regulation of ERAD pathway
|
17
|
9.43e-01
|
9.95e-03
|
9.84e-01
|
GO:0006264 mitochondrial DNA replication
|
9
|
9.59e-01
|
-9.91e-03
|
9.89e-01
|
GO:0005683 U7 snRNP
|
7
|
9.64e-01
|
-9.86e-03
|
9.90e-01
|
GO:1990742 microvesicle
|
6
|
9.67e-01
|
9.65e-03
|
9.92e-01
|
GO:0042474 middle ear morphogenesis
|
9
|
9.60e-01
|
-9.64e-03
|
9.90e-01
|
GO:0002687 positive regulation of leukocyte migration
|
10
|
9.58e-01
|
-9.62e-03
|
9.89e-01
|
GO:0051650 establishment of vesicle localization
|
7
|
9.65e-01
|
-9.57e-03
|
9.91e-01
|
GO:0006396 RNA processing
|
71
|
8.89e-01
|
-9.56e-03
|
9.76e-01
|
GO:0072657 protein localization to membrane
|
24
|
9.36e-01
|
-9.53e-03
|
9.84e-01
|
GO:0016055 Wnt signaling pathway
|
108
|
8.64e-01
|
9.52e-03
|
9.70e-01
|
GO:0021915 neural tube development
|
23
|
9.37e-01
|
-9.46e-03
|
9.84e-01
|
GO:0030017 sarcomere
|
22
|
9.39e-01
|
-9.45e-03
|
9.84e-01
|
GO:0002230 positive regulation of defense response to virus by host
|
26
|
9.34e-01
|
-9.43e-03
|
9.84e-01
|
GO:0046975 histone H3K36 methyltransferase activity
|
10
|
9.59e-01
|
9.42e-03
|
9.89e-01
|
GO:0040018 positive regulation of multicellular organism growth
|
16
|
9.48e-01
|
9.41e-03
|
9.86e-01
|
GO:0003073 regulation of systemic arterial blood pressure
|
7
|
9.66e-01
|
-9.39e-03
|
9.92e-01
|
GO:0048477 oogenesis
|
22
|
9.40e-01
|
-9.34e-03
|
9.84e-01
|
GO:0007218 neuropeptide signaling pathway
|
27
|
9.33e-01
|
-9.34e-03
|
9.84e-01
|
GO:0005759 mitochondrial matrix
|
377
|
7.57e-01
|
9.33e-03
|
9.35e-01
|
GO:0015820 L-leucine transport
|
8
|
9.64e-01
|
-9.27e-03
|
9.90e-01
|
GO:0005545 1-phosphatidylinositol binding
|
13
|
9.54e-01
|
-9.21e-03
|
9.88e-01
|
GO:0047035 testosterone dehydrogenase (NAD+) activity
|
5
|
9.72e-01
|
-9.20e-03
|
9.94e-01
|
GO:0001841 neural tube formation
|
6
|
9.69e-01
|
-9.13e-03
|
9.93e-01
|
GO:0035025 positive regulation of Rho protein signal transduction
|
16
|
9.50e-01
|
9.09e-03
|
9.87e-01
|
GO:0061630 ubiquitin protein ligase activity
|
257
|
8.02e-01
|
-9.09e-03
|
9.49e-01
|
GO:0000346 transcription export complex
|
12
|
9.57e-01
|
-8.97e-03
|
9.89e-01
|
GO:0046826 negative regulation of protein export from nucleus
|
7
|
9.67e-01
|
8.91e-03
|
9.92e-01
|
GO:0003407 neural retina development
|
16
|
9.51e-01
|
-8.85e-03
|
9.88e-01
|
GO:0004864 protein phosphatase inhibitor activity
|
29
|
9.34e-01
|
-8.83e-03
|
9.84e-01
|
GO:0042608 T cell receptor binding
|
8
|
9.66e-01
|
8.72e-03
|
9.92e-01
|
GO:0030163 protein catabolic process
|
55
|
9.12e-01
|
8.60e-03
|
9.80e-01
|
GO:0001915 negative regulation of T cell mediated cytotoxicity
|
5
|
9.74e-01
|
8.49e-03
|
9.95e-01
|
GO:0016301 kinase activity
|
46
|
9.21e-01
|
-8.47e-03
|
9.83e-01
|
GO:0051289 protein homotetramerization
|
49
|
9.18e-01
|
-8.47e-03
|
9.83e-01
|
GO:0048787 presynaptic active zone membrane
|
19
|
9.49e-01
|
-8.44e-03
|
9.87e-01
|
GO:0045444 fat cell differentiation
|
57
|
9.12e-01
|
8.44e-03
|
9.80e-01
|
GO:0031519 PcG protein complex
|
24
|
9.44e-01
|
8.32e-03
|
9.84e-01
|
GO:0046324 regulation of D-glucose import
|
6
|
9.72e-01
|
-8.29e-03
|
9.94e-01
|
GO:0009267 cellular response to starvation
|
63
|
9.11e-01
|
8.16e-03
|
9.80e-01
|
GO:0016925 protein sumoylation
|
49
|
9.22e-01
|
8.12e-03
|
9.83e-01
|
GO:0042733 embryonic digit morphogenesis
|
27
|
9.42e-01
|
8.11e-03
|
9.84e-01
|
GO:0031966 mitochondrial membrane
|
128
|
8.75e-01
|
-8.09e-03
|
9.73e-01
|
GO:0048298 positive regulation of isotype switching to IgA isotypes
|
6
|
9.73e-01
|
-7.97e-03
|
9.95e-01
|
GO:0005763 mitochondrial small ribosomal subunit
|
32
|
9.38e-01
|
7.91e-03
|
9.84e-01
|
GO:0046907 intracellular transport
|
32
|
9.39e-01
|
7.86e-03
|
9.84e-01
|
GO:1902430 negative regulation of amyloid-beta formation
|
14
|
9.60e-01
|
7.77e-03
|
9.90e-01
|
GO:0140933 5’-(N(7)-methylguanosine 5’-triphospho)-[mRNA] hydrolase activity
|
10
|
9.67e-01
|
7.63e-03
|
9.92e-01
|
GO:0070936 protein K48-linked ubiquitination
|
91
|
9.00e-01
|
7.62e-03
|
9.78e-01
|
GO:0001682 tRNA 5’-leader removal
|
13
|
9.62e-01
|
-7.59e-03
|
9.90e-01
|
GO:0051354 negative regulation of oxidoreductase activity
|
5
|
9.77e-01
|
-7.56e-03
|
9.96e-01
|
GO:0006398 mRNA 3’-end processing by stem-loop binding and cleavage
|
6
|
9.75e-01
|
7.49e-03
|
9.96e-01
|
GO:0000301 retrograde transport, vesicle recycling within Golgi
|
9
|
9.69e-01
|
-7.49e-03
|
9.93e-01
|
GO:0042756 drinking behavior
|
5
|
9.77e-01
|
-7.40e-03
|
9.96e-01
|
GO:0000049 tRNA binding
|
68
|
9.17e-01
|
-7.34e-03
|
9.82e-01
|
GO:0031929 TOR signaling
|
20
|
9.55e-01
|
7.34e-03
|
9.88e-01
|
GO:0140346 phosphatidylserine flippase activity
|
5
|
9.77e-01
|
7.32e-03
|
9.96e-01
|
GO:0060074 synapse maturation
|
6
|
9.75e-01
|
-7.31e-03
|
9.96e-01
|
GO:0005666 RNA polymerase III complex
|
18
|
9.57e-01
|
7.30e-03
|
9.89e-01
|
GO:0032968 positive regulation of transcription elongation by RNA polymerase II
|
48
|
9.31e-01
|
-7.21e-03
|
9.84e-01
|
GO:0032743 positive regulation of interleukin-2 production
|
29
|
9.47e-01
|
-7.11e-03
|
9.86e-01
|
GO:0052816 long-chain fatty acyl-CoA hydrolase activity
|
11
|
9.68e-01
|
7.07e-03
|
9.92e-01
|
GO:0004930 G protein-coupled receptor activity
|
70
|
9.19e-01
|
7.04e-03
|
9.83e-01
|
GO:0030672 synaptic vesicle membrane
|
74
|
9.18e-01
|
-6.90e-03
|
9.83e-01
|
GO:0051082 unfolded protein binding
|
95
|
9.08e-01
|
-6.87e-03
|
9.79e-01
|
GO:0031398 positive regulation of protein ubiquitination
|
64
|
9.25e-01
|
6.77e-03
|
9.83e-01
|
GO:0050890 cognition
|
32
|
9.47e-01
|
6.77e-03
|
9.86e-01
|
GO:0016471 vacuolar proton-transporting V-type ATPase complex
|
9
|
9.72e-01
|
-6.73e-03
|
9.94e-01
|
GO:0007220 Notch receptor processing
|
8
|
9.74e-01
|
-6.66e-03
|
9.95e-01
|
GO:1902065 response to L-glutamate
|
8
|
9.74e-01
|
6.63e-03
|
9.95e-01
|
GO:0007178 cell surface receptor protein serine/threonine kinase signaling pathway
|
7
|
9.76e-01
|
-6.57e-03
|
9.96e-01
|
GO:0020037 heme binding
|
66
|
9.27e-01
|
-6.52e-03
|
9.83e-01
|
GO:0070006 metalloaminopeptidase activity
|
22
|
9.58e-01
|
-6.49e-03
|
9.89e-01
|
GO:0010800 positive regulation of peptidyl-threonine phosphorylation
|
17
|
9.64e-01
|
-6.33e-03
|
9.90e-01
|
GO:2000147 positive regulation of cell motility
|
12
|
9.70e-01
|
-6.30e-03
|
9.93e-01
|
GO:0031902 late endosome membrane
|
128
|
9.03e-01
|
-6.27e-03
|
9.78e-01
|
GO:0004535 poly(A)-specific ribonuclease activity
|
12
|
9.70e-01
|
6.27e-03
|
9.93e-01
|
GO:0043066 negative regulation of apoptotic process
|
316
|
8.49e-01
|
6.24e-03
|
9.68e-01
|
GO:0031994 insulin-like growth factor I binding
|
8
|
9.76e-01
|
-6.18e-03
|
9.96e-01
|
GO:0045087 innate immune response
|
325
|
8.49e-01
|
6.17e-03
|
9.68e-01
|
GO:0061631 ubiquitin conjugating enzyme activity
|
31
|
9.53e-01
|
6.14e-03
|
9.88e-01
|
GO:0055074 calcium ion homeostasis
|
19
|
9.64e-01
|
6.05e-03
|
9.90e-01
|
GO:0036396 RNA N6-methyladenosine methyltransferase complex
|
9
|
9.75e-01
|
-5.99e-03
|
9.96e-01
|
GO:0034097 response to cytokine
|
32
|
9.53e-01
|
-5.99e-03
|
9.88e-01
|
GO:0001540 amyloid-beta binding
|
60
|
9.37e-01
|
-5.93e-03
|
9.84e-01
|
GO:0055038 recycling endosome membrane
|
83
|
9.26e-01
|
-5.92e-03
|
9.83e-01
|
GO:0010961 intracellular magnesium ion homeostasis
|
5
|
9.82e-01
|
-5.87e-03
|
9.98e-01
|
GO:0070207 protein homotrimerization
|
11
|
9.73e-01
|
5.79e-03
|
9.95e-01
|
GO:0030878 thyroid gland development
|
16
|
9.68e-01
|
-5.78e-03
|
9.92e-01
|
GO:0021854 hypothalamus development
|
7
|
9.79e-01
|
5.77e-03
|
9.97e-01
|
GO:0016601 Rac protein signal transduction
|
23
|
9.62e-01
|
5.73e-03
|
9.90e-01
|
GO:0005509 calcium ion binding
|
327
|
8.59e-01
|
-5.72e-03
|
9.70e-01
|
GO:0010467 gene expression
|
100
|
9.22e-01
|
5.67e-03
|
9.83e-01
|
GO:0045652 regulation of megakaryocyte differentiation
|
7
|
9.80e-01
|
5.58e-03
|
9.97e-01
|
GO:0005007 fibroblast growth factor receptor activity
|
15
|
9.70e-01
|
5.52e-03
|
9.93e-01
|
GO:0045111 intermediate filament cytoskeleton
|
33
|
9.57e-01
|
5.47e-03
|
9.89e-01
|
GO:0003995 acyl-CoA dehydrogenase activity
|
8
|
9.79e-01
|
-5.47e-03
|
9.97e-01
|
GO:0072540 T-helper 17 cell lineage commitment
|
8
|
9.79e-01
|
5.45e-03
|
9.97e-01
|
GO:0060155 platelet dense granule organization
|
23
|
9.64e-01
|
5.42e-03
|
9.90e-01
|
GO:0051087 protein-folding chaperone binding
|
79
|
9.34e-01
|
-5.35e-03
|
9.84e-01
|
GO:0006828 manganese ion transport
|
5
|
9.84e-01
|
-5.33e-03
|
9.98e-01
|
GO:0098982 GABA-ergic synapse
|
42
|
9.53e-01
|
5.29e-03
|
9.88e-01
|
GO:0050832 defense response to fungus
|
14
|
9.73e-01
|
-5.27e-03
|
9.95e-01
|
GO:0006703 estrogen biosynthetic process
|
7
|
9.81e-01
|
5.23e-03
|
9.97e-01
|
GO:0030165 PDZ domain binding
|
52
|
9.48e-01
|
5.21e-03
|
9.86e-01
|
GO:0045745 positive regulation of G protein-coupled receptor signaling pathway
|
8
|
9.80e-01
|
-5.20e-03
|
9.97e-01
|
GO:0000118 histone deacetylase complex
|
37
|
9.57e-01
|
-5.10e-03
|
9.89e-01
|
GO:0070986 left/right axis specification
|
10
|
9.79e-01
|
-4.89e-03
|
9.97e-01
|
GO:0050821 protein stabilization
|
189
|
9.08e-01
|
4.89e-03
|
9.79e-01
|
GO:0048167 regulation of synaptic plasticity
|
32
|
9.62e-01
|
4.82e-03
|
9.90e-01
|
GO:0034599 cellular response to oxidative stress
|
91
|
9.37e-01
|
-4.82e-03
|
9.84e-01
|
GO:0007567 parturition
|
6
|
9.84e-01
|
4.81e-03
|
9.98e-01
|
GO:0033619 membrane protein proteolysis
|
10
|
9.79e-01
|
4.81e-03
|
9.97e-01
|
GO:0099128 mitochondrial [2Fe-2S] assembly complex
|
5
|
9.85e-01
|
4.73e-03
|
9.98e-01
|
GO:2000347 positive regulation of hepatocyte proliferation
|
7
|
9.83e-01
|
4.70e-03
|
9.98e-01
|
GO:2000779 regulation of double-strand break repair
|
27
|
9.66e-01
|
-4.68e-03
|
9.92e-01
|
GO:0008585 female gonad development
|
9
|
9.81e-01
|
4.67e-03
|
9.97e-01
|
GO:0000932 P-body
|
89
|
9.41e-01
|
-4.54e-03
|
9.84e-01
|
GO:0038084 vascular endothelial growth factor signaling pathway
|
23
|
9.70e-01
|
4.53e-03
|
9.93e-01
|
GO:0033630 positive regulation of cell adhesion mediated by integrin
|
12
|
9.79e-01
|
-4.42e-03
|
9.97e-01
|
GO:0032436 positive regulation of proteasomal ubiquitin-dependent protein catabolic process
|
68
|
9.50e-01
|
-4.38e-03
|
9.87e-01
|
GO:0034702 monoatomic ion channel complex
|
16
|
9.76e-01
|
-4.31e-03
|
9.96e-01
|
GO:0045591 positive regulation of regulatory T cell differentiation
|
16
|
9.76e-01
|
4.28e-03
|
9.96e-01
|
GO:0070588 calcium ion transmembrane transport
|
74
|
9.50e-01
|
-4.18e-03
|
9.87e-01
|
GO:0008089 anterograde axonal transport
|
25
|
9.71e-01
|
4.13e-03
|
9.94e-01
|
GO:0031116 positive regulation of microtubule polymerization
|
20
|
9.75e-01
|
-4.11e-03
|
9.96e-01
|
GO:0150077 regulation of neuroinflammatory response
|
5
|
9.87e-01
|
4.05e-03
|
9.99e-01
|
GO:0070914 UV-damage excision repair
|
10
|
9.83e-01
|
-3.95e-03
|
9.98e-01
|
GO:0050810 regulation of steroid biosynthetic process
|
6
|
9.87e-01
|
-3.95e-03
|
9.99e-01
|
GO:1990756 ubiquitin-like ligase-substrate adaptor activity
|
84
|
9.51e-01
|
-3.85e-03
|
9.88e-01
|
GO:0032922 circadian regulation of gene expression
|
54
|
9.61e-01
|
-3.83e-03
|
9.90e-01
|
GO:0005078 MAP-kinase scaffold activity
|
9
|
9.84e-01
|
-3.81e-03
|
9.98e-01
|
GO:0032797 SMN complex
|
10
|
9.83e-01
|
3.79e-03
|
9.98e-01
|
GO:1904357 negative regulation of telomere maintenance via telomere lengthening
|
10
|
9.84e-01
|
-3.76e-03
|
9.98e-01
|
GO:0051781 positive regulation of cell division
|
25
|
9.75e-01
|
3.60e-03
|
9.96e-01
|
GO:0015804 neutral amino acid transport
|
13
|
9.82e-01
|
-3.59e-03
|
9.98e-01
|
GO:0034145 positive regulation of toll-like receptor 4 signaling pathway
|
10
|
9.84e-01
|
3.57e-03
|
9.98e-01
|
GO:0031124 mRNA 3’-end processing
|
24
|
9.76e-01
|
-3.54e-03
|
9.96e-01
|
GO:0015093 ferrous iron transmembrane transporter activity
|
6
|
9.88e-01
|
-3.50e-03
|
9.99e-01
|
GO:0070628 proteasome binding
|
17
|
9.80e-01
|
-3.45e-03
|
9.97e-01
|
GO:0071947 protein deubiquitination involved in ubiquitin-dependent protein catabolic process
|
6
|
9.88e-01
|
3.41e-03
|
9.99e-01
|
GO:0045727 positive regulation of translation
|
70
|
9.61e-01
|
3.37e-03
|
9.90e-01
|
GO:0070370 cellular heat acclimation
|
6
|
9.89e-01
|
-3.32e-03
|
9.99e-01
|
GO:0031957 very long-chain fatty acid-CoA ligase activity
|
6
|
9.89e-01
|
3.16e-03
|
9.99e-01
|
GO:0012501 programmed cell death
|
12
|
9.85e-01
|
3.14e-03
|
9.98e-01
|
GO:0032479 regulation of type I interferon production
|
8
|
9.88e-01
|
-3.02e-03
|
9.99e-01
|
GO:0004653 polypeptide N-acetylgalactosaminyltransferase activity
|
11
|
9.86e-01
|
-2.96e-03
|
9.99e-01
|
GO:0046965 nuclear retinoid X receptor binding
|
14
|
9.85e-01
|
2.92e-03
|
9.98e-01
|
GO:0043653 mitochondrial fragmentation involved in apoptotic process
|
6
|
9.90e-01
|
2.84e-03
|
1.00e+00
|
GO:2001237 negative regulation of extrinsic apoptotic signaling pathway
|
31
|
9.79e-01
|
2.79e-03
|
9.97e-01
|
GO:0008091 spectrin
|
6
|
9.91e-01
|
2.75e-03
|
1.00e+00
|
GO:0045665 negative regulation of neuron differentiation
|
29
|
9.80e-01
|
-2.73e-03
|
9.97e-01
|
GO:0005246 calcium channel regulator activity
|
19
|
9.84e-01
|
2.68e-03
|
9.98e-01
|
GO:0042267 natural killer cell mediated cytotoxicity
|
23
|
9.82e-01
|
2.65e-03
|
9.98e-01
|
GO:0006783 heme biosynthetic process
|
23
|
9.83e-01
|
-2.61e-03
|
9.98e-01
|
GO:0051959 dynein light intermediate chain binding
|
20
|
9.84e-01
|
-2.52e-03
|
9.98e-01
|
GO:0046716 muscle cell cellular homeostasis
|
18
|
9.85e-01
|
-2.49e-03
|
9.98e-01
|
GO:0030155 regulation of cell adhesion
|
34
|
9.80e-01
|
2.49e-03
|
9.97e-01
|
GO:0043153 entrainment of circadian clock by photoperiod
|
20
|
9.85e-01
|
2.47e-03
|
9.98e-01
|
GO:0003691 double-stranded telomeric DNA binding
|
9
|
9.90e-01
|
-2.43e-03
|
9.99e-01
|
GO:0032287 peripheral nervous system myelin maintenance
|
6
|
9.92e-01
|
2.43e-03
|
1.00e+00
|
GO:0070372 regulation of ERK1 and ERK2 cascade
|
24
|
9.84e-01
|
-2.40e-03
|
9.98e-01
|
GO:0016032 viral process
|
7
|
9.91e-01
|
-2.38e-03
|
1.00e+00
|
GO:0006997 nucleus organization
|
27
|
9.83e-01
|
2.37e-03
|
9.98e-01
|
GO:0016779 nucleotidyltransferase activity
|
29
|
9.83e-01
|
-2.32e-03
|
9.98e-01
|
GO:0006015 5-phosphoribose 1-diphosphate biosynthetic process
|
5
|
9.93e-01
|
-2.25e-03
|
1.00e+00
|
GO:1902236 negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway
|
16
|
9.88e-01
|
2.22e-03
|
9.99e-01
|
GO:0005739 mitochondrion
|
1430
|
8.92e-01
|
2.18e-03
|
9.77e-01
|
GO:0030513 positive regulation of BMP signaling pathway
|
19
|
9.87e-01
|
-2.11e-03
|
9.99e-01
|
GO:0160072 ubiquitin ligase complex scaffold activity
|
8
|
9.92e-01
|
2.08e-03
|
1.00e+00
|
GO:0034384 high-density lipoprotein particle clearance
|
5
|
9.94e-01
|
1.95e-03
|
1.00e+00
|
GO:0060065 uterus development
|
11
|
9.91e-01
|
-1.90e-03
|
1.00e+00
|
GO:0043025 neuronal cell body
|
213
|
9.62e-01
|
1.90e-03
|
9.90e-01
|
GO:0050998 nitric-oxide synthase binding
|
7
|
9.93e-01
|
-1.90e-03
|
1.00e+00
|
GO:0007041 lysosomal transport
|
19
|
9.89e-01
|
-1.86e-03
|
9.99e-01
|
GO:0034634 glutathione transmembrane transporter activity
|
5
|
9.94e-01
|
1.84e-03
|
1.00e+00
|
GO:0035872 nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway
|
6
|
9.94e-01
|
1.82e-03
|
1.00e+00
|
GO:0008320 protein transmembrane transporter activity
|
25
|
9.88e-01
|
-1.76e-03
|
9.99e-01
|
GO:0048666 neuron development
|
33
|
9.86e-01
|
-1.75e-03
|
9.98e-01
|
GO:0019789 SUMO transferase activity
|
21
|
9.89e-01
|
-1.73e-03
|
9.99e-01
|
GO:0042129 regulation of T cell proliferation
|
11
|
9.92e-01
|
1.73e-03
|
1.00e+00
|
GO:0097066 response to thyroid hormone
|
6
|
9.94e-01
|
1.64e-03
|
1.00e+00
|
GO:0071549 cellular response to dexamethasone stimulus
|
21
|
9.90e-01
|
-1.58e-03
|
9.99e-01
|
GO:0003676 nucleic acid binding
|
83
|
9.80e-01
|
1.58e-03
|
9.97e-01
|
GO:0051168 nuclear export
|
12
|
9.92e-01
|
1.57e-03
|
1.00e+00
|
GO:0043394 proteoglycan binding
|
9
|
9.94e-01
|
-1.52e-03
|
1.00e+00
|
GO:0002250 adaptive immune response
|
114
|
9.78e-01
|
-1.49e-03
|
9.97e-01
|
GO:0034237 protein kinase A regulatory subunit binding
|
20
|
9.91e-01
|
1.46e-03
|
1.00e+00
|
GO:0060218 hematopoietic stem cell differentiation
|
16
|
9.92e-01
|
-1.46e-03
|
1.00e+00
|
GO:0035493 SNARE complex assembly
|
9
|
9.94e-01
|
1.37e-03
|
1.00e+00
|
GO:0090316 positive regulation of intracellular protein transport
|
22
|
9.92e-01
|
-1.30e-03
|
1.00e+00
|
GO:0016805 dipeptidase activity
|
6
|
9.96e-01
|
1.27e-03
|
1.00e+00
|
GO:0017185 peptidyl-lysine hydroxylation
|
5
|
9.97e-01
|
1.13e-03
|
1.00e+00
|
GO:0006616 SRP-dependent cotranslational protein targeting to membrane, translocation
|
7
|
9.96e-01
|
1.06e-03
|
1.00e+00
|
GO:0043130 ubiquitin binding
|
98
|
9.86e-01
|
1.02e-03
|
9.98e-01
|
GO:0032940 secretion by cell
|
6
|
9.97e-01
|
9.99e-04
|
1.00e+00
|
GO:0004950 chemokine receptor activity
|
5
|
9.97e-01
|
9.95e-04
|
1.00e+00
|
GO:0003180 aortic valve morphogenesis
|
17
|
9.94e-01
|
9.75e-04
|
1.00e+00
|
GO:0035642 histone H3R17 methyltransferase activity
|
8
|
9.96e-01
|
-9.37e-04
|
1.00e+00
|
GO:0019722 calcium-mediated signaling
|
66
|
9.90e-01
|
9.20e-04
|
9.99e-01
|
GO:0042574 retinal metabolic process
|
10
|
9.96e-01
|
-8.59e-04
|
1.00e+00
|
GO:0001921 positive regulation of receptor recycling
|
11
|
9.96e-01
|
-8.49e-04
|
1.00e+00
|
GO:0000209 protein polyubiquitination
|
120
|
9.87e-01
|
-8.42e-04
|
9.99e-01
|
GO:2000049 positive regulation of cell-cell adhesion mediated by cadherin
|
6
|
9.98e-01
|
-7.27e-04
|
1.00e+00
|
GO:0034101 erythrocyte homeostasis
|
10
|
9.97e-01
|
-7.22e-04
|
1.00e+00
|
GO:0035116 embryonic hindlimb morphogenesis
|
10
|
9.97e-01
|
-7.22e-04
|
1.00e+00
|
GO:0004579 dolichyl-diphosphooligosaccharide-protein glycotransferase activity
|
5
|
9.98e-01
|
-7.22e-04
|
1.00e+00
|
GO:0006559 L-phenylalanine catabolic process
|
5
|
9.98e-01
|
-6.68e-04
|
1.00e+00
|
GO:0005732 sno(s)RNA-containing ribonucleoprotein complex
|
8
|
9.97e-01
|
6.47e-04
|
1.00e+00
|
GO:0036261 7-methylguanosine cap hypermethylation
|
8
|
9.98e-01
|
5.28e-04
|
1.00e+00
|
GO:0006120 mitochondrial electron transport, NADH to ubiquinone
|
45
|
9.95e-01
|
4.93e-04
|
1.00e+00
|
GO:0001952 regulation of cell-matrix adhesion
|
7
|
9.98e-01
|
-4.57e-04
|
1.00e+00
|
GO:0090399 replicative senescence
|
13
|
9.98e-01
|
-4.56e-04
|
1.00e+00
|
GO:0008236 serine-type peptidase activity
|
17
|
9.98e-01
|
-4.29e-04
|
1.00e+00
|
GO:0042147 retrograde transport, endosome to Golgi
|
73
|
9.95e-01
|
-3.97e-04
|
1.00e+00
|
GO:0060079 excitatory postsynaptic potential
|
28
|
9.97e-01
|
-3.61e-04
|
1.00e+00
|
GO:0046039 GTP metabolic process
|
14
|
9.98e-01
|
-3.60e-04
|
1.00e+00
|
GO:0014044 Schwann cell development
|
13
|
9.98e-01
|
3.09e-04
|
1.00e+00
|
GO:0001094 TFIID-class transcription factor complex binding
|
10
|
9.99e-01
|
-2.86e-04
|
1.00e+00
|
GO:0008104 protein localization
|
109
|
9.96e-01
|
-2.81e-04
|
1.00e+00
|
GO:0032091 negative regulation of protein binding
|
36
|
9.98e-01
|
-2.62e-04
|
1.00e+00
|
GO:0030667 secretory granule membrane
|
77
|
9.97e-01
|
2.12e-04
|
1.00e+00
|
GO:0070328 triglyceride homeostasis
|
14
|
9.99e-01
|
-1.75e-04
|
1.00e+00
|
GO:0046486 glycerolipid metabolic process
|
7
|
9.99e-01
|
-1.46e-04
|
1.00e+00
|
GO:0030127 COPII vesicle coat
|
16
|
9.99e-01
|
1.45e-04
|
1.00e+00
|
GO:0032469 endoplasmic reticulum calcium ion homeostasis
|
18
|
9.99e-01
|
-9.85e-05
|
1.00e+00
|
GO:0005964 phosphorylase kinase complex
|
5
|
1.00e+00
|
6.81e-05
|
1.00e+00
|
GO:0035612 AP-2 adaptor complex binding
|
10
|
1.00e+00
|
2.73e-05
|
1.00e+00
|
GO:1990253 cellular response to leucine starvation
|
11
|
1.00e+00
|
-1.86e-05
|
1.00e+00
|
GO:0002726 positive regulation of T cell cytokine production
|
11
|
1.00e+00
|
-6.20e-06
|
1.00e+00
|